data_2jz6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jz6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mptt . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.631 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 23.5 ptt-85 -135.76 -174.08 3.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.44 119.69 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.732 0.301 . . . . 0.0 110.379 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.09 -5.52 46.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.145 0.498 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.22 -51.2 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.6 m -114.13 -12.6 12.51 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 -16.57 60.34 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.733 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -74.99 153.57 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.52 0.66 . . . . 0.0 111.267 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.19 153.78 69.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.181 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.851 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 94.3 Cg_endo -80.13 91.28 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.722 2.281 . . . . 0.0 111.464 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.036 -173.788 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.866 0.278 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 67.63 8.99 6.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.93 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.851 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 12.7 mt -116.95 122.76 45.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.255 0.55 . . . . 0.0 111.964 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.49 116.85 32.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.079 173.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 53' ' ' MET . 80.2 mttt -74.49 116.17 14.87 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 168.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.55 136.78 44.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.296 0.569 . . . . 0.0 109.526 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 42' ' ' ARG . 26.5 ttm180 -80.7 106.46 12.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.546 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 53' ' ' MET . 28.9 m -111.04 170.04 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.369 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.88 131.34 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 85.6 mt -90.52 144.18 30.3 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.058 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 25.3 Cg_exo -64.11 -14.58 44.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.947 2.431 . . . . 0.0 112.507 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.85 -4.0 57.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.636 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.77 55.05 2.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.82 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 m -149.14 159.02 44.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.94 127.12 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.87 141.85 44.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.428 . . . . 0.0 111.694 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -91.26 120.44 32.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 49.8 mtm -125.3 149.41 48.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.875 0.369 . . . . 0.0 111.015 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -80.11 107.95 13.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.17 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.36 134.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.6 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 17' ' ' PRO . 44.2 t -74.9 149.56 39.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.269 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.7 m -56.04 -30.99 62.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.344 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -59.11 -49.22 78.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.189 0.519 . . . . 0.0 110.151 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.4 m -69.11 -37.01 78.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.378 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.26 -41.29 99.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.143 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.55 -39.72 64.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -68.9 -32.94 72.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.7 62.05 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.727 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.29 19.14 7.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.052 0.453 . . . . 0.0 111.486 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -102.7 162.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.92 106.75 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -121.55 152.03 39.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.681 -167.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.026 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 122.057 0.932 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' A' ' 14' ' ' GLY . 21.3 ptt180 -97.74 -177.87 3.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.203 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.3 t -67.37 120.79 14.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 167.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 53' ' ' MET . 41.6 mt-10 -71.71 -10.84 60.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.061 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 65' ' ' VAL . 58.5 t -81.9 -71.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -97.41 -46.72 5.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 0.0 111.022 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 9' ' ' ARG . . . 120.27 21.3 3.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.059 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.73 177.57 8.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.877 0.339 . . . . 0.0 111.396 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.62 91.35 12.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.692 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 36.2 Cg_endo -63.37 146.94 93.82 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.644 2.229 . . . . 0.0 112.093 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.78 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--O 1.233 0.23 0 N-CA-C 112.714 0.236 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 63.04 13.87 7.11 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.718 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 54' ' ' ARG . 14.1 mt -117.44 152.12 35.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.12 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.436 ' HB2' HD12 ' A' ' 60' ' ' LEU . 31.5 mm-40 -118.66 97.89 5.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 53' ' ' MET . 61.1 pttt -81.45 112.68 18.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.228 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.88 168.37 21.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.836 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -78.66 135.51 37.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.5 HG22 ' HE2' ' A' ' 53' ' ' MET . 29.1 m -125.88 143.91 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.92 136.19 45.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.396 0.617 . . . . 0.0 110.873 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' A' ' 49' ' ' THR . 96.0 mt -98.53 143.01 25.54 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.486 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.61 -15.75 48.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.856 2.37 . . . . 0.0 112.321 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.63 -16.21 60.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.441 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 52.24 0.88 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.143 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.478 ' HB ' HD11 ' A' ' 45' ' ' LEU . 1.8 m -145.95 154.51 42.0 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.575 -0.368 . . . . 0.0 110.561 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.36 117.29 44.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -120.89 142.64 49.49 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -101.72 119.11 38.27 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.546 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 62.8 mtm -133.99 155.5 49.86 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.099 0.476 . . . . 0.0 111.834 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.636 ' HB3' HD21 ' A' ' 38' ' ' LEU . 69.3 mtm180 -76.12 116.41 16.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.86 148.47 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.823 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 10.9 p -91.22 155.94 18.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.602 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -61.36 -26.71 68.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.095 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 p -64.51 -41.3 96.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.72 0.295 . . . . 0.0 110.836 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.22 -34.45 61.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.52 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 57' ' ' THR . 92.4 mt -59.34 -51.82 68.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.269 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -72.5 -33.98 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.8 p -74.37 -24.71 59.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.072 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.33 44.01 23.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.276 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -95.26 11.9 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.448 0.642 . . . . 0.0 109.932 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 HG13 ' A' ' 12' ' ' VAL . 28.5 m -120.94 138.46 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.898 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.657 ' HZ2' ' HB2' ' A' ' 66' ' ' LYS . 4.0 ttmp? -86.08 98.89 11.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -94.4 30.8 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.952 -166.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.212 177.156 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 85.0 tttt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -74.47 178.41 5.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.432 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.771 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 41.5 t -55.02 128.68 34.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.071 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' HG2' ' HE2' ' A' ' 8' ' ' LYS . 38.7 mt-10 -76.57 5.14 7.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.639 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.28 -58.38 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.1 -23.09 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.93 4.4 36.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.474 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mttp -74.15 176.75 6.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.74 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.05 144.52 29.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.217 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 89.4 Cg_endo -82.28 150.87 15.53 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.4 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.448 . . . . 0.0 109.986 177.304 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo . . . . . 0 N--CA 1.464 -0.232 0 CA-C-O 121.158 0.399 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 18.8 m120 -84.52 -171.13 3.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.276 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 28.6 mt 68.46 106.8 0.05 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.652 0.739 . . . . 0.0 110.162 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.43 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -77.66 93.43 4.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.783 -173.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 53' ' ' MET . 17.3 pttp -78.01 109.85 12.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.641 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.47 160.71 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.527 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -95.12 126.84 40.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.704 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 67' ' ' LYS . 34.3 m -123.42 156.04 29.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.014 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 68' ' ' TYR . 7.2 p -109.11 122.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.636 0.731 . . . . 0.0 110.44 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.9 mt -79.37 143.43 59.99 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.374 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.8 -21.48 69.41 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.98 2.453 . . . . 0.0 112.795 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.72 -23.89 56.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.111 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.404 ' C ' ' HG1' ' A' ' 49' ' ' THR . . . 116.27 67.09 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.695 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.487 ' HB ' HD12 ' A' ' 45' ' ' LEU . 3.4 m -153.38 154.6 34.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.578 -0.366 . . . . 0.0 110.13 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.58 113.28 22.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -134.84 148.23 50.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.765 0.317 . . . . 0.0 111.229 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -99.21 119.77 38.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.7 mtm -132.58 157.6 44.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.027 0.442 . . . . 0.0 110.851 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.674 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 49.9 mtm180 -87.68 103.92 16.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.464 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.771 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 17.7 t -98.98 154.34 4.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.825 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 15' ' ' LYS . 28.4 p -90.02 149.79 22.38 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.173 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -57.5 -29.45 64.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.111 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -62.68 -47.73 82.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.797 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.0 m -64.94 -34.29 78.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.293 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.18 -50.53 72.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -66.06 -30.31 70.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.13 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -31.75 54.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.73 31.18 56.68 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.571 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -79.02 -25.45 43.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.964 0.411 . . . . 0.0 110.91 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 28.0 m -77.04 143.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.61 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.06 -3.65 55.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HA ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 45.47 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.226 . . . . 0.0 114.206 174.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.8 t80 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.734 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 tttm . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.586 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 10.0 ptp180 -152.83 169.71 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.817 -172.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.25 127.84 34.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 38.3 mt-10 -73.99 -15.02 61.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.758 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.02 -57.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.463 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -102.0 -36.14 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 103.39 8.34 41.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.572 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -87.36 150.23 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.83 144.49 85.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 71.5 Cg_endo -94.97 141.73 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.382 2.721 . . . . 0.0 113.312 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 173.788 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.531 0.357 0 N-CA-C 113.704 0.617 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 m120 71.48 -8.1 1.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.56 172.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.8 mt -117.55 123.62 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.296 0.569 . . . . 0.0 111.758 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.44 107.69 18.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.561 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.648 ' HZ1' ' HA ' ' A' ' 53' ' ' MET . 19.1 ttmm -76.57 108.51 9.61 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.67 168.91 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.945 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -81.02 117.33 21.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.785 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . 33.6 m -117.29 163.5 14.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.81 134.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.497 . . . . 0.0 110.245 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 49' ' ' THR . 90.0 mt -93.14 153.3 41.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.805 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.74 -27.58 43.41 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.34 2.694 . . . . 0.0 113.355 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.88 -1.44 52.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 111.63 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.93 2.19 59.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.3 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.54 ' HB ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -77.56 152.5 33.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.786 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.11 126.75 70.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -141.83 157.22 45.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.38 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 99.4 mtt180 -98.36 129.88 45.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.648 ' HA ' ' HZ1' ' A' ' 40' ' ' LYS . 55.2 mtm -138.33 150.91 47.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.201 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 79.3 mtm180 -76.88 119.59 20.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 65' ' ' VAL . 37.6 t -120.77 148.18 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 17' ' ' PRO . 20.2 p -87.13 149.75 24.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.419 ' HA ' HD13 ' A' ' 60' ' ' LEU . 5.5 m -56.75 -30.26 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.499 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.76 -40.25 91.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.238 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.7 m -79.53 -35.53 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 57' ' ' THR . 95.2 mt -60.01 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -78.92 -5.54 53.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.316 0.579 . . . . 0.0 110.644 -176.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -94.34 -27.4 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 109.74 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.79 56.12 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -89.25 30.59 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.75 0.31 . . . . 0.0 110.983 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 55' ' ' VAL . 20.1 m -122.12 129.43 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.674 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -80.49 98.28 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.0 pttt -110.77 177.54 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.727 -167.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.0 t80 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.87 172.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.284 0.564 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -124.44 -176.2 3.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.246 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.1 t -64.89 123.68 20.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.13 -4.28 34.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 0.0 111.301 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.7 t -92.58 -65.88 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 111.12 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.02 -13.95 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.734 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.57 86.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.546 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.15 158.57 34.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.55 148.05 87.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.7 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.1 Cg_endo -74.12 113.77 3.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.482 2.121 . . . . 0.0 112.062 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.658 -178.088 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.475 0.403 0 N-CA-C 113.751 0.635 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -111.9 -9.19 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.55 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 mt -121.14 118.67 30.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.083 0.468 . . . . 0.0 111.212 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -88.37 107.65 18.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.249 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -81.71 110.21 16.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.684 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.696 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 24.7 m -122.83 157.92 27.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.674 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 50' ' ' ILE . 68.5 mtp180 -92.73 123.28 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.104 0.478 . . . . 0.0 110.44 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 32.9 m -115.86 164.75 11.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.07 128.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.67 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -95.17 150.54 37.8 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.782 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.46 -11.28 27.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.772 2.315 . . . . 0.0 112.254 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.11 -13.67 56.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.713 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.37 3.66 58.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.576 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.83 154.45 17.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.523 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 42' ' ' ARG . 55.4 mt -115.21 110.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.142 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.95 151.23 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.089 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 52' ' ' ARG . 65.2 mtt180 -84.16 137.76 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.411 ' SD ' HG23 ' A' ' 43' ' ' VAL . 86.7 mtp -133.04 154.64 50.35 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -85.73 103.88 14.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.86 146.15 18.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.961 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 28.0 p -96.24 157.52 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.76 0.314 . . . . 0.0 110.82 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.456 ' HA ' HD13 ' A' ' 60' ' ' LEU . 1.2 p -61.13 -25.04 66.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.737 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.409 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 32.1 t -58.65 -52.38 65.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.3 m -64.3 -34.28 77.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.444 . . . . 0.0 111.006 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 57' ' ' THR . 81.4 mt -63.71 -50.51 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.22 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -81.13 -19.21 44.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 m -81.86 -12.16 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.992 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.77 54.91 25.56 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.372 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -135.89 76.02 1.58 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 0.0 109.449 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.77 172.86 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.51 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 12.1 ptmm? -122.37 45.75 2.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.613 0.721 . . . . 0.0 110.258 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.696 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 2.8 mmmp? -80.9 -177.91 6.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.162 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 . . . . . 0 C--N 1.325 -0.5 0 CA-C-O 121.086 0.47 . . . . 0.0 111.084 177.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.323 0.582 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.605 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.9 ptm180 -150.04 166.4 29.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.759 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.44 124.75 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.128 0.267 . . . . 0.0 110.354 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.22 -7.87 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.464 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -85.79 -67.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 111.114 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.2 m -94.16 -22.89 18.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.256 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.32 -2.7 61.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.329 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.66 166.12 23.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.74 0.305 . . . . 0.0 111.74 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.63 144.12 72.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.906 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 95.9 Cg_endo -85.64 151.82 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.791 2.327 . . . . 0.0 113.644 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.966 173.079 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 N-CA-C 112.944 0.325 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.91 3.48 17.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 109.826 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 54' ' ' ARG . 23.0 mt -126.3 129.73 49.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.239 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -82.82 89.19 6.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.327 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.53 114.22 4.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.103 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.55 153.86 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -93.32 124.84 37.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.941 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.52 HG21 ' HE2' ' A' ' 53' ' ' MET . 32.3 m -115.86 155.46 17.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.02 117.56 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.274 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.511 HD13 ' HB ' ' A' ' 49' ' ' THR . 85.2 mt -82.07 152.87 69.0 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.938 175.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.75 -29.96 64.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.851 2.367 . . . . 0.0 112.917 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.15 -27.97 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.177 0.513 . . . . 0.0 110.65 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.86 7.05 25.91 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' HD13 ' A' ' 45' ' ' LEU . 1.3 m -83.1 151.03 25.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.051 0.453 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.5 mt -105.51 108.34 24.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -112.8 134.42 54.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.977 0.418 . . . . 0.0 111.199 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -91.0 120.5 32.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.52 ' HE2' HG21 ' A' ' 43' ' ' VAL . 43.3 mtm -127.62 157.01 41.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.566 0.698 . . . . 0.0 111.513 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.622 ' HB3' HD11 ' A' ' 38' ' ' LEU . 77.1 mtm180 -87.58 101.02 13.23 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.439 174.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 65' ' ' VAL . 21.2 t -115.12 145.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.56 -175.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.4 p -90.32 153.51 20.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.178 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.489 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -56.99 -26.38 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.595 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 t -64.09 -48.52 75.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.2 m -67.44 -33.26 74.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 57' ' ' THR . 76.1 mt -62.04 -53.38 56.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -77.75 -54.59 6.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.289 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -107.01 2.7 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.33 23.09 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.257 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 78.36 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.344 0.592 . . . . 0.0 111.056 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 55' ' ' VAL . 17.5 m -105.72 125.06 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 0.0 110.679 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -77.23 82.14 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -69.47 128.12 35.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.93 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.614 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 17' ' ' PRO . 22.4 pttp . . . . . 0 C--O 1.227 -0.084 0 CA-C-O 121.524 0.678 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.536 ' C ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -103.29 176.5 5.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.012 177.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 40.6 t -60.1 124.35 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HB2' ' HE1' ' A' ' 53' ' ' MET . 8.5 mm-40 -60.09 -22.1 62.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.117 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 65' ' ' VAL . 40.3 t -98.75 -70.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.517 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -78.68 -19.02 53.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.841 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.79 2.37 81.16 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.337 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -80.19 164.63 23.13 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.788 0.328 . . . . 0.0 110.75 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.79 147.94 89.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.486 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.774 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 90.6 Cg_endo -79.04 122.32 5.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.765 2.31 . . . . 0.0 111.827 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 . . . . . 0 C--N 1.321 -0.647 0 CA-C-O 121.278 0.561 . . . . 0.0 110.575 -178.839 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo . . . . . 0 C--O 1.235 0.362 0 CA-C-O 121.066 0.361 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 17' ' ' PRO . 43.4 m-80 -136.37 166.1 24.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.487 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 18.8 mt 71.87 112.95 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.967 0.792 . . . . 0.0 111.032 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -104.48 113.75 27.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.668 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 53' ' ' MET . 21.7 pttp -77.24 110.38 11.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.98 168.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.424 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -96.1 115.61 27.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.874 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.2 155.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.759 0.314 . . . . 0.0 110.178 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.5 126.85 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.256 0.551 . . . . 0.0 109.924 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD13 ' HB ' ' A' ' 49' ' ' THR . 89.1 mt -79.69 144.89 61.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.929 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -21.3 60.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.54 2.16 . . . . 0.0 111.936 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.04 -17.23 62.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.522 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.59 3.93 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.108 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.456 ' HB ' HD13 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -123.03 153.34 39.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.684 0.278 . . . . 0.0 110.787 -176.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.51 119.8 52.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -136.27 137.26 40.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -90.69 124.33 35.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.416 ' HE1' ' HB2' ' A' ' 11' ' ' GLU . 88.1 mtp -134.62 160.78 37.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.001 0.429 . . . . 0.0 111.345 -175.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' HB3' HD23 ' A' ' 38' ' ' LEU . 50.3 mtt85 -81.83 102.1 10.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.339 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.8 138.16 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 83.3 m -80.04 153.74 28.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.595 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 60' ' ' LEU . 3.4 m -61.15 -26.35 67.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.454 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -62.78 -42.77 99.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.325 0.583 . . . . 0.0 110.148 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -70.86 -33.78 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.121 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 57' ' ' THR . 96.4 mt -63.86 -36.03 82.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.2 -63.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.618 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -92.93 -24.62 18.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.869 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.02 -101.79 1.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.826 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' CA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 56.3 17.8 3.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.587 . . . . 0.0 111.067 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 12' ' ' VAL . 27.4 m -141.33 -179.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -79.39 -44.35 21.64 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 70.43 143.69 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 111.176 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 111.02 -177.288 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -86.33 -179.05 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.812 174.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.96 114.58 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -62.74 -14.63 46.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 65' ' ' VAL . 45.8 t -80.39 -63.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.611 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 82.5 m -120.77 6.55 10.45 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -172.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.538 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 71.79 25.3 75.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.934 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.591 ' HG3' ' SG ' ' A' ' 59' ' ' CYS . 29.3 mmmt -74.9 160.91 30.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.74 144.04 28.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.02 136.95 3.08 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.904 2.403 . . . . 0.0 113.19 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.563 174.171 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 CA-C-O 121.142 0.392 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.1 -5.9 32.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 54' ' ' ARG . 37.6 mt -116.3 135.91 53.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.671 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.406 ' CB ' HD13 ' A' ' 60' ' ' LEU . 7.9 mm-40 -86.64 109.79 19.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.528 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.66 109.12 15.79 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.59 165.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 3.4 mpt_? -105.06 124.51 49.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.74 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 51' ' ' LYS . 25.0 m -108.0 152.64 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.893 0.378 . . . . 0.0 110.268 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.76 111.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.52 HD13 ' HB ' ' A' ' 49' ' ' THR . 93.3 mt -71.3 145.11 90.34 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.786 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.72 -15.2 30.44 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -85.08 1.78 46.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.116 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.17 34.42 29.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.345 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.52 ' HB ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -120.6 148.98 43.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.55 118.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' O ' HG21 ' A' ' 43' ' ' VAL . 59.3 tttm -124.12 124.91 43.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 0.0 110.004 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 3.1 ppt_? -97.63 136.0 38.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.112 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 70.6 mtm -142.61 169.19 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.546 ' HB3' HD12 ' A' ' 38' ' ' LEU . 36.2 mtm180 -91.13 109.39 20.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.714 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.8 t -122.85 152.13 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.3 p -91.39 147.54 22.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.514 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 m -57.43 -28.13 63.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.827 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 p -61.74 -42.34 98.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.66 0.267 . . . . 0.0 111.095 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.591 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 57.3 m -70.56 -34.77 72.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.2 0.524 . . . . 0.0 110.543 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 57' ' ' THR . 53.9 mt -58.34 -51.85 68.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.977 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -79.61 -22.88 43.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.386 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 m -74.9 -28.21 60.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.17 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.43 29.56 63.77 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.248 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -79.17 -17.4 55.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 110.085 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.594 HG13 HG12 ' A' ' 12' ' ' VAL . 32.6 m -97.54 162.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.844 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -81.45 73.65 8.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.406 0.622 . . . . 0.0 110.538 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -84.6 139.78 31.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.727 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.188 0.518 . . . . 0.0 110.077 177.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.56 0.695 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -112.44 176.7 4.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.841 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.787 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 42.4 t -78.98 125.87 29.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.84 -15.29 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG12 HG13 ' A' ' 65' ' ' VAL . 56.5 t -92.35 -64.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.773 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.723 ' HG ' ' HD2' ' A' ' 64' ' ' LYS . 62.3 m -93.0 -20.55 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -172.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.85 -1.45 85.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.1 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -68.18 162.19 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.62 0.248 . . . . 0.0 110.915 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -83.88 143.18 42.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.319 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.3 Cg_endo -90.72 96.48 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.825 2.35 . . . . 0.0 113.011 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.24 176.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 73.2 Cg_exo . . . . . 0 N--CA 1.464 -0.264 0 CA-C-O 120.602 0.168 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 17.6 m120 74.4 -0.69 3.28 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.345 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.3 mt -120.79 119.7 33.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.421 0.629 . . . . 0.0 112.022 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -92.68 118.87 31.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.807 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -86.14 118.25 25.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.065 0.459 . . . . 0.0 110.289 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.5 m -127.62 153.28 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.599 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 93.3 mtt180 -90.04 124.38 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.559 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 51' ' ' LYS . 29.1 m -109.08 155.84 9.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.24 134.35 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 49' ' ' THR . 96.8 mt -98.38 147.37 33.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.999 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.11 -13.85 38.01 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.62 1.78 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.787 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.14 63.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.452 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.506 ' HB ' HD13 ' A' ' 45' ' ' LEU . 2.1 m -97.42 152.04 19.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.029 0.442 . . . . 0.0 110.834 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.51 130.11 70.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.178 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' O ' HG21 ' A' ' 43' ' ' VAL . 63.0 tttp -136.46 129.77 31.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 3.1 ptt180 -91.41 130.41 37.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.1 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.4 mtp -129.41 157.57 41.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -82.43 107.52 15.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.571 0.7 . . . . 0.0 110.484 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.787 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 48.4 t -116.11 137.79 48.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.512 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.41 153.69 26.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.44 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -59.55 -30.63 68.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.551 -177.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -61.9 -42.35 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.7 -35.34 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 57' ' ' THR . 78.9 mt -63.43 -48.64 76.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.375 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -67.22 -37.08 82.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 m -78.83 -31.89 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.229 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 49.34 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.056 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.723 ' HD2' ' HG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -90.62 -22.72 21.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.65 HG13 HG12 ' A' ' 12' ' ' VAL . 35.4 m -69.21 148.01 11.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.972 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.69 -51.6 66.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.474 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' HB2' HG21 ' A' ' 65' ' ' VAL . 75.9 tttt 66.88 152.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.913 0.758 . . . . 0.0 112.463 169.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.1 t80 . . . . . 0 C--N 1.322 -0.597 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.848 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.403 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 7.3 ppt_? -121.43 171.02 9.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.32 140.98 56.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 40.7 mt-10 -74.38 -8.18 55.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.046 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t -111.22 -72.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.385 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.8 t -67.23 -34.94 78.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.998 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 98.8 -15.8 60.36 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.277 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.77 152.3 25.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.682 0.277 . . . . 0.0 110.69 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.59 144.31 27.62 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.89 145.96 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.104 2.536 . . . . 0.0 112.418 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.221 179.051 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--O 1.234 0.292 0 N-CA-C 111.495 -0.233 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 -40.62 0.48 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.572 0.749 . . . . 0.0 111.583 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.6 mt -70.78 132.89 46.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.796 0.331 . . . . 0.0 110.618 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.444 ' HB2' HD13 ' A' ' 60' ' ' LEU . 20.1 mt-30 -103.92 131.54 51.04 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' MET . 11.8 ptmt -92.05 109.95 21.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.6 m -116.46 156.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.536 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -88.43 128.16 35.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.587 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.56 153.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 67' ' ' LYS . 88.2 t -83.2 126.45 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.746 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD13 ' HE3' ' A' ' 51' ' ' LYS . 87.0 mt -97.67 143.78 26.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.46 -8.86 20.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.932 2.422 . . . . 0.0 111.604 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -78.49 -3.75 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.499 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.48 37.45 27.36 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.341 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -140.19 155.73 46.81 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.51 121.82 62.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HE3' HD13 ' A' ' 45' ' ' LEU . 41.1 ttmt -123.38 138.15 54.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.131 0.491 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -92.38 106.87 18.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.687 174.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 87.0 mtp -101.59 158.36 16.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.838 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 86.4 mtm180 -83.74 100.82 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.75 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.51 146.69 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.593 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.4 p -92.64 159.23 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 t -58.3 -26.7 63.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t -61.84 -51.14 69.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 110.403 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 75.4 m -65.21 -38.0 89.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.569 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 39' ' ' GLN . 91.5 mt -65.28 -43.33 91.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.624 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -64.48 -45.61 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.823 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 t -72.68 -32.01 65.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.822 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.31 29.44 66.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.883 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -97.54 49.56 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.663 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 176.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.185 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -79.07 -57.7 3.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.652 0.263 . . . . 0.0 110.808 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.41 ' O ' HG21 ' A' ' 44' ' ' VAL . 42.1 mttt 64.99 172.29 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.654 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.806 173.841 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.418 0.627 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -102.7 171.9 7.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.789 -175.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.712 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 50.2 t -69.83 131.2 44.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 169.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.544 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 45.1 mt-10 -68.37 -15.16 63.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.857 0.361 . . . . 0.0 111.065 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.23 -70.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.52 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.6 m -82.49 -32.91 28.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.911 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 95.71 10.7 56.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.101 -174.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -74.78 162.4 28.72 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.452 0.301 . . . . 0.0 110.973 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.66 151.07 49.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.887 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 86.5 Cg_endo -82.76 115.44 2.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.751 2.301 . . . . 0.0 113.119 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.881 175.81 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 38' ' ' LEU . 60.2 Cg_endo . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.729 0.22 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.93 -7.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.481 0.712 . . . . 0.0 111.76 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.887 ' HG ' ' HB3' ' A' ' 17' ' ' PRO . 7.4 mt -95.52 107.02 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.094 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' A' ' 39' ' ' GLN . 5.8 mt-30 -84.44 106.7 16.23 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.769 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.0 ptmt -75.69 111.59 11.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 28.1 m -110.77 164.94 6.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.567 -173.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -89.29 106.56 18.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.662 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 28.0 m -118.66 170.81 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.72 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 68' ' ' TYR . 7.3 p -102.59 132.55 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.404 0.621 . . . . 0.0 110.879 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 49' ' ' THR . 83.3 mt -90.94 144.39 30.03 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.088 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.53 -22.13 73.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.716 2.277 . . . . 0.0 111.308 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.1 -15.79 63.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.931 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 40.23 5.3 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.487 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.42 ' HB ' HD11 ' A' ' 45' ' ' LEU . 2.5 m -138.28 158.2 44.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 126.49 55.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -134.81 144.42 47.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.903 0.382 . . . . 0.0 110.909 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.2 mtt180 -97.92 113.95 25.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.8 mtp -121.68 142.26 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.506 -174.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 42.2 mtm105 -65.96 113.2 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.108 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.712 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 46.3 t -124.61 130.92 73.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.615 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 p -78.1 150.52 33.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 27.4 m -57.89 -30.21 65.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.138 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -60.56 -38.68 85.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.597 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.1 m -79.32 -34.97 41.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.62 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 57' ' ' THR . 85.3 mt -62.8 -38.36 90.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.706 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -58.24 -58.75 7.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.709 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 m -68.9 -31.25 70.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.04 38.88 84.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.64 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 15.44 12.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.203 0.525 . . . . 0.0 111.078 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.6 m -98.66 168.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.599 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mttt -78.72 81.79 5.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.324 0.583 . . . . 0.0 110.572 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.69 143.85 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.429 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 60.7 t80 . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.98 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 38' ' ' LEU . 22.7 pttm . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.57 0.7 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 165.58 12.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.853 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' C ' ' H ' ' A' ' 12' ' ' VAL . 50.6 t -82.02 114.53 20.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.87 28.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.487 0.661 . . . . 0.0 110.971 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 10' ' ' CYS . 63.9 t -128.22 -62.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.549 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.76 -29.42 7.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.181 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.06 5.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.368 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -102.15 174.62 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.18 89.55 39.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' A' ' 38' ' ' LEU . 43.4 Cg_endo -67.03 119.66 6.7 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.166 2.577 . . . . 0.0 113.125 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.6 mtt-85 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 C--O 1.233 0.26 0 N-CA-C 109.927 -0.836 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 7.9 p30 -71.25 -165.85 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.95 173.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 54' ' ' ARG . 29.1 mt 66.47 114.7 0.03 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.584 0.707 . . . . 0.0 110.423 -174.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.428 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -75.14 94.5 2.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.867 177.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -92.48 107.72 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.553 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.68 169.07 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.859 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -83.13 131.11 35.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.523 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.518 HG21 ' HE2' ' A' ' 53' ' ' MET . 31.3 m -123.74 166.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.078 177.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.724 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 34.6 t -101.77 135.87 36.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.941 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.745 HD11 ' HD3' ' A' ' 51' ' ' LYS . 71.8 mt -90.67 152.53 45.04 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.408 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.16 -25.51 64.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.316 2.011 . . . . 0.0 111.753 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.9 -28.98 69.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.83 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.41 -7.3 34.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 45' ' ' LEU . 2.4 m -77.18 156.48 31.53 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.876 0.37 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.53 113.55 38.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.225 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HD3' HD11 ' A' ' 45' ' ' LEU . 18.0 tptp -102.47 152.86 20.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -113.61 114.14 26.04 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.518 ' HE2' HG21 ' A' ' 43' ' ' VAL . 55.0 mtm -131.52 163.6 27.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.373 0.606 . . . . 0.0 112.162 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.63 ' HB3' HD21 ' A' ' 38' ' ' LEU . 36.7 mtm180 -93.04 108.64 20.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.44 153.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.896 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.11 152.83 19.03 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.763 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -58.89 -28.67 66.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -60.34 -50.23 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.5 m -65.62 -34.31 77.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.082 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 60' ' ' LEU . 10.8 mt -68.08 -44.96 75.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.26 -40.5 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.792 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -75.7 -19.52 59.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.22 45.51 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.779 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -95.52 4.46 53.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.173 0.511 . . . . 0.0 110.445 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.96 150.85 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.095 0.474 . . . . 0.0 111.621 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.724 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 57.7 tptt -75.22 97.12 3.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -111.63 147.29 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.166 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.2 p90 . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.706 176.758 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 mttt . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -90.92 170.95 9.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.5 t -59.6 115.7 3.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.3 -1.83 16.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.562 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.8 t -90.96 -64.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 110.62 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -94.47 -54.42 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.152 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.27 6.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.346 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.11 169.73 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.711 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.74 143.68 27.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.777 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.54 77.09 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.768 2.312 . . . . 0.0 112.337 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.274 0.559 . . . . 0.0 110.143 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 39.2 Cg_exo . . . . . 0 C--O 1.236 0.41 0 N-CA-C 111.347 -0.29 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 54.1 m-80 71.33 -160.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.015 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 42.7 mt 71.86 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.676 0.751 . . . . 0.0 111.125 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -98.52 96.94 8.32 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 20.8 pttp -74.47 110.06 8.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.81 164.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.294 0.569 . . . . 0.0 111.594 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -99.59 109.83 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.488 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -109.08 161.77 7.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.58 129.38 60.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 0.0 110.63 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.57 HD12 ' HB ' ' A' ' 49' ' ' THR . 74.8 mt -88.66 151.49 47.92 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.88 -32.66 86.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.508 2.805 . . . . 0.0 113.751 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.32 -2.85 54.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.119 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.5 42.35 3.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.281 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.57 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.5 149.88 35.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.73 120.74 58.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 2.0 tpmt? -132.78 138.76 47.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 0.0 111.636 -174.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -91.87 122.7 34.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 79.3 mtp -128.68 150.51 50.22 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.843 0.354 . . . . 0.0 110.812 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -91.14 101.63 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.415 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG13 HG11 ' A' ' 65' ' ' VAL . 27.2 t -112.36 152.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.582 -173.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.3 p -92.06 154.6 18.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -61.52 -21.98 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.092 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -62.5 -51.7 66.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.407 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.8 m -64.81 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.571 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.99 -42.12 97.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.55 -48.73 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.12 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.4 m -64.89 -22.61 67.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.02 48.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.703 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -92.16 3.81 54.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.333 0.587 . . . . 0.0 110.556 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG11 HG13 ' A' ' 55' ' ' VAL . 31.4 m -109.31 139.48 32.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.995 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.6 88.77 4.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.952 0.882 . . . . 0.0 109.156 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -76.22 148.38 37.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.191 -170.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.4 t80 . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 110.453 179.374 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.237 0.541 . . . . 0.0 111.35 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.595 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 9.6 ptm85 -154.14 162.0 41.49 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.742 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.85 123.51 19.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.22 -1.55 23.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.071 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.631 HG22 HG11 ' A' ' 65' ' ' VAL . 51.7 t -98.4 -70.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.032 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.2 m -91.56 -15.81 28.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.75 27.99 52.33 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.131 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -100.57 144.65 29.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 144.54 86.79 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.595 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 84.1 Cg_endo -82.29 64.64 8.31 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.693 2.262 . . . . 0.0 111.798 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.121 177.356 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 120.747 0.228 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 m120 75.5 -12.04 1.03 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.872 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 11.9 mt -106.85 101.29 10.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.526 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -83.48 108.26 16.5 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 -177.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 53' ' ' MET . 51.7 mtmt -71.4 110.78 6.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.531 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.64 146.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.905 0.383 . . . . 0.0 110.35 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -83.53 120.16 25.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.241 0.543 . . . . 0.0 110.038 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.14 145.17 22.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.908 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 67' ' ' LYS . 14.2 p -89.02 113.37 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.678 0.751 . . . . 0.0 110.323 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 49' ' ' THR . 94.6 mt -74.83 147.81 84.39 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.269 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.6 -15.27 45.0 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.263 . . . . 0.0 111.668 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.85 -21.79 60.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.727 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.47 0.82 46.92 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.807 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.552 ' HB ' HD13 ' A' ' 45' ' ' LEU . 1.7 m -91.14 155.89 18.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.844 0.354 . . . . 0.0 110.438 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.91 127.14 62.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.258 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -132.35 136.62 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.878 0.371 . . . . 0.0 110.841 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -89.29 117.5 28.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.2 mtp -110.65 143.21 41.44 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.092 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 38' ' ' LEU . 54.4 mtt85 -79.52 100.18 7.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.767 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.16 138.6 40.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.001 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 23.1 p -88.94 163.85 15.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.922 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.1 p -59.0 -30.2 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.11 -177.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -59.84 -51.97 67.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.967 0.413 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.62 -33.8 69.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.8 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 57' ' ' THR . 79.7 mt -54.99 -43.42 73.56 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.46 -26.93 55.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.537 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.6 m -74.9 -31.56 61.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.897 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.22 77.3 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.593 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.16 -3.0 58.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.309 0.575 . . . . 0.0 110.484 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.64 HG22 ' HG3' ' A' ' 67' ' ' LYS . 31.3 m -85.91 156.36 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.394 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -66.32 -37.85 86.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.514 -176.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.64 ' HG3' HG22 ' A' ' 65' ' ' VAL . 97.3 mttt 61.33 -172.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.702 0.627 . . . . 0.0 111.488 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.384 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.931 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 ptp180 -144.84 173.76 11.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.38 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 52.4 t -70.04 114.49 8.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.63 -5.73 21.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 0.0 111.617 -171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.405 HG21 ' CG1' ' A' ' 65' ' ' VAL . 48.5 t -88.95 -58.28 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.166 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 m -102.18 -24.22 13.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.931 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 91.68 22.72 30.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.567 -177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.899 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -93.37 151.42 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.775 -0.25 . . . . 0.0 110.94 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 145.24 69.46 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.369 . . . . 0.0 111.475 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 37.7 Cg_endo -66.71 149.29 83.77 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.867 2.378 . . . . 0.0 111.871 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -175.395 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.46 -0.442 0 CA-C-O 121.063 0.359 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -133.89 -47.16 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.684 0.754 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.53 HD13 ' HB3' ' A' ' 54' ' ' ARG . 13.9 mt -85.0 153.4 22.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.043 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -119.75 110.02 16.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -84.43 109.39 17.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.42 165.45 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.68 114.56 24.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.96 148.78 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.421 . . . . 0.0 110.408 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -102.48 124.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.446 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 49' ' ' THR . 89.9 mt -84.66 146.34 46.48 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.03 -21.93 61.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.748 2.299 . . . . 0.0 111.83 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.69 -26.56 67.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.522 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.69 -0.72 23.24 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.125 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.431 ' HB ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -87.01 149.77 24.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 111.398 -176.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -111.59 113.22 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HG3' ' HG3' ' A' ' 53' ' ' MET . 55.0 tptt -129.03 130.94 47.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.109 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -80.95 115.94 20.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.479 ' HG3' ' HG3' ' A' ' 51' ' ' LYS . 64.0 mtm -123.88 157.51 34.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.319 0.581 . . . . 0.0 111.6 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' CYS . 87.0 mtm180 -77.72 109.4 11.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.757 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.82 141.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.514 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.52 159.28 16.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.561 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -59.25 -32.62 70.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.188 -177.149 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -60.91 -38.86 87.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.307 0.575 . . . . 0.0 110.765 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.66 -34.21 60.48 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.446 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 57' ' ' THR . 91.5 mt -61.09 -53.25 59.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.325 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -60.22 -50.61 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.13 0.491 . . . . 0.0 111.327 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -73.96 -17.46 61.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.138 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.41 40.75 96.53 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -73.16 -14.52 61.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.66 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 67' ' ' LYS . 35.0 m -108.46 158.81 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.132 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -54.59 -52.0 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.719 ' HB2' HG21 ' A' ' 65' ' ' VAL . 34.1 ttpt 62.06 12.91 5.29 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.739 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 t80 . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.345 -179.305 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttp . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.533 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.3 ppt_? -96.46 -164.75 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.918 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.635 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 47.9 t -55.11 135.32 49.3 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.053 0.454 . . . . 0.0 110.799 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.06 3.22 27.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.042 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.25 -73.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.544 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 83.5 m -108.85 8.33 26.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 84.28 -18.34 23.8 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.382 -0.913 . . . . 0.0 114.416 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -58.39 139.99 54.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.182 0.491 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 69.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.767 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.649 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 61.0 Cg_endo -71.97 94.62 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 111.653 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.688 -176.06 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.532 0.396 0 N-CA-C 113.746 0.633 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.71 -16.36 61.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.248 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.736 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 19.2 mt -89.1 108.33 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.508 HE21 ' HB3' ' A' ' 39' ' ' GLN . 3.3 mt-30 -68.67 97.38 0.8 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.638 0.732 . . . . 0.0 111.022 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 8.2 ptpp? -73.16 110.78 7.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.978 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.64 168.09 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.227 0.537 . . . . 0.0 111.173 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -88.68 114.81 25.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.702 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 m -120.97 159.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.282 0.563 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.0 t -104.57 124.26 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.231 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 49' ' ' THR . 38.8 mt -60.64 148.69 81.13 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.989 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.54 -7.58 9.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.306 2.67 . . . . 0.0 113.774 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -98.78 -69.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.734 0.302 . . . . 0.0 110.249 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.46 57.89 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.021 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 45' ' ' LEU . 1.1 m -144.5 156.65 44.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.52 129.26 67.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.794 0.331 . . . . 0.0 110.149 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HE2' HD22 ' A' ' 45' ' ' LEU . 39.3 ttpt -146.72 152.93 39.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.045 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -94.63 127.16 40.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.4 mtp -135.36 152.18 51.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.736 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 56.8 mtt85 -91.36 110.64 21.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.697 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.635 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 25.4 t -112.29 138.2 42.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.074 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.4 p -88.63 159.55 17.81 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.79 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 t -58.93 -25.82 63.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.572 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 m -63.74 -47.92 79.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 75.4 m -70.58 -34.5 72.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.3 -41.54 97.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.671 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -81.06 -24.81 37.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.157 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.2 t -68.28 -33.02 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.02 22.49 55.37 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.156 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 8.99 28.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.944 0.872 . . . . 0.0 111.182 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.21 161.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.724 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -76.29 147.72 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -152.2 160.56 43.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.0 111.971 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.861 172.829 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 121.239 0.542 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -128.35 161.3 29.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.615 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -62.48 135.62 57.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.602 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 49.6 mt-10 -81.98 3.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.229 0.538 . . . . 0.0 110.833 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.37 -60.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 t -96.8 -17.4 20.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.285 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.06 84.02 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.846 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -75.19 143.46 43.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.707 0.253 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.86 144.5 36.97 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.871 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -86.21 -0.22 8.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.159 2.572 . . . . 0.0 113.006 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.467 0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.391 -178.211 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.459 -0.544 0 CA-C-O 120.742 0.226 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -151.93 -47.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.888 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 54' ' ' ARG . 9.0 mt -71.12 113.07 7.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.847 0.356 . . . . 0.0 111.628 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.97 100.9 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.252 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.615 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 24.4 ttmt -75.86 110.62 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.73 159.15 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.686 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HE ' HG21 ' A' ' 50' ' ' ILE . 65.9 ttt180 -87.02 117.65 25.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.389 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.74 157.33 30.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.857 0.36 . . . . 0.0 110.767 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.5 139.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.693 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD11 ' HB ' ' A' ' 49' ' ' THR . 73.6 mt -86.43 153.32 56.02 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.47 -26.17 52.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.933 2.422 . . . . 0.0 112.689 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.31 -21.88 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.276 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.72 -1.8 26.05 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.231 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.553 ' HB ' HD11 ' A' ' 45' ' ' LEU . 1.4 m -81.41 159.18 24.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.584 HG21 ' HE ' ' A' ' 42' ' ' ARG . 57.5 mt -121.8 133.19 68.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.674 0.273 . . . . 0.0 110.754 -177.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HD2' HD12 ' A' ' 45' ' ' LEU . 63.5 mttm -140.03 164.52 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -121.63 117.63 27.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.2 mtm -138.7 165.4 27.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.964 0.411 . . . . 0.0 111.823 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' HB2' ' A' ' 40' ' ' LYS . 27.8 mmt180 -76.87 119.56 20.8 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.734 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 39.4 t -126.64 139.71 50.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 p -77.39 145.81 37.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.438 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 t -55.08 -30.49 59.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -61.05 -47.39 86.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 55.5 m -72.19 -33.9 68.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.857 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.98 -53.19 60.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.6 -45.67 57.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.589 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 t -69.4 -26.74 64.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.646 0.26 . . . . 0.0 110.997 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.94 48.36 7.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.753 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.25 -28.63 22.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.203 0.525 . . . . 0.0 109.671 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.83 171.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 41.1 tptt -69.32 -44.91 70.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.616 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.8 tttt 71.07 135.19 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.771 0.669 . . . . 0.0 111.227 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 178.902 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.352 0.596 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.431 ' H ' ' CD ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -80.43 155.29 27.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.738 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 48.8 t -60.61 144.68 51.24 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.05 -8.79 59.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.961 0.41 . . . . 0.0 110.933 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.562 HG21 HG21 ' A' ' 55' ' ' VAL . 57.6 t -100.3 -62.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 42.8 t -91.06 -47.53 7.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.819 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.02 -9.98 27.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.224 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.538 ' HG3' ' SG ' ' A' ' 13' ' ' CYS . 28.7 mtpp -77.5 162.68 26.96 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.711 -0.288 . . . . 0.0 110.25 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.88 144.33 76.02 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.966 0.413 . . . . 0.0 111.416 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.641 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 98.2 Cg_endo -89.7 94.88 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.193 2.595 . . . . 0.0 112.178 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 . . . . . 0 C--O 1.236 0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.642 -179.413 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo . . . . . 0 N--CA 1.473 0.265 0 CA-C-O 121.057 0.357 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -109.81 -10.16 14.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.634 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.789 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 22.3 mt -120.02 99.75 6.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.706 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.463 ' NE2' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -89.68 123.19 33.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 15.4 ptmt -72.73 122.52 21.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.782 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 t -114.8 156.2 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.639 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -85.46 106.56 16.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.73 166.78 10.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.462 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.17 136.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.594 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 49' ' ' THR . 79.2 mt -97.42 152.2 38.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.55 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.37 -15.75 50.29 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.0 2.467 . . . . 0.0 112.704 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.16 -15.19 57.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.1 15.36 26.22 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.14 -0.553 . . . . 0.0 111.797 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -89.34 149.22 23.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.843 0.354 . . . . 0.0 110.247 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -128.05 111.69 25.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.72 149.42 34.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.788 0.328 . . . . 0.0 110.543 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.27 120.95 31.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.497 ' HE3' HG23 ' A' ' 12' ' ' VAL . 65.7 mtm -130.28 149.85 51.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.932 -177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.789 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 81.9 mtm180 -76.26 113.35 13.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.421 0.629 . . . . 0.0 110.923 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.642 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.9 t -105.23 148.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.089 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.82 148.55 25.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.326 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -58.71 -25.59 63.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.38 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -60.53 -40.72 92.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.365 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.79 -33.89 62.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.565 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.463 HD12 ' NE2' ' A' ' 39' ' ' GLN . 16.1 mt -56.67 -53.59 55.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 61' ' ' LYS . 21.5 ptmt -81.76 -2.49 50.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -86.8 -32.0 20.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.56 46.92 93.32 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.996 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.86 33.74 3.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.163 0.506 . . . . 0.0 111.213 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.22 149.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.779 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -86.37 102.79 14.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.536 0.684 . . . . 0.0 109.887 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -94.78 146.95 23.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.972 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.8 t80 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.864 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.12 0.486 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.3 ptm180 -143.77 155.6 44.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.513 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.523 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -68.4 131.95 46.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.502 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.83 2.93 24.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.219 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 65' ' ' VAL . 49.1 t -102.54 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.809 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.495 ' SG ' ' HD2' ' A' ' 64' ' ' LYS . 72.2 m -101.72 -21.23 14.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.581 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.607 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -79.29 145.83 33.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . . . -78.41 155.46 79.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.516 -176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.773 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 84.6 Cg_endo -78.05 109.33 2.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.992 2.462 . . . . 0.0 112.509 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 178.448 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.463 -0.295 0 N-CA-C 112.854 0.29 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -112.48 -27.42 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.497 0.665 . . . . 0.0 109.487 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.472 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 57.2 mt -86.26 159.77 19.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.609 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -123.39 132.38 53.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -85.41 113.5 21.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.44 167.17 9.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.55 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 18.0 ptp180 -101.13 120.6 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.299 0.571 . . . . 0.0 110.935 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 34.1 m -110.46 167.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.112 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 68' ' ' TYR . 11.9 p -101.65 131.41 49.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.133 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.0 144.92 28.61 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.665 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 -20.1 57.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.616 2.211 . . . . 0.0 111.58 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.19 -27.15 68.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.524 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.74 44.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -99.77 158.31 15.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.757 0.313 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 42' ' ' ARG . 63.7 mt -105.3 116.38 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -106.14 144.75 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.087 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -110.6 125.84 53.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.116 0.484 . . . . 0.0 110.338 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.41 ' HE1' HG22 ' A' ' 43' ' ' VAL . 72.3 mtm -139.22 163.76 31.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.698 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -84.18 120.45 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.523 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 58.5 t -122.87 147.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.706 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 24.7 p -88.57 155.13 19.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.488 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -57.49 -32.71 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.039 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -65.54 -43.08 91.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.977 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.5 m -72.65 -35.58 67.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.664 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.6 -47.01 87.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.614 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.117 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -70.41 -29.41 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.36 28.32 73.64 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.012 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.5 tmtp? -82.83 -21.08 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.379 0.609 . . . . 0.0 109.783 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 55' ' ' VAL . 35.4 m -61.79 163.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.331 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 31.5 mmtp -78.58 59.75 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.576 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -57.59 140.84 49.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.528 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.517 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p90 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.639 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.363 0.601 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -139.0 165.24 27.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.044 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.653 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 42.6 t -82.01 143.47 31.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.59 -2.22 25.03 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.68 -67.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.0 p -85.28 -39.41 17.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.777 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 9.97 51.11 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.125 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 56' ' ' CYS . 73.6 mmtt -82.59 158.46 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.37 149.53 47.06 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.022 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.8 Cg_endo -75.16 110.43 3.11 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.691 2.261 . . . . 0.0 112.299 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.47 -179.771 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--O 1.233 0.225 0 N-CA-C 113.46 0.523 . . . . 0.0 113.46 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -89.36 -5.45 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 mt -90.48 109.21 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -77.82 101.57 6.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.497 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' MET . 20.5 pttp -78.82 110.23 13.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 33.5 m -125.01 162.25 27.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.301 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.13 120.1 29.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 0.0 110.914 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.53 167.7 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.404 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.579 ' N ' ' HA ' ' A' ' 68' ' ' TYR . 9.5 p -89.31 138.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.614 0.721 . . . . 0.0 111.063 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 49' ' ' THR . 88.6 mt -92.52 157.85 39.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.74 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.11 -24.29 39.98 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.724 2.282 . . . . 0.0 112.496 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.95 -19.01 60.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.486 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.71 54.61 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.493 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.9 m -86.73 158.38 19.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.163 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.14 122.81 66.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 45' ' ' LEU . 41.0 ttmt -141.51 147.72 38.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.5 mtm180 -88.0 134.98 33.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 63.0 mtm -138.56 170.61 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.485 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -82.54 110.72 17.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.079 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.653 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 49.6 t -115.57 144.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.927 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HG ' ' HB2' ' A' ' 15' ' ' LYS . 25.5 p -90.79 152.47 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.517 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -58.94 -25.42 63.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 m -61.08 -45.43 94.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.444 . . . . 0.0 110.351 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.71 -34.58 75.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.02 -45.55 77.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.796 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.59 -7.78 53.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.753 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 t -117.2 -4.12 11.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.866 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.92 62.05 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.118 -175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -87.64 56.77 4.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.983 0.897 . . . . 0.0 111.08 -171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.536 HG21 ' HD3' ' A' ' 67' ' ' LYS . 5.6 m -143.43 156.84 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 3.14 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.57 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HD3' HG21 ' A' ' 65' ' ' VAL . 3.7 mppt? 57.77 -168.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.911 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.579 ' HA ' ' N ' ' A' ' 44' ' ' VAL . 13.1 p90 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 110.956 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.717 ' HG2' ' H ' ' A' ' 2' ' ' GLY . 25.8 tt0 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.717 ' H ' ' HG2' ' A' ' 1' ' ' GLN . . . 118.59 -14.8 11.68 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.922 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -97.24 -23.28 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.7 99.84 4.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 pt -103.39 9.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.7 ttm -86.06 88.47 7.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 110.108 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.08 157.71 38.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.732 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -91.11 122.04 33.42 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.631 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 23.5 ptt-85 -135.76 -174.08 3.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.44 119.69 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.732 0.301 . . . . 0.0 110.379 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.09 -5.52 46.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.145 0.498 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.22 -51.2 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.6 m -114.13 -12.6 12.51 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 -16.57 60.34 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.733 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -74.99 153.57 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.52 0.66 . . . . 0.0 111.267 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.19 153.78 69.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.181 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.851 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 94.3 Cg_endo -80.13 91.28 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.722 2.281 . . . . 0.0 111.464 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.036 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.9 m -149.94 101.68 3.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.795 0.331 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.45 25.63 4.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.014 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -88.28 76.43 8.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 110.549 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -155.27 112.47 3.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.21 118.68 30.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.329 0.585 . . . . 0.0 110.638 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -91.9 165.09 13.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.784 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -137.31 148.23 46.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.885 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.4 m 75.29 6.26 4.14 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.066 0.854 . . . . 0.0 112.297 174.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' C ' ' HD3' ' A' ' 28' ' ' LYS . 5.3 m-20 -78.03 -65.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.408 0.151 . . . . 0.0 111.408 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 43.92 28.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.348 1.059 . . . . 0.0 111.951 -173.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -90.41 160.1 16.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.576 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 t -153.01 100.26 2.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.194 0.521 . . . . 0.0 111.064 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.83 71.57 1.3 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 32' ' ' ARG . 22.7 ttt180 58.52 48.71 11.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.605 -167.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 61.49 -169.73 0.17 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -100.83 153.58 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -96.36 156.19 37.16 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.07 98.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.48 2.12 . . . . 0.0 112.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 67.63 8.99 6.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.93 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.851 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 12.7 mt -116.95 122.76 45.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.255 0.55 . . . . 0.0 111.964 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.49 116.85 32.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.079 173.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 53' ' ' MET . 80.2 mttt -74.49 116.17 14.87 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 168.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.55 136.78 44.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.296 0.569 . . . . 0.0 109.526 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 42' ' ' ARG . 26.5 ttm180 -80.7 106.46 12.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.546 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 53' ' ' MET . 28.9 m -111.04 170.04 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.369 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.88 131.34 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 85.6 mt -90.52 144.18 30.3 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.058 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 25.3 Cg_exo -64.11 -14.58 44.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.947 2.431 . . . . 0.0 112.507 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.85 -4.0 57.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.636 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.77 55.05 2.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.82 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 m -149.14 159.02 44.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.94 127.12 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.87 141.85 44.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.428 . . . . 0.0 111.694 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -91.26 120.44 32.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 49.8 mtm -125.3 149.41 48.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.875 0.369 . . . . 0.0 111.015 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -80.11 107.95 13.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.17 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.36 134.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.6 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 17' ' ' PRO . 44.2 t -74.9 149.56 39.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.269 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.7 m -56.04 -30.99 62.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.344 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -59.11 -49.22 78.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.189 0.519 . . . . 0.0 110.151 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.4 m -69.11 -37.01 78.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.378 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.26 -41.29 99.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.143 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.55 -39.72 64.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -68.9 -32.94 72.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.7 62.05 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.727 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.29 19.14 7.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.052 0.453 . . . . 0.0 111.486 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -102.7 162.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.92 106.75 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -121.55 152.03 39.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.681 -167.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -114.33 15.5 18.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t 67.09 91.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.838 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.3 25.06 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.71 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.95 119.55 26.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m -122.03 22.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.023 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -57.37 142.42 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.2 -12.67 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.369 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.72 134.57 36.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.687 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.36 -63.15 3.36 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.584 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.804 175.421 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.13 133.09 1.55 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.349 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.89 -30.52 21.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.92 0.39 . . . . 0.0 111.215 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 94.92 8.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.823 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tt -147.16 123.91 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.77 85.84 0.07 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.081 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.38 25.32 11.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.567 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 57.61 77.18 0.29 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.057 0.932 . . . . 0.0 109.912 -174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' A' ' 14' ' ' GLY . 21.3 ptt180 -97.74 -177.87 3.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.203 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.3 t -67.37 120.79 14.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 167.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 53' ' ' MET . 41.6 mt-10 -71.71 -10.84 60.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.061 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 65' ' ' VAL . 58.5 t -81.9 -71.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -97.41 -46.72 5.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 0.0 111.022 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 9' ' ' ARG . . . 120.27 21.3 3.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.059 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.73 177.57 8.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.877 0.339 . . . . 0.0 111.396 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.62 91.35 12.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.692 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 36.2 Cg_endo -63.37 146.94 93.82 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.644 2.229 . . . . 0.0 112.093 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.53 13.94 0.85 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.78 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.8 p -90.57 115.83 28.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.52 -9.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.007 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -78.02 98.95 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.046 0.451 . . . . 0.0 110.554 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.478 HG21 HG21 ' A' ' 23' ' ' VAL . 15.1 t -170.81 157.05 5.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.725 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 22' ' ' THR . 25.5 m 43.69 85.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 124.373 1.045 . . . . 0.0 113.118 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -65.49 -46.5 79.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.052 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -160.2 28.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -71.41 107.42 4.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.338 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t0 69.05 134.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.87 0.731 . . . . 0.0 110.057 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.47 -9.15 56.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.17 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.534 ' HZ1' ' HB3' ' A' ' 29' ' ' LYS . 9.1 mtpm? -107.31 90.05 3.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -80.68 74.9 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -44.72 -64.3 0.73 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.915 -169.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -134.06 30.52 3.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.76 0.79 . . . . 0.0 109.386 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -102.72 78.07 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.74 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.526 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 76.0 t80 -160.11 98.36 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.521 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -146.89 144.48 20.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 83.3 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.803 2.335 . . . . 0.0 112.714 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 63.04 13.87 7.11 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.718 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 54' ' ' ARG . 14.1 mt -117.44 152.12 35.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.12 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.436 ' HB2' HD12 ' A' ' 60' ' ' LEU . 31.5 mm-40 -118.66 97.89 5.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 53' ' ' MET . 61.1 pttt -81.45 112.68 18.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.228 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.88 168.37 21.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.836 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -78.66 135.51 37.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.5 HG22 ' HE2' ' A' ' 53' ' ' MET . 29.1 m -125.88 143.91 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.92 136.19 45.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.396 0.617 . . . . 0.0 110.873 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' A' ' 49' ' ' THR . 96.0 mt -98.53 143.01 25.54 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.486 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.61 -15.75 48.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.856 2.37 . . . . 0.0 112.321 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.63 -16.21 60.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.441 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 52.24 0.88 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.143 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.478 ' HB ' HD11 ' A' ' 45' ' ' LEU . 1.8 m -145.95 154.51 42.0 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.575 -0.368 . . . . 0.0 110.561 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.36 117.29 44.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -120.89 142.64 49.49 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -101.72 119.11 38.27 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.546 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 62.8 mtm -133.99 155.5 49.86 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.099 0.476 . . . . 0.0 111.834 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.636 ' HB3' HD21 ' A' ' 38' ' ' LEU . 69.3 mtm180 -76.12 116.41 16.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.86 148.47 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.823 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 10.9 p -91.22 155.94 18.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.602 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -61.36 -26.71 68.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.095 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 p -64.51 -41.3 96.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.72 0.295 . . . . 0.0 110.836 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.22 -34.45 61.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.52 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 57' ' ' THR . 92.4 mt -59.34 -51.82 68.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.269 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -72.5 -33.98 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.8 p -74.37 -24.71 59.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.072 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.33 44.01 23.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.276 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -95.26 11.9 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.448 0.642 . . . . 0.0 109.932 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 HG13 ' A' ' 12' ' ' VAL . 28.5 m -120.94 138.46 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.898 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.657 ' HZ2' ' HB2' ' A' ' 66' ' ' LYS . 4.0 ttmp? -86.08 98.89 11.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -94.4 30.8 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.952 -166.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 66.64 12.18 8.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.212 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t 63.56 100.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.512 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 175.88 110.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.684 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -96.32 105.52 17.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.08 117.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.056 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 t -146.85 128.05 14.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -92.08 130.98 37.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.952 0.406 . . . . 0.0 110.455 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.8 -30.94 39.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.53 141.05 45.23 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.254 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.315 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.68 0.276 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.87 95.02 2.12 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.027 0.441 . . . . 0.0 110.13 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.9 ttm -76.22 -44.88 35.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.582 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.99 127.99 41.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.443 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.0 ttm -138.61 168.65 19.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.99 -60.4 2.64 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.418 0.449 . . . . 0.0 111.577 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 85.0 tttt -159.1 137.53 10.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -74.47 178.41 5.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.432 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.771 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 41.5 t -55.02 128.68 34.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.071 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.467 ' HG2' ' HE2' ' A' ' 8' ' ' LYS . 38.7 mt-10 -76.57 5.14 7.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.639 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.28 -58.38 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.1 -23.09 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.93 4.4 36.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.474 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mttp -74.15 176.75 6.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.74 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.05 144.52 29.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.217 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 89.4 Cg_endo -82.28 150.87 15.53 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.4 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -101.38 -51.79 3.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.448 . . . . 0.0 109.986 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.1 t -88.03 -175.53 5.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.72 175.4 42.66 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 155.46 21.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.593 0.196 . . . . 0.0 110.78 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 m -61.34 106.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.139 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.41 135.25 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 106.78 5.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.97 125.14 25.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 110.76 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.1 m -116.23 130.68 56.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.585 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.68 5.91 31.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.905 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -126.17 148.56 49.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.747 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.686 ' HG2' ' H ' ' A' ' 30' ' ' SER . 72.1 tttt 69.31 -178.81 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.482 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.686 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 4.6 p -65.65 155.88 34.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.418 0.627 . . . . 0.0 112.596 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.27 80.4 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.676 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -79.84 146.81 32.03 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -44.86 127.46 6.4 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.834 0.709 . . . . 0.0 112.004 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -82.57 141.46 32.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' N ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -132.49 85.4 48.34 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 177.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.97 -35.31 5.52 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.684 2.256 . . . . 0.0 111.137 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 18.8 m120 -84.52 -171.13 3.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.276 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 28.6 mt 68.46 106.8 0.05 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.652 0.739 . . . . 0.0 110.162 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.43 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -77.66 93.43 4.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.783 -173.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 53' ' ' MET . 17.3 pttp -78.01 109.85 12.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.641 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.47 160.71 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.527 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -95.12 126.84 40.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.704 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 67' ' ' LYS . 34.3 m -123.42 156.04 29.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.014 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 68' ' ' TYR . 7.2 p -109.11 122.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.636 0.731 . . . . 0.0 110.44 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.9 mt -79.37 143.43 59.99 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.374 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.8 -21.48 69.41 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.98 2.453 . . . . 0.0 112.795 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.72 -23.89 56.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.111 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.404 ' C ' ' HG1' ' A' ' 49' ' ' THR . . . 116.27 67.09 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.695 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.487 ' HB ' HD12 ' A' ' 45' ' ' LEU . 3.4 m -153.38 154.6 34.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.578 -0.366 . . . . 0.0 110.13 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.58 113.28 22.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -134.84 148.23 50.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.765 0.317 . . . . 0.0 111.229 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -99.21 119.77 38.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.7 mtm -132.58 157.6 44.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.027 0.442 . . . . 0.0 110.851 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.674 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 49.9 mtm180 -87.68 103.92 16.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.464 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.771 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 17.7 t -98.98 154.34 4.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.825 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 15' ' ' LYS . 28.4 p -90.02 149.79 22.38 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.173 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -57.5 -29.45 64.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.111 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -62.68 -47.73 82.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.797 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.0 m -64.94 -34.29 78.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.293 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.18 -50.53 72.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -66.06 -30.31 70.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.13 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -31.75 54.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.73 31.18 56.68 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.571 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -79.02 -25.45 43.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.964 0.411 . . . . 0.0 110.91 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 28.0 m -77.04 143.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.61 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.06 -3.65 55.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HA ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 45.47 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.226 . . . . 0.0 114.206 174.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.8 t80 -142.06 14.59 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.734 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 69' ' ' VAL . 10.2 t 62.99 20.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.46 -175.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.17 137.97 41.03 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.806 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -94.07 105.0 17.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.725 0.298 . . . . 0.0 110.443 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.91 154.69 37.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.132 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.0 m -126.57 132.24 51.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.673 0.273 . . . . 0.0 110.706 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -81.67 151.13 27.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.72 -23.5 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -170.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.82 -129.4 2.31 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.129 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.769 -177.035 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.3 150.73 24.96 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 58.84 32.65 22.43 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.4 tpt -54.13 -48.79 70.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.046 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mm -103.28 17.16 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.526 0.679 . . . . 0.0 110.158 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.5 ttt -100.43 6.07 44.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.248 0.547 . . . . 0.0 109.867 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 61.32 73.54 0.47 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.792 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -97.0 70.51 2.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.586 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 10.0 ptp180 -152.83 169.71 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.817 -172.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.25 127.84 34.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 38.3 mt-10 -73.99 -15.02 61.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.758 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.02 -57.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.463 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -102.0 -36.14 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 103.39 8.34 41.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.572 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -87.36 150.23 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.83 144.49 85.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 71.5 Cg_endo -94.97 141.73 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.382 2.721 . . . . 0.0 113.312 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -121.4 -5.76 9.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.668 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 11.7 t 63.69 -155.67 0.32 Allowed 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.666 0.604 . . . . 0.0 109.943 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.81 -147.02 4.93 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -87.1 124.69 33.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.296 0.548 . . . . 0.0 109.699 175.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 m -81.21 92.76 6.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.965 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -79.61 118.99 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 64.63 -173.21 0.17 Allowed 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.686 0.616 . . . . 0.0 110.178 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -169.93 159.04 7.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -59.32 104.75 0.28 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.253 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -83.3 -31.6 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 55.5 mmtt -133.4 -171.98 2.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.726 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 74.69 96.65 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 O-C-N 124.304 1.003 . . . . 0.0 110.028 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.475 ' HA ' ' CZ2' ' A' ' 33' ' ' TRP . 6.4 m -82.07 38.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.66 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -130.96 104.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 63.05 86.06 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.854 0.721 . . . . 0.0 110.984 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.475 ' CZ2' ' HA ' ' A' ' 30' ' ' SER . 81.8 m95 -78.51 -59.83 2.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.648 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -173.93 147.39 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.82 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -127.03 152.03 75.07 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.49 100.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.704 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.668 ' HA ' ' HB2' ' A' ' 19' ' ' SER . 19.8 m120 71.48 -8.1 1.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.56 172.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.8 mt -117.55 123.62 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.296 0.569 . . . . 0.0 111.758 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.44 107.69 18.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.561 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.648 ' HZ1' ' HA ' ' A' ' 53' ' ' MET . 19.1 ttmm -76.57 108.51 9.61 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.67 168.91 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.945 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -81.02 117.33 21.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.785 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . 33.6 m -117.29 163.5 14.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.81 134.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.497 . . . . 0.0 110.245 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 49' ' ' THR . 90.0 mt -93.14 153.3 41.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.805 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.74 -27.58 43.41 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.34 2.694 . . . . 0.0 113.355 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.88 -1.44 52.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 111.63 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.93 2.19 59.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.3 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.54 ' HB ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -77.56 152.5 33.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.786 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.11 126.75 70.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -141.83 157.22 45.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.38 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 99.4 mtt180 -98.36 129.88 45.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.648 ' HA ' ' HZ1' ' A' ' 40' ' ' LYS . 55.2 mtm -138.33 150.91 47.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.201 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 79.3 mtm180 -76.88 119.59 20.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 65' ' ' VAL . 37.6 t -120.77 148.18 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 17' ' ' PRO . 20.2 p -87.13 149.75 24.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 19' ' ' SER . 5.5 m -56.75 -30.26 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.499 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.76 -40.25 91.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.238 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.7 m -79.53 -35.53 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 57' ' ' THR . 95.2 mt -60.01 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -78.92 -5.54 53.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.316 0.579 . . . . 0.0 110.644 -176.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -94.34 -27.4 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 109.74 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.79 56.12 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -89.25 30.59 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.75 0.31 . . . . 0.0 110.983 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 55' ' ' VAL . 20.1 m -122.12 129.43 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.674 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -80.49 98.28 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.0 pttt -110.77 177.54 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.727 -167.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' GLY . 19.0 t80 -99.81 63.54 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.87 172.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 70' ' ' GLY . 13.0 p 52.13 -60.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.229 1.812 . . . . 0.0 115.79 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' N ' HG11 ' A' ' 69' ' ' VAL . . . -68.94 86.56 0.22 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 118.183 0.447 . . . . 0.0 113.879 -171.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' HG3' ' HD2' ' A' ' 67' ' ' LYS . 15.5 mm100 -109.08 3.65 22.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.165 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.739 HG21 ' H ' ' A' ' 73' ' ' SER . 16.3 m 44.79 -84.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.739 ' H ' HG21 ' A' ' 72' ' ' VAL . 18.4 t -98.0 26.49 5.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.863 0.363 . . . . 0.0 111.105 -171.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 71' ' ' GLN . 33.3 tt0 -69.37 117.27 10.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.62 93.59 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.42 -42.39 0.27 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.184 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.671 179.72 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.777 0.322 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.74 -78.78 0.36 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -72.33 160.71 31.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 0.0 110.6 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -73.2 104.11 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.416 . . . . 0.0 111.387 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.709 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -98.06 160.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.78 ' HG3' ' HG3' ' A' ' 9' ' ' ARG . 24.7 ttt 66.88 95.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.655 0.597 . . . . 0.0 110.65 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.39 -79.65 0.27 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.08 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -127.96 103.19 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 109.903 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.78 ' HG3' ' HG3' ' A' ' 6' ' ' MET . 3.6 mmm180 -124.44 -176.2 3.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.246 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.1 t -64.89 123.68 20.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.13 -4.28 34.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 0.0 111.301 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.7 t -92.58 -65.88 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 111.12 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.02 -13.95 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.734 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.57 86.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.546 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.15 158.57 34.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.55 148.05 87.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.7 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.1 Cg_endo -74.12 113.77 3.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.482 2.121 . . . . 0.0 112.062 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -59.8 122.96 15.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.658 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -110.55 139.15 46.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.64 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.15 -178.06 17.8 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.62 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 72.2 -65.07 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.994 0.918 . . . . 0.0 112.231 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 m 66.46 102.06 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.33 0.586 . . . . 0.0 110.321 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.66 80.18 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.484 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 70.19 146.91 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.875 0.845 . . . . 0.0 112.566 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -124.32 149.24 46.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.025 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 p -160.27 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 67.27 91.08 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.537 0.685 . . . . 0.0 111.146 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -100.16 8.08 44.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.083 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt 59.63 59.0 2.69 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.928 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 t -93.72 -29.74 15.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 57.7 -85.57 0.02 OUTLIER 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 113.822 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.31 25.53 5.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.359 -166.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -74.91 -39.42 61.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.114 0.483 . . . . 0.0 109.974 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.554 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 92.1 m-85 -119.35 -178.04 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.892 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 17.3 mmt180 -114.69 148.05 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.887 171.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.72 -36.44 81.9 Favored 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 122.876 2.384 . . . . 0.0 113.751 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -111.9 -9.19 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.55 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 35' ' ' ARG . 35.1 mt -121.14 118.67 30.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.083 0.468 . . . . 0.0 111.212 -174.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -88.37 107.65 18.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.249 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' ' 34' ' ' PHE . 47.0 mtpt -81.71 110.21 16.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.684 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.696 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 24.7 m -122.83 157.92 27.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.674 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 50' ' ' ILE . 68.5 mtp180 -92.73 123.28 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.104 0.478 . . . . 0.0 110.44 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.642 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 32.9 m -115.86 164.75 11.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.07 128.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.67 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -95.17 150.54 37.8 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.782 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.46 -11.28 27.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.772 2.315 . . . . 0.0 112.254 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.11 -13.67 56.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.713 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.37 3.66 58.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.576 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.83 154.45 17.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.523 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.507 HG22 ' HB3' ' A' ' 42' ' ' ARG . 55.4 mt -115.21 110.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.142 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.95 151.23 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.089 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 52' ' ' ARG . 65.2 mtt180 -84.16 137.76 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.411 ' SD ' HG23 ' A' ' 43' ' ' VAL . 86.7 mtp -133.04 154.64 50.35 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -85.73 103.88 14.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.86 146.15 18.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.961 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 28.0 p -96.24 157.52 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.76 0.314 . . . . 0.0 110.82 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.456 ' HA ' HD13 ' A' ' 60' ' ' LEU . 1.2 p -61.13 -25.04 66.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.737 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.409 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 32.1 t -58.65 -52.38 65.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.3 m -64.3 -34.28 77.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.444 . . . . 0.0 111.006 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 57' ' ' THR . 81.4 mt -63.71 -50.51 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.22 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -81.13 -19.21 44.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 m -81.86 -12.16 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.992 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.543 ' HA3' ' HG3' ' A' ' 71' ' ' GLN . . . 64.77 54.91 25.56 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.372 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -135.89 76.02 1.58 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 0.0 109.449 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.77 172.86 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.51 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 12.1 ptmm? -122.37 45.75 2.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.613 0.721 . . . . 0.0 110.258 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.696 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 2.8 mmmp? -80.9 -177.91 6.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.162 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -89.38 -14.25 35.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.086 0.47 . . . . 0.0 111.084 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.89 155.04 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.369 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.53 -132.63 11.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.969 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' HG3' ' HA3' ' A' ' 63' ' ' GLY . 3.0 mm100 -76.61 94.91 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.7 109.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.865 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 m -83.55 82.02 8.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.31 123.59 20.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.029 -168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 75' ' ' VAL . 16.1 t 69.37 5.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.177 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.49 -84.47 1.46 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.628 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.252 1.2 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.867 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.762 0.315 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.64 165.34 39.44 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.794 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 38.7 p-80 -125.31 93.42 3.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.368 0.604 . . . . 0.0 110.455 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.0 ttm -90.12 136.74 32.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.791 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 16' ' ' ALA . 51.9 mt -84.54 112.81 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.075 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.5 ttt -112.55 -85.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.35 -57.34 2.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.55 107.93 1.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 110.155 173.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.605 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.9 ptm180 -150.04 166.4 29.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.759 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.44 124.75 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.128 0.267 . . . . 0.0 110.354 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.22 -7.87 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.464 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -85.79 -67.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 111.114 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.2 m -94.16 -22.89 18.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.256 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.32 -2.7 61.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.329 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.66 166.12 23.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.74 0.305 . . . . 0.0 111.74 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 5' ' ' ILE . . . -76.63 144.12 72.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.906 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 95.9 Cg_endo -85.64 151.82 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.791 2.327 . . . . 0.0 113.644 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.92 103.66 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.966 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.436 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 21.0 p -70.63 137.44 49.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.769 -177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.13 -179.75 52.96 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.96 -40.31 80.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.264 0.225 . . . . 0.0 110.702 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m 71.48 102.6 0.07 Allowed 'General case' 0 CA--C 1.531 0.213 0 O-C-N 123.824 0.702 . . . . 0.0 111.418 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.62 -34.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.192 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -71.29 113.83 8.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.476 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -71.82 175.35 5.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.997 0.427 . . . . 0.0 110.691 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -107.05 170.33 8.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.532 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.65 118.85 24.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.087 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -74.06 86.18 1.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.452 0.644 . . . . 0.0 110.8 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.49 -56.06 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 m -101.91 106.44 17.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.811 171.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.73 17.16 4.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.703 -173.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 135.94 54.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.823 0.344 . . . . 0.0 110.366 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 16.3 m-90 -105.0 128.36 53.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.47 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -78.0 106.64 10.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HB3' HD12 ' A' ' 38' ' ' LEU . 2.9 mpt_? 64.4 74.23 0.42 Allowed Pre-proline 0 N--CA 1.464 0.257 0 O-C-N 123.846 0.716 . . . . 0.0 110.256 -174.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.6 ' HB3' ' HB2' ' A' ' 33' ' ' TRP . 96.5 Cg_endo -81.12 5.02 6.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.905 2.403 . . . . 0.0 112.944 -175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 13.3 m120 -111.91 3.48 17.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 109.826 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 54' ' ' ARG . 23.0 mt -126.3 129.73 49.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.239 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -82.82 89.19 6.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.327 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.53 114.22 4.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.103 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.55 153.86 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -93.32 124.84 37.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.941 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.52 HG21 ' HE2' ' A' ' 53' ' ' MET . 32.3 m -115.86 155.46 17.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.02 117.56 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.274 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.511 HD13 ' HB ' ' A' ' 49' ' ' THR . 85.2 mt -82.07 152.87 69.0 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.938 175.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.75 -29.96 64.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.851 2.367 . . . . 0.0 112.917 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.15 -27.97 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.177 0.513 . . . . 0.0 110.65 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.86 7.05 25.91 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' HD13 ' A' ' 45' ' ' LEU . 1.3 m -83.1 151.03 25.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.051 0.453 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.5 mt -105.51 108.34 24.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -112.8 134.42 54.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.977 0.418 . . . . 0.0 111.199 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -91.0 120.5 32.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.52 ' HE2' HG21 ' A' ' 43' ' ' VAL . 43.3 mtm -127.62 157.01 41.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.566 0.698 . . . . 0.0 111.513 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.622 ' HB3' HD11 ' A' ' 38' ' ' LEU . 77.1 mtm180 -87.58 101.02 13.23 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.439 174.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 65' ' ' VAL . 21.2 t -115.12 145.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.56 -175.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.4 p -90.32 153.51 20.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.178 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.489 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -56.99 -26.38 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.595 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 t -64.09 -48.52 75.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.2 m -67.44 -33.26 74.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 57' ' ' THR . 76.1 mt -62.04 -53.38 56.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -77.75 -54.59 6.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.289 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -107.01 2.7 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.33 23.09 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.257 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 78.36 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.344 0.592 . . . . 0.0 111.056 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 55' ' ' VAL . 17.5 m -105.72 125.06 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 0.0 110.679 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -77.23 82.14 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -69.47 128.12 35.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.93 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.13 52.99 1.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t 61.96 91.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.575 0.702 . . . . 0.0 111.057 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.0 152.15 17.3 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -86.03 8.79 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.247 0.546 . . . . 0.0 110.893 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.92 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.45 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.5 p -104.77 133.46 49.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.22 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.42 179.7 6.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.06 0.457 . . . . 0.0 110.356 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.38 144.92 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.032 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.19 74.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.459 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.474 177.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.4 -137.96 8.18 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.457 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.0 m80 69.02 16.08 8.74 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.034 0.534 . . . . 0.0 110.379 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.443 ' SD ' ' HB1' ' A' ' 16' ' ' ALA . 50.8 ttp -107.44 2.02 23.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.529 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.3 mt -75.73 92.41 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.382 0.61 . . . . 0.0 110.88 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.6 tpt -152.05 145.84 25.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.3 71.37 2.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.958 0.408 . . . . 0.0 111.773 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 17' ' ' PRO . 22.4 pttp -168.2 36.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.524 0.678 . . . . 0.0 109.703 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.536 ' C ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -103.29 176.5 5.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.012 177.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 40.6 t -60.1 124.35 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HB2' ' HE1' ' A' ' 53' ' ' MET . 8.5 mm-40 -60.09 -22.1 62.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.117 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 65' ' ' VAL . 40.3 t -98.75 -70.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.517 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -78.68 -19.02 53.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.841 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.79 2.37 81.16 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.337 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -80.19 164.63 23.13 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.788 0.328 . . . . 0.0 110.75 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB1' ' SD ' ' A' ' 4' ' ' MET . . . -72.79 147.94 89.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.486 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.774 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 90.6 Cg_endo -79.04 122.32 5.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.765 2.31 . . . . 0.0 111.827 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -140.75 96.9 3.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.278 0.561 . . . . 0.0 110.575 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p -83.26 -44.96 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.74 -48.85 2.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.644 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -132.25 144.46 50.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 110.586 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.6 t -99.73 127.01 45.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.18 -24.57 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.467 0.651 . . . . 0.0 109.935 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -81.15 107.21 13.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.208 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -68.69 -41.58 78.99 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.43 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 5.2 m -126.14 135.08 51.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.054 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.55 -44.29 74.83 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.764 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 9.0 mtmp? 64.91 160.87 0.12 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? 63.41 -167.86 0.21 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.062 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -141.7 156.06 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.042 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 58.19 84.44 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.455 0.645 . . . . 0.0 110.249 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.646 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -109.06 22.66 15.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.176 0.512 . . . . 0.0 110.728 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -137.98 155.31 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.391 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 90.9 mtt180 -121.9 160.62 46.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.106 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 35' ' ' ARG . 28.3 Cg_endo -63.69 -18.42 64.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.0 112.115 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 17' ' ' PRO . 43.4 m-80 -136.37 166.1 24.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.487 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 18.8 mt 71.87 112.95 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.967 0.792 . . . . 0.0 111.032 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -104.48 113.75 27.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.668 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 53' ' ' MET . 21.7 pttp -77.24 110.38 11.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.98 168.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.424 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -96.1 115.61 27.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.874 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.2 155.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.759 0.314 . . . . 0.0 110.178 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.5 126.85 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.256 0.551 . . . . 0.0 109.924 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.456 HD13 ' HB ' ' A' ' 49' ' ' THR . 89.1 mt -79.69 144.89 61.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.929 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -21.3 60.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.54 2.16 . . . . 0.0 111.936 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.04 -17.23 62.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.522 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.59 3.93 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.108 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.456 ' HB ' HD13 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -123.03 153.34 39.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.684 0.278 . . . . 0.0 110.787 -176.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.51 119.8 52.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -136.27 137.26 40.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -90.69 124.33 35.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.416 ' HE1' ' HB2' ' A' ' 11' ' ' GLU . 88.1 mtp -134.62 160.78 37.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.001 0.429 . . . . 0.0 111.345 -175.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' HB3' HD23 ' A' ' 38' ' ' LEU . 50.3 mtt85 -81.83 102.1 10.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.339 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.8 138.16 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 83.3 m -80.04 153.74 28.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.595 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 60' ' ' LEU . 3.4 m -61.15 -26.35 67.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.454 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -62.78 -42.77 99.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.325 0.583 . . . . 0.0 110.148 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -70.86 -33.78 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.121 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 57' ' ' THR . 96.4 mt -63.86 -36.03 82.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.2 -63.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.618 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HA ' ' HA3' ' A' ' 76' ' ' GLY . 14.8 m -92.93 -24.62 18.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.869 -170.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.02 -101.79 1.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.826 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' CA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 56.3 17.8 3.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.587 . . . . 0.0 111.067 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 12' ' ' VAL . 27.4 m -141.33 -179.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -79.39 -44.35 21.64 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HZ1' HG13 ' A' ' 72' ' ' VAL . 57.0 tttt 70.43 143.69 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 111.176 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -81.85 42.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 111.02 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.1 m 43.93 32.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.275 1.03 . . . . 0.0 112.922 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.95 -178.73 35.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.501 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -63.18 139.27 58.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG13 ' HZ1' ' A' ' 67' ' ' LYS . 11.5 m -123.75 108.53 21.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -70.14 -17.16 63.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.08 154.74 28.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.02 -32.42 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 62' ' ' SER . . . 78.67 -62.12 3.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.816 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.253 1.237 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.002 -178.54 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.745 0.307 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.3 126.8 1.41 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.21 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -96.85 -6.75 35.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -75.02 48.74 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.366 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 tt -143.45 -41.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.4 mmm 70.42 -47.96 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.726 0.81 . . . . 0.0 112.321 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.21 146.22 55.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.969 0.414 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.77 85.39 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.309 0.576 . . . . 0.0 111.531 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -86.33 -179.05 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.812 174.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.96 114.58 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -62.74 -14.63 46.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 65' ' ' VAL . 45.8 t -80.39 -63.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.611 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 82.5 m -120.77 6.55 10.45 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -172.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.538 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 71.79 25.3 75.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.934 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.591 ' HG3' ' SG ' ' A' ' 59' ' ' CYS . 29.3 mmmt -74.9 160.91 30.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.74 144.04 28.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -89.02 136.95 3.08 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.904 2.403 . . . . 0.0 113.19 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -146.2 117.74 8.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.563 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.5 m 59.87 68.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.706 0.629 . . . . 0.0 111.054 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.56 17.42 57.65 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.839 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.437 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 49.3 t30 66.51 127.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.666 0.746 . . . . 0.0 112.207 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 23' ' ' VAL . 6.0 m -64.54 -29.27 70.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.166 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 22' ' ' THR . 3.7 m 55.15 -179.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.796 1.238 . . . . 0.0 112.492 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 t -143.56 -170.11 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.795 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.8 t60 71.31 100.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.948 0.78 . . . . 0.0 111.233 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -107.07 119.68 40.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.1 m-20 -123.78 -158.76 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.46 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 90.2 mttt -51.4 132.58 29.54 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.921 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HD3' ' HZ ' ' A' ' 34' ' ' PHE . 88.9 mttt -87.21 111.75 21.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.258 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 m -145.08 78.77 1.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.239 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.92 32.12 21.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.369 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -136.55 167.12 21.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.171 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.6 m95 67.59 -165.22 0.21 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.694 0.621 . . . . 0.0 110.6 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.545 ' HZ ' ' HD3' ' A' ' 29' ' ' LYS . 73.1 m-85 66.75 -0.81 1.5 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.183 0.593 . . . . 0.0 112.201 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 2.1 mmp_? -129.16 86.8 55.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.501 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HB3' ' HA ' ' A' ' 22' ' ' THR . 6.3 Cg_exo -75.63 -6.53 17.73 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.003 2.468 . . . . 0.0 112.306 176.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.1 -5.9 32.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 54' ' ' ARG . 37.6 mt -116.3 135.91 53.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.671 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 21' ' ' ASN . 7.9 mm-40 -86.64 109.79 19.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.528 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.66 109.12 15.79 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.59 165.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 3.4 mpt_? -105.06 124.51 49.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.74 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 51' ' ' LYS . 25.0 m -108.0 152.64 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.893 0.378 . . . . 0.0 110.268 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.76 111.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD13 ' HB ' ' A' ' 49' ' ' THR . 93.3 mt -71.3 145.11 90.34 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.786 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.72 -15.2 30.44 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -85.08 1.78 46.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.116 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.17 34.42 29.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.345 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.52 ' HB ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -120.6 148.98 43.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 59.5 mt -98.55 118.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' O ' HG21 ' A' ' 43' ' ' VAL . 59.3 tttm -124.12 124.91 43.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 0.0 110.004 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 3.1 ppt_? -97.63 136.0 38.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.112 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 70.6 mtm -142.61 169.19 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.546 ' HB3' HD12 ' A' ' 38' ' ' LEU . 36.2 mtm180 -91.13 109.39 20.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.714 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.8 t -122.85 152.13 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.3 p -91.39 147.54 22.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.514 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 m -57.43 -28.13 63.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.827 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 p -61.74 -42.34 98.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.66 0.267 . . . . 0.0 111.095 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.591 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 57.3 m -70.56 -34.77 72.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.2 0.524 . . . . 0.0 110.543 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 57' ' ' THR . 53.9 mt -58.34 -51.85 68.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.977 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -79.61 -22.88 43.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.386 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 m -74.9 -28.21 60.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.17 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.43 29.56 63.77 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.248 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -79.17 -17.4 55.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 110.085 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.594 HG13 HG12 ' A' ' 12' ' ' VAL . 32.6 m -97.54 162.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.844 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -81.45 73.65 8.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.406 0.622 . . . . 0.0 110.538 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -84.6 139.78 31.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.727 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.2 -6.69 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.188 0.518 . . . . 0.0 110.077 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.1 t 61.33 94.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.386 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.59 82.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.028 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 60.12 83.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.21 154.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.188 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 t -127.18 135.88 51.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.57 -31.7 28.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.717 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t 58.94 86.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 123.856 0.722 . . . . 0.0 111.274 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -176.34 39.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.598 179.273 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.61 37.76 92.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.594 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -88.03 -23.44 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.558 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 ttm -158.02 115.86 3.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 mp -103.06 113.26 39.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.931 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -118.09 143.62 46.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.387 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 64.89 177.35 0.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.805 0.691 . . . . 0.0 111.465 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -93.09 79.63 4.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.56 0.695 . . . . 0.0 110.154 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -112.44 176.7 4.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.841 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.787 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 42.4 t -78.98 125.87 29.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.84 -15.29 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG12 HG13 ' A' ' 65' ' ' VAL . 56.5 t -92.35 -64.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.773 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.723 ' HG ' ' HD2' ' A' ' 64' ' ' LYS . 62.3 m -93.0 -20.55 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -172.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.85 -1.45 85.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.1 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -68.18 162.19 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.62 0.248 . . . . 0.0 110.915 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -83.88 143.18 42.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.319 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.3 Cg_endo -90.72 96.48 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.825 2.35 . . . . 0.0 113.011 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -143.91 135.25 25.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.24 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.0 m -141.5 -66.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.4 -162.07 35.62 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -149.62 117.45 6.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.922 0.391 . . . . 0.0 110.834 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.9 m -152.33 126.34 9.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.971 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.52 -14.82 7.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.323 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.9 m -66.16 112.44 3.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.597 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m80 63.31 22.49 13.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.788 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -94.2 -25.38 17.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -139.85 151.67 45.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 112.034 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -111.44 -49.88 2.97 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 55.5 tttp -155.46 26.15 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.635 -171.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 t -96.1 160.74 14.29 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.814 -0.554 . . . . 0.0 109.733 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -128.82 -46.41 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -151.92 94.52 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.959 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.42 ' O ' ' HE2' ' A' ' 40' ' ' LYS . 51.2 t-105 -99.02 -18.09 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.959 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.91 178.2 9.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.312 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -88.06 157.28 51.36 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 123.332 0.395 . . . . 0.0 110.316 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 73.2 Cg_exo -50.34 109.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.667 2.245 . . . . 0.0 112.227 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 17.6 m120 74.4 -0.69 3.28 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.345 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.3 mt -120.79 119.7 33.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.421 0.629 . . . . 0.0 112.022 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -92.68 118.87 31.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.807 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 33' ' ' TRP . 55.4 pttt -86.14 118.25 25.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.065 0.459 . . . . 0.0 110.289 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.5 m -127.62 153.28 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.599 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 93.3 mtt180 -90.04 124.38 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.559 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 51' ' ' LYS . 29.1 m -109.08 155.84 9.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.24 134.35 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 49' ' ' THR . 96.8 mt -98.38 147.37 33.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.999 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.11 -13.85 38.01 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.62 1.78 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.787 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.14 63.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.452 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.506 ' HB ' HD13 ' A' ' 45' ' ' LEU . 2.1 m -97.42 152.04 19.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.029 0.442 . . . . 0.0 110.834 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.51 130.11 70.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.178 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' O ' HG21 ' A' ' 43' ' ' VAL . 63.0 tttp -136.46 129.77 31.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 3.1 ptt180 -91.41 130.41 37.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.1 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.4 mtp -129.41 157.57 41.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -82.43 107.52 15.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.571 0.7 . . . . 0.0 110.484 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.787 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 48.4 t -116.11 137.79 48.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.512 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.41 153.69 26.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.44 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -59.55 -30.63 68.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.551 -177.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -61.9 -42.35 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.7 -35.34 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 57' ' ' THR . 78.9 mt -63.43 -48.64 76.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.375 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.521 ' HE3' ' HB2' ' A' ' 77' ' ' SER . 31.3 mmmt -67.22 -37.08 82.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 m -78.83 -31.89 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.229 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 49.34 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.056 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.723 ' HD2' ' HG ' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -90.62 -22.72 21.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.65 HG13 HG12 ' A' ' 12' ' ' VAL . 35.4 m -69.21 148.01 11.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.972 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.69 -51.6 66.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.474 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' HB2' HG21 ' A' ' 65' ' ' VAL . 75.9 tttt 66.88 152.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.913 0.758 . . . . 0.0 112.463 169.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -96.39 87.88 4.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.419 HG13 ' H ' ' A' ' 70' ' ' GLY . 7.2 p 44.67 -75.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.419 ' H ' HG13 ' A' ' 69' ' ' VAL . . . -150.96 168.45 30.65 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.873 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.74 -44.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.748 0.274 . . . . 0.0 111.243 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.8 164.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 m -61.18 119.76 9.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 0.0 110.426 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.521 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 10.6 tm-20 -109.38 -76.83 0.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 74' ' ' GLU . 7.8 p 168.56 -31.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.82 172.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 178.71 29.07 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.477 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.521 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.8 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.081 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.587 0.232 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.22 60.2 9.28 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.088 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -79.59 81.01 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.197 0.522 . . . . 0.0 109.886 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.6 mtp -133.99 110.73 9.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.265 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.2 mm -110.17 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.768 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 168.08 20.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.68 -25.39 68.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.3 68.89 5.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.403 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 7.3 ppt_? -121.43 171.02 9.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.32 140.98 56.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 40.7 mt-10 -74.38 -8.18 55.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.046 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t -111.22 -72.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.385 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.8 t -67.23 -34.94 78.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.998 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 98.8 -15.8 60.36 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.277 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.77 152.3 25.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.682 0.277 . . . . 0.0 110.69 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.59 144.31 27.62 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.89 145.96 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.104 2.536 . . . . 0.0 112.418 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.86 -14.45 14.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.221 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.7 m -144.1 143.92 31.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.987 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.78 145.36 15.96 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.52 -154.34 0.34 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -146.06 -85.26 0.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -139.25 -26.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.782 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -86.89 143.41 27.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.145 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -87.45 171.13 10.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.291 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.6 m -67.0 116.04 7.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.314 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.62 136.75 51.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.211 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.7 tttm 70.18 17.56 7.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.784 0.802 . . . . 0.0 109.776 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.601 ' HG2' ' H ' ' A' ' 30' ' ' SER . 20.2 ttmm -155.08 -178.81 7.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.193 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.601 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 24.1 m -138.86 48.54 1.9 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 61.29 -175.65 0.12 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -170.94 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.448 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -142.75 126.5 17.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.17 0.51 . . . . 0.0 111.366 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -135.69 -171.55 2.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.029 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.76 ' HG3' ' HG2' ' A' ' 54' ' ' ARG . 32.3 mmt180 -111.87 164.55 14.87 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.74 102.16 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.243 1.962 . . . . 0.0 111.495 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 -40.62 0.48 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.572 0.749 . . . . 0.0 111.583 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 27.6 mt -70.78 132.89 46.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.796 0.331 . . . . 0.0 110.618 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.444 ' HB2' HD13 ' A' ' 60' ' ' LEU . 20.1 mt-30 -103.92 131.54 51.04 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' MET . 11.8 ptmt -92.05 109.95 21.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.6 m -116.46 156.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.536 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -88.43 128.16 35.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.587 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.56 153.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 67' ' ' LYS . 88.2 t -83.2 126.45 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.746 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD13 ' HE3' ' A' ' 51' ' ' LYS . 87.0 mt -97.67 143.78 26.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.46 -8.86 20.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.932 2.422 . . . . 0.0 111.604 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -78.49 -3.75 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.499 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.48 37.45 27.36 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.341 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -140.19 155.73 46.81 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.51 121.82 62.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HE3' HD13 ' A' ' 45' ' ' LEU . 41.1 ttmt -123.38 138.15 54.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.131 0.491 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -92.38 106.87 18.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.687 174.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 87.0 mtp -101.59 158.36 16.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.838 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.76 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 86.4 mtm180 -83.74 100.82 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.75 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.51 146.69 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.593 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.4 p -92.64 159.23 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.406 ' OG1' ' HA3' ' A' ' 76' ' ' GLY . 6.1 t -58.3 -26.7 63.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t -61.84 -51.14 69.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 110.403 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 75.4 m -65.21 -38.0 89.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.569 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 39' ' ' GLN . 91.5 mt -65.28 -43.33 91.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.624 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -64.48 -45.61 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.823 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 t -72.68 -32.01 65.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.822 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.31 29.44 66.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.883 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -97.54 49.56 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.663 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 176.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.185 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -79.07 -57.7 3.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.652 0.263 . . . . 0.0 110.808 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.41 ' O ' HG21 ' A' ' 44' ' ' VAL . 42.1 mttt 64.99 172.29 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.654 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -146.15 88.74 1.82 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.806 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.0 m 42.38 85.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.23 0.956 . . . . 0.0 113.186 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.06 130.81 1.89 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.885 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -144.57 130.08 18.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.17 18.68 2.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.556 0.694 . . . . 0.0 109.983 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m 64.94 40.69 5.16 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.752 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -65.77 104.87 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.31 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.95 -49.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA3' ' OG1' ' A' ' 57' ' ' THR . . . 77.43 -130.5 10.38 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.757 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.248 0.995 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.034 176.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.724 0.297 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.05 93.67 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.258 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -104.26 127.19 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 110.62 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.48 -25.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 tt -163.68 145.46 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.209 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -117.36 81.76 1.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.574 0.702 . . . . 0.0 110.307 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.01 88.71 6.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.546 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 62.27 84.37 0.14 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.503 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -102.7 171.9 7.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.789 -175.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.712 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 50.2 t -69.83 131.2 44.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 169.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.544 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 45.1 mt-10 -68.37 -15.16 63.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.857 0.361 . . . . 0.0 111.065 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.23 -70.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.52 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.6 m -82.49 -32.91 28.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.911 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 95.71 10.7 56.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.101 -174.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -74.78 162.4 28.72 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.452 0.301 . . . . 0.0 110.973 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.66 151.07 49.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.887 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 86.5 Cg_endo -82.76 115.44 2.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.751 2.301 . . . . 0.0 113.119 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.66 111.2 9.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.881 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' ' OG1' ' A' ' 22' ' ' THR . 7.4 m -143.84 -24.05 0.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.202 0.525 . . . . 0.0 111.169 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.23 -73.72 2.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.447 ' HB3' HG21 ' A' ' 23' ' ' VAL . 59.2 m-80 -138.49 -72.82 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 19' ' ' SER . 6.1 m 62.22 5.09 1.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.623 0.725 . . . . 0.0 111.626 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 21' ' ' ASN . 27.3 m -86.38 14.96 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -59.33 -46.99 87.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.718 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -155.19 96.53 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.434 0.635 . . . . 0.0 110.764 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 m -96.65 -71.31 0.68 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -149.83 142.09 24.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.726 ' HA ' HH21 ' A' ' 32' ' ' ARG . 0.0 OUTLIER -119.93 18.38 12.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.839 0.352 . . . . 0.0 111.484 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 -38.2 2.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 p -89.51 171.51 9.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.89 0.376 . . . . 0.0 111.517 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -81.63 131.95 35.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.726 HH21 ' HA ' ' A' ' 28' ' ' LYS . 41.6 mtt180 -103.01 103.22 13.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -80.44 -71.86 0.44 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.738 0.304 . . . . 0.0 110.318 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -163.88 137.84 5.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.583 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.9 88.11 4.92 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.52 0.676 . . . . 0.0 111.043 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 38' ' ' LEU . 60.2 Cg_endo -72.78 75.88 2.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.718 2.278 . . . . 0.0 112.239 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.93 -7.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.481 0.712 . . . . 0.0 111.76 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.887 ' HG ' ' HB3' ' A' ' 17' ' ' PRO . 7.4 mt -95.52 107.02 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.094 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' A' ' 39' ' ' GLN . 5.8 mt-30 -84.44 106.7 16.23 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.769 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.0 ptmt -75.69 111.59 11.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 28.1 m -110.77 164.94 6.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.567 -173.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.4 ttp-105 -89.29 106.56 18.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.662 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 28.0 m -118.66 170.81 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.72 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 68' ' ' TYR . 7.3 p -102.59 132.55 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.404 0.621 . . . . 0.0 110.879 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.42 HD11 ' HB ' ' A' ' 49' ' ' THR . 83.3 mt -90.94 144.39 30.03 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.088 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.53 -22.13 73.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.716 2.277 . . . . 0.0 111.308 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.1 -15.79 63.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.931 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 40.23 5.3 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.487 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.42 ' HB ' HD11 ' A' ' 45' ' ' LEU . 2.5 m -138.28 158.2 44.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 126.49 55.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -134.81 144.42 47.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.903 0.382 . . . . 0.0 110.909 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.2 mtt180 -97.92 113.95 25.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.8 mtp -121.68 142.26 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.506 -174.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 42.2 mtm105 -65.96 113.2 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.108 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.712 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 46.3 t -124.61 130.92 73.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.615 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 p -78.1 150.52 33.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 27.4 m -57.89 -30.21 65.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.138 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -60.56 -38.68 85.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.597 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.1 m -79.32 -34.97 41.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.62 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 57' ' ' THR . 85.3 mt -62.8 -38.36 90.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.706 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -58.24 -58.75 7.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.709 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 m -68.9 -31.25 70.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.04 38.88 84.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.64 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 15.44 12.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.203 0.525 . . . . 0.0 111.078 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.6 m -98.66 168.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.599 175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mttt -78.72 81.79 5.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.324 0.583 . . . . 0.0 110.572 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -81.69 143.85 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.429 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 60.7 t80 -91.26 107.91 19.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.98 175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.4 t -92.56 108.9 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.208 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.99 81.1 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.32 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 57.42 45.79 19.24 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.358 0.599 . . . . 0.0 111.003 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -93.94 21.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.732 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.2 m 66.59 41.35 3.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.276 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -76.3 -14.26 60.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.661 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.25 138.07 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -48.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.815 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.612 175.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.835 0.35 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.96 -159.32 9.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -83.25 3.52 30.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.674 0.737 . . . . 0.0 110.087 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 mtm -71.03 -29.4 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.248 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.892 HG23 ' H ' ' A' ' 6' ' ' MET . 6.8 mt 60.02 -164.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.43 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.892 ' H ' HG23 ' A' ' 5' ' ' ILE . 66.1 mtt -87.52 108.48 19.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.23 63.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.915 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 38' ' ' LEU . 22.7 pttm -81.54 64.92 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.57 0.7 . . . . 0.0 111.191 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 165.58 12.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.853 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' C ' ' H ' ' A' ' 12' ' ' VAL . 50.6 t -82.02 114.53 20.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.87 28.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.487 0.661 . . . . 0.0 110.971 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 10' ' ' CYS . 63.9 t -128.22 -62.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.549 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.76 -29.42 7.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.181 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.06 5.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.368 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -102.15 174.62 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.18 89.55 39.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' A' ' 38' ' ' LEU . 43.4 Cg_endo -67.03 119.66 6.7 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.166 2.577 . . . . 0.0 113.125 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.6 mtt-85 -96.05 102.12 13.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.1 m 69.56 164.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.416 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.33 -66.32 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -163.09 105.31 1.01 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.129 0.49 . . . . 0.0 109.683 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -84.67 91.4 7.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.294 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 HG21 ' HE2' ' A' ' 28' ' ' LYS . 21.5 m -73.58 152.23 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.84 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 t -77.87 -164.64 0.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.7 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -113.13 93.62 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 112.201 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -77.32 -56.93 4.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 167.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -143.34 93.93 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.529 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HE2' HG21 ' A' ' 23' ' ' VAL . 65.8 mttp -137.97 97.85 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.827 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -78.66 84.15 4.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.546 0.689 . . . . 0.0 111.312 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 p -173.36 117.68 0.28 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.348 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.66 -50.05 75.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -105.42 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -67.48 99.96 0.81 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.227 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB3' HH11 ' A' ' 35' ' ' ARG . 91.2 t80 -63.45 -25.64 68.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.417 0.627 . . . . 0.0 110.953 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.517 HH11 ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -140.35 84.5 14.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.04 178.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.67 -39.27 4.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.738 2.292 . . . . 0.0 109.927 172.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 7.9 p30 -71.25 -165.85 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.95 173.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 54' ' ' ARG . 29.1 mt 66.47 114.7 0.03 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.584 0.707 . . . . 0.0 110.423 -174.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.428 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -75.14 94.5 2.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.867 177.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -92.48 107.72 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.553 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.68 169.07 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.859 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -83.13 131.11 35.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.523 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.518 HG21 ' HE2' ' A' ' 53' ' ' MET . 31.3 m -123.74 166.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.078 177.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.724 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 34.6 t -101.77 135.87 36.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.941 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.745 HD11 ' HD3' ' A' ' 51' ' ' LYS . 71.8 mt -90.67 152.53 45.04 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.408 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.16 -25.51 64.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.316 2.011 . . . . 0.0 111.753 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.9 -28.98 69.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.83 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.41 -7.3 34.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 45' ' ' LEU . 2.4 m -77.18 156.48 31.53 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.876 0.37 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.53 113.55 38.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.225 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HD3' HD11 ' A' ' 45' ' ' LEU . 18.0 tptp -102.47 152.86 20.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -113.61 114.14 26.04 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.518 ' HE2' HG21 ' A' ' 43' ' ' VAL . 55.0 mtm -131.52 163.6 27.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.373 0.606 . . . . 0.0 112.162 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.63 ' HB3' HD21 ' A' ' 38' ' ' LEU . 36.7 mtm180 -93.04 108.64 20.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.44 153.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.896 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.11 152.83 19.03 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.763 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -58.89 -28.67 66.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -60.34 -50.23 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.5 m -65.62 -34.31 77.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.082 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 60' ' ' LEU . 10.8 mt -68.08 -44.96 75.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.26 -40.5 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.792 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -75.7 -19.52 59.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.22 45.51 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.779 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -95.52 4.46 53.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.173 0.511 . . . . 0.0 110.445 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.96 150.85 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.095 0.474 . . . . 0.0 111.621 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.724 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 57.7 tptt -75.22 97.12 3.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -111.63 147.29 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.166 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -94.08 24.84 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.706 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.0 t 68.87 102.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.565 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.25 -178.53 42.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.258 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.28 -41.64 19.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.062 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 m -78.48 61.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.457 0.646 . . . . 0.0 111.896 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 t -81.82 -15.87 52.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.656 0.741 . . . . 0.0 109.024 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.98 141.57 48.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.616 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -80.21 118.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 111.146 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.96 70.47 2.29 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.056 -176.883 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.18 -132.99 7.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.237 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 m170 49.43 66.18 1.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.172 0.51 . . . . 0.0 111.247 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.2 ttp -84.5 106.02 15.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.253 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.73 100.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.886 ' HE2' ' HA ' ' A' ' 6' ' ' MET . 0.9 OUTLIER -81.36 76.82 8.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -175.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.52 -172.98 1.56 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -87.84 165.47 15.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -90.92 170.95 9.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.5 t -59.6 115.7 3.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.3 -1.83 16.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.562 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.8 t -90.96 -64.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 110.62 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -94.47 -54.42 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.152 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.27 6.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.346 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.11 169.73 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.711 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.74 143.68 27.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.777 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.54 77.09 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.768 2.312 . . . . 0.0 112.337 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -80.0 -34.62 38.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.274 0.559 . . . . 0.0 110.143 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 m -94.69 153.31 17.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.435 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.72 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.58 115.01 9.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 110.205 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m -107.34 2.6 24.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.454 0.645 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 t -82.89 83.04 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.159 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -152.98 168.57 25.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.72 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -115.31 107.86 15.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -67.61 109.69 3.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 29' ' ' LYS . 25.4 t70 -144.53 143.71 30.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 40.2 ttmt 74.73 -24.06 0.22 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.219 0.608 . . . . 0.0 111.449 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 27' ' ' ASP . 18.3 ttmm -89.64 30.64 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.0 110.881 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.0 m 74.15 -54.17 0.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.7 25.59 11.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.712 0.405 . . . . 0.0 110.624 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -93.84 -53.43 4.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.04 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -118.87 95.58 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.542 0.686 . . . . 0.0 111.43 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -146.13 127.35 14.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.102 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -97.89 165.37 15.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.151 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 39.2 Cg_exo -60.89 100.07 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.275 1.984 . . . . 0.0 111.347 173.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 54.1 m-80 71.33 -160.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.015 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 42.7 mt 71.86 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.676 0.751 . . . . 0.0 111.125 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -98.52 96.94 8.32 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 20.8 pttp -74.47 110.06 8.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.81 164.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.294 0.569 . . . . 0.0 111.594 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -99.59 109.83 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.488 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -109.08 161.77 7.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.58 129.38 60.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 0.0 110.63 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.57 HD12 ' HB ' ' A' ' 49' ' ' THR . 74.8 mt -88.66 151.49 47.92 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.88 -32.66 86.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.508 2.805 . . . . 0.0 113.751 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.32 -2.85 54.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.119 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.5 42.35 3.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.281 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.57 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.5 149.88 35.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -106.73 120.74 58.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 2.0 tpmt? -132.78 138.76 47.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 0.0 111.636 -174.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -91.87 122.7 34.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 79.3 mtp -128.68 150.51 50.22 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.843 0.354 . . . . 0.0 110.812 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -91.14 101.63 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.415 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG13 HG11 ' A' ' 65' ' ' VAL . 27.2 t -112.36 152.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.582 -173.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.3 p -92.06 154.6 18.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -61.52 -21.98 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.092 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -62.5 -51.7 66.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.407 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.8 m -64.81 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.571 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.99 -42.12 97.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.55 -48.73 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.12 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.4 m -64.89 -22.61 67.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.02 48.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.703 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -92.16 3.81 54.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.333 0.587 . . . . 0.0 110.556 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG11 HG13 ' A' ' 55' ' ' VAL . 31.4 m -109.31 139.48 32.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.995 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.6 88.77 4.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.952 0.882 . . . . 0.0 109.156 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.758 ' HE2' ' HB3' ' A' ' 71' ' ' GLN . 71.9 tttt -76.22 148.38 37.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.191 -170.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -81.59 11.62 4.52 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 110.453 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t 75.24 -34.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.514 0.726 . . . . 0.0 112.794 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.24 66.28 0.72 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.758 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 5.9 tp-100 -176.04 99.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.361 0.664 . . . . 0.0 109.428 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.499 ' C ' ' HG ' ' A' ' 73' ' ' SER . 43.4 t -95.59 -35.84 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.119 -176.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.499 ' HG ' ' C ' ' A' ' 72' ' ' VAL . 13.4 p 53.57 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.001 0.92 . . . . 0.0 112.422 -174.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -99.53 127.32 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.02 -0.425 . . . . 0.0 110.538 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -91.59 100.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.871 0.367 . . . . 0.0 110.25 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.09 74.67 2.37 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.315 -177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.322 179.222 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.665 0.269 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.17 144.75 14.32 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.567 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -85.51 74.31 10.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.11 -0.82 29.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.079 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt 72.62 119.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.259 0.552 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.2 ttt -66.69 113.25 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.5 80.97 3.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -54.53 140.83 33.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.35 -176.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.595 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 9.6 ptm85 -154.14 162.0 41.49 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.742 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.85 123.51 19.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.22 -1.55 23.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.071 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.631 HG22 HG11 ' A' ' 65' ' ' VAL . 51.7 t -98.4 -70.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.032 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.2 m -91.56 -15.81 28.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.75 27.99 52.33 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.131 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -100.57 144.65 29.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 144.54 86.79 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.595 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 84.1 Cg_endo -82.29 64.64 8.31 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.693 2.262 . . . . 0.0 111.798 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -98.8 106.27 18.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.121 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 m -99.13 -38.68 8.83 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.728 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.09 -115.23 7.51 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.678 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -167.76 123.27 1.04 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.991 0.424 . . . . 0.0 110.056 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 p -71.76 -58.6 3.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 109.937 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.04 -70.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -178.18 126.99 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.845 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -103.49 151.04 23.3 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -80.89 18.74 0.95 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.1 t0 64.55 167.36 0.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.719 0.407 . . . . 0.0 110.98 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt 50.08 54.06 11.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.523 0.678 . . . . 0.0 109.844 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.802 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -80.06 44.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -173.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m 61.04 26.49 16.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.299 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 24.5 tt0 -64.85 -56.4 13.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.745 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 62.51 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 167.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -108.89 2.91 21.82 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.427 0.632 . . . . 0.0 110.762 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.543 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 44.0 m-85 -84.1 176.56 8.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.638 ' HD2' ' HD2' ' A' ' 36' ' ' PRO . 21.0 tpt180 -95.7 143.07 25.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.638 ' HD2' ' HD2' ' A' ' 35' ' ' ARG . 4.5 Cg_endo -48.07 108.21 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.958 2.438 . . . . 0.0 112.656 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 m120 75.5 -12.04 1.03 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.872 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 11.9 mt -106.85 101.29 10.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.526 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -83.48 108.26 16.5 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 -177.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HE2' ' HA ' ' A' ' 34' ' ' PHE . 51.7 mtmt -71.4 110.78 6.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.531 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.64 146.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.905 0.383 . . . . 0.0 110.35 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -83.53 120.16 25.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.241 0.543 . . . . 0.0 110.038 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.14 145.17 22.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.908 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 67' ' ' LYS . 14.2 p -89.02 113.37 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.678 0.751 . . . . 0.0 110.323 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 49' ' ' THR . 94.6 mt -74.83 147.81 84.39 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.269 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.6 -15.27 45.0 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.263 . . . . 0.0 111.668 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.85 -21.79 60.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.727 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.47 0.82 46.92 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.807 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.552 ' HB ' HD13 ' A' ' 45' ' ' LEU . 1.7 m -91.14 155.89 18.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.844 0.354 . . . . 0.0 110.438 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.91 127.14 62.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.258 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -132.35 136.62 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.878 0.371 . . . . 0.0 110.841 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -89.29 117.5 28.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.2 mtp -110.65 143.21 41.44 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.092 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 38' ' ' LEU . 54.4 mtt85 -79.52 100.18 7.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.767 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.16 138.6 40.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.001 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 23.1 p -88.94 163.85 15.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.922 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.548 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.1 p -59.0 -30.2 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.11 -177.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -59.84 -51.97 67.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.967 0.413 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.62 -33.8 69.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.8 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 57' ' ' THR . 79.7 mt -54.99 -43.42 73.56 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.46 -26.93 55.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.537 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.6 m -74.9 -31.56 61.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.897 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.22 77.3 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.593 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.16 -3.0 58.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.309 0.575 . . . . 0.0 110.484 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.64 HG22 ' HG3' ' A' ' 67' ' ' LYS . 31.3 m -85.91 156.36 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.394 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -66.32 -37.85 86.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.514 -176.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.64 ' HG3' HG22 ' A' ' 65' ' ' VAL . 97.3 mttt 61.33 -172.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.702 0.627 . . . . 0.0 111.488 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -115.58 70.5 0.75 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.48 -45.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.614 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.96 -76.81 1.87 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.809 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -78.78 122.47 26.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.711 0.291 . . . . 0.0 111.098 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.84 105.49 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.2 m -117.95 152.78 34.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.767 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -84.52 87.93 7.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.036 0.446 . . . . 0.0 110.14 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -171.16 148.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.118 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.16 39.02 0.61 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.832 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.275 179.039 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.747 0.308 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.35 -59.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.588 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -86.61 85.76 7.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -82.64 -20.88 35.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.67 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' HD12 ' A' ' 5' ' ' ILE . 1.4 pp -87.76 140.48 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 67.3 mtt 59.43 -164.87 0.2 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -166.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 9' ' ' ARG . . . 55.09 30.34 14.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.25 100.33 2.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.931 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 ptp180 -144.84 173.76 11.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.38 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 52.4 t -70.04 114.49 8.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.63 -5.73 21.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 0.0 111.617 -171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.405 HG21 ' CG1' ' A' ' 65' ' ' VAL . 48.5 t -88.95 -58.28 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.166 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 m -102.18 -24.22 13.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.931 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 91.68 22.72 30.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.567 -177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.899 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -93.37 151.42 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.775 -0.25 . . . . 0.0 110.94 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 145.24 69.46 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.369 . . . . 0.0 111.475 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 37.7 Cg_endo -66.71 149.29 83.77 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.867 2.378 . . . . 0.0 111.871 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -153.64 112.16 3.65 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 m 69.95 -56.06 0.59 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.161 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.92 -127.99 9.78 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.49 110.19 4.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -116.79 148.66 40.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.054 0.454 . . . . 0.0 111.424 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -161.85 140.21 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.152 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 p -87.11 100.69 12.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.107 0.48 . . . . 0.0 110.673 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -155.94 73.98 0.84 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.5 m -80.68 95.43 6.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.331 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -148.98 107.59 3.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 59.2 92.8 0.04 OUTLIER 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.986 0.804 . . . . 0.0 111.357 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.88 -175.05 2.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.781 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.4 t -139.12 -178.44 5.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.668 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.02 -5.6 52.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.607 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.3 mpt_? -87.44 86.53 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.494 0.664 . . . . 0.0 111.446 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -116.77 98.84 6.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.403 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -144.44 22.03 1.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.278 0.561 . . . . 0.0 110.254 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 15.9 ptt180 -140.58 64.22 22.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.464 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.27 -16.18 2.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.459 2.106 . . . . 0.0 112.629 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -133.89 -47.16 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.684 0.754 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.53 HD13 ' HB3' ' A' ' 54' ' ' ARG . 13.9 mt -85.0 153.4 22.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.043 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -119.75 110.02 16.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -84.43 109.39 17.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.42 165.45 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.68 114.56 24.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.96 148.78 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.421 . . . . 0.0 110.408 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -102.48 124.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.446 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 49' ' ' THR . 89.9 mt -84.66 146.34 46.48 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.03 -21.93 61.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.748 2.299 . . . . 0.0 111.83 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.69 -26.56 67.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.522 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.69 -0.72 23.24 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.125 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.431 ' HB ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -87.01 149.77 24.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 111.398 -176.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -111.59 113.22 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HG3' ' HG3' ' A' ' 53' ' ' MET . 55.0 tptt -129.03 130.94 47.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.109 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -80.95 115.94 20.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.479 ' HG3' ' HG3' ' A' ' 51' ' ' LYS . 64.0 mtm -123.88 157.51 34.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.319 0.581 . . . . 0.0 111.6 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' CYS . 87.0 mtm180 -77.72 109.4 11.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.757 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.82 141.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.514 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.52 159.28 16.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.561 ' HA ' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -59.25 -32.62 70.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.188 -177.149 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -60.91 -38.86 87.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.307 0.575 . . . . 0.0 110.765 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.66 -34.21 60.48 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.446 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 57' ' ' THR . 91.5 mt -61.09 -53.25 59.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.325 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -60.22 -50.61 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.13 0.491 . . . . 0.0 111.327 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -73.96 -17.46 61.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.138 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.41 40.75 96.53 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -73.16 -14.52 61.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.66 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 67' ' ' LYS . 35.0 m -108.46 158.81 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.132 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -54.59 -52.0 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.719 ' HB2' HG21 ' A' ' 65' ' ' VAL . 34.1 ttpt 62.06 12.91 5.29 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.739 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 t80 65.74 18.67 11.24 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.345 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 69' ' ' VAL . 6.4 t 61.87 30.64 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.631 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . -70.72 162.65 53.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.859 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 96.5 mt-30 68.39 161.94 0.2 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.81 0.444 . . . . 0.0 111.351 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p 43.5 45.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 122.102 0.953 . . . . 0.0 111.201 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.86 -82.85 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.272 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -167.29 100.56 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.263 0.554 . . . . 0.0 110.921 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.8 103.22 13.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.069 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.64 76.23 0.55 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.633 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.251 1.163 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.828 0.347 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.33 105.32 0.51 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.292 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -96.59 -39.56 9.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.807 0.337 . . . . 0.0 111.272 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.1 ttm -149.84 135.62 18.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.865 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.7 mp -89.12 -38.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.2 ttp 71.29 -69.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.036 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.95 -58.62 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -156.17 110.69 2.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.098 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.533 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.3 ppt_? -96.46 -164.75 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.918 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.635 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 47.9 t -55.11 135.32 49.3 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.053 0.454 . . . . 0.0 110.799 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.06 3.22 27.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.042 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.25 -73.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.544 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 83.5 m -108.85 8.33 26.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 84.28 -18.34 23.8 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.382 -0.913 . . . . 0.0 114.416 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -58.39 139.99 54.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.182 0.491 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 69.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.767 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.649 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 61.0 Cg_endo -71.97 94.62 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 111.653 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -62.96 -56.82 13.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.688 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -143.27 -67.63 0.35 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.354 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.38 -63.59 0.31 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.152 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.552 ' O ' ' HB ' ' A' ' 22' ' ' THR . 64.0 t30 74.42 164.7 0.28 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.347 0.659 . . . . 0.0 110.147 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 21' ' ' ASN . 1.1 m 75.36 142.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.903 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.02 123.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.646 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -71.17 98.71 1.74 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.897 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -148.47 133.45 18.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.294 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -142.49 -75.86 0.27 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 18.8 t0 -162.38 135.53 6.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -87.32 76.45 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.6 . . . . 0.0 110.641 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 56.1 mttp -126.16 101.37 6.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.479 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 m 65.84 17.87 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.816 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 57.58 77.4 0.28 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.312 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -95.32 76.65 3.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 109.052 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.9 t-105 -119.93 19.46 12.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.132 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -63.61 112.64 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 57.29 82.21 0.24 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.904 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.53 -38.87 2.25 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.903 2.402 . . . . 0.0 113.746 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.71 -16.36 61.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.248 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.736 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 19.2 mt -89.1 108.33 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.508 HE21 ' HB3' ' A' ' 39' ' ' GLN . 3.3 mt-30 -68.67 97.38 0.8 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.638 0.732 . . . . 0.0 111.022 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 8.2 ptpp? -73.16 110.78 7.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.978 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.64 168.09 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.227 0.537 . . . . 0.0 111.173 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -88.68 114.81 25.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.702 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 m -120.97 159.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.282 0.563 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.0 t -104.57 124.26 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.231 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 49' ' ' THR . 38.8 mt -60.64 148.69 81.13 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.989 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.54 -7.58 9.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.306 2.67 . . . . 0.0 113.774 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -98.78 -69.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.734 0.302 . . . . 0.0 110.249 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.46 57.89 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.021 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 45' ' ' LEU . 1.1 m -144.5 156.65 44.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.52 129.26 67.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.794 0.331 . . . . 0.0 110.149 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HE2' HD22 ' A' ' 45' ' ' LEU . 39.3 ttpt -146.72 152.93 39.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.045 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -94.63 127.16 40.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.4 mtp -135.36 152.18 51.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.736 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 56.8 mtt85 -91.36 110.64 21.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.697 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.635 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 25.4 t -112.29 138.2 42.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.074 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.4 p -88.63 159.55 17.81 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.79 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 t -58.93 -25.82 63.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.572 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 m -63.74 -47.92 79.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 75.4 m -70.58 -34.5 72.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.3 -41.54 97.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.671 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -81.06 -24.81 37.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.157 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.2 t -68.28 -33.02 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.02 22.49 55.37 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.156 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 8.99 28.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.944 0.872 . . . . 0.0 111.182 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.21 161.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.724 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -76.29 147.72 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -152.2 160.56 43.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.0 111.971 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -102.92 3.8 36.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.861 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t 63.49 86.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.08 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.43 -147.45 16.99 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.427 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -136.88 140.94 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 0.0 110.899 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -116.48 27.64 3.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.207 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m 74.9 146.33 0.09 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.739 -170.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.82 115.55 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.459 . . . . 0.0 110.845 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.05 -48.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.94 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.87 -144.24 49.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.007 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.19 -0.91 . . . . 0.0 109.494 176.015 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.27 53.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.933 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -80.83 87.63 5.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.147 0.499 . . . . 0.0 110.437 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.415 ' N ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -148.25 79.55 1.45 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 173.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 4' ' ' MET . 4.5 mp -125.81 89.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.46 -176.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -87.55 -60.25 2.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.94 -41.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.29 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.22 89.75 0.1 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.922 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -128.35 161.3 29.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.615 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -62.48 135.62 57.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.602 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 49.6 mt-10 -81.98 3.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.229 0.538 . . . . 0.0 110.833 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.37 -60.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 t -96.8 -17.4 20.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.285 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.06 84.02 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.846 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -75.19 143.46 43.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.707 0.253 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.86 144.5 36.97 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.871 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -86.21 -0.22 8.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.159 2.572 . . . . 0.0 113.006 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 60.01 -164.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.391 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -116.83 113.36 22.4 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.788 0.327 . . . . 0.0 110.379 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.74 -175.19 28.39 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.775 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -149.67 157.47 43.27 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.573 ' O ' HG13 ' A' ' 23' ' ' VAL . 12.5 t -76.67 -10.94 59.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.474 0.176 . . . . 0.0 111.474 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 22' ' ' THR . 0.9 OUTLIER 66.31 -40.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.433 1.493 . . . . 0.0 113.9 174.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 100.24 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.955 0.407 . . . . 0.0 110.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -178.79 130.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -90.1 -65.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.944 0.402 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -154.33 104.09 2.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.194 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -144.09 -49.32 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.568 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt 69.81 -53.75 0.61 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.324 0.649 . . . . 0.0 110.412 -170.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.6 m 68.2 82.07 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.589 0.756 . . . . 0.0 111.975 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.8 80.15 2.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -141.54 61.69 1.47 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.486 -1.234 . . . . 0.0 107.862 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 60.2 79.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.196 -167.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -68.24 121.95 17.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.024 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.568 ' H ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -130.8 143.61 50.07 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.937 -177.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.78 -37.38 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.525 2.15 . . . . 0.0 112.345 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -151.93 -47.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.888 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 54' ' ' ARG . 9.0 mt -71.12 113.07 7.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.847 0.356 . . . . 0.0 111.628 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.97 100.9 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.252 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.615 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 24.4 ttmt -75.86 110.62 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.73 159.15 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.686 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.584 ' HE ' HG21 ' A' ' 50' ' ' ILE . 65.9 ttt180 -87.02 117.65 25.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.389 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.74 157.33 30.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.857 0.36 . . . . 0.0 110.767 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.5 139.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.693 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD11 ' HB ' ' A' ' 49' ' ' THR . 73.6 mt -86.43 153.32 56.02 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.47 -26.17 52.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.933 2.422 . . . . 0.0 112.689 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.31 -21.88 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.276 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.72 -1.8 26.05 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.231 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.553 ' HB ' HD11 ' A' ' 45' ' ' LEU . 1.4 m -81.41 159.18 24.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.584 HG21 ' HE ' ' A' ' 42' ' ' ARG . 57.5 mt -121.8 133.19 68.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.674 0.273 . . . . 0.0 110.754 -177.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HD2' HD12 ' A' ' 45' ' ' LEU . 63.5 mttm -140.03 164.52 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -121.63 117.63 27.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.2 mtm -138.7 165.4 27.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.964 0.411 . . . . 0.0 111.823 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' HB2' ' A' ' 40' ' ' LYS . 27.8 mmt180 -76.87 119.56 20.8 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.734 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 39.4 t -126.64 139.71 50.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 p -77.39 145.81 37.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.438 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 t -55.08 -30.49 59.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -61.05 -47.39 86.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 55.5 m -72.19 -33.9 68.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.857 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.98 -53.19 60.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.6 -45.67 57.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.589 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 t -69.4 -26.74 64.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.646 0.26 . . . . 0.0 110.997 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.94 48.36 7.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.753 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.25 -28.63 22.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.203 0.525 . . . . 0.0 109.671 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.83 171.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 41.1 tptt -69.32 -44.91 70.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.616 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.602 ' HG2' ' H ' ' A' ' 69' ' ' VAL . 85.8 tttt 71.07 135.19 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.771 0.669 . . . . 0.0 111.227 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.63 -15.22 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.602 ' H ' ' HG2' ' A' ' 67' ' ' LYS . 35.4 t 57.47 78.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.184 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 -56.24 1.66 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 167.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -99.99 141.49 32.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.735 HG22 ' H ' ' A' ' 73' ' ' SER . 2.5 m -84.38 -75.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.735 ' H ' HG22 ' A' ' 72' ' ' VAL . 10.6 p -99.99 156.23 17.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.608 0.242 . . . . 0.0 110.874 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.46 128.68 36.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.2 126.61 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.953 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.52 -27.0 3.01 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.248 0.982 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.12 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.908 0.385 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.63 -44.41 3.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.929 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -98.99 93.8 6.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.733 0.301 . . . . 0.0 110.544 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.7 ttt -95.87 70.71 2.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.487 0.66 . . . . 0.0 110.108 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.9 mm -99.02 99.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.531 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 145.89 28.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.765 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.14 71.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.71 50.49 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.352 0.596 . . . . 0.0 110.554 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.431 ' H ' ' CD ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -80.43 155.29 27.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.738 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 48.8 t -60.61 144.68 51.24 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.05 -8.79 59.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.961 0.41 . . . . 0.0 110.933 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.562 HG21 HG21 ' A' ' 55' ' ' VAL . 57.6 t -100.3 -62.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 42.8 t -91.06 -47.53 7.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.819 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.02 -9.98 27.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.224 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.538 ' HG3' ' SG ' ' A' ' 13' ' ' CYS . 28.7 mtpp -77.5 162.68 26.96 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.711 -0.288 . . . . 0.0 110.25 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.88 144.33 76.02 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.966 0.413 . . . . 0.0 111.416 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.641 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 98.2 Cg_endo -89.7 94.88 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.193 2.595 . . . . 0.0 112.178 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -77.6 -28.47 51.55 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.642 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 57.82 -155.42 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.921 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.64 23.05 30.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.699 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 m120 59.97 61.96 1.76 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m 75.09 145.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.14 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.59 170.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t 65.04 -158.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -95.57 -12.55 25.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 110.654 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 p -142.16 -68.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.001 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.73 -58.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.548 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 25.2 ttmm 66.57 -70.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.447 0.699 . . . . 0.0 111.304 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 28' ' ' LYS . 27.1 mmtp -133.76 -52.13 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.465 0.174 . . . . 0.0 111.149 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t 72.63 -1.82 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.065 0.853 . . . . 0.0 110.888 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 61.55 102.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.611 0.764 . . . . 0.0 112.083 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 73.27 138.17 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.454 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -90.31 -28.19 18.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.718 0.771 . . . . 0.0 108.957 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -85.11 104.83 15.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.493 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 35' ' ' ARG . 29.6 mmt180 61.16 69.98 0.98 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.67 0.607 . . . . 0.0 110.579 -175.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.64 5.43 2.88 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.264 2.643 . . . . 0.0 112.797 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -109.81 -10.16 14.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.634 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.789 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 22.3 mt -120.02 99.75 6.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.706 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.463 ' NE2' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -89.68 123.19 33.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 15.4 ptmt -72.73 122.52 21.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.782 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 t -114.8 156.2 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.639 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -85.46 106.56 16.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.73 166.78 10.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.462 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.17 136.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.594 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 49' ' ' THR . 79.2 mt -97.42 152.2 38.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.55 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.37 -15.75 50.29 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.0 2.467 . . . . 0.0 112.704 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.16 -15.19 57.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.1 15.36 26.22 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.14 -0.553 . . . . 0.0 111.797 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -89.34 149.22 23.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.843 0.354 . . . . 0.0 110.247 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -128.05 111.69 25.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.72 149.42 34.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.788 0.328 . . . . 0.0 110.543 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.27 120.95 31.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.497 ' HE3' HG23 ' A' ' 12' ' ' VAL . 65.7 mtm -130.28 149.85 51.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.932 -177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.789 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 81.9 mtm180 -76.26 113.35 13.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.421 0.629 . . . . 0.0 110.923 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.642 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.9 t -105.23 148.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.089 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.82 148.55 25.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.326 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -58.71 -25.59 63.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.38 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -60.53 -40.72 92.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.365 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.79 -33.89 62.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.565 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.463 HD12 ' NE2' ' A' ' 39' ' ' GLN . 16.1 mt -56.67 -53.59 55.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 61' ' ' LYS . 21.5 ptmt -81.76 -2.49 50.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -86.8 -32.0 20.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.56 46.92 93.32 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.996 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.86 33.74 3.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.163 0.506 . . . . 0.0 111.213 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.22 149.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.779 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -86.37 102.79 14.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.536 0.684 . . . . 0.0 109.887 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -94.78 146.95 23.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.972 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -107.25 43.85 1.13 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.4 t 67.72 102.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.824 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -161.72 121.37 1.02 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.709 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 68.88 89.26 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.406 0.622 . . . . 0.0 111.175 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.17 145.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.662 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.0 m 64.05 75.25 0.39 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.406 0.622 . . . . 0.0 110.282 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -83.47 146.49 28.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.86 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.76 100.5 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.0 82.71 1.67 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.687 179.238 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.31 0.576 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.12 -25.49 55.17 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.471 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -87.64 158.01 18.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -77.2 93.33 3.93 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.762 HD13 ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -66.0 105.55 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.646 0.736 . . . . 0.0 111.156 -178.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -114.0 147.32 38.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.024 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.72 174.75 7.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -67.53 109.66 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.968 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.3 ptm180 -143.77 155.6 44.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.513 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.523 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -68.4 131.95 46.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.502 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.83 2.93 24.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.219 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 65' ' ' VAL . 49.1 t -102.54 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.809 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.495 ' SG ' ' HD2' ' A' ' 64' ' ' LYS . 72.2 m -101.72 -21.23 14.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.581 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.607 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -79.29 145.83 33.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . . . -78.41 155.46 79.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.516 -176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.773 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 84.6 Cg_endo -78.05 109.33 2.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.992 2.462 . . . . 0.0 112.509 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.01 85.9 3.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -100.66 101.75 12.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.351 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.9 -9.27 32.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.698 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -92.03 -28.24 17.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 109.96 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 m 56.94 76.44 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.139 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.86 119.78 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.608 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -144.98 106.3 4.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 111.232 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -120.73 112.11 18.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.549 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.3 m -136.16 12.79 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.47 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 11.7 t70 -173.45 -86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.014 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 25.0 mmmt -173.78 -52.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 29' ' ' LYS . 28.3 ttpt -78.62 -55.04 5.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.358 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m 54.73 69.19 0.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.408 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -82.98 160.54 21.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 1.002 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 60.1 mtt-85 -118.43 104.97 11.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 111.666 -170.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -125.37 -66.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.83 -13.58 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.734 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -151.45 86.25 4.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.265 177.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 1.002 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 2.9 Cg_exo -76.72 -55.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.843 2.362 . . . . 0.0 112.854 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -112.48 -27.42 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.497 0.665 . . . . 0.0 109.487 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.634 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 57.2 mt -86.26 159.77 19.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.609 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -123.39 132.38 53.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -85.41 113.5 21.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.44 167.17 9.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.55 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 18.0 ptp180 -101.13 120.6 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.299 0.571 . . . . 0.0 110.935 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 34.1 m -110.46 167.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.112 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 68' ' ' TYR . 11.9 p -101.65 131.41 49.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.133 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.0 144.92 28.61 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.665 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 -20.1 57.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.616 2.211 . . . . 0.0 111.58 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.19 -27.15 68.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.524 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.74 44.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -99.77 158.31 15.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.757 0.313 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 42' ' ' ARG . 63.7 mt -105.3 116.38 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -106.14 144.75 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.087 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -110.6 125.84 53.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.116 0.484 . . . . 0.0 110.338 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.41 ' HE1' HG22 ' A' ' 43' ' ' VAL . 72.3 mtm -139.22 163.76 31.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.698 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -84.18 120.45 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.523 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 58.5 t -122.87 147.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.706 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 24.7 p -88.57 155.13 19.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.488 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -57.49 -32.71 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.039 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -65.54 -43.08 91.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.977 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.5 m -72.65 -35.58 67.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.664 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.6 -47.01 87.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.614 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.117 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -70.41 -29.41 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.36 28.32 73.64 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.012 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.5 tmtp? -82.83 -21.08 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.379 0.609 . . . . 0.0 109.783 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 55' ' ' VAL . 35.4 m -61.79 163.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.331 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 31.5 mmtp -78.58 59.75 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.576 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -57.59 140.84 49.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.528 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.517 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p90 -78.11 14.49 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.639 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 p 44.36 82.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 112.026 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.7 52.55 0.19 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.692 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 59.33 88.92 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.278 0.561 . . . . 0.0 111.72 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.74 6.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.409 0.623 . . . . 0.0 110.658 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -96.08 108.66 21.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.526 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.89 95.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.56 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -134.88 93.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.665 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.82 -92.92 2.17 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.245 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.046 178.739 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.07 -143.72 5.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.373 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -94.1 91.19 6.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.052 0.453 . . . . 0.0 110.721 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 mmt -127.35 -24.41 3.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.5 mt 69.55 -58.74 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.585 0.553 . . . . 0.0 111.334 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 167.33 11.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.22 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.62 -37.9 0.45 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 58.18 85.16 0.09 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.879 0.737 . . . . 0.0 111.446 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -139.0 165.24 27.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.044 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.653 ' HG ' ' HA ' ' A' ' 55' ' ' VAL . 42.6 t -82.01 143.47 31.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.59 -2.22 25.03 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.68 -67.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.0 p -85.28 -39.41 17.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.777 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 9.97 51.11 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.125 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 56' ' ' CYS . 73.6 mmtt -82.59 158.46 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.37 149.53 47.06 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.022 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.8 Cg_endo -75.16 110.43 3.11 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.691 2.261 . . . . 0.0 112.299 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -91.67 88.36 6.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.47 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.0 m 65.5 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.004 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.02 174.6 39.08 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.834 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -117.05 163.88 15.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.263 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -82.93 142.31 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 0.0 110.798 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.03 -38.12 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.648 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 p -162.85 -36.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.67 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.61 103.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.879 0.737 . . . . 0.0 110.688 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -67.93 -62.94 1.17 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.486 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t70 56.0 26.62 10.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.597 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.943 ' HB3' ' HG2' ' A' ' 31' ' ' GLU . 82.1 tttt -82.84 133.89 35.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.961 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -67.79 -5.33 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.037 0.446 . . . . 0.0 111.511 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.405 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 5.1 m -104.01 3.15 33.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.943 ' HG2' ' HB3' ' A' ' 28' ' ' LYS . 43.0 mm-40 -76.71 126.1 30.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -76.75 167.24 22.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -54.04 109.84 0.52 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.274 0.559 . . . . 0.0 111.901 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 36.8 p90 -106.54 -166.38 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.261 -175.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.724 ' HB3' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -112.43 86.96 8.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.158 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 34' ' ' PHE . 16.7 Cg_exo -67.55 -55.68 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.796 2.331 . . . . 0.0 113.46 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -89.36 -5.45 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.724 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . 20.6 mt -90.48 109.21 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -77.82 101.57 6.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.497 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' MET . 20.5 pttp -78.82 110.23 13.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 33.5 m -125.01 162.25 27.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.301 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.13 120.1 29.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 0.0 110.914 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.53 167.7 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.404 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' N ' ' HA ' ' A' ' 68' ' ' TYR . 9.5 p -89.31 138.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.614 0.721 . . . . 0.0 111.063 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 49' ' ' THR . 88.6 mt -92.52 157.85 39.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.74 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.11 -24.29 39.98 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.724 2.282 . . . . 0.0 112.496 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.95 -19.01 60.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.486 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.71 54.61 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.493 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.9 m -86.73 158.38 19.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.163 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.14 122.81 66.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 45' ' ' LEU . 41.0 ttmt -141.51 147.72 38.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.5 mtm180 -88.0 134.98 33.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 63.0 mtm -138.56 170.61 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.485 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -82.54 110.72 17.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.079 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.653 ' HA ' ' HG ' ' A' ' 10' ' ' CYS . 49.6 t -115.57 144.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.927 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HG ' ' HB2' ' A' ' 15' ' ' LYS . 25.5 p -90.79 152.47 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.517 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -58.94 -25.42 63.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 m -61.08 -45.43 94.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.444 . . . . 0.0 110.351 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.71 -34.58 75.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.02 -45.55 77.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.796 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.59 -7.78 53.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.753 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 t -117.2 -4.12 11.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.866 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.92 62.05 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.118 -175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -87.64 56.77 4.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.983 0.897 . . . . 0.0 111.08 -171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.536 HG21 ' HD3' ' A' ' 67' ' ' LYS . 5.6 m -143.43 156.84 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 3.14 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.57 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HD3' HG21 ' A' ' 65' ' ' VAL . 3.7 mppt? 57.77 -168.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.911 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.579 ' HA ' ' N ' ' A' ' 44' ' ' VAL . 13.1 p90 -94.83 -12.05 27.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 110.956 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.31 -52.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.91 144.36 4.43 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -144.28 148.9 35.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.69 -177.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.181 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.0 m 67.52 23.87 8.84 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.507 0.504 . . . . 0.0 111.327 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.37 -33.46 75.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.446 0.641 . . . . 0.0 109.634 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.08 40.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.023 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.11 -25.57 69.67 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.063 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.958 177.414 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mptt . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 23.5 ptt-85 -135.76 -174.08 3.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.44 119.69 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.732 0.301 . . . . 0.0 110.379 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.09 -5.52 46.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.145 0.498 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.22 -51.2 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.6 m -114.13 -12.6 12.51 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 -16.57 60.34 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.733 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -74.99 153.57 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.52 0.66 . . . . 0.0 111.267 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.19 153.78 69.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.181 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.847 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 94.3 Cg_endo -80.13 91.28 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.722 2.281 . . . . 0.0 111.464 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.036 -173.788 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.866 0.278 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 67.63 8.99 6.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.93 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.847 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 12.7 mt -116.95 122.76 45.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.255 0.55 . . . . 0.0 111.964 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -106.49 116.85 32.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.079 173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 53' ' ' MET . 80.2 mttt -74.49 116.17 14.87 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 168.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.55 136.78 44.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.296 0.569 . . . . 0.0 109.526 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 42' ' ' ARG . 26.5 ttm180 -80.7 106.46 12.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.546 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -111.04 170.04 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.369 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.88 131.34 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 85.6 mt -90.52 144.18 30.3 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.058 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 25.3 Cg_exo -64.11 -14.58 44.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.947 2.431 . . . . 0.0 112.507 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.85 -4.0 57.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.636 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.77 55.05 2.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.82 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 m -149.14 159.02 44.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.94 127.12 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.87 141.85 44.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.428 . . . . 0.0 111.694 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -91.26 120.44 32.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 49.8 mtm -125.3 149.41 48.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.875 0.369 . . . . 0.0 111.015 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -80.11 107.95 13.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.17 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.36 134.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.6 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 17' ' ' PRO . 44.2 t -74.9 149.56 39.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.269 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.7 m -56.04 -30.99 62.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.344 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -59.11 -49.22 78.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.189 0.519 . . . . 0.0 110.151 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.4 m -69.11 -37.01 78.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.378 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.26 -41.29 99.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.143 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.55 -39.72 64.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -68.9 -32.94 72.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.7 62.05 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.727 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.29 19.14 7.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.052 0.453 . . . . 0.0 111.486 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -102.7 162.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.92 106.75 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -121.55 152.03 39.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.681 -167.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.026 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 122.057 0.932 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' A' ' 14' ' ' GLY . 21.3 ptt180 -97.74 -177.87 3.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.203 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.3 t -67.37 120.79 14.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 167.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 53' ' ' MET . 41.6 mt-10 -71.71 -10.84 60.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.061 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG11 HG12 ' A' ' 65' ' ' VAL . 58.5 t -81.9 -71.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -97.41 -46.72 5.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 0.0 111.022 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 9' ' ' ARG . . . 120.27 21.3 3.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.059 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.73 177.57 8.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.877 0.339 . . . . 0.0 111.396 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . . . -110.62 91.35 12.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.692 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 36.2 Cg_endo -63.37 146.94 93.82 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.644 2.229 . . . . 0.0 112.093 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.78 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--O 1.233 0.23 0 N-CA-C 112.714 0.236 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 63.04 13.87 7.11 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.718 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 54' ' ' ARG . 14.1 mt -117.44 152.12 35.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.12 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.448 ' HB2' HD11 ' A' ' 60' ' ' LEU . 31.5 mm-40 -118.66 97.89 5.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 53' ' ' MET . 61.1 pttt -81.45 112.68 18.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.228 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.88 168.37 21.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.836 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -78.66 135.51 37.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.88 143.91 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.92 136.19 45.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.396 0.617 . . . . 0.0 110.873 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.0 mt -98.53 143.01 25.54 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.486 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.61 -15.75 48.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.856 2.37 . . . . 0.0 112.321 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.63 -16.21 60.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.441 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 52.24 0.88 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.143 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.8 m -145.95 154.51 42.0 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.575 -0.368 . . . . 0.0 110.561 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.36 117.29 44.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -120.89 142.64 49.49 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -101.72 119.11 38.27 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.572 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 62.8 mtm -133.99 155.5 49.86 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.099 0.476 . . . . 0.0 111.834 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HB3' HD22 ' A' ' 38' ' ' LEU . 69.3 mtm180 -76.12 116.41 16.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.86 148.47 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.823 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 10.9 p -91.22 155.94 18.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.602 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -61.36 -26.71 68.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.095 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 p -64.51 -41.3 96.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.72 0.295 . . . . 0.0 110.836 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.22 -34.45 61.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.52 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 92.4 mt -59.34 -51.82 68.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.269 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -72.5 -33.98 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.8 p -74.37 -24.71 59.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.072 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.33 44.01 23.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.276 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -95.26 11.9 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.448 0.642 . . . . 0.0 109.932 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 HG11 ' A' ' 12' ' ' VAL . 28.5 m -120.94 138.46 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.898 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -86.08 98.89 11.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -94.4 30.8 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.952 -166.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.212 177.156 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.471 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 85.0 tttt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -74.47 178.41 5.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.432 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 41.5 t -55.02 128.68 34.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.071 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 8' ' ' LYS . 38.7 mt-10 -76.57 5.14 7.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.639 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.28 -58.38 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.1 -23.09 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.93 4.4 36.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.474 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mttp -74.15 176.75 6.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.74 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.05 144.52 29.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.217 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 89.4 Cg_endo -82.28 150.87 15.53 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.4 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.448 . . . . 0.0 109.986 177.304 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo . . . . . 0 N--CA 1.464 -0.232 0 CA-C-O 121.158 0.399 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 18.8 m120 -84.52 -171.13 3.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.276 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 28.6 mt 68.46 106.8 0.05 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.652 0.739 . . . . 0.0 110.162 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' A' ' 39' ' ' GLN . 6.6 mm-40 -77.66 93.43 4.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.783 -173.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' MET . 17.3 pttp -78.01 109.85 12.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.641 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.47 160.71 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.527 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -95.12 126.84 40.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.704 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 67' ' ' LYS . 34.3 m -123.42 156.04 29.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.014 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 68' ' ' TYR . 7.2 p -109.11 122.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.636 0.731 . . . . 0.0 110.44 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.9 mt -79.37 143.43 59.99 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.374 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.8 -21.48 69.41 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.98 2.453 . . . . 0.0 112.795 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.72 -23.89 56.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.111 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.27 67.09 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.695 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.489 ' HB ' HD12 ' A' ' 45' ' ' LEU . 3.4 m -153.38 154.6 34.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.578 -0.366 . . . . 0.0 110.13 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.58 113.28 22.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -134.84 148.23 50.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.765 0.317 . . . . 0.0 111.229 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -99.21 119.77 38.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.7 mtm -132.58 157.6 44.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.027 0.442 . . . . 0.0 110.851 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.683 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 49.9 mtm180 -87.68 103.92 16.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.464 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.505 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.7 t -98.98 154.34 4.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.825 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 15' ' ' LYS . 28.4 p -90.02 149.79 22.38 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.173 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -57.5 -29.45 64.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.111 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -62.68 -47.73 82.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.797 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.0 m -64.94 -34.29 78.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.293 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.18 -50.53 72.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -66.06 -30.31 70.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.13 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -31.75 54.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.73 31.18 56.68 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.571 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -79.02 -25.45 43.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.964 0.411 . . . . 0.0 110.91 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.489 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 28.0 m -77.04 143.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.61 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.06 -3.65 55.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.598 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 45.47 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.226 . . . . 0.0 114.206 174.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.8 t80 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.734 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 tttm . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.605 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 10.0 ptp180 -152.83 169.71 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.817 -172.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.25 127.84 34.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 38.3 mt-10 -73.99 -15.02 61.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.758 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.02 -57.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.463 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -102.0 -36.14 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 103.39 8.34 41.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.572 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -87.36 150.23 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.83 144.49 85.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 71.5 Cg_endo -94.97 141.73 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.382 2.721 . . . . 0.0 113.312 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 173.788 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.531 0.357 0 N-CA-C 113.704 0.617 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' PRO . 41.7 m-80 71.48 -8.1 1.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.56 172.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.8 mt -117.55 123.62 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.296 0.569 . . . . 0.0 111.758 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -105.44 107.69 18.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.561 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 19.1 ttmm -76.57 108.51 9.61 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.67 168.91 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.945 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -81.02 117.33 21.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.785 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . 33.6 m -117.29 163.5 14.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.81 134.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.497 . . . . 0.0 110.245 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' A' ' 49' ' ' THR . 90.0 mt -93.14 153.3 41.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.805 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.74 -27.58 43.41 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.34 2.694 . . . . 0.0 113.355 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.88 -1.44 52.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 111.63 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.93 2.19 59.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.3 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.556 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -77.56 152.5 33.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.786 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.11 126.75 70.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -141.83 157.22 45.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.38 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 99.4 mtt180 -98.36 129.88 45.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.2 mtm -138.33 150.91 47.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.201 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 79.3 mtm180 -76.88 119.59 20.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 65' ' ' VAL . 37.6 t -120.77 148.18 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 17' ' ' PRO . 20.2 p -87.13 149.75 24.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.431 ' HA ' HD12 ' A' ' 60' ' ' LEU . 5.5 m -56.75 -30.26 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.499 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.76 -40.25 91.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.238 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.7 m -79.53 -35.53 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 57' ' ' THR . 95.2 mt -60.01 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -78.92 -5.54 53.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.316 0.579 . . . . 0.0 110.644 -176.271 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -94.34 -27.4 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 109.74 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.79 56.12 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 9.4 mmmm -89.25 30.59 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.75 0.31 . . . . 0.0 110.983 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 55' ' ' VAL . 20.1 m -122.12 129.43 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.674 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -80.49 98.28 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.0 pttt -110.77 177.54 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.727 -167.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.0 t80 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.87 172.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.284 0.564 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -124.44 -176.2 3.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.246 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 53.1 t -64.89 123.68 20.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.13 -4.28 34.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 0.0 111.301 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.7 t -92.58 -65.88 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 111.12 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.02 -13.95 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.734 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.57 86.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.546 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.15 158.57 34.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.55 148.05 87.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.7 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.1 Cg_endo -74.12 113.77 3.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.482 2.121 . . . . 0.0 112.062 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 8.7 tpt180 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.658 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.475 0.403 0 N-CA-C 113.751 0.635 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -111.9 -9.19 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.55 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 mt -121.14 118.67 30.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.083 0.468 . . . . 0.0 111.212 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -88.37 107.65 18.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.249 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -81.71 110.21 16.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.684 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.725 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 24.7 m -122.83 157.92 27.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.674 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 50' ' ' ILE . 68.5 mtp180 -92.73 123.28 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.104 0.478 . . . . 0.0 110.44 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.666 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 32.9 m -115.86 164.75 11.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.07 128.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.67 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -95.17 150.54 37.8 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.782 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.46 -11.28 27.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.772 2.315 . . . . 0.0 112.254 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.11 -13.67 56.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.713 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.37 3.66 58.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.576 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.83 154.45 17.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.523 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 42' ' ' ARG . 55.4 mt -115.21 110.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.142 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.95 151.23 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.089 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 65.2 mtt180 -84.16 137.76 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 43' ' ' VAL . 86.7 mtp -133.04 154.64 50.35 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -85.73 103.88 14.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.86 146.15 18.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.961 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 28.0 p -96.24 157.52 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.76 0.314 . . . . 0.0 110.82 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 p -61.13 -25.04 66.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.737 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.421 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 32.1 t -58.65 -52.38 65.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.3 m -64.3 -34.28 77.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.444 . . . . 0.0 111.006 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 57' ' ' THR . 81.4 mt -63.71 -50.51 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.22 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -81.13 -19.21 44.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 m -81.86 -12.16 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.992 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.77 54.91 25.56 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.372 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -135.89 76.02 1.58 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 0.0 109.449 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.77 172.86 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.51 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 12.1 ptmm? -122.37 45.75 2.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.613 0.721 . . . . 0.0 110.258 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.725 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 2.8 mmmp? -80.9 -177.91 6.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.162 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 . . . . . 0 C--N 1.325 -0.5 0 CA-C-O 121.086 0.47 . . . . 0.0 111.084 177.311 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.323 0.582 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.9 ptm180 -150.04 166.4 29.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.759 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.44 124.75 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.128 0.267 . . . . 0.0 110.354 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.22 -7.87 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.464 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -85.79 -67.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 111.114 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.2 m -94.16 -22.89 18.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.256 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.32 -2.7 61.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.329 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.66 166.12 23.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.74 0.305 . . . . 0.0 111.74 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.63 144.12 72.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.906 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 95.9 Cg_endo -85.64 151.82 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.791 2.327 . . . . 0.0 113.644 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.966 173.079 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 N-CA-C 112.944 0.325 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.91 3.48 17.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 109.826 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 54' ' ' ARG . 23.0 mt -126.3 129.73 49.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.239 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -82.82 89.19 6.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.327 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.53 114.22 4.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.103 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.55 153.86 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -93.32 124.84 37.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.941 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.86 155.46 17.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.02 117.56 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.274 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' HB ' ' A' ' 49' ' ' THR . 85.2 mt -82.07 152.87 69.0 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.938 175.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.75 -29.96 64.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.851 2.367 . . . . 0.0 112.917 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.15 -27.97 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.177 0.513 . . . . 0.0 110.65 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.86 7.05 25.91 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.3 m -83.1 151.03 25.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.051 0.453 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.5 mt -105.51 108.34 24.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -112.8 134.42 54.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.977 0.418 . . . . 0.0 111.199 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -91.0 120.5 32.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 43.3 mtm -127.62 157.01 41.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.566 0.698 . . . . 0.0 111.513 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.648 ' HB3' HD13 ' A' ' 38' ' ' LEU . 77.1 mtm180 -87.58 101.02 13.23 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.439 174.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 65' ' ' VAL . 21.2 t -115.12 145.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.56 -175.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.4 p -90.32 153.51 20.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.178 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.487 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -56.99 -26.38 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.595 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 t -64.09 -48.52 75.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.2 m -67.44 -33.26 74.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 57' ' ' THR . 76.1 mt -62.04 -53.38 56.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -77.75 -54.59 6.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.289 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -107.01 2.7 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.33 23.09 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.257 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 78.36 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.344 0.592 . . . . 0.0 111.056 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 55' ' ' VAL . 17.5 m -105.72 125.06 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 0.0 110.679 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -77.23 82.14 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -69.47 128.12 35.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.93 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.614 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' PRO . 22.4 pttp . . . . . 0 C--O 1.227 -0.084 0 CA-C-O 121.524 0.678 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD2' ' C ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -103.29 176.5 5.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.012 177.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 40.6 t -60.1 124.35 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 54' ' ' ARG . 8.5 mm-40 -60.09 -22.1 62.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.117 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 40.3 t -98.75 -70.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.517 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -78.68 -19.02 53.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.841 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.79 2.37 81.16 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.337 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -80.19 164.63 23.13 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.788 0.328 . . . . 0.0 110.75 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.79 147.94 89.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.486 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.798 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 90.6 Cg_endo -79.04 122.32 5.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.765 2.31 . . . . 0.0 111.827 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 . . . . . 0 C--N 1.321 -0.647 0 CA-C-O 121.278 0.561 . . . . 0.0 110.575 -178.839 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo . . . . . 0 C--O 1.235 0.362 0 CA-C-O 121.066 0.361 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 17' ' ' PRO . 43.4 m-80 -136.37 166.1 24.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.487 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 18.8 mt 71.87 112.95 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.967 0.792 . . . . 0.0 111.032 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -104.48 113.75 27.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.668 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 53' ' ' MET . 21.7 pttp -77.24 110.38 11.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.98 168.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.424 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -96.1 115.61 27.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.874 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.2 155.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.759 0.314 . . . . 0.0 110.178 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.5 126.85 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.256 0.551 . . . . 0.0 109.924 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.469 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.1 mt -79.69 144.89 61.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.929 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 31.3 Cg_exo -59.35 -21.3 60.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.54 2.16 . . . . 0.0 111.936 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.04 -17.23 62.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.522 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.59 3.93 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.108 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -123.03 153.34 39.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.684 0.278 . . . . 0.0 110.787 -176.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.51 119.8 52.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -136.27 137.26 40.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -90.69 124.33 35.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 88.1 mtp -134.62 160.78 37.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.001 0.429 . . . . 0.0 111.345 -175.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HB3' HD22 ' A' ' 38' ' ' LEU . 50.3 mtt85 -81.83 102.1 10.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.339 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.8 138.16 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 83.3 m -80.04 153.74 28.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.595 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 60' ' ' LEU . 3.4 m -61.15 -26.35 67.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.454 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -62.78 -42.77 99.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.325 0.583 . . . . 0.0 110.148 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 62.1 m -70.86 -33.78 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.121 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 57' ' ' THR . 96.4 mt -63.86 -36.03 82.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.2 -63.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.618 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -92.93 -24.62 18.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.869 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' CYS . . . 113.02 -101.79 1.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.826 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 17.8 3.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.587 . . . . 0.0 111.067 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 27.4 m -141.33 -179.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -79.39 -44.35 21.64 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 70.43 143.69 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 111.176 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 111.02 -177.288 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -86.33 -179.05 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.812 174.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' HB3' ' H ' ' A' ' 15' ' ' LYS . 44.8 t -60.96 114.58 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -62.74 -14.63 46.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 65' ' ' VAL . 45.8 t -80.39 -63.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.611 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 82.5 m -120.77 6.55 10.45 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -172.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.544 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 71.79 25.3 75.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.934 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG3' ' SG ' ' A' ' 59' ' ' CYS . 29.3 mmmt -74.9 160.91 30.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -91.74 144.04 28.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.4 Cg_endo -89.02 136.95 3.08 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.904 2.403 . . . . 0.0 113.19 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 18' ' ' ARG . 24.6 mtm180 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.563 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 CA-C-O 121.142 0.392 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.1 -5.9 32.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 54' ' ' ARG . 37.6 mt -116.3 135.91 53.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.671 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' CB ' HD11 ' A' ' 60' ' ' LEU . 7.9 mm-40 -86.64 109.79 19.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.528 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.66 109.12 15.79 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.59 165.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 42' ' ' ARG . 3.4 mpt_? -105.06 124.51 49.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.74 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 51' ' ' LYS . 25.0 m -108.0 152.64 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.893 0.378 . . . . 0.0 110.268 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.76 111.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HB ' ' A' ' 49' ' ' THR . 93.3 mt -71.3 145.11 90.34 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.786 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 32.7 Cg_exo -59.72 -15.2 30.44 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -85.08 1.78 46.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.116 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.17 34.42 29.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.345 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -120.6 148.98 43.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 42' ' ' ARG . 59.5 mt -98.55 118.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.3 tttm -124.12 124.91 43.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 0.0 110.004 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 3.1 ppt_? -97.63 136.0 38.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.112 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 70.6 mtm -142.61 169.19 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HB3' HD13 ' A' ' 38' ' ' LEU . 36.2 mtm180 -91.13 109.39 20.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.714 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.8 t -122.85 152.13 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.3 p -91.39 147.54 22.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.504 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 m -57.43 -28.13 63.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.827 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 p -61.74 -42.34 98.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.66 0.267 . . . . 0.0 111.095 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.606 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 57.3 m -70.56 -34.77 72.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.2 0.524 . . . . 0.0 110.543 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 57' ' ' THR . 53.9 mt -58.34 -51.85 68.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.977 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -79.61 -22.88 43.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.386 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 m -74.9 -28.21 60.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.17 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.43 29.56 63.77 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.248 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -79.17 -17.4 55.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 110.085 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 12' ' ' VAL . 32.6 m -97.54 162.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.844 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -81.45 73.65 8.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.406 0.622 . . . . 0.0 110.538 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -84.6 139.78 31.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.727 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.188 0.518 . . . . 0.0 110.077 177.88 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.56 0.695 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -112.44 176.7 4.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.841 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.4 t -78.98 125.87 29.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.84 -15.29 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 56.5 t -92.35 -64.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.773 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.3 m -93.0 -20.55 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.85 -1.45 85.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.1 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -68.18 162.19 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.62 0.248 . . . . 0.0 110.915 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -83.88 143.18 42.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.319 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.3 Cg_endo -90.72 96.48 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.825 2.35 . . . . 0.0 113.011 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.24 176.994 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 73.2 Cg_exo . . . . . 0 N--CA 1.464 -0.264 0 CA-C-O 120.602 0.168 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 17.6 m120 74.4 -0.69 3.28 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.345 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.3 mt -120.79 119.7 33.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.421 0.629 . . . . 0.0 112.022 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -92.68 118.87 31.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.807 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -86.14 118.25 25.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.065 0.459 . . . . 0.0 110.289 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.5 m -127.62 153.28 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.599 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 93.3 mtt180 -90.04 124.38 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.559 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.1 m -109.08 155.84 9.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.24 134.35 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.519 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.8 mt -98.38 147.37 33.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.999 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.11 -13.85 38.01 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.62 1.78 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.787 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.14 63.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.452 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.1 m -97.42 152.04 19.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.029 0.442 . . . . 0.0 110.834 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.51 130.11 70.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.178 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 43' ' ' VAL . 63.0 tttp -136.46 129.77 31.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' ARG . 3.1 ptt180 -91.41 130.41 37.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.1 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.4 mtp -129.41 157.57 41.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -82.43 107.52 15.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.571 0.7 . . . . 0.0 110.484 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.645 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 48.4 t -116.11 137.79 48.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.512 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.41 153.69 26.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -59.55 -30.63 68.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.551 -177.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -61.9 -42.35 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.7 -35.34 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 57' ' ' THR . 78.9 mt -63.43 -48.64 76.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.375 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -67.22 -37.08 82.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 m -78.83 -31.89 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.229 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 49.34 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.056 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -90.62 -22.72 21.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 35.4 m -69.21 148.01 11.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.972 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.69 -51.6 66.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.474 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 65' ' ' VAL . 75.9 tttt 66.88 152.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.913 0.758 . . . . 0.0 112.463 169.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.1 t80 . . . . . 0 C--N 1.322 -0.597 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.848 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 7.3 ppt_? -121.43 171.02 9.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.32 140.98 56.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 40.7 mt-10 -74.38 -8.18 55.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.046 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t -111.22 -72.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.385 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.8 t -67.23 -34.94 78.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.998 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 98.8 -15.8 60.36 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.277 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.77 152.3 25.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.682 0.277 . . . . 0.0 110.69 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.59 144.31 27.62 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.89 145.96 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.104 2.536 . . . . 0.0 112.418 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.221 179.051 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--O 1.234 0.292 0 N-CA-C 111.495 -0.233 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 -40.62 0.48 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.572 0.749 . . . . 0.0 111.583 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.6 mt -70.78 132.89 46.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.796 0.331 . . . . 0.0 110.618 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HB2' HD11 ' A' ' 60' ' ' LEU . 70.1 mt-30 -103.92 131.54 51.04 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' MET . 11.8 ptmt -92.05 109.95 21.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.6 m -116.46 156.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.536 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -88.43 128.16 35.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.587 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.8 m -124.56 153.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.563 177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 67' ' ' LYS . 88.2 t -83.2 126.45 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.746 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.505 HD11 ' HE3' ' A' ' 51' ' ' LYS . 87.0 mt -97.67 143.78 26.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.46 -8.86 20.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.932 2.422 . . . . 0.0 111.604 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -78.49 -3.75 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.499 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.48 37.45 27.36 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.341 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -140.19 155.73 46.81 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.51 121.82 62.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.1 ttmt -123.38 138.15 54.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.131 0.491 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -92.38 106.87 18.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.687 174.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 87.0 mtp -101.59 158.36 16.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.838 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 86.4 mtm180 -83.74 100.82 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.75 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.51 146.69 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.593 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.4 p -92.64 159.23 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 t -58.3 -26.7 63.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t -61.84 -51.14 69.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 110.403 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.64 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 75.4 m -65.21 -38.0 89.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.569 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 39' ' ' GLN . 91.5 mt -65.28 -43.33 91.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.624 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -64.48 -45.61 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.823 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 t -72.68 -32.01 65.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.822 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.31 29.44 66.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.883 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.64 ' HE2' ' HA ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -97.54 49.56 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.663 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 176.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.185 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -79.07 -57.7 3.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.652 0.263 . . . . 0.0 110.808 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.1 mttt 64.99 172.29 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.654 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.806 173.841 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.418 0.627 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -102.7 171.9 7.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.789 -175.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 50.2 t -69.83 131.2 44.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 169.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 45.1 mt-10 -68.37 -15.16 63.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.857 0.361 . . . . 0.0 111.065 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.23 -70.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.52 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.6 m -82.49 -32.91 28.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.911 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 95.71 10.7 56.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.101 -174.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -74.78 162.4 28.72 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.452 0.301 . . . . 0.0 110.973 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.66 151.07 49.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.92 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 86.5 Cg_endo -82.76 115.44 2.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.751 2.301 . . . . 0.0 113.119 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.881 175.81 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LEU . 60.2 Cg_endo . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.729 0.22 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.93 -7.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.481 0.712 . . . . 0.0 111.76 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.92 ' HG ' ' HB3' ' A' ' 17' ' ' PRO . 7.4 mt -95.52 107.02 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.094 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -84.44 106.7 16.23 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.769 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.0 ptmt -75.69 111.59 11.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 28.1 m -110.77 164.94 6.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.567 -173.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 42' ' ' ARG . 35.4 ttp-105 -89.29 106.56 18.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.662 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 28.0 m -118.66 170.81 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.72 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 68' ' ' TYR . 7.3 p -102.59 132.55 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.404 0.621 . . . . 0.0 110.879 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 49' ' ' THR . 83.3 mt -90.94 144.39 30.03 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.088 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.53 -22.13 73.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.716 2.277 . . . . 0.0 111.308 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.1 -15.79 63.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.931 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 40.23 5.3 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.487 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.5 m -138.28 158.2 44.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 126.49 55.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -134.81 144.42 47.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.903 0.382 . . . . 0.0 110.909 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.2 mtt180 -97.92 113.95 25.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.8 mtp -121.68 142.26 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.506 -174.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 42.2 mtm105 -65.96 113.2 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.108 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.713 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 46.3 t -124.61 130.92 73.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.615 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 p -78.1 150.52 33.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 27.4 m -57.89 -30.21 65.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.138 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -60.56 -38.68 85.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.597 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.1 m -79.32 -34.97 41.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.62 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 57' ' ' THR . 85.3 mt -62.8 -38.36 90.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.706 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -58.24 -58.75 7.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.709 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 m -68.9 -31.25 70.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.04 38.88 84.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.64 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 15.44 12.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.203 0.525 . . . . 0.0 111.078 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' LYS . 35.6 m -98.66 168.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.599 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mttt -78.72 81.79 5.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.324 0.583 . . . . 0.0 110.572 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG3' HG23 ' A' ' 65' ' ' VAL . 56.7 mtpt -81.69 143.85 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.429 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 60.7 t80 . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.98 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 38' ' ' LEU . 22.7 pttm . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.57 0.7 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 165.58 12.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.853 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 12' ' ' VAL . 50.6 t -82.02 114.53 20.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.87 28.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.487 0.661 . . . . 0.0 110.971 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 10' ' ' CYS . 63.9 t -128.22 -62.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.549 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.76 -29.42 7.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.181 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.06 5.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.368 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' CYS . 48.9 mtpt -102.15 174.62 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.18 89.55 39.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 38' ' ' LEU . 43.4 Cg_endo -67.03 119.66 6.7 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.166 2.577 . . . . 0.0 113.125 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.6 mtt-85 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.82 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 C--O 1.233 0.26 0 N-CA-C 109.927 -0.836 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 7.9 p30 -71.25 -165.85 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.95 173.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 54' ' ' ARG . 29.1 mt 66.47 114.7 0.03 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.584 0.707 . . . . 0.0 110.423 -174.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -75.14 94.5 2.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.867 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -92.48 107.72 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.553 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.68 169.07 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.859 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -83.13 131.11 35.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.523 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.74 166.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.078 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.752 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 34.6 t -101.77 135.87 36.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.941 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.769 HD11 ' HD3' ' A' ' 51' ' ' LYS . 71.8 mt -90.67 152.53 45.04 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.408 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.16 -25.51 64.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.316 2.011 . . . . 0.0 111.753 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.9 -28.98 69.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.83 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.41 -7.3 34.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.566 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.4 m -77.18 156.48 31.53 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.876 0.37 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.53 113.55 38.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.225 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HD3' HD11 ' A' ' 45' ' ' LEU . 18.0 tptp -102.47 152.86 20.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -113.61 114.14 26.04 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.0 mtm -131.52 163.6 27.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.373 0.606 . . . . 0.0 112.162 -173.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HB3' HD22 ' A' ' 38' ' ' LEU . 36.7 mtm180 -93.04 108.64 20.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.44 153.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.896 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.11 152.83 19.03 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.763 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -58.89 -28.67 66.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -60.34 -50.23 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.5 m -65.62 -34.31 77.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.082 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 60' ' ' LEU . 10.8 mt -68.08 -44.96 75.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.26 -40.5 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.792 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -75.7 -19.52 59.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.22 45.51 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.779 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -95.52 4.46 53.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.173 0.511 . . . . 0.0 110.445 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.96 150.85 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.095 0.474 . . . . 0.0 111.621 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.752 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 57.7 tptt -75.22 97.12 3.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -111.63 147.29 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.166 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.2 p90 . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.706 176.758 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' O ' HD11 ' A' ' 38' ' ' LEU . 25.1 mttt . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -90.92 170.95 9.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.5 t -59.6 115.7 3.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.3 -1.83 16.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.562 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.8 t -90.96 -64.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 110.62 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -94.47 -54.42 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.152 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.27 6.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.346 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.11 169.73 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.711 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.74 143.68 27.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.777 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.54 77.09 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.768 2.312 . . . . 0.0 112.337 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.274 0.559 . . . . 0.0 110.143 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 0 C--O 1.236 0.41 0 N-CA-C 111.347 -0.29 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 54.1 m-80 71.33 -160.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.015 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 42.7 mt 71.86 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.676 0.751 . . . . 0.0 111.125 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -98.52 96.94 8.32 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 20.8 pttp -74.47 110.06 8.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.81 164.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.294 0.569 . . . . 0.0 111.594 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 42' ' ' ARG . 37.3 ttp180 -99.59 109.83 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.488 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -109.08 161.77 7.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.58 129.38 60.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 0.0 110.63 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 49' ' ' THR . 74.8 mt -88.66 151.49 47.92 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.88 -32.66 86.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.508 2.805 . . . . 0.0 113.751 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.32 -2.85 54.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.119 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.5 42.35 3.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.281 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.578 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.5 149.88 35.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.3 mp -106.73 120.74 58.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 2.0 tpmt? -132.78 138.76 47.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 0.0 111.636 -174.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -91.87 122.7 34.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 79.3 mtp -128.68 150.51 50.22 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.843 0.354 . . . . 0.0 110.812 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 8' ' ' LYS . 67.0 mtt85 -91.14 101.63 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.415 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 65' ' ' VAL . 27.2 t -112.36 152.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.582 -173.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.3 p -92.06 154.6 18.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -61.52 -21.98 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.092 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -62.5 -51.7 66.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.407 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.8 m -64.81 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.571 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.99 -42.12 97.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.55 -48.73 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.12 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.4 m -64.89 -22.61 67.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.02 48.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.703 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -92.16 3.81 54.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.333 0.587 . . . . 0.0 110.556 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 55' ' ' VAL . 31.4 m -109.31 139.48 32.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.995 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.6 88.77 4.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.952 0.882 . . . . 0.0 109.156 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -76.22 148.38 37.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.191 -170.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.4 t80 . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 110.453 179.374 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.237 0.541 . . . . 0.0 111.35 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.617 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 9.6 ptm85 -154.14 162.0 41.49 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.742 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.85 123.51 19.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.22 -1.55 23.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.071 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 65' ' ' VAL . 51.7 t -98.4 -70.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.032 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.2 m -91.56 -15.81 28.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.75 27.99 52.33 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.131 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -100.57 144.65 29.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 144.54 86.79 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.617 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 84.1 Cg_endo -82.29 64.64 8.31 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.693 2.262 . . . . 0.0 111.798 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.121 177.356 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 120.747 0.228 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 m120 75.5 -12.04 1.03 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.872 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 11.9 mt -106.85 101.29 10.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -83.48 108.26 16.5 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 53' ' ' MET . 51.7 mtmt -71.4 110.78 6.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.531 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.64 146.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.905 0.383 . . . . 0.0 110.35 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -83.53 120.16 25.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.241 0.543 . . . . 0.0 110.038 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.2 m -116.14 145.17 22.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.908 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 67' ' ' LYS . 14.2 p -89.02 113.37 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.678 0.751 . . . . 0.0 110.323 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.6 mt -74.83 147.81 84.39 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.269 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.6 -15.27 45.0 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.263 . . . . 0.0 111.668 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.85 -21.79 60.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.727 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.47 0.82 46.92 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.807 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.572 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.7 m -91.14 155.89 18.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.844 0.354 . . . . 0.0 110.438 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.91 127.14 62.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.258 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -132.35 136.62 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.878 0.371 . . . . 0.0 110.841 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -89.29 117.5 28.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.2 mtp -110.65 143.21 41.44 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.092 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HB3' HD13 ' A' ' 38' ' ' LEU . 54.4 mtt85 -79.52 100.18 7.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.767 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.16 138.6 40.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.001 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 23.1 p -88.94 163.85 15.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.922 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.561 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.1 p -59.0 -30.2 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.11 -177.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -59.84 -51.97 67.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.967 0.413 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.62 -33.8 69.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.8 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 57' ' ' THR . 79.7 mt -54.99 -43.42 73.56 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.46 -26.93 55.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.537 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.6 m -74.9 -31.56 61.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.897 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.22 77.3 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.593 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.16 -3.0 58.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.309 0.575 . . . . 0.0 110.484 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 67' ' ' LYS . 31.3 m -85.91 156.36 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.394 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.764 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -66.32 -37.85 86.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.514 -176.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' A' ' 65' ' ' VAL . 97.3 mttt 61.33 -172.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.702 0.627 . . . . 0.0 111.488 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.384 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 ptp180 -144.84 173.76 11.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.38 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 52.4 t -70.04 114.49 8.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 37.3 mt-10 -68.63 -5.73 21.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 0.0 111.617 -171.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' CG1' ' A' ' 65' ' ' VAL . 48.5 t -88.95 -58.28 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.166 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 m -102.18 -24.22 13.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.95 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 91.68 22.72 30.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.567 -177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.922 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -93.37 151.42 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.775 -0.25 . . . . 0.0 110.94 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 145.24 69.46 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.369 . . . . 0.0 111.475 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 37.7 Cg_endo -66.71 149.29 83.77 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.867 2.378 . . . . 0.0 111.871 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -175.395 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.46 -0.442 0 CA-C-O 121.063 0.359 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -133.89 -47.16 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.684 0.754 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' A' ' 54' ' ' ARG . 13.9 mt -85.0 153.4 22.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.043 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -119.75 110.02 16.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -84.43 109.39 17.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.42 165.45 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.68 114.56 24.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.96 148.78 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.421 . . . . 0.0 110.408 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -102.48 124.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.446 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.9 mt -84.66 146.34 46.48 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.03 -21.93 61.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.748 2.299 . . . . 0.0 111.83 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.69 -26.56 67.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.522 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.69 -0.72 23.24 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.125 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -87.01 149.77 24.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 111.398 -176.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -111.59 113.22 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 53' ' ' MET . 55.0 tptt -129.03 130.94 47.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.109 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -80.95 115.94 20.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 51' ' ' LYS . 64.0 mtm -123.88 157.51 34.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.319 0.581 . . . . 0.0 111.6 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 38' ' ' LEU . 87.0 mtm180 -77.72 109.4 11.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.757 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.82 141.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.514 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.52 159.28 16.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -59.25 -32.62 70.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.188 -177.149 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -60.91 -38.86 87.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.307 0.575 . . . . 0.0 110.765 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.66 -34.21 60.48 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.446 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 91.5 mt -61.09 -53.25 59.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.325 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -60.22 -50.61 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.13 0.491 . . . . 0.0 111.327 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -73.96 -17.46 61.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.138 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.41 40.75 96.53 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -73.16 -14.52 61.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.66 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 67' ' ' LYS . 35.0 m -108.46 158.81 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.132 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -54.59 -52.0 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.738 ' HB2' HG23 ' A' ' 65' ' ' VAL . 34.1 ttpt 62.06 12.91 5.29 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.739 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 t80 . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.345 -179.305 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttp . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.3 ppt_? -96.46 -164.75 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.918 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 47.9 t -55.11 135.32 49.3 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.053 0.454 . . . . 0.0 110.799 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.06 3.22 27.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.042 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.25 -73.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.544 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 83.5 m -108.85 8.33 26.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 84.28 -18.34 23.8 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.382 -0.913 . . . . 0.0 114.416 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -58.39 139.99 54.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.182 0.491 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 69.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.767 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.642 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 61.0 Cg_endo -71.97 94.62 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 111.653 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.688 -176.06 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.532 0.396 0 N-CA-C 113.746 0.633 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.71 -16.36 61.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.248 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 19.2 mt -89.1 108.33 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -68.67 97.38 0.8 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.638 0.732 . . . . 0.0 111.022 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 8.2 ptpp? -73.16 110.78 7.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.978 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.64 168.09 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.227 0.537 . . . . 0.0 111.173 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -88.68 114.81 25.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.702 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 m -120.97 159.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.282 0.563 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.0 t -104.57 124.26 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.231 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.595 HD12 ' HB ' ' A' ' 49' ' ' THR . 38.8 mt -60.64 148.69 81.13 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.989 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.54 -7.58 9.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.306 2.67 . . . . 0.0 113.774 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -98.78 -69.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.734 0.302 . . . . 0.0 110.249 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.46 57.89 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.021 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.595 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.1 m -144.5 156.65 44.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.52 129.26 67.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.794 0.331 . . . . 0.0 110.149 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HE2' HD21 ' A' ' 45' ' ' LEU . 39.3 ttpt -146.72 152.93 39.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.045 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -94.63 127.16 40.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.4 mtp -135.36 152.18 51.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 56.8 mtt85 -91.36 110.64 21.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.697 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.522 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 25.4 t -112.29 138.2 42.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.074 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.4 p -88.63 159.55 17.81 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.79 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 t -58.93 -25.82 63.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.572 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 m -63.74 -47.92 79.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 75.4 m -70.58 -34.5 72.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 56' ' ' CYS . 83.4 mt -61.3 -41.54 97.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.671 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -81.06 -24.81 37.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.157 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.2 t -68.28 -33.02 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.02 22.49 55.37 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.156 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 8.99 28.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.944 0.872 . . . . 0.0 111.182 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.21 161.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.724 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -76.29 147.72 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -152.2 160.56 43.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.0 111.971 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.861 172.829 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 121.239 0.542 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -128.35 161.3 29.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -62.48 135.62 57.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.602 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 49.6 mt-10 -81.98 3.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.229 0.538 . . . . 0.0 110.833 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.37 -60.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 t -96.8 -17.4 20.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.285 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.06 84.02 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.846 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -75.19 143.46 43.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.707 0.253 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.86 144.5 36.97 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.871 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -86.21 -0.22 8.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.159 2.572 . . . . 0.0 113.006 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.467 0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.391 -178.211 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.459 -0.544 0 CA-C-O 120.742 0.226 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -151.93 -47.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.888 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 54' ' ' ARG . 9.0 mt -71.12 113.07 7.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.847 0.356 . . . . 0.0 111.628 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -83.97 100.9 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.622 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 24.4 ttmt -75.86 110.62 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.73 159.15 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.686 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.629 ' HE ' HG21 ' A' ' 50' ' ' ILE . 65.9 ttt180 -87.02 117.65 25.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.389 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.74 157.33 30.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.857 0.36 . . . . 0.0 110.767 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.5 139.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.693 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' HB ' ' A' ' 49' ' ' THR . 73.6 mt -86.43 153.32 56.02 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.47 -26.17 52.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.933 2.422 . . . . 0.0 112.689 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.31 -21.88 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.276 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.72 -1.8 26.05 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.231 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.567 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.4 m -81.41 159.18 24.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.629 HG21 ' HE ' ' A' ' 42' ' ' ARG . 57.5 mt -121.8 133.19 68.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.674 0.273 . . . . 0.0 110.754 -177.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HD2' HD11 ' A' ' 45' ' ' LEU . 63.5 mttm -140.03 164.52 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -121.63 117.63 27.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.2 mtm -138.7 165.4 27.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.964 0.411 . . . . 0.0 111.823 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.634 ' HB3' HD22 ' A' ' 38' ' ' LEU . 27.8 mmt180 -76.87 119.56 20.8 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.734 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.619 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 39.4 t -126.64 139.71 50.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 p -77.39 145.81 37.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.438 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 t -55.08 -30.49 59.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -61.05 -47.39 86.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 55.5 m -72.19 -33.9 68.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.857 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.98 -53.19 60.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.6 -45.67 57.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.589 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 t -69.4 -26.74 64.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.646 0.26 . . . . 0.0 110.997 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.94 48.36 7.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.753 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.25 -28.63 22.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.203 0.525 . . . . 0.0 109.671 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.83 171.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 41.1 tptt -69.32 -44.91 70.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.616 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.8 tttt 71.07 135.19 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.771 0.669 . . . . 0.0 111.227 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 178.902 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.352 0.596 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.513 ' H ' ' CD ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -80.43 155.29 27.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.738 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 48.8 t -60.61 144.68 51.24 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.05 -8.79 59.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.961 0.41 . . . . 0.0 110.933 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 55' ' ' VAL . 57.6 t -100.3 -62.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 42.8 t -91.06 -47.53 7.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.819 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 10' ' ' CYS . . . 112.02 -9.98 27.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 13' ' ' CYS . 28.7 mtpp -77.5 162.68 26.96 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.711 -0.288 . . . . 0.0 110.25 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.88 144.33 76.02 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.966 0.413 . . . . 0.0 111.416 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.644 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 98.2 Cg_endo -89.7 94.88 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.193 2.595 . . . . 0.0 112.178 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 . . . . . 0 C--O 1.236 0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.642 -179.413 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo . . . . . 0 N--CA 1.473 0.265 0 CA-C-O 121.057 0.357 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -109.81 -10.16 14.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.634 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 22.3 mt -120.02 99.75 6.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.706 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.68 123.19 33.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 15.4 ptmt -72.73 122.52 21.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.782 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 t -114.8 156.2 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.639 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -85.46 106.56 16.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.73 166.78 10.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.462 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.17 136.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.594 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 49' ' ' THR . 79.2 mt -97.42 152.2 38.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.55 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.37 -15.75 50.29 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.0 2.467 . . . . 0.0 112.704 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.16 -15.19 57.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.1 15.36 26.22 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.14 -0.553 . . . . 0.0 111.797 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.542 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -89.34 149.22 23.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.843 0.354 . . . . 0.0 110.247 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -128.05 111.69 25.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.72 149.42 34.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.788 0.328 . . . . 0.0 110.543 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.27 120.95 31.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.44 ' HE3' HG22 ' A' ' 12' ' ' VAL . 65.7 mtm -130.28 149.85 51.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.932 -177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 81.9 mtm180 -76.26 113.35 13.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.421 0.629 . . . . 0.0 110.923 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.9 t -105.23 148.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.089 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.82 148.55 25.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.326 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -58.71 -25.59 63.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.38 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -60.53 -40.72 92.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.365 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.79 -33.89 62.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.565 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.67 -53.59 55.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 61' ' ' LYS . 21.5 ptmt -81.76 -2.49 50.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -86.8 -32.0 20.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.56 46.92 93.32 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.996 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.86 33.74 3.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.163 0.506 . . . . 0.0 111.213 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.22 149.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.779 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -86.37 102.79 14.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.536 0.684 . . . . 0.0 109.887 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -94.78 146.95 23.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.972 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.8 t80 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.864 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.12 0.486 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.3 ptm180 -143.77 155.6 44.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.513 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 55' ' ' VAL . 49.8 t -68.4 131.95 46.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.502 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.83 2.93 24.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.219 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 65' ' ' VAL . 49.1 t -102.54 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.809 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 64' ' ' LYS . 72.2 m -101.72 -21.23 14.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.581 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.607 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -79.29 145.83 33.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . . . -78.41 155.46 79.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.516 -176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.732 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 84.6 Cg_endo -78.05 109.33 2.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.992 2.462 . . . . 0.0 112.509 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 178.448 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.463 -0.295 0 N-CA-C 112.854 0.29 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -112.48 -27.42 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.497 0.665 . . . . 0.0 109.487 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 57.2 mt -86.26 159.77 19.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.609 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.39 132.38 53.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -85.41 113.5 21.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.44 167.17 9.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.55 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 18.0 ptp180 -101.13 120.6 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.299 0.571 . . . . 0.0 110.935 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 34.1 m -110.46 167.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.112 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 68' ' ' TYR . 11.9 p -101.65 131.41 49.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.133 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.0 144.92 28.61 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.665 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 -20.1 57.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.616 2.211 . . . . 0.0 111.58 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.19 -27.15 68.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.524 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.74 44.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -99.77 158.31 15.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.757 0.313 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 42' ' ' ARG . 63.7 mt -105.3 116.38 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -106.14 144.75 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.087 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -110.6 125.84 53.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.116 0.484 . . . . 0.0 110.338 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.41 ' HE2' HG21 ' A' ' 43' ' ' VAL . 72.3 mtm -139.22 163.76 31.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.698 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -84.18 120.45 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 65' ' ' VAL . 58.5 t -122.87 147.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.706 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.732 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 24.7 p -88.57 155.13 19.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.488 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -57.49 -32.71 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.039 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -65.54 -43.08 91.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.977 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.5 m -72.65 -35.58 67.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.664 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.6 -47.01 87.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.614 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.117 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -70.41 -29.41 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.36 28.32 73.64 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.012 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.5 tmtp? -82.83 -21.08 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.379 0.609 . . . . 0.0 109.783 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 55' ' ' VAL . 35.4 m -61.79 163.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.331 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 31.5 mmtp -78.58 59.75 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.576 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -57.59 140.84 49.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.528 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p90 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.639 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.363 0.601 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -139.0 165.24 27.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.044 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.6 t -82.01 143.47 31.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.59 -2.22 25.03 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.68 -67.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.0 p -85.28 -39.41 17.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.777 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 9.97 51.11 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.125 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.59 158.46 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.37 149.53 47.06 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.022 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.8 Cg_endo -75.16 110.43 3.11 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.691 2.261 . . . . 0.0 112.299 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.47 -179.771 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--O 1.233 0.225 0 N-CA-C 113.46 0.523 . . . . 0.0 113.46 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -89.36 -5.45 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 mt -90.48 109.21 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -77.82 101.57 6.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.497 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' MET . 20.5 pttp -78.82 110.23 13.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 33.5 m -125.01 162.25 27.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.301 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.13 120.1 29.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 0.0 110.914 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.53 167.7 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.404 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' N ' ' HA ' ' A' ' 68' ' ' TYR . 9.5 p -89.31 138.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.614 0.721 . . . . 0.0 111.063 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.509 HD12 ' HB ' ' A' ' 49' ' ' THR . 88.6 mt -92.52 157.85 39.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.74 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.11 -24.29 39.98 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.724 2.282 . . . . 0.0 112.496 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.95 -19.01 60.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.486 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.71 54.61 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.509 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.9 m -86.73 158.38 19.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.163 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.14 122.81 66.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.0 ttmt -141.51 147.72 38.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.5 mtm180 -88.0 134.98 33.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 63.0 mtm -138.56 170.61 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.485 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -82.54 110.72 17.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.079 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 49.6 t -115.57 144.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.927 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 25.5 p -90.79 152.47 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.517 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -58.94 -25.42 63.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 m -61.08 -45.43 94.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.444 . . . . 0.0 110.351 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.71 -34.58 75.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.02 -45.55 77.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.796 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.59 -7.78 53.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.753 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 t -117.2 -4.12 11.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.866 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.92 62.05 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.118 -175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 64' ' ' LYS . 38.7 tptt -87.64 56.77 4.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.983 0.897 . . . . 0.0 111.08 -171.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 67' ' ' LYS . 5.6 m -143.43 156.84 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 3.14 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.57 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 65' ' ' VAL . 3.7 mppt? 57.77 -168.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.911 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.588 ' HA ' ' N ' ' A' ' 44' ' ' VAL . 13.1 p90 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 110.956 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.705 ' HG2' ' H ' ' A' ' 2' ' ' GLY . 25.8 tt0 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.705 ' H ' ' HG2' ' A' ' 1' ' ' GLN . . . 118.59 -14.8 11.68 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.922 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -97.24 -23.28 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.7 99.84 4.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 pt -103.39 9.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.7 ttm -86.06 88.47 7.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 110.108 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.08 157.71 38.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.732 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -91.11 122.04 33.42 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 23.5 ptt-85 -135.76 -174.08 3.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.44 119.69 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.732 0.301 . . . . 0.0 110.379 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.09 -5.52 46.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.145 0.498 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.22 -51.2 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.6 m -114.13 -12.6 12.51 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 -16.57 60.34 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.733 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -74.99 153.57 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.52 0.66 . . . . 0.0 111.267 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.19 153.78 69.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.181 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.847 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 94.3 Cg_endo -80.13 91.28 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.722 2.281 . . . . 0.0 111.464 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.036 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.9 m -149.94 101.68 3.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.795 0.331 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.45 25.63 4.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.014 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -88.28 76.43 8.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 110.549 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -155.27 112.47 3.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.21 118.68 30.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.329 0.585 . . . . 0.0 110.638 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -91.9 165.09 13.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.784 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -137.31 148.23 46.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.885 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.4 m 75.29 6.26 4.14 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.066 0.854 . . . . 0.0 112.297 174.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' C ' ' HD3' ' A' ' 28' ' ' LYS . 5.3 m-20 -78.03 -65.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.408 0.151 . . . . 0.0 111.408 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 43.92 28.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.348 1.059 . . . . 0.0 111.951 -173.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -90.41 160.1 16.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.576 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 t -153.01 100.26 2.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.194 0.521 . . . . 0.0 111.064 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.83 71.57 1.3 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 32' ' ' ARG . 22.7 ttt180 58.52 48.71 11.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.605 -167.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 61.49 -169.73 0.17 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -100.83 153.58 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -96.36 156.19 37.16 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.07 98.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.48 2.12 . . . . 0.0 112.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 67.63 8.99 6.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.93 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.847 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 12.7 mt -116.95 122.76 45.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.255 0.55 . . . . 0.0 111.964 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.4 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -106.49 116.85 32.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.079 173.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 53' ' ' MET . 80.2 mttt -74.49 116.17 14.87 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 168.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.55 136.78 44.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.296 0.569 . . . . 0.0 109.526 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 42' ' ' ARG . 26.5 ttm180 -80.7 106.46 12.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.546 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -111.04 170.04 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.369 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.88 131.34 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 85.6 mt -90.52 144.18 30.3 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.058 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 25.3 Cg_exo -64.11 -14.58 44.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.947 2.431 . . . . 0.0 112.507 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.85 -4.0 57.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.636 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.77 55.05 2.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.82 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 m -149.14 159.02 44.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.94 127.12 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.87 141.85 44.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.428 . . . . 0.0 111.694 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -91.26 120.44 32.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 49.8 mtm -125.3 149.41 48.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.875 0.369 . . . . 0.0 111.015 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -80.11 107.95 13.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.17 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.36 134.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.6 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 17' ' ' PRO . 44.2 t -74.9 149.56 39.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.269 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.7 m -56.04 -30.99 62.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.344 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -59.11 -49.22 78.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.189 0.519 . . . . 0.0 110.151 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.4 m -69.11 -37.01 78.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.378 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.26 -41.29 99.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.143 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.55 -39.72 64.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -68.9 -32.94 72.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.7 62.05 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.727 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.29 19.14 7.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.052 0.453 . . . . 0.0 111.486 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -102.7 162.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.92 106.75 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -121.55 152.03 39.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.681 -167.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -114.33 15.5 18.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t 67.09 91.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.838 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.3 25.06 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.71 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.95 119.55 26.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m -122.03 22.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.023 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -57.37 142.42 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.2 -12.67 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.369 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.72 134.57 36.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.687 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.36 -63.15 3.36 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.584 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.804 175.421 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.13 133.09 1.55 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.349 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.89 -30.52 21.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.92 0.39 . . . . 0.0 111.215 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 94.92 8.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.823 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tt -147.16 123.91 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.77 85.84 0.07 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.081 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.38 25.32 11.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.567 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 57.61 77.18 0.29 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.057 0.932 . . . . 0.0 109.912 -174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' A' ' 14' ' ' GLY . 21.3 ptt180 -97.74 -177.87 3.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.203 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.3 t -67.37 120.79 14.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 167.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 53' ' ' MET . 41.6 mt-10 -71.71 -10.84 60.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.061 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG11 HG12 ' A' ' 65' ' ' VAL . 58.5 t -81.9 -71.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -97.41 -46.72 5.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 0.0 111.022 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 9' ' ' ARG . . . 120.27 21.3 3.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.059 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.73 177.57 8.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.877 0.339 . . . . 0.0 111.396 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . . . -110.62 91.35 12.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.692 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 36.2 Cg_endo -63.37 146.94 93.82 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.644 2.229 . . . . 0.0 112.093 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.53 13.94 0.85 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.78 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.8 p -90.57 115.83 28.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.52 -9.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.007 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -78.02 98.95 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.046 0.451 . . . . 0.0 110.554 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 23' ' ' VAL . 15.1 t -170.81 157.05 5.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.725 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.497 HG22 HG23 ' A' ' 22' ' ' THR . 25.5 m 43.69 85.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 124.373 1.045 . . . . 0.0 113.118 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -65.49 -46.5 79.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.052 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -160.2 28.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -71.41 107.42 4.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.338 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t0 69.05 134.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.87 0.731 . . . . 0.0 110.057 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.47 -9.15 56.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.17 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' NZ ' ' HB3' ' A' ' 29' ' ' LYS . 9.1 mtpm? -107.31 90.05 3.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -80.68 74.9 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -44.72 -64.3 0.73 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.915 -169.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -134.06 30.52 3.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.76 0.79 . . . . 0.0 109.386 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -102.72 78.07 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.74 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.531 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 76.0 t80 -160.11 98.36 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.521 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -146.89 144.48 20.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 83.3 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.803 2.335 . . . . 0.0 112.714 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 63.04 13.87 7.11 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.718 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 54' ' ' ARG . 14.1 mt -117.44 152.12 35.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.12 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.448 ' HB2' HD11 ' A' ' 60' ' ' LEU . 16.3 mm100 -118.66 97.89 5.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 53' ' ' MET . 61.1 pttt -81.45 112.68 18.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.228 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.88 168.37 21.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.836 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -78.66 135.51 37.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.88 143.91 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.92 136.19 45.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.396 0.617 . . . . 0.0 110.873 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.0 mt -98.53 143.01 25.54 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.486 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.61 -15.75 48.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.856 2.37 . . . . 0.0 112.321 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.63 -16.21 60.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.441 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 52.24 0.88 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.143 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.8 m -145.95 154.51 42.0 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.575 -0.368 . . . . 0.0 110.561 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.36 117.29 44.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -120.89 142.64 49.49 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -101.72 119.11 38.27 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.572 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 62.8 mtm -133.99 155.5 49.86 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.099 0.476 . . . . 0.0 111.834 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HB3' HD22 ' A' ' 38' ' ' LEU . 69.3 mtm180 -76.12 116.41 16.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.86 148.47 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.823 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 10.9 p -91.22 155.94 18.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.602 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -61.36 -26.71 68.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.095 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 p -64.51 -41.3 96.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.72 0.295 . . . . 0.0 110.836 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.22 -34.45 61.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.52 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 92.4 mt -59.34 -51.82 68.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.269 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -72.5 -33.98 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.8 p -74.37 -24.71 59.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.072 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.33 44.01 23.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.276 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -95.26 11.9 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.448 0.642 . . . . 0.0 109.932 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 HG11 ' A' ' 12' ' ' VAL . 28.5 m -120.94 138.46 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.898 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -86.08 98.89 11.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -94.4 30.8 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.952 -166.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 66.64 12.18 8.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.212 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t 63.56 100.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.512 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 175.88 110.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.684 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -96.32 105.52 17.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.08 117.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.056 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 t -146.85 128.05 14.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -92.08 130.98 37.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.952 0.406 . . . . 0.0 110.455 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.8 -30.94 39.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.53 141.05 45.23 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.254 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.315 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.68 0.276 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.87 95.02 2.12 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.027 0.441 . . . . 0.0 110.13 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.9 ttm -76.22 -44.88 35.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.582 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.99 127.99 41.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.443 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.0 ttm -138.61 168.65 19.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.99 -60.4 2.64 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.418 0.449 . . . . 0.0 111.577 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.471 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 85.0 tttt -159.1 137.53 10.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -74.47 178.41 5.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.432 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 41.5 t -55.02 128.68 34.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.071 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 8' ' ' LYS . 38.7 mt-10 -76.57 5.14 7.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.639 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.28 -58.38 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.1 -23.09 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.93 4.4 36.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.474 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mttp -74.15 176.75 6.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.74 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.05 144.52 29.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.217 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 89.4 Cg_endo -82.28 150.87 15.53 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.4 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -101.38 -51.79 3.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.448 . . . . 0.0 109.986 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.1 t -88.03 -175.53 5.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.72 175.4 42.66 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 155.46 21.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.593 0.196 . . . . 0.0 110.78 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 m -61.34 106.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.139 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.41 135.25 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 106.78 5.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.97 125.14 25.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 110.76 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.1 m -116.23 130.68 56.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.585 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.68 5.91 31.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.905 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -126.17 148.56 49.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.747 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.694 ' HG2' ' H ' ' A' ' 30' ' ' SER . 72.1 tttt 69.31 -178.81 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.482 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.694 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 4.6 p -65.65 155.88 34.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.418 0.627 . . . . 0.0 112.596 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.27 80.4 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.676 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -79.84 146.81 32.03 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -44.86 127.46 6.4 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.834 0.709 . . . . 0.0 112.004 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -82.57 141.46 32.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.445 ' N ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -132.49 85.4 48.34 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 177.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.97 -35.31 5.52 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.684 2.256 . . . . 0.0 111.137 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 18.8 m120 -84.52 -171.13 3.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.276 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 28.6 mt 68.46 106.8 0.05 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.652 0.739 . . . . 0.0 110.162 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -77.66 93.43 4.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.783 -173.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' MET . 17.3 pttp -78.01 109.85 12.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.641 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.47 160.71 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.527 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -95.12 126.84 40.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.704 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 67' ' ' LYS . 34.3 m -123.42 156.04 29.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.014 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 68' ' ' TYR . 7.2 p -109.11 122.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.636 0.731 . . . . 0.0 110.44 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.9 mt -79.37 143.43 59.99 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.374 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.8 -21.48 69.41 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.98 2.453 . . . . 0.0 112.795 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.72 -23.89 56.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.111 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.27 67.09 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.695 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.489 ' HB ' HD12 ' A' ' 45' ' ' LEU . 3.4 m -153.38 154.6 34.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.578 -0.366 . . . . 0.0 110.13 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.58 113.28 22.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -134.84 148.23 50.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.765 0.317 . . . . 0.0 111.229 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -99.21 119.77 38.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.7 mtm -132.58 157.6 44.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.027 0.442 . . . . 0.0 110.851 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.683 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 49.9 mtm180 -87.68 103.92 16.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.464 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.505 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.7 t -98.98 154.34 4.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.825 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 15' ' ' LYS . 28.4 p -90.02 149.79 22.38 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.173 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -57.5 -29.45 64.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.111 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -62.68 -47.73 82.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.797 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.0 m -64.94 -34.29 78.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.293 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.18 -50.53 72.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -66.06 -30.31 70.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.13 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -31.75 54.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.73 31.18 56.68 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.571 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -79.02 -25.45 43.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.964 0.411 . . . . 0.0 110.91 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.489 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 28.0 m -77.04 143.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.61 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.06 -3.65 55.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.598 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 45.47 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.226 . . . . 0.0 114.206 174.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.8 t80 -142.06 14.59 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.734 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 69' ' ' VAL . 10.2 t 62.99 20.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.46 -175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.17 137.97 41.03 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.806 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -94.07 105.0 17.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.725 0.298 . . . . 0.0 110.443 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.91 154.69 37.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.132 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.0 m -126.57 132.24 51.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.673 0.273 . . . . 0.0 110.706 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 76' ' ' GLY . 2.1 tm-20 -81.67 151.13 27.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.72 -23.5 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -170.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' H ' ' CD ' ' A' ' 74' ' ' GLU . . . -85.82 -129.4 2.31 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.129 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.769 -177.035 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.3 150.73 24.96 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 58.84 32.65 22.43 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.4 tpt -54.13 -48.79 70.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.046 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 5' ' ' ILE . 14.9 mm -103.28 17.16 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.526 0.679 . . . . 0.0 110.158 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.5 ttt -100.43 6.07 44.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.248 0.547 . . . . 0.0 109.867 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 61.32 73.54 0.47 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.792 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -97.0 70.51 2.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.605 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 10.0 ptp180 -152.83 169.71 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.817 -172.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.25 127.84 34.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 38.3 mt-10 -73.99 -15.02 61.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.758 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.02 -57.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.463 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -102.0 -36.14 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 103.39 8.34 41.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.572 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -87.36 150.23 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.83 144.49 85.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 71.5 Cg_endo -94.97 141.73 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.382 2.721 . . . . 0.0 113.312 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -121.4 -5.76 9.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.673 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 11.7 t 63.69 -155.67 0.32 Allowed 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.666 0.604 . . . . 0.0 109.943 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.81 -147.02 4.93 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -87.1 124.69 33.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.296 0.548 . . . . 0.0 109.699 175.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 m -81.21 92.76 6.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.965 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -79.61 118.99 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 64.63 -173.21 0.17 Allowed 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.686 0.616 . . . . 0.0 110.178 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -169.93 159.04 7.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -59.32 104.75 0.28 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.253 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -83.3 -31.6 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 55.5 mmtt -133.4 -171.98 2.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.726 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 74.69 96.65 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 O-C-N 124.304 1.003 . . . . 0.0 110.028 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 33' ' ' TRP . 6.4 m -82.07 38.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.66 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -130.96 104.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 63.05 86.06 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.854 0.721 . . . . 0.0 110.984 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 30' ' ' SER . 81.8 m95 -78.51 -59.83 2.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.648 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -173.93 147.39 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.82 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -127.03 152.03 75.07 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.49 100.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.704 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.673 ' HA ' ' HB2' ' A' ' 19' ' ' SER . 41.7 m-80 71.48 -8.1 1.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.56 172.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.8 mt -117.55 123.62 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.296 0.569 . . . . 0.0 111.758 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -105.44 107.69 18.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.561 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 19.1 ttmm -76.57 108.51 9.61 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.67 168.91 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.945 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -81.02 117.33 21.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.785 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . 33.6 m -117.29 163.5 14.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.81 134.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.497 . . . . 0.0 110.245 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' A' ' 49' ' ' THR . 90.0 mt -93.14 153.3 41.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.805 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.74 -27.58 43.41 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.34 2.694 . . . . 0.0 113.355 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.88 -1.44 52.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 111.63 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.93 2.19 59.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.3 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.556 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -77.56 152.5 33.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.786 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.11 126.75 70.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -141.83 157.22 45.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.38 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 99.4 mtt180 -98.36 129.88 45.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.2 mtm -138.33 150.91 47.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.201 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 79.3 mtm180 -76.88 119.59 20.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 65' ' ' VAL . 37.6 t -120.77 148.18 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 17' ' ' PRO . 20.2 p -87.13 149.75 24.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 19' ' ' SER . 5.5 m -56.75 -30.26 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.499 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.76 -40.25 91.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.238 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.7 m -79.53 -35.53 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 57' ' ' THR . 95.2 mt -60.01 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -78.92 -5.54 53.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.316 0.579 . . . . 0.0 110.644 -176.271 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -94.34 -27.4 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 109.74 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.79 56.12 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 9.4 mmmm -89.25 30.59 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.75 0.31 . . . . 0.0 110.983 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 55' ' ' VAL . 20.1 m -122.12 129.43 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.674 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -80.49 98.28 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.0 pttt -110.77 177.54 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.727 -167.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' GLY . 19.0 t80 -99.81 63.54 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.87 172.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 70' ' ' GLY . 13.0 p 52.13 -60.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.229 1.812 . . . . 0.0 115.79 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' TYR . . . -68.94 86.56 0.22 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 118.183 0.447 . . . . 0.0 113.879 -171.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.525 ' HG3' ' HD2' ' A' ' 67' ' ' LYS . 15.5 mm100 -109.08 3.65 22.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.165 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 73' ' ' SER . 16.3 m 44.79 -84.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.76 ' H ' HG23 ' A' ' 72' ' ' VAL . 18.4 t -98.0 26.49 5.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.863 0.363 . . . . 0.0 111.105 -171.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 71' ' ' GLN . 33.3 tt0 -69.37 117.27 10.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.62 93.59 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.42 -42.39 0.27 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.184 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.671 179.72 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.777 0.322 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.74 -78.78 0.36 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -72.33 160.71 31.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 0.0 110.6 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -73.2 104.11 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.416 . . . . 0.0 111.387 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.776 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -98.06 160.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.817 ' HG3' ' HG3' ' A' ' 9' ' ' ARG . 24.7 ttt 66.88 95.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.655 0.597 . . . . 0.0 110.65 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.39 -79.65 0.27 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.08 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -127.96 103.19 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 109.903 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.817 ' HG3' ' HG3' ' A' ' 6' ' ' MET . 3.6 mmm180 -124.44 -176.2 3.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.246 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 53.1 t -64.89 123.68 20.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.13 -4.28 34.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 0.0 111.301 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.7 t -92.58 -65.88 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 111.12 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.02 -13.95 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.734 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.57 86.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.546 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.15 158.57 34.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.55 148.05 87.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.7 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.1 Cg_endo -74.12 113.77 3.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.482 2.121 . . . . 0.0 112.062 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 8.7 tpt180 -59.8 122.96 15.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.658 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -110.55 139.15 46.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.64 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.15 -178.06 17.8 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.62 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 72.2 -65.07 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.994 0.918 . . . . 0.0 112.231 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 m 66.46 102.06 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.33 0.586 . . . . 0.0 110.321 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.66 80.18 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.484 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 70.19 146.91 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.875 0.845 . . . . 0.0 112.566 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -124.32 149.24 46.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.025 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 p -160.27 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 67.27 91.08 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.537 0.685 . . . . 0.0 111.146 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -100.16 8.08 44.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.083 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt 59.63 59.0 2.69 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.928 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 t -93.72 -29.74 15.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 57.7 -85.57 0.02 OUTLIER 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 113.822 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.31 25.53 5.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.359 -166.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -74.91 -39.42 61.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.114 0.483 . . . . 0.0 109.974 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 92.1 m-85 -119.35 -178.04 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.892 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 17.3 mmt180 -114.69 148.05 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.887 171.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.72 -36.44 81.9 Favored 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 122.876 2.384 . . . . 0.0 113.751 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -111.9 -9.19 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.55 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 35' ' ' ARG . 35.1 mt -121.14 118.67 30.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.083 0.468 . . . . 0.0 111.212 -174.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -88.37 107.65 18.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.249 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.584 ' HD3' ' HA ' ' A' ' 34' ' ' PHE . 47.0 mtpt -81.71 110.21 16.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.684 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.725 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 24.7 m -122.83 157.92 27.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.674 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 50' ' ' ILE . 68.5 mtp180 -92.73 123.28 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.104 0.478 . . . . 0.0 110.44 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.666 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 32.9 m -115.86 164.75 11.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.07 128.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.67 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -95.17 150.54 37.8 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.782 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.46 -11.28 27.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.772 2.315 . . . . 0.0 112.254 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.11 -13.67 56.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.713 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.37 3.66 58.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.576 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.83 154.45 17.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.523 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 42' ' ' ARG . 55.4 mt -115.21 110.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.142 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.95 151.23 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.089 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 65.2 mtt180 -84.16 137.76 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 43' ' ' VAL . 86.7 mtp -133.04 154.64 50.35 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -85.73 103.88 14.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.86 146.15 18.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.961 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 28.0 p -96.24 157.52 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.76 0.314 . . . . 0.0 110.82 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 p -61.13 -25.04 66.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.737 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.421 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 32.1 t -58.65 -52.38 65.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.3 m -64.3 -34.28 77.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.444 . . . . 0.0 111.006 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 57' ' ' THR . 81.4 mt -63.71 -50.51 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.22 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -81.13 -19.21 44.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 m -81.86 -12.16 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.992 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.566 ' HA3' ' HG3' ' A' ' 71' ' ' GLN . . . 64.77 54.91 25.56 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.372 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -135.89 76.02 1.58 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 0.0 109.449 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.77 172.86 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.51 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 12.1 ptmm? -122.37 45.75 2.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.613 0.721 . . . . 0.0 110.258 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.725 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 2.8 mmmp? -80.9 -177.91 6.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.162 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -89.38 -14.25 35.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.086 0.47 . . . . 0.0 111.084 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.89 155.04 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.369 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.53 -132.63 11.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.969 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.566 ' HG3' ' HA3' ' A' ' 63' ' ' GLY . 3.0 mm100 -76.61 94.91 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.7 109.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.865 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 m -83.55 82.02 8.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.31 123.59 20.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.029 -168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 75' ' ' VAL . 16.1 t 69.37 5.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.177 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.49 -84.47 1.46 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.628 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.252 1.2 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.867 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.762 0.315 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.64 165.34 39.44 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.794 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -125.31 93.42 3.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.368 0.604 . . . . 0.0 110.455 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.0 ttm -90.12 136.74 32.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.791 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 16' ' ' ALA . 51.9 mt -84.54 112.81 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.075 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.5 ttt -112.55 -85.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.35 -57.34 2.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -63.55 107.93 1.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 110.155 173.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.9 ptm180 -150.04 166.4 29.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.759 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.44 124.75 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.128 0.267 . . . . 0.0 110.354 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.22 -7.87 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.464 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -85.79 -67.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 111.114 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.2 m -94.16 -22.89 18.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.256 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.32 -2.7 61.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.329 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.66 166.12 23.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.74 0.305 . . . . 0.0 111.74 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HB2' HG12 ' A' ' 5' ' ' ILE . . . -76.63 144.12 72.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.906 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 95.9 Cg_endo -85.64 151.82 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.791 2.327 . . . . 0.0 113.644 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.92 103.66 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.966 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 21.0 p -70.63 137.44 49.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.769 -177.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.13 -179.75 52.96 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.96 -40.31 80.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.264 0.225 . . . . 0.0 110.702 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m 71.48 102.6 0.07 Allowed 'General case' 0 CA--C 1.531 0.213 0 O-C-N 123.824 0.702 . . . . 0.0 111.418 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.62 -34.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.192 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -71.29 113.83 8.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.476 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -71.82 175.35 5.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.997 0.427 . . . . 0.0 110.691 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -107.05 170.33 8.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.532 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.65 118.85 24.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.087 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -74.06 86.18 1.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.452 0.644 . . . . 0.0 110.8 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.49 -56.06 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 m -101.91 106.44 17.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.811 171.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -87.73 17.16 4.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.703 -173.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 135.94 54.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.823 0.344 . . . . 0.0 110.366 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.607 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 16.3 m-90 -105.0 128.36 53.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.47 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -78.0 106.64 10.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.56 ' HB3' HD12 ' A' ' 38' ' ' LEU . 2.9 mpt_? 64.4 74.23 0.42 Allowed Pre-proline 0 N--CA 1.464 0.257 0 O-C-N 123.846 0.716 . . . . 0.0 110.256 -174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.607 ' HB3' ' HB2' ' A' ' 33' ' ' TRP . 96.5 Cg_endo -81.12 5.02 6.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.905 2.403 . . . . 0.0 112.944 -175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 13.3 m120 -111.91 3.48 17.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 109.826 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 54' ' ' ARG . 23.0 mt -126.3 129.73 49.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.239 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -82.82 89.19 6.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.327 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.53 114.22 4.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.103 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.55 153.86 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -93.32 124.84 37.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.941 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.86 155.46 17.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.02 117.56 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.274 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' HB ' ' A' ' 49' ' ' THR . 85.2 mt -82.07 152.87 69.0 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.938 175.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.75 -29.96 64.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.851 2.367 . . . . 0.0 112.917 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.15 -27.97 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.177 0.513 . . . . 0.0 110.65 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.86 7.05 25.91 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.3 m -83.1 151.03 25.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.051 0.453 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.5 mt -105.51 108.34 24.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -112.8 134.42 54.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.977 0.418 . . . . 0.0 111.199 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -91.0 120.5 32.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 43.3 mtm -127.62 157.01 41.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.566 0.698 . . . . 0.0 111.513 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.648 ' HB3' HD13 ' A' ' 38' ' ' LEU . 77.1 mtm180 -87.58 101.02 13.23 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.439 174.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 65' ' ' VAL . 21.2 t -115.12 145.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.56 -175.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.4 p -90.32 153.51 20.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.178 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.487 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -56.99 -26.38 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.595 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 t -64.09 -48.52 75.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.2 m -67.44 -33.26 74.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 57' ' ' THR . 76.1 mt -62.04 -53.38 56.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -77.75 -54.59 6.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.289 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -107.01 2.7 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.33 23.09 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.257 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 78.36 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.344 0.592 . . . . 0.0 111.056 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 55' ' ' VAL . 17.5 m -105.72 125.06 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 0.0 110.679 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -77.23 82.14 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -69.47 128.12 35.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.93 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.13 52.99 1.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t 61.96 91.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.575 0.702 . . . . 0.0 111.057 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.0 152.15 17.3 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -86.03 8.79 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.247 0.546 . . . . 0.0 110.893 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.92 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.45 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.5 p -104.77 133.46 49.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.22 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.42 179.7 6.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.06 0.457 . . . . 0.0 110.356 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.38 144.92 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.032 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.19 74.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.459 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.474 177.875 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.4 -137.96 8.18 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.457 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.0 m80 69.02 16.08 8.74 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.034 0.534 . . . . 0.0 110.379 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.439 ' SD ' ' HB2' ' A' ' 16' ' ' ALA . 50.8 ttp -107.44 2.02 23.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.529 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.3 mt -75.73 92.41 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.382 0.61 . . . . 0.0 110.88 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.6 tpt -152.05 145.84 25.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.3 71.37 2.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.958 0.408 . . . . 0.0 111.773 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' PRO . 22.4 pttp -168.2 36.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.524 0.678 . . . . 0.0 109.703 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD2' ' C ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -103.29 176.5 5.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.012 177.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 40.6 t -60.1 124.35 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 54' ' ' ARG . 8.5 mm-40 -60.09 -22.1 62.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.117 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 40.3 t -98.75 -70.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.517 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -78.68 -19.02 53.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.841 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.79 2.37 81.16 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.337 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -80.19 164.63 23.13 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.788 0.328 . . . . 0.0 110.75 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HB2' ' SD ' ' A' ' 4' ' ' MET . . . -72.79 147.94 89.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.486 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.798 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 90.6 Cg_endo -79.04 122.32 5.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.765 2.31 . . . . 0.0 111.827 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -140.75 96.9 3.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.278 0.561 . . . . 0.0 110.575 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p -83.26 -44.96 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.74 -48.85 2.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.644 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -132.25 144.46 50.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 110.586 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.6 t -99.73 127.01 45.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.18 -24.57 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.467 0.651 . . . . 0.0 109.935 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -81.15 107.21 13.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.208 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -68.69 -41.58 78.99 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.429 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 5.2 m -126.14 135.08 51.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.054 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.55 -44.29 74.83 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 26' ' ' SER . 9.0 mtmp? 64.91 160.87 0.12 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? 63.41 -167.86 0.21 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.062 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -141.7 156.06 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.042 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 58.19 84.44 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.455 0.645 . . . . 0.0 110.249 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.646 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -109.06 22.66 15.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.176 0.512 . . . . 0.0 110.728 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -137.98 155.31 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.391 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 90.9 mtt180 -121.9 160.62 46.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.106 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 35' ' ' ARG . 28.3 Cg_endo -63.69 -18.42 64.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.0 112.115 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 17' ' ' PRO . 43.4 m-80 -136.37 166.1 24.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.487 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 18.8 mt 71.87 112.95 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.967 0.792 . . . . 0.0 111.032 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -104.48 113.75 27.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.668 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 53' ' ' MET . 21.7 pttp -77.24 110.38 11.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.98 168.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.424 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -96.1 115.61 27.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.874 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.2 155.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.759 0.314 . . . . 0.0 110.178 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.5 126.85 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.256 0.551 . . . . 0.0 109.924 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.469 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.1 mt -79.69 144.89 61.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.929 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 31.3 Cg_exo -59.35 -21.3 60.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.54 2.16 . . . . 0.0 111.936 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.04 -17.23 62.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.522 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.59 3.93 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.108 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -123.03 153.34 39.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.684 0.278 . . . . 0.0 110.787 -176.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.51 119.8 52.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -136.27 137.26 40.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -90.69 124.33 35.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 88.1 mtp -134.62 160.78 37.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.001 0.429 . . . . 0.0 111.345 -175.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HB3' HD22 ' A' ' 38' ' ' LEU . 50.3 mtt85 -81.83 102.1 10.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.339 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.8 138.16 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 83.3 m -80.04 153.74 28.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.595 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 60' ' ' LEU . 3.4 m -61.15 -26.35 67.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.454 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -62.78 -42.77 99.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.325 0.583 . . . . 0.0 110.148 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 62.1 m -70.86 -33.78 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.121 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 57' ' ' THR . 96.4 mt -63.86 -36.03 82.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.2 -63.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.618 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.517 ' HA ' ' HA3' ' A' ' 76' ' ' GLY . 14.8 m -92.93 -24.62 18.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.869 -170.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' CYS . . . 113.02 -101.79 1.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.826 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 17.8 3.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.587 . . . . 0.0 111.067 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 27.4 m -141.33 -179.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -79.39 -44.35 21.64 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 70.43 143.69 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 111.176 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -81.85 42.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 111.02 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.1 m 43.93 32.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.275 1.03 . . . . 0.0 112.922 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.95 -178.73 35.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.501 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -63.18 139.27 58.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.75 108.53 21.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -70.14 -17.16 63.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.08 154.74 28.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.02 -32.42 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 62' ' ' SER . . . 78.67 -62.12 3.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.816 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.253 1.237 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.002 -178.54 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.745 0.307 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.3 126.8 1.41 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.21 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -96.85 -6.75 35.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -75.02 48.74 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.366 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 tt -143.45 -41.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.4 mmm 70.42 -47.96 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.726 0.81 . . . . 0.0 112.321 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.21 146.22 55.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.969 0.414 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.77 85.39 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.309 0.576 . . . . 0.0 111.531 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -86.33 -179.05 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.812 174.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' HB3' ' H ' ' A' ' 15' ' ' LYS . 44.8 t -60.96 114.58 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -62.74 -14.63 46.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 65' ' ' VAL . 45.8 t -80.39 -63.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.611 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 82.5 m -120.77 6.55 10.45 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -172.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.544 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 71.79 25.3 75.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.934 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG3' ' SG ' ' A' ' 59' ' ' CYS . 29.3 mmmt -74.9 160.91 30.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -91.74 144.04 28.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.4 Cg_endo -89.02 136.95 3.08 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.904 2.403 . . . . 0.0 113.19 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 18' ' ' ARG . 24.6 mtm180 -146.2 117.74 8.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.563 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.5 m 59.87 68.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.706 0.629 . . . . 0.0 111.054 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.56 17.42 57.65 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.839 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.448 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 49.3 t30 66.51 127.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.666 0.746 . . . . 0.0 112.207 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' HG22 ' A' ' 23' ' ' VAL . 6.0 m -64.54 -29.27 70.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.166 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 22' ' ' THR . 3.7 m 55.15 -179.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.796 1.238 . . . . 0.0 112.492 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 t -143.56 -170.11 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.795 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.8 t60 71.31 100.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.948 0.78 . . . . 0.0 111.233 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -107.07 119.68 40.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.1 m-20 -123.78 -158.76 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.46 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 90.2 mttt -51.4 132.58 29.54 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.921 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HD3' ' HZ ' ' A' ' 34' ' ' PHE . 88.9 mttt -87.21 111.75 21.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.258 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 m -145.08 78.77 1.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.239 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.92 32.12 21.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.369 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -136.55 167.12 21.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.171 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.6 m95 67.59 -165.22 0.21 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.694 0.621 . . . . 0.0 110.6 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.552 ' HZ ' ' HD3' ' A' ' 29' ' ' LYS . 73.1 m-85 66.75 -0.81 1.5 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.183 0.593 . . . . 0.0 112.201 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 2.1 mmp_? -129.16 86.8 55.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.501 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 22' ' ' THR . 6.3 Cg_exo -75.63 -6.53 17.73 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.003 2.468 . . . . 0.0 112.306 176.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.1 -5.9 32.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 54' ' ' ARG . 37.6 mt -116.3 135.91 53.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.671 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 21' ' ' ASN . 7.9 mm-40 -86.64 109.79 19.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.528 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.66 109.12 15.79 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.59 165.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 42' ' ' ARG . 3.4 mpt_? -105.06 124.51 49.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.74 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 51' ' ' LYS . 25.0 m -108.0 152.64 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.893 0.378 . . . . 0.0 110.268 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.76 111.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HB ' ' A' ' 49' ' ' THR . 93.3 mt -71.3 145.11 90.34 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.786 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 32.7 Cg_exo -59.72 -15.2 30.44 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -85.08 1.78 46.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.116 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.17 34.42 29.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.345 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -120.6 148.98 43.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 42' ' ' ARG . 59.5 mt -98.55 118.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.3 tttm -124.12 124.91 43.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 0.0 110.004 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 3.1 ppt_? -97.63 136.0 38.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.112 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 70.6 mtm -142.61 169.19 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HB3' HD13 ' A' ' 38' ' ' LEU . 36.2 mtm180 -91.13 109.39 20.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.714 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.8 t -122.85 152.13 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.3 p -91.39 147.54 22.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.504 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 m -57.43 -28.13 63.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.827 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 p -61.74 -42.34 98.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.66 0.267 . . . . 0.0 111.095 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.606 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 57.3 m -70.56 -34.77 72.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.2 0.524 . . . . 0.0 110.543 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 57' ' ' THR . 53.9 mt -58.34 -51.85 68.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.977 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -79.61 -22.88 43.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.386 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 m -74.9 -28.21 60.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.17 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.43 29.56 63.77 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.248 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -79.17 -17.4 55.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 110.085 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 12' ' ' VAL . 32.6 m -97.54 162.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.844 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -81.45 73.65 8.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.406 0.622 . . . . 0.0 110.538 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -84.6 139.78 31.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.727 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.2 -6.69 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.188 0.518 . . . . 0.0 110.077 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.1 t 61.33 94.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.386 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.59 82.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.028 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 60.12 83.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.21 154.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.188 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 t -127.18 135.88 51.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.57 -31.7 28.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.717 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t 58.94 86.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 123.856 0.722 . . . . 0.0 111.274 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -176.34 39.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.598 179.273 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.61 37.76 92.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.594 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -88.03 -23.44 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.558 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 ttm -158.02 115.86 3.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 mp -103.06 113.26 39.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.931 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -118.09 143.62 46.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.387 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 64.89 177.35 0.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.805 0.691 . . . . 0.0 111.465 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -93.09 79.63 4.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.56 0.695 . . . . 0.0 110.154 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -112.44 176.7 4.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.841 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.4 t -78.98 125.87 29.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.84 -15.29 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 56.5 t -92.35 -64.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.773 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.3 m -93.0 -20.55 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.85 -1.45 85.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.1 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -68.18 162.19 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.62 0.248 . . . . 0.0 110.915 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -83.88 143.18 42.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.319 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.3 Cg_endo -90.72 96.48 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.825 2.35 . . . . 0.0 113.011 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -143.91 135.25 25.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.24 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.0 m -141.5 -66.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.4 -162.07 35.62 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -149.62 117.45 6.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.922 0.391 . . . . 0.0 110.834 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.9 m -152.33 126.34 9.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.971 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.52 -14.82 7.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.323 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.9 m -66.16 112.44 3.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.597 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m80 63.31 22.49 13.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.788 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -94.2 -25.38 17.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -139.85 151.67 45.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 112.034 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -111.44 -49.88 2.97 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 55.5 tttp -155.46 26.15 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.635 -171.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 t -96.1 160.74 14.29 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.814 -0.554 . . . . 0.0 109.733 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -128.82 -46.41 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -151.92 94.52 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.959 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.425 ' O ' ' HE2' ' A' ' 40' ' ' LYS . 51.2 t-105 -99.02 -18.09 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.959 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.91 178.2 9.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.312 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -88.06 157.28 51.36 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 123.332 0.395 . . . . 0.0 110.316 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 73.2 Cg_exo -50.34 109.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.667 2.245 . . . . 0.0 112.227 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 17.6 m120 74.4 -0.69 3.28 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.345 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.3 mt -120.79 119.7 33.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.421 0.629 . . . . 0.0 112.022 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -92.68 118.87 31.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.807 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 33' ' ' TRP . 55.4 pttt -86.14 118.25 25.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.065 0.459 . . . . 0.0 110.289 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.5 m -127.62 153.28 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.599 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 93.3 mtt180 -90.04 124.38 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.559 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.1 m -109.08 155.84 9.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.24 134.35 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.519 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.8 mt -98.38 147.37 33.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.999 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.11 -13.85 38.01 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.62 1.78 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.787 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.14 63.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.452 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.1 m -97.42 152.04 19.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.029 0.442 . . . . 0.0 110.834 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.51 130.11 70.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.178 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 43' ' ' VAL . 63.0 tttp -136.46 129.77 31.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' ARG . 3.1 ptt180 -91.41 130.41 37.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.1 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.4 mtp -129.41 157.57 41.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -82.43 107.52 15.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.571 0.7 . . . . 0.0 110.484 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 48.4 t -116.11 137.79 48.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.512 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.41 153.69 26.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -59.55 -30.63 68.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.551 -177.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -61.9 -42.35 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.7 -35.34 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 57' ' ' THR . 78.9 mt -63.43 -48.64 76.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.375 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HE3' ' HB2' ' A' ' 77' ' ' SER . 31.3 mmmt -67.22 -37.08 82.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 m -78.83 -31.89 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.229 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 49.34 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.056 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -90.62 -22.72 21.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 35.4 m -69.21 148.01 11.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.972 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.69 -51.6 66.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.474 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 65' ' ' VAL . 75.9 tttt 66.88 152.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.913 0.758 . . . . 0.0 112.463 169.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -96.39 87.88 4.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 70' ' ' GLY . 7.2 p 44.67 -75.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.601 ' H ' HG13 ' A' ' 69' ' ' VAL . . . -150.96 168.45 30.65 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.873 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -134.74 -44.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.748 0.274 . . . . 0.0 111.243 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.8 164.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 m -61.18 119.76 9.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 0.0 110.426 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 10.6 tm-20 -109.38 -76.83 0.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 74' ' ' GLU . 7.8 p 168.56 -31.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.82 172.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 178.71 29.07 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.477 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.545 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.8 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.081 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.587 0.232 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.22 60.2 9.28 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.088 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -79.59 81.01 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.197 0.522 . . . . 0.0 109.886 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.6 mtp -133.99 110.73 9.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.265 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.2 mm -110.17 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.768 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 168.08 20.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.68 -25.39 68.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.3 68.89 5.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 7.3 ppt_? -121.43 171.02 9.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.32 140.98 56.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 40.7 mt-10 -74.38 -8.18 55.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.046 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t -111.22 -72.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.385 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.8 t -67.23 -34.94 78.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.998 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 98.8 -15.8 60.36 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.277 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.77 152.3 25.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.682 0.277 . . . . 0.0 110.69 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.59 144.31 27.62 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.89 145.96 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.104 2.536 . . . . 0.0 112.418 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.86 -14.45 14.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.221 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.7 m -144.1 143.92 31.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.987 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.78 145.36 15.96 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.52 -154.34 0.34 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -146.06 -85.26 0.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -139.25 -26.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.782 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -86.89 143.41 27.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.145 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -87.45 171.13 10.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.291 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.6 m -67.0 116.04 7.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.314 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.62 136.75 51.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.211 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.7 tttm 70.18 17.56 7.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.784 0.802 . . . . 0.0 109.776 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HG2' ' H ' ' A' ' 30' ' ' SER . 20.2 ttmm -155.08 -178.81 7.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.193 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.634 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 24.1 m -138.86 48.54 1.9 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 61.29 -175.65 0.12 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -170.94 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.448 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -142.75 126.5 17.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.17 0.51 . . . . 0.0 111.366 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -135.69 -171.55 2.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.029 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.775 ' HG3' ' HG2' ' A' ' 54' ' ' ARG . 32.3 mmt180 -111.87 164.55 14.87 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.74 102.16 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.243 1.962 . . . . 0.0 111.495 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 -40.62 0.48 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.572 0.749 . . . . 0.0 111.583 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 27.6 mt -70.78 132.89 46.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.796 0.331 . . . . 0.0 110.618 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HB2' HD11 ' A' ' 60' ' ' LEU . 20.1 mt-30 -103.92 131.54 51.04 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' MET . 11.8 ptmt -92.05 109.95 21.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.6 m -116.46 156.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.536 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -88.43 128.16 35.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.587 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.8 m -124.56 153.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.563 177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 67' ' ' LYS . 88.2 t -83.2 126.45 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.746 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.505 HD11 ' HE3' ' A' ' 51' ' ' LYS . 87.0 mt -97.67 143.78 26.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.46 -8.86 20.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.932 2.422 . . . . 0.0 111.604 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -78.49 -3.75 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.499 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.48 37.45 27.36 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.341 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -140.19 155.73 46.81 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.51 121.82 62.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.1 ttmt -123.38 138.15 54.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.131 0.491 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -92.38 106.87 18.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.687 174.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 87.0 mtp -101.59 158.36 16.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.838 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.775 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 86.4 mtm180 -83.74 100.82 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.75 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.51 146.69 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.593 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.4 p -92.64 159.23 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.417 ' OG1' ' HA3' ' A' ' 76' ' ' GLY . 6.1 t -58.3 -26.7 63.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t -61.84 -51.14 69.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 110.403 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.64 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 75.4 m -65.21 -38.0 89.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.569 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 39' ' ' GLN . 91.5 mt -65.28 -43.33 91.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.624 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -64.48 -45.61 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.823 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 t -72.68 -32.01 65.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.822 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.31 29.44 66.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.883 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.64 ' HE2' ' HA ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -97.54 49.56 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.663 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 176.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.185 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -79.07 -57.7 3.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.652 0.263 . . . . 0.0 110.808 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.1 mttt 64.99 172.29 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.654 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -146.15 88.74 1.82 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.806 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.0 m 42.38 85.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.23 0.956 . . . . 0.0 113.186 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.06 130.81 1.89 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.885 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -144.57 130.08 18.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.17 18.68 2.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.556 0.694 . . . . 0.0 109.983 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m 64.94 40.69 5.16 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.752 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -65.77 104.87 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.31 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.95 -49.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' OG1' ' A' ' 57' ' ' THR . . . 77.43 -130.5 10.38 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.757 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.248 0.995 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.034 176.946 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.724 0.297 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.05 93.67 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.258 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -104.26 127.19 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 110.62 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.48 -25.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 tt -163.68 145.46 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.209 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -117.36 81.76 1.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.574 0.702 . . . . 0.0 110.307 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.01 88.71 6.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.546 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 62.27 84.37 0.14 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.503 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -102.7 171.9 7.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.789 -175.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 50.2 t -69.83 131.2 44.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 169.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 45.1 mt-10 -68.37 -15.16 63.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.857 0.361 . . . . 0.0 111.065 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.23 -70.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.52 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.6 m -82.49 -32.91 28.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.911 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 95.71 10.7 56.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.101 -174.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -74.78 162.4 28.72 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.452 0.301 . . . . 0.0 110.973 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.66 151.07 49.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.92 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 86.5 Cg_endo -82.76 115.44 2.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.751 2.301 . . . . 0.0 113.119 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.66 111.2 9.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.881 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.459 ' HB3' ' OG1' ' A' ' 22' ' ' THR . 7.4 m -143.84 -24.05 0.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.202 0.525 . . . . 0.0 111.169 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.23 -73.72 2.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' HB3' HG22 ' A' ' 23' ' ' VAL . 59.2 m-80 -138.49 -72.82 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 19' ' ' SER . 6.1 m 62.22 5.09 1.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.623 0.725 . . . . 0.0 111.626 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 21' ' ' ASN . 27.3 m -86.38 14.96 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -59.33 -46.99 87.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.718 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -155.19 96.53 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.434 0.635 . . . . 0.0 110.764 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 m -96.65 -71.31 0.68 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -149.83 142.09 24.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HA ' HH21 ' A' ' 32' ' ' ARG . 0.0 OUTLIER -119.93 18.38 12.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.839 0.352 . . . . 0.0 111.484 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 -38.2 2.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 p -89.51 171.51 9.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.89 0.376 . . . . 0.0 111.517 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -81.63 131.95 35.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.745 HH21 ' HA ' ' A' ' 28' ' ' LYS . 41.6 mtt180 -103.01 103.22 13.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -80.44 -71.86 0.44 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.738 0.304 . . . . 0.0 110.318 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -163.88 137.84 5.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.9 88.11 4.92 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.52 0.676 . . . . 0.0 111.043 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LEU . 60.2 Cg_endo -72.78 75.88 2.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.718 2.278 . . . . 0.0 112.239 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.93 -7.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.481 0.712 . . . . 0.0 111.76 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.92 ' HG ' ' HB3' ' A' ' 17' ' ' PRO . 7.4 mt -95.52 107.02 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.094 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -84.44 106.7 16.23 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.769 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.0 ptmt -75.69 111.59 11.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 28.1 m -110.77 164.94 6.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.567 -173.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 42' ' ' ARG . 35.4 ttp-105 -89.29 106.56 18.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.662 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 28.0 m -118.66 170.81 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.72 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 68' ' ' TYR . 7.3 p -102.59 132.55 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.404 0.621 . . . . 0.0 110.879 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 49' ' ' THR . 83.3 mt -90.94 144.39 30.03 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.088 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.53 -22.13 73.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.716 2.277 . . . . 0.0 111.308 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.1 -15.79 63.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.931 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 40.23 5.3 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.487 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.5 m -138.28 158.2 44.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 126.49 55.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -134.81 144.42 47.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.903 0.382 . . . . 0.0 110.909 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.2 mtt180 -97.92 113.95 25.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.8 mtp -121.68 142.26 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.506 -174.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 42.2 mtm105 -65.96 113.2 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.108 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.713 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 46.3 t -124.61 130.92 73.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.615 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 p -78.1 150.52 33.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 27.4 m -57.89 -30.21 65.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.138 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -60.56 -38.68 85.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.597 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.1 m -79.32 -34.97 41.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.62 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 57' ' ' THR . 85.3 mt -62.8 -38.36 90.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.706 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -58.24 -58.75 7.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.709 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 m -68.9 -31.25 70.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.04 38.88 84.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.64 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 15.44 12.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.203 0.525 . . . . 0.0 111.078 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' LYS . 35.6 m -98.66 168.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.599 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mttt -78.72 81.79 5.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.324 0.583 . . . . 0.0 110.572 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG3' HG23 ' A' ' 65' ' ' VAL . 56.7 mtpt -81.69 143.85 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.429 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 60.7 t80 -91.26 107.91 19.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.98 175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.4 t -92.56 108.9 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.208 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.99 81.1 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.32 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 57.42 45.79 19.24 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.358 0.599 . . . . 0.0 111.003 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -93.94 21.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.732 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.2 m 66.59 41.35 3.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.276 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -76.3 -14.26 60.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.661 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.25 138.07 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -48.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.815 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.612 175.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.835 0.35 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.96 -159.32 9.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -83.25 3.52 30.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.674 0.737 . . . . 0.0 110.087 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 mtm -71.03 -29.4 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.248 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.878 HG22 ' H ' ' A' ' 6' ' ' MET . 6.8 mt 60.02 -164.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.43 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.878 ' H ' HG22 ' A' ' 5' ' ' ILE . 66.1 mtt -87.52 108.48 19.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.23 63.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.915 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 38' ' ' LEU . 22.7 pttm -81.54 64.92 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.57 0.7 . . . . 0.0 111.191 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 165.58 12.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.853 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 12' ' ' VAL . 50.6 t -82.02 114.53 20.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.87 28.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.487 0.661 . . . . 0.0 110.971 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 10' ' ' CYS . 63.9 t -128.22 -62.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.549 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.76 -29.42 7.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.181 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.06 5.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.368 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' CYS . 48.9 mtpt -102.15 174.62 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.18 89.55 39.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 38' ' ' LEU . 43.4 Cg_endo -67.03 119.66 6.7 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.166 2.577 . . . . 0.0 113.125 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.6 mtt-85 -96.05 102.12 13.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.1 m 69.56 164.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.416 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.33 -66.32 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -163.09 105.31 1.01 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.129 0.49 . . . . 0.0 109.683 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -84.67 91.4 7.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.294 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.408 HG23 ' HE2' ' A' ' 28' ' ' LYS . 21.5 m -73.58 152.23 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.84 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 t -77.87 -164.64 0.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.7 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -113.13 93.62 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 112.201 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -77.32 -56.93 4.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 167.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -143.34 93.93 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.529 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HE2' HG23 ' A' ' 23' ' ' VAL . 65.8 mttp -137.97 97.85 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.827 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 16.5 pttm -78.66 84.15 4.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.546 0.689 . . . . 0.0 111.312 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 p -173.36 117.68 0.28 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.348 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.66 -50.05 75.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -105.42 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -67.48 99.96 0.81 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.227 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.547 ' HB3' HH11 ' A' ' 35' ' ' ARG . 91.2 t80 -63.45 -25.64 68.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.417 0.627 . . . . 0.0 110.953 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.547 HH11 ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -140.35 84.5 14.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.04 178.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.67 -39.27 4.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.738 2.292 . . . . 0.0 109.927 172.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 7.9 p30 -71.25 -165.85 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.95 173.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 54' ' ' ARG . 29.1 mt 66.47 114.7 0.03 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.584 0.707 . . . . 0.0 110.423 -174.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -75.14 94.5 2.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.867 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -92.48 107.72 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.553 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.68 169.07 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.859 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -83.13 131.11 35.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.523 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.74 166.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.078 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.752 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 34.6 t -101.77 135.87 36.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.941 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.769 HD11 ' HD3' ' A' ' 51' ' ' LYS . 71.8 mt -90.67 152.53 45.04 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.408 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.16 -25.51 64.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.316 2.011 . . . . 0.0 111.753 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.9 -28.98 69.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.83 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.41 -7.3 34.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.566 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.4 m -77.18 156.48 31.53 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.876 0.37 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.53 113.55 38.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.225 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HD3' HD11 ' A' ' 45' ' ' LEU . 18.0 tptp -102.47 152.86 20.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -113.61 114.14 26.04 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.0 mtm -131.52 163.6 27.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.373 0.606 . . . . 0.0 112.162 -173.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HB3' HD22 ' A' ' 38' ' ' LEU . 36.7 mtm180 -93.04 108.64 20.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.44 153.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.896 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.11 152.83 19.03 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.763 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -58.89 -28.67 66.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -60.34 -50.23 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.5 m -65.62 -34.31 77.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.082 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 60' ' ' LEU . 10.8 mt -68.08 -44.96 75.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.26 -40.5 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.792 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -75.7 -19.52 59.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.22 45.51 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.779 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -95.52 4.46 53.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.173 0.511 . . . . 0.0 110.445 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.96 150.85 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.095 0.474 . . . . 0.0 111.621 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.752 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 57.7 tptt -75.22 97.12 3.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -111.63 147.29 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.166 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -94.08 24.84 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.706 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.0 t 68.87 102.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.565 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.25 -178.53 42.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.258 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.28 -41.64 19.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.062 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 m -78.48 61.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.457 0.646 . . . . 0.0 111.896 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 t -81.82 -15.87 52.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.656 0.741 . . . . 0.0 109.024 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.98 141.57 48.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.616 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -80.21 118.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 111.146 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.96 70.47 2.29 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.056 -176.883 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.18 -132.99 7.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.237 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 m170 49.43 66.18 1.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.172 0.51 . . . . 0.0 111.247 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.2 ttp -84.5 106.02 15.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.253 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.73 100.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.595 ' HA ' ' CE ' ' A' ' 6' ' ' MET . 0.9 OUTLIER -81.36 76.82 8.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -175.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.52 -172.98 1.56 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' O ' HD11 ' A' ' 38' ' ' LEU . 25.1 mttt -87.84 165.47 15.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -90.92 170.95 9.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.5 t -59.6 115.7 3.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.3 -1.83 16.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.562 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.8 t -90.96 -64.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 110.62 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -94.47 -54.42 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.152 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.27 6.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.346 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.11 169.73 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.711 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.74 143.68 27.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.777 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.54 77.09 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.768 2.312 . . . . 0.0 112.337 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -80.0 -34.62 38.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.274 0.559 . . . . 0.0 110.143 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 m -94.69 153.31 17.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.435 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.72 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.58 115.01 9.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 110.205 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m -107.34 2.6 24.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.454 0.645 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 t -82.89 83.04 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.159 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -152.98 168.57 25.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.72 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -115.31 107.86 15.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -67.61 109.69 3.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.4 t70 -144.53 143.71 30.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 40.2 ttmt 74.73 -24.06 0.22 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.219 0.608 . . . . 0.0 111.449 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 27' ' ' ASP . 18.3 ttmm -89.64 30.64 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.0 110.881 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.0 m 74.15 -54.17 0.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.7 25.59 11.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.712 0.405 . . . . 0.0 110.624 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -93.84 -53.43 4.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.04 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -118.87 95.58 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.542 0.686 . . . . 0.0 111.43 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -146.13 127.35 14.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.102 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -97.89 165.37 15.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.151 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.89 100.07 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.275 1.984 . . . . 0.0 111.347 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 54.1 m-80 71.33 -160.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.015 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 42.7 mt 71.86 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.676 0.751 . . . . 0.0 111.125 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -98.52 96.94 8.32 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 20.8 pttp -74.47 110.06 8.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.81 164.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.294 0.569 . . . . 0.0 111.594 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 42' ' ' ARG . 37.3 ttp180 -99.59 109.83 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.488 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -109.08 161.77 7.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.58 129.38 60.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 0.0 110.63 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 49' ' ' THR . 74.8 mt -88.66 151.49 47.92 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.88 -32.66 86.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.508 2.805 . . . . 0.0 113.751 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.32 -2.85 54.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.119 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.5 42.35 3.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.281 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.578 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.5 149.88 35.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.3 mp -106.73 120.74 58.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 2.0 tpmt? -132.78 138.76 47.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 0.0 111.636 -174.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -91.87 122.7 34.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 79.3 mtp -128.68 150.51 50.22 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.843 0.354 . . . . 0.0 110.812 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 8' ' ' LYS . 67.0 mtt85 -91.14 101.63 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.415 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 65' ' ' VAL . 27.2 t -112.36 152.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.582 -173.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.3 p -92.06 154.6 18.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -61.52 -21.98 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.092 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -62.5 -51.7 66.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.407 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.8 m -64.81 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.571 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.99 -42.12 97.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.55 -48.73 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.12 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.4 m -64.89 -22.61 67.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.02 48.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.703 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -92.16 3.81 54.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.333 0.587 . . . . 0.0 110.556 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 55' ' ' VAL . 31.4 m -109.31 139.48 32.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.995 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.6 88.77 4.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.952 0.882 . . . . 0.0 109.156 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.782 ' HE2' ' HB3' ' A' ' 71' ' ' GLN . 71.9 tttt -76.22 148.38 37.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.191 -170.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -81.59 11.62 4.52 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 110.453 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t 75.24 -34.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.514 0.726 . . . . 0.0 112.794 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.24 66.28 0.72 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.782 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 5.9 tp-100 -176.04 99.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.361 0.664 . . . . 0.0 109.428 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.59 -35.84 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.119 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.4 p 53.57 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.001 0.92 . . . . 0.0 112.422 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -99.53 127.32 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.02 -0.425 . . . . 0.0 110.538 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -91.59 100.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.871 0.367 . . . . 0.0 110.25 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.09 74.67 2.37 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.315 -177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.322 179.222 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.665 0.269 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.17 144.75 14.32 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.567 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -85.51 74.31 10.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.11 -0.82 29.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.079 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt 72.62 119.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.259 0.552 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.2 ttt -66.69 113.25 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.5 80.97 3.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -54.53 140.83 33.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.35 -176.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.617 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 9.6 ptm85 -154.14 162.0 41.49 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.742 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.85 123.51 19.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.22 -1.55 23.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.071 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 65' ' ' VAL . 51.7 t -98.4 -70.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.032 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.2 m -91.56 -15.81 28.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.75 27.99 52.33 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.131 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -100.57 144.65 29.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 144.54 86.79 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.617 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 84.1 Cg_endo -82.29 64.64 8.31 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.693 2.262 . . . . 0.0 111.798 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -98.8 106.27 18.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.121 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 m -99.13 -38.68 8.83 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.728 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.09 -115.23 7.51 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.678 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -167.76 123.27 1.04 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.991 0.424 . . . . 0.0 110.056 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 p -71.76 -58.6 3.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 109.937 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.04 -70.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -178.18 126.99 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.845 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -103.49 151.04 23.3 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -80.89 18.74 0.95 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.1 t0 64.55 167.36 0.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.719 0.407 . . . . 0.0 110.98 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt 50.08 54.06 11.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.523 0.678 . . . . 0.0 109.844 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.879 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -80.06 44.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -173.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m 61.04 26.49 16.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.299 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 24.5 tt0 -64.85 -56.4 13.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.745 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 62.51 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 167.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -108.89 2.91 21.82 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.427 0.632 . . . . 0.0 110.762 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.566 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 44.0 m-85 -84.1 176.56 8.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.646 ' HD2' ' HD2' ' A' ' 36' ' ' PRO . 21.0 tpt180 -95.7 143.07 25.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.646 ' HD2' ' HD2' ' A' ' 35' ' ' ARG . 4.5 Cg_endo -48.07 108.21 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.958 2.438 . . . . 0.0 112.656 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 m120 75.5 -12.04 1.03 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.872 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 11.9 mt -106.85 101.29 10.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -83.48 108.26 16.5 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 34' ' ' PHE . 51.7 mtmt -71.4 110.78 6.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.531 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.64 146.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.905 0.383 . . . . 0.0 110.35 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -83.53 120.16 25.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.241 0.543 . . . . 0.0 110.038 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.2 m -116.14 145.17 22.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.908 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 67' ' ' LYS . 14.2 p -89.02 113.37 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.678 0.751 . . . . 0.0 110.323 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.6 mt -74.83 147.81 84.39 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.269 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.6 -15.27 45.0 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.263 . . . . 0.0 111.668 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.85 -21.79 60.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.727 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.47 0.82 46.92 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.807 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.572 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.7 m -91.14 155.89 18.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.844 0.354 . . . . 0.0 110.438 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.91 127.14 62.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.258 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -132.35 136.62 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.878 0.371 . . . . 0.0 110.841 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -89.29 117.5 28.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.2 mtp -110.65 143.21 41.44 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.092 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HB3' HD13 ' A' ' 38' ' ' LEU . 54.4 mtt85 -79.52 100.18 7.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.767 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.16 138.6 40.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.001 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 23.1 p -88.94 163.85 15.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.922 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.561 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.1 p -59.0 -30.2 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.11 -177.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -59.84 -51.97 67.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.967 0.413 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.62 -33.8 69.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.8 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 57' ' ' THR . 79.7 mt -54.99 -43.42 73.56 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.46 -26.93 55.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.537 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.6 m -74.9 -31.56 61.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.897 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.22 77.3 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.593 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.16 -3.0 58.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.309 0.575 . . . . 0.0 110.484 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 67' ' ' LYS . 31.3 m -85.91 156.36 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.394 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.764 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -66.32 -37.85 86.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.514 -176.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' A' ' 65' ' ' VAL . 97.3 mttt 61.33 -172.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.702 0.627 . . . . 0.0 111.488 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -115.58 70.5 0.75 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.48 -45.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.614 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.96 -76.81 1.87 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.809 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -78.78 122.47 26.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.711 0.291 . . . . 0.0 111.098 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.84 105.49 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.2 m -117.95 152.78 34.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.767 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -84.52 87.93 7.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.036 0.446 . . . . 0.0 110.14 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -171.16 148.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.118 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.16 39.02 0.61 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.832 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.275 179.039 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.747 0.308 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.35 -59.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.588 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -86.61 85.76 7.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -82.64 -20.88 35.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.67 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 5' ' ' ILE . 1.4 pp -87.76 140.48 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 67.3 mtt 59.43 -164.87 0.2 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -166.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 9' ' ' ARG . . . 55.09 30.34 14.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.25 100.33 2.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 ptp180 -144.84 173.76 11.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.38 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 52.4 t -70.04 114.49 8.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 37.3 mt-10 -68.63 -5.73 21.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 0.0 111.617 -171.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' CG1' ' A' ' 65' ' ' VAL . 48.5 t -88.95 -58.28 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.166 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 m -102.18 -24.22 13.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.95 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 91.68 22.72 30.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.567 -177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.922 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.9 mmpt? -93.37 151.42 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.775 -0.25 . . . . 0.0 110.94 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 145.24 69.46 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.369 . . . . 0.0 111.475 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 37.7 Cg_endo -66.71 149.29 83.77 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.867 2.378 . . . . 0.0 111.871 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -153.64 112.16 3.65 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 m 69.95 -56.06 0.59 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.161 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.92 -127.99 9.78 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.49 110.19 4.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -116.79 148.66 40.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.054 0.454 . . . . 0.0 111.424 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -161.85 140.21 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.152 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 p -87.11 100.69 12.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.107 0.48 . . . . 0.0 110.673 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -155.94 73.98 0.84 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.5 m -80.68 95.43 6.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.331 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -148.98 107.59 3.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 59.2 92.8 0.04 OUTLIER 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.986 0.804 . . . . 0.0 111.357 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.88 -175.05 2.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.781 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.4 t -139.12 -178.44 5.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.668 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.02 -5.6 52.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.607 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' A' ' 32' ' ' ARG . 3.3 mpt_? -87.44 86.53 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.494 0.664 . . . . 0.0 111.446 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -116.77 98.84 6.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.403 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -144.44 22.03 1.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.278 0.561 . . . . 0.0 110.254 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 15.9 ptt180 -140.58 64.22 22.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.464 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.27 -16.18 2.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.459 2.106 . . . . 0.0 112.629 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -133.89 -47.16 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.684 0.754 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' A' ' 54' ' ' ARG . 13.9 mt -85.0 153.4 22.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.043 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -119.75 110.02 16.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -84.43 109.39 17.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.42 165.45 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.68 114.56 24.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.96 148.78 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.421 . . . . 0.0 110.408 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -102.48 124.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.446 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.9 mt -84.66 146.34 46.48 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.03 -21.93 61.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.748 2.299 . . . . 0.0 111.83 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.69 -26.56 67.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.522 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.69 -0.72 23.24 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.125 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -87.01 149.77 24.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 111.398 -176.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -111.59 113.22 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 53' ' ' MET . 55.0 tptt -129.03 130.94 47.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.109 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -80.95 115.94 20.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 51' ' ' LYS . 64.0 mtm -123.88 157.51 34.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.319 0.581 . . . . 0.0 111.6 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 38' ' ' LEU . 87.0 mtm180 -77.72 109.4 11.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.757 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.82 141.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.514 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.52 159.28 16.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -59.25 -32.62 70.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.188 -177.149 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -60.91 -38.86 87.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.307 0.575 . . . . 0.0 110.765 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.66 -34.21 60.48 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.446 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 91.5 mt -61.09 -53.25 59.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.325 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -60.22 -50.61 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.13 0.491 . . . . 0.0 111.327 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -73.96 -17.46 61.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.138 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.41 40.75 96.53 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -73.16 -14.52 61.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.66 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 67' ' ' LYS . 35.0 m -108.46 158.81 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.132 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -54.59 -52.0 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.738 ' HB2' HG23 ' A' ' 65' ' ' VAL . 34.1 ttpt 62.06 12.91 5.29 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.739 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 t80 65.74 18.67 11.24 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.345 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 69' ' ' VAL . 6.4 t 61.87 30.64 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.631 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . -70.72 162.65 53.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.859 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 96.5 mt-30 68.39 161.94 0.2 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.81 0.444 . . . . 0.0 111.351 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p 43.5 45.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 122.102 0.953 . . . . 0.0 111.201 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.86 -82.85 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.272 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -167.29 100.56 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.263 0.554 . . . . 0.0 110.921 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.8 103.22 13.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.069 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.64 76.23 0.55 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.633 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.251 1.163 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.828 0.347 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.33 105.32 0.51 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.292 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -96.59 -39.56 9.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.807 0.337 . . . . 0.0 111.272 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.1 ttm -149.84 135.62 18.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.865 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.7 mp -89.12 -38.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.2 ttp 71.29 -69.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.036 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.95 -58.62 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -156.17 110.69 2.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.098 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.3 ppt_? -96.46 -164.75 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.918 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 47.9 t -55.11 135.32 49.3 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.053 0.454 . . . . 0.0 110.799 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.06 3.22 27.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.042 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.25 -73.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.544 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 83.5 m -108.85 8.33 26.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 84.28 -18.34 23.8 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.382 -0.913 . . . . 0.0 114.416 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -58.39 139.99 54.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.182 0.491 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 69.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.767 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.642 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 61.0 Cg_endo -71.97 94.62 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 111.653 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -62.96 -56.82 13.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.688 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -143.27 -67.63 0.35 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.354 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.38 -63.59 0.31 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.152 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.578 ' O ' ' HB ' ' A' ' 22' ' ' THR . 64.0 t30 74.42 164.7 0.28 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.347 0.659 . . . . 0.0 110.147 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 21' ' ' ASN . 1.1 m 75.36 142.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.903 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.02 123.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.646 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -71.17 98.71 1.74 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.897 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -148.47 133.45 18.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.294 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -142.49 -75.86 0.27 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -162.38 135.53 6.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -87.32 76.45 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.6 . . . . 0.0 110.641 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -126.16 101.37 6.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.479 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 m 65.84 17.87 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.816 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 57.58 77.4 0.28 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.312 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -95.32 76.65 3.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 109.052 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.9 t-105 -119.93 19.46 12.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.132 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -63.61 112.64 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 57.29 82.21 0.24 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.904 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.53 -38.87 2.25 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.903 2.402 . . . . 0.0 113.746 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.71 -16.36 61.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.248 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 19.2 mt -89.1 108.33 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -68.67 97.38 0.8 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.638 0.732 . . . . 0.0 111.022 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 8.2 ptpp? -73.16 110.78 7.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.978 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.64 168.09 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.227 0.537 . . . . 0.0 111.173 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -88.68 114.81 25.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.702 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 m -120.97 159.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.282 0.563 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.0 t -104.57 124.26 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.231 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.595 HD12 ' HB ' ' A' ' 49' ' ' THR . 38.8 mt -60.64 148.69 81.13 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.989 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.54 -7.58 9.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.306 2.67 . . . . 0.0 113.774 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -98.78 -69.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.734 0.302 . . . . 0.0 110.249 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.46 57.89 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.021 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.595 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.1 m -144.5 156.65 44.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.52 129.26 67.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.794 0.331 . . . . 0.0 110.149 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HE2' HD21 ' A' ' 45' ' ' LEU . 39.3 ttpt -146.72 152.93 39.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.045 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -94.63 127.16 40.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.4 mtp -135.36 152.18 51.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 56.8 mtt85 -91.36 110.64 21.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.697 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 25.4 t -112.29 138.2 42.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.074 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.4 p -88.63 159.55 17.81 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.79 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 t -58.93 -25.82 63.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.572 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 m -63.74 -47.92 79.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 75.4 m -70.58 -34.5 72.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 56' ' ' CYS . 83.4 mt -61.3 -41.54 97.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.671 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -81.06 -24.81 37.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.157 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.2 t -68.28 -33.02 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.02 22.49 55.37 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.156 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 8.99 28.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.944 0.872 . . . . 0.0 111.182 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.21 161.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.724 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -76.29 147.72 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -152.2 160.56 43.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.0 111.971 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -102.92 3.8 36.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.861 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t 63.49 86.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.08 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.43 -147.45 16.99 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.427 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -136.88 140.94 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 0.0 110.899 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -116.48 27.64 3.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.207 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m 74.9 146.33 0.09 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.739 -170.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.82 115.55 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.459 . . . . 0.0 110.845 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.05 -48.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.94 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.87 -144.24 49.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.007 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.19 -0.91 . . . . 0.0 109.494 176.015 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.27 53.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.933 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -80.83 87.63 5.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.147 0.499 . . . . 0.0 110.437 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.419 ' N ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -148.25 79.55 1.45 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 173.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 4' ' ' MET . 4.5 mp -125.81 89.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.46 -176.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -87.55 -60.25 2.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.94 -41.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.29 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.22 89.75 0.1 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.922 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -128.35 161.3 29.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -62.48 135.62 57.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.602 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 49.6 mt-10 -81.98 3.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.229 0.538 . . . . 0.0 110.833 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.37 -60.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 t -96.8 -17.4 20.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.285 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.06 84.02 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.846 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -75.19 143.46 43.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.707 0.253 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.86 144.5 36.97 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.871 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -86.21 -0.22 8.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.159 2.572 . . . . 0.0 113.006 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 60.01 -164.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.391 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -116.83 113.36 22.4 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.788 0.327 . . . . 0.0 110.379 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.74 -175.19 28.39 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.775 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -149.67 157.47 43.27 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.5 t -76.67 -10.94 59.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.474 0.176 . . . . 0.0 111.474 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 22' ' ' THR . 0.9 OUTLIER 66.31 -40.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.433 1.493 . . . . 0.0 113.9 174.001 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 100.24 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.955 0.407 . . . . 0.0 110.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -178.79 130.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -90.1 -65.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.944 0.402 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -154.33 104.09 2.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.194 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 86.7 mttt -144.09 -49.32 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.568 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 39.0 ttmt 69.81 -53.75 0.61 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.324 0.649 . . . . 0.0 110.412 -170.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.6 m 68.2 82.07 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.589 0.756 . . . . 0.0 111.975 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.8 80.15 2.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -141.54 61.69 1.47 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.486 -1.234 . . . . 0.0 107.862 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 60.2 79.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.196 -167.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -68.24 121.95 17.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.024 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.599 ' H ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -130.8 143.61 50.07 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.937 -177.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' ARG . 5.7 Cg_exo -78.78 -37.38 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.525 2.15 . . . . 0.0 112.345 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -151.93 -47.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.888 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 54' ' ' ARG . 9.0 mt -71.12 113.07 7.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.847 0.356 . . . . 0.0 111.628 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -83.97 100.9 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.622 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 24.4 ttmt -75.86 110.62 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.73 159.15 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.686 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.629 ' HE ' HG21 ' A' ' 50' ' ' ILE . 65.9 ttt180 -87.02 117.65 25.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.389 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.74 157.33 30.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.857 0.36 . . . . 0.0 110.767 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.5 139.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.693 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' HB ' ' A' ' 49' ' ' THR . 73.6 mt -86.43 153.32 56.02 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.47 -26.17 52.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.933 2.422 . . . . 0.0 112.689 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.31 -21.88 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.276 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.72 -1.8 26.05 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.231 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.567 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.4 m -81.41 159.18 24.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.629 HG21 ' HE ' ' A' ' 42' ' ' ARG . 57.5 mt -121.8 133.19 68.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.674 0.273 . . . . 0.0 110.754 -177.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HD2' HD11 ' A' ' 45' ' ' LEU . 63.5 mttm -140.03 164.52 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -121.63 117.63 27.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.2 mtm -138.7 165.4 27.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.964 0.411 . . . . 0.0 111.823 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.634 ' HB3' HD22 ' A' ' 38' ' ' LEU . 27.8 mmt180 -76.87 119.56 20.8 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.734 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.619 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 39.4 t -126.64 139.71 50.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 p -77.39 145.81 37.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.438 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 t -55.08 -30.49 59.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -61.05 -47.39 86.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 55.5 m -72.19 -33.9 68.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.857 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.98 -53.19 60.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.6 -45.67 57.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.589 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 t -69.4 -26.74 64.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.646 0.26 . . . . 0.0 110.997 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.94 48.36 7.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.753 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.25 -28.63 22.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.203 0.525 . . . . 0.0 109.671 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.83 171.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 41.1 tptt -69.32 -44.91 70.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.616 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.703 ' HG2' ' H ' ' A' ' 69' ' ' VAL . 85.8 tttt 71.07 135.19 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.771 0.669 . . . . 0.0 111.227 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.63 -15.22 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.703 ' H ' ' HG2' ' A' ' 67' ' ' LYS . 35.4 t 57.47 78.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.184 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 -56.24 1.66 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 167.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -99.99 141.49 32.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.736 HG23 ' H ' ' A' ' 73' ' ' SER . 2.5 m -84.38 -75.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.736 ' H ' HG23 ' A' ' 72' ' ' VAL . 10.6 p -99.99 156.23 17.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.608 0.242 . . . . 0.0 110.874 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.46 128.68 36.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.2 126.61 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.953 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.52 -27.0 3.01 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.248 0.982 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.12 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.908 0.385 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.63 -44.41 3.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.929 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -98.99 93.8 6.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.733 0.301 . . . . 0.0 110.544 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.7 ttt -95.87 70.71 2.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.487 0.66 . . . . 0.0 110.108 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.9 mm -99.02 99.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.531 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 145.89 28.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.765 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.14 71.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.71 50.49 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.352 0.596 . . . . 0.0 110.554 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.513 ' H ' ' CD ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -80.43 155.29 27.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.738 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 48.8 t -60.61 144.68 51.24 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.05 -8.79 59.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.961 0.41 . . . . 0.0 110.933 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 55' ' ' VAL . 57.6 t -100.3 -62.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 42.8 t -91.06 -47.53 7.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.819 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 10' ' ' CYS . . . 112.02 -9.98 27.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 13' ' ' CYS . 28.7 mtpp -77.5 162.68 26.96 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.711 -0.288 . . . . 0.0 110.25 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.88 144.33 76.02 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.966 0.413 . . . . 0.0 111.416 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.644 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 98.2 Cg_endo -89.7 94.88 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.193 2.595 . . . . 0.0 112.178 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -77.6 -28.47 51.55 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.642 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 57.82 -155.42 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.921 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.64 23.05 30.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.699 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 m120 59.97 61.96 1.76 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m 75.09 145.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.14 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.59 170.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t 65.04 -158.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -95.57 -12.55 25.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 110.654 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 p -142.16 -68.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.001 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.73 -58.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.548 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 25.2 ttmm 66.57 -70.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.447 0.699 . . . . 0.0 111.304 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 28' ' ' LYS . 27.1 mmtp -133.76 -52.13 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.465 0.174 . . . . 0.0 111.149 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t 72.63 -1.82 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.065 0.853 . . . . 0.0 110.888 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 61.55 102.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.611 0.764 . . . . 0.0 112.083 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 73.27 138.17 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.454 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -90.31 -28.19 18.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.718 0.771 . . . . 0.0 108.957 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -85.11 104.83 15.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.493 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 35' ' ' ARG . 29.6 mmt180 61.16 69.98 0.98 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.67 0.607 . . . . 0.0 110.579 -175.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.64 5.43 2.88 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.264 2.643 . . . . 0.0 112.797 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -109.81 -10.16 14.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.634 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 22.3 mt -120.02 99.75 6.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.706 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.68 123.19 33.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 15.4 ptmt -72.73 122.52 21.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.782 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 t -114.8 156.2 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.639 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -85.46 106.56 16.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.73 166.78 10.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.462 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.17 136.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.594 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 49' ' ' THR . 79.2 mt -97.42 152.2 38.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.55 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.37 -15.75 50.29 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.0 2.467 . . . . 0.0 112.704 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.16 -15.19 57.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.1 15.36 26.22 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.14 -0.553 . . . . 0.0 111.797 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.542 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -89.34 149.22 23.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.843 0.354 . . . . 0.0 110.247 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -128.05 111.69 25.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.72 149.42 34.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.788 0.328 . . . . 0.0 110.543 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.27 120.95 31.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.44 ' HE3' HG22 ' A' ' 12' ' ' VAL . 65.7 mtm -130.28 149.85 51.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.932 -177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 81.9 mtm180 -76.26 113.35 13.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.421 0.629 . . . . 0.0 110.923 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.9 t -105.23 148.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.089 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.82 148.55 25.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.326 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -58.71 -25.59 63.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.38 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -60.53 -40.72 92.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.365 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.79 -33.89 62.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.565 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.67 -53.59 55.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 61' ' ' LYS . 21.5 ptmt -81.76 -2.49 50.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -86.8 -32.0 20.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.56 46.92 93.32 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.996 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.86 33.74 3.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.163 0.506 . . . . 0.0 111.213 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.22 149.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.779 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -86.37 102.79 14.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.536 0.684 . . . . 0.0 109.887 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -94.78 146.95 23.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.972 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -107.25 43.85 1.13 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.4 t 67.72 102.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.824 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -161.72 121.37 1.02 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.709 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 68.88 89.26 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.406 0.622 . . . . 0.0 111.175 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.17 145.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.662 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.0 m 64.05 75.25 0.39 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.406 0.622 . . . . 0.0 110.282 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -83.47 146.49 28.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.86 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.76 100.5 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.0 82.71 1.67 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.687 179.238 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.31 0.576 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.12 -25.49 55.17 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.471 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -87.64 158.01 18.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -77.2 93.33 3.93 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.839 HD13 ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -66.0 105.55 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.646 0.736 . . . . 0.0 111.156 -178.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -114.0 147.32 38.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.024 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.72 174.75 7.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -67.53 109.66 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.968 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.3 ptm180 -143.77 155.6 44.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.513 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 55' ' ' VAL . 49.8 t -68.4 131.95 46.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.502 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.83 2.93 24.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.219 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 65' ' ' VAL . 49.1 t -102.54 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.809 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 64' ' ' LYS . 72.2 m -101.72 -21.23 14.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.581 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.607 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -79.29 145.83 33.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . . . -78.41 155.46 79.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.516 -176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.732 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 84.6 Cg_endo -78.05 109.33 2.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.992 2.462 . . . . 0.0 112.509 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.01 85.9 3.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -100.66 101.75 12.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.351 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.9 -9.27 32.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.698 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -92.03 -28.24 17.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 109.96 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 m 56.94 76.44 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.139 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.86 119.78 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.608 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -144.98 106.3 4.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 111.232 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -120.73 112.11 18.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.549 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.3 m -136.16 12.79 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.47 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 11.7 t70 -173.45 -86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.014 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 25.0 mmmt -173.78 -52.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 29' ' ' LYS . 28.3 ttpt -78.62 -55.04 5.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.358 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m 54.73 69.19 0.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.408 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -82.98 160.54 21.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 1.014 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 60.1 mtt-85 -118.43 104.97 11.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 111.666 -170.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -125.37 -66.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.83 -13.58 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.734 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.647 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -151.45 86.25 4.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.265 177.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.014 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 2.9 Cg_exo -76.72 -55.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.843 2.362 . . . . 0.0 112.854 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -112.48 -27.42 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.497 0.665 . . . . 0.0 109.487 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.647 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 57.2 mt -86.26 159.77 19.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.609 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.39 132.38 53.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -85.41 113.5 21.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.44 167.17 9.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.55 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 18.0 ptp180 -101.13 120.6 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.299 0.571 . . . . 0.0 110.935 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 34.1 m -110.46 167.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.112 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 68' ' ' TYR . 11.9 p -101.65 131.41 49.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.133 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.0 144.92 28.61 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.665 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 -20.1 57.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.616 2.211 . . . . 0.0 111.58 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.19 -27.15 68.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.524 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.74 44.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -99.77 158.31 15.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.757 0.313 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 42' ' ' ARG . 63.7 mt -105.3 116.38 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -106.14 144.75 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.087 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -110.6 125.84 53.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.116 0.484 . . . . 0.0 110.338 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.41 ' HE2' HG21 ' A' ' 43' ' ' VAL . 72.3 mtm -139.22 163.76 31.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.698 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -84.18 120.45 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 65' ' ' VAL . 58.5 t -122.87 147.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.706 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.732 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 24.7 p -88.57 155.13 19.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.488 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -57.49 -32.71 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.039 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -65.54 -43.08 91.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.977 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.5 m -72.65 -35.58 67.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.664 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.6 -47.01 87.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.614 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.117 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -70.41 -29.41 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.36 28.32 73.64 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.012 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.5 tmtp? -82.83 -21.08 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.379 0.609 . . . . 0.0 109.783 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 55' ' ' VAL . 35.4 m -61.79 163.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.331 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 31.5 mmtp -78.58 59.75 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.576 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -57.59 140.84 49.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.528 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p90 -78.11 14.49 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.639 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 p 44.36 82.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 112.026 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.7 52.55 0.19 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.692 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 59.33 88.92 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.278 0.561 . . . . 0.0 111.72 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.74 6.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.409 0.623 . . . . 0.0 110.658 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -96.08 108.66 21.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.526 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.89 95.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.56 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -134.88 93.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.665 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.82 -92.92 2.17 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.245 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.046 178.739 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.07 -143.72 5.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.373 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -94.1 91.19 6.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.052 0.453 . . . . 0.0 110.721 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 mmt -127.35 -24.41 3.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.5 mt 69.55 -58.74 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.585 0.553 . . . . 0.0 111.334 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 167.33 11.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.22 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.62 -37.9 0.45 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 58.18 85.16 0.09 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.879 0.737 . . . . 0.0 111.446 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -139.0 165.24 27.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.044 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.6 t -82.01 143.47 31.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.59 -2.22 25.03 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.68 -67.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.0 p -85.28 -39.41 17.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.777 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 9.97 51.11 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.125 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.59 158.46 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.37 149.53 47.06 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.022 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.8 Cg_endo -75.16 110.43 3.11 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.691 2.261 . . . . 0.0 112.299 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -91.67 88.36 6.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.47 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.0 m 65.5 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.004 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.02 174.6 39.08 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.834 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -117.05 163.88 15.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.263 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -82.93 142.31 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 0.0 110.798 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.03 -38.12 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.648 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 p -162.85 -36.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.67 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.61 103.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.879 0.737 . . . . 0.0 110.688 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -67.93 -62.94 1.17 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.486 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t70 56.0 26.62 10.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.597 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.961 ' HB3' ' HG2' ' A' ' 31' ' ' GLU . 82.1 tttt -82.84 133.89 35.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.961 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -67.79 -5.33 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.037 0.446 . . . . 0.0 111.511 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.459 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 5.1 m -104.01 3.15 33.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.961 ' HG2' ' HB3' ' A' ' 28' ' ' LYS . 43.0 mm-40 -76.71 126.1 30.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -76.75 167.24 22.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -54.04 109.84 0.52 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.274 0.559 . . . . 0.0 111.901 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.498 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 36.8 p90 -106.54 -166.38 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.261 -175.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.743 ' HB3' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -112.43 86.96 8.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.158 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 34' ' ' PHE . 16.7 Cg_exo -67.55 -55.68 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.796 2.331 . . . . 0.0 113.46 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -89.36 -5.45 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.743 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . 20.6 mt -90.48 109.21 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -77.82 101.57 6.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.497 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' MET . 20.5 pttp -78.82 110.23 13.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 33.5 m -125.01 162.25 27.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.301 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.13 120.1 29.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 0.0 110.914 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.53 167.7 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.404 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' N ' ' HA ' ' A' ' 68' ' ' TYR . 9.5 p -89.31 138.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.614 0.721 . . . . 0.0 111.063 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.509 HD12 ' HB ' ' A' ' 49' ' ' THR . 88.6 mt -92.52 157.85 39.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.74 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.11 -24.29 39.98 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.724 2.282 . . . . 0.0 112.496 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.95 -19.01 60.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.486 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.71 54.61 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.509 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.9 m -86.73 158.38 19.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.163 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.14 122.81 66.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.0 ttmt -141.51 147.72 38.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.5 mtm180 -88.0 134.98 33.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 63.0 mtm -138.56 170.61 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.485 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -82.54 110.72 17.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.079 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 49.6 t -115.57 144.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.927 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 25.5 p -90.79 152.47 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.517 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -58.94 -25.42 63.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 m -61.08 -45.43 94.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.444 . . . . 0.0 110.351 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.71 -34.58 75.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.02 -45.55 77.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.796 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.59 -7.78 53.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.753 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 t -117.2 -4.12 11.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.866 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.92 62.05 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.118 -175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 64' ' ' LYS . 38.7 tptt -87.64 56.77 4.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.983 0.897 . . . . 0.0 111.08 -171.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 67' ' ' LYS . 5.6 m -143.43 156.84 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 3.14 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.57 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 65' ' ' VAL . 3.7 mppt? 57.77 -168.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.911 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.588 ' HA ' ' N ' ' A' ' 44' ' ' VAL . 13.1 p90 -94.83 -12.05 27.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 110.956 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.31 -52.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.91 144.36 4.43 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -144.28 148.9 35.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.69 -177.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.181 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.0 m 67.52 23.87 8.84 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.507 0.504 . . . . 0.0 111.327 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.37 -33.46 75.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.446 0.641 . . . . 0.0 109.634 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.08 40.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.023 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.11 -25.57 69.67 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.063 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.958 177.414 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mptt . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 23.5 ptt-85 -135.76 -174.08 3.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.44 119.69 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.732 0.301 . . . . 0.0 110.379 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.09 -5.52 46.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.145 0.498 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.22 -51.2 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.6 m -114.13 -12.6 12.51 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 -16.57 60.34 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.733 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -74.99 153.57 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.52 0.66 . . . . 0.0 111.267 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.19 153.78 69.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.181 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.847 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 94.3 Cg_endo -80.13 91.28 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.722 2.281 . . . . 0.0 111.464 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.036 -173.788 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.866 0.278 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 67.63 8.99 6.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.93 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.847 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 12.7 mt -116.95 122.76 45.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.255 0.55 . . . . 0.0 111.964 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.4 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -106.49 116.85 32.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.079 173.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 53' ' ' MET . 80.2 mttt -74.49 116.17 14.87 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 168.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.55 136.78 44.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.296 0.569 . . . . 0.0 109.526 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 42' ' ' ARG . 26.5 ttm180 -80.7 106.46 12.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.546 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -111.04 170.04 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.369 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.88 131.34 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 85.6 mt -90.52 144.18 30.3 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.058 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 25.3 Cg_exo -64.11 -14.58 44.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.947 2.431 . . . . 0.0 112.507 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.85 -4.0 57.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.636 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.77 55.05 2.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.82 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 m -149.14 159.02 44.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.94 127.12 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.87 141.85 44.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.428 . . . . 0.0 111.694 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -91.26 120.44 32.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 49.8 mtm -125.3 149.41 48.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.875 0.369 . . . . 0.0 111.015 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -80.11 107.95 13.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.17 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.36 134.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.6 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 17' ' ' PRO . 44.2 t -74.9 149.56 39.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.269 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.7 m -56.04 -30.99 62.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.344 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -59.11 -49.22 78.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.189 0.519 . . . . 0.0 110.151 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.4 m -69.11 -37.01 78.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.378 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.26 -41.29 99.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.143 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.55 -39.72 64.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -68.9 -32.94 72.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.7 62.05 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.727 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.29 19.14 7.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.052 0.453 . . . . 0.0 111.486 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -102.7 162.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.92 106.75 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -121.55 152.03 39.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.681 -167.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.026 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 122.057 0.932 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' A' ' 14' ' ' GLY . 21.3 ptt180 -97.74 -177.87 3.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.203 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.3 t -67.37 120.79 14.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 167.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 53' ' ' MET . 41.6 mt-10 -71.71 -10.84 60.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.061 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG11 HG12 ' A' ' 65' ' ' VAL . 58.5 t -81.9 -71.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -97.41 -46.72 5.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 0.0 111.022 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 9' ' ' ARG . . . 120.27 21.3 3.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.059 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.73 177.57 8.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.877 0.339 . . . . 0.0 111.396 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . . . -110.62 91.35 12.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.692 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 36.2 Cg_endo -63.37 146.94 93.82 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.644 2.229 . . . . 0.0 112.093 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.78 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--O 1.233 0.23 0 N-CA-C 112.714 0.236 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 63.04 13.87 7.11 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.718 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 54' ' ' ARG . 14.1 mt -117.44 152.12 35.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.12 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.448 ' HB2' HD11 ' A' ' 60' ' ' LEU . 31.5 mm-40 -118.66 97.89 5.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 53' ' ' MET . 61.1 pttt -81.45 112.68 18.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.228 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.88 168.37 21.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.836 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -78.66 135.51 37.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.88 143.91 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.92 136.19 45.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.396 0.617 . . . . 0.0 110.873 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.0 mt -98.53 143.01 25.54 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.486 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.61 -15.75 48.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.856 2.37 . . . . 0.0 112.321 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.63 -16.21 60.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.441 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 52.24 0.88 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.143 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.8 m -145.95 154.51 42.0 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.575 -0.368 . . . . 0.0 110.561 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.36 117.29 44.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -120.89 142.64 49.49 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -101.72 119.11 38.27 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.572 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 62.8 mtm -133.99 155.5 49.86 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.099 0.476 . . . . 0.0 111.834 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HB3' HD22 ' A' ' 38' ' ' LEU . 69.3 mtm180 -76.12 116.41 16.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.86 148.47 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.823 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 10.9 p -91.22 155.94 18.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.602 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -61.36 -26.71 68.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.095 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 p -64.51 -41.3 96.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.72 0.295 . . . . 0.0 110.836 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.22 -34.45 61.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.52 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 92.4 mt -59.34 -51.82 68.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.269 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -72.5 -33.98 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.8 p -74.37 -24.71 59.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.072 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.33 44.01 23.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.276 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -95.26 11.9 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.448 0.642 . . . . 0.0 109.932 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 HG11 ' A' ' 12' ' ' VAL . 28.5 m -120.94 138.46 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.898 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -86.08 98.89 11.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -94.4 30.8 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.952 -166.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.212 177.156 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.471 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 85.0 tttt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -74.47 178.41 5.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.432 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 41.5 t -55.02 128.68 34.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.071 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 8' ' ' LYS . 38.7 mt-10 -76.57 5.14 7.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.639 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.28 -58.38 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.1 -23.09 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.93 4.4 36.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.474 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mttp -74.15 176.75 6.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.74 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.05 144.52 29.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.217 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 89.4 Cg_endo -82.28 150.87 15.53 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.4 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.448 . . . . 0.0 109.986 177.304 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo . . . . . 0 N--CA 1.464 -0.232 0 CA-C-O 121.158 0.399 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 18.8 m120 -84.52 -171.13 3.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.276 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 28.6 mt 68.46 106.8 0.05 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.652 0.739 . . . . 0.0 110.162 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -77.66 93.43 4.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.783 -173.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' MET . 17.3 pttp -78.01 109.85 12.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.641 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.47 160.71 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.527 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -95.12 126.84 40.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.704 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 67' ' ' LYS . 34.3 m -123.42 156.04 29.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.014 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 68' ' ' TYR . 7.2 p -109.11 122.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.636 0.731 . . . . 0.0 110.44 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.9 mt -79.37 143.43 59.99 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.374 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.8 -21.48 69.41 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.98 2.453 . . . . 0.0 112.795 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.72 -23.89 56.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.111 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.27 67.09 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.695 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.489 ' HB ' HD12 ' A' ' 45' ' ' LEU . 3.4 m -153.38 154.6 34.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.578 -0.366 . . . . 0.0 110.13 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.58 113.28 22.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -134.84 148.23 50.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.765 0.317 . . . . 0.0 111.229 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -99.21 119.77 38.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.7 mtm -132.58 157.6 44.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.027 0.442 . . . . 0.0 110.851 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.683 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 49.9 mtm180 -87.68 103.92 16.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.464 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.505 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.7 t -98.98 154.34 4.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.825 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 15' ' ' LYS . 28.4 p -90.02 149.79 22.38 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.173 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -57.5 -29.45 64.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.111 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -62.68 -47.73 82.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.797 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.0 m -64.94 -34.29 78.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.293 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.18 -50.53 72.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -66.06 -30.31 70.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.13 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -31.75 54.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.73 31.18 56.68 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.571 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -79.02 -25.45 43.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.964 0.411 . . . . 0.0 110.91 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.489 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 28.0 m -77.04 143.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.61 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.06 -3.65 55.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.598 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 45.47 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.226 . . . . 0.0 114.206 174.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.8 t80 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.734 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 tttm . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.605 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 10.0 ptp180 -152.83 169.71 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.817 -172.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.25 127.84 34.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 38.3 mt-10 -73.99 -15.02 61.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.758 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.02 -57.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.463 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -102.0 -36.14 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 103.39 8.34 41.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.572 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -87.36 150.23 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.83 144.49 85.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 71.5 Cg_endo -94.97 141.73 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.382 2.721 . . . . 0.0 113.312 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 173.788 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.531 0.357 0 N-CA-C 113.704 0.617 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' PRO . 19.8 m120 71.48 -8.1 1.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.56 172.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.8 mt -117.55 123.62 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.296 0.569 . . . . 0.0 111.758 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -105.44 107.69 18.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.561 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 19.1 ttmm -76.57 108.51 9.61 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.67 168.91 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.945 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -81.02 117.33 21.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.785 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . 33.6 m -117.29 163.5 14.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.81 134.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.497 . . . . 0.0 110.245 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' A' ' 49' ' ' THR . 90.0 mt -93.14 153.3 41.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.805 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.74 -27.58 43.41 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.34 2.694 . . . . 0.0 113.355 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.88 -1.44 52.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 111.63 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.93 2.19 59.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.3 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.556 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -77.56 152.5 33.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.786 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.11 126.75 70.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -141.83 157.22 45.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.38 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 99.4 mtt180 -98.36 129.88 45.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.2 mtm -138.33 150.91 47.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.201 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 79.3 mtm180 -76.88 119.59 20.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 65' ' ' VAL . 37.6 t -120.77 148.18 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 17' ' ' PRO . 20.2 p -87.13 149.75 24.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.431 ' HA ' HD12 ' A' ' 60' ' ' LEU . 5.5 m -56.75 -30.26 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.499 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.76 -40.25 91.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.238 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.7 m -79.53 -35.53 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 57' ' ' THR . 95.2 mt -60.01 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -78.92 -5.54 53.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.316 0.579 . . . . 0.0 110.644 -176.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -94.34 -27.4 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 109.74 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.79 56.12 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 9.4 mmmm -89.25 30.59 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.75 0.31 . . . . 0.0 110.983 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 55' ' ' VAL . 20.1 m -122.12 129.43 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.674 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -80.49 98.28 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.0 pttt -110.77 177.54 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.727 -167.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.0 t80 . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.87 172.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.284 0.564 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -124.44 -176.2 3.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.246 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 53.1 t -64.89 123.68 20.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.13 -4.28 34.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 0.0 111.301 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.7 t -92.58 -65.88 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 111.12 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.02 -13.95 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.734 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.57 86.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.546 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.15 158.57 34.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.55 148.05 87.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.7 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.1 Cg_endo -74.12 113.77 3.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.482 2.121 . . . . 0.0 112.062 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 8.7 tpt180 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.658 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.475 0.403 0 N-CA-C 113.751 0.635 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -111.9 -9.19 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.55 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 mt -121.14 118.67 30.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.083 0.468 . . . . 0.0 111.212 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -88.37 107.65 18.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.249 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -81.71 110.21 16.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.684 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.725 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 24.7 m -122.83 157.92 27.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.674 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 50' ' ' ILE . 68.5 mtp180 -92.73 123.28 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.104 0.478 . . . . 0.0 110.44 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.666 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 32.9 m -115.86 164.75 11.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.07 128.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.67 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -95.17 150.54 37.8 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.782 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.46 -11.28 27.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.772 2.315 . . . . 0.0 112.254 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.11 -13.67 56.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.713 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.37 3.66 58.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.576 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.83 154.45 17.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.523 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 42' ' ' ARG . 55.4 mt -115.21 110.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.142 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.95 151.23 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.089 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 65.2 mtt180 -84.16 137.76 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 43' ' ' VAL . 86.7 mtp -133.04 154.64 50.35 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -85.73 103.88 14.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.86 146.15 18.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.961 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 28.0 p -96.24 157.52 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.76 0.314 . . . . 0.0 110.82 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 p -61.13 -25.04 66.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.737 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.421 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 32.1 t -58.65 -52.38 65.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.3 m -64.3 -34.28 77.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.444 . . . . 0.0 111.006 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 57' ' ' THR . 81.4 mt -63.71 -50.51 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.22 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -81.13 -19.21 44.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 m -81.86 -12.16 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.992 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.77 54.91 25.56 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.372 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -135.89 76.02 1.58 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 0.0 109.449 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.77 172.86 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.51 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 12.1 ptmm? -122.37 45.75 2.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.613 0.721 . . . . 0.0 110.258 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.725 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 2.8 mmmp? -80.9 -177.91 6.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.162 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 . . . . . 0 C--N 1.325 -0.5 0 CA-C-O 121.086 0.47 . . . . 0.0 111.084 177.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.323 0.582 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.9 ptm180 -150.04 166.4 29.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.759 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.44 124.75 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.128 0.267 . . . . 0.0 110.354 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.22 -7.87 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.464 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -85.79 -67.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 111.114 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.2 m -94.16 -22.89 18.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.256 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.32 -2.7 61.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.329 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.66 166.12 23.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.74 0.305 . . . . 0.0 111.74 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.63 144.12 72.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.906 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 95.9 Cg_endo -85.64 151.82 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.791 2.327 . . . . 0.0 113.644 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.966 173.079 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 N-CA-C 112.944 0.325 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.91 3.48 17.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 109.826 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 54' ' ' ARG . 23.0 mt -126.3 129.73 49.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.239 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -82.82 89.19 6.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.327 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.53 114.22 4.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.103 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.55 153.86 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -93.32 124.84 37.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.941 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.86 155.46 17.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.02 117.56 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.274 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' HB ' ' A' ' 49' ' ' THR . 85.2 mt -82.07 152.87 69.0 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.938 175.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.75 -29.96 64.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.851 2.367 . . . . 0.0 112.917 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.15 -27.97 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.177 0.513 . . . . 0.0 110.65 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.86 7.05 25.91 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.3 m -83.1 151.03 25.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.051 0.453 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.5 mt -105.51 108.34 24.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -112.8 134.42 54.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.977 0.418 . . . . 0.0 111.199 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -91.0 120.5 32.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 43.3 mtm -127.62 157.01 41.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.566 0.698 . . . . 0.0 111.513 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.648 ' HB3' HD13 ' A' ' 38' ' ' LEU . 77.1 mtm180 -87.58 101.02 13.23 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.439 174.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 65' ' ' VAL . 21.2 t -115.12 145.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.56 -175.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.4 p -90.32 153.51 20.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.178 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.487 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -56.99 -26.38 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.595 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 t -64.09 -48.52 75.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.2 m -67.44 -33.26 74.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 57' ' ' THR . 76.1 mt -62.04 -53.38 56.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -77.75 -54.59 6.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.289 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -107.01 2.7 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.33 23.09 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.257 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 78.36 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.344 0.592 . . . . 0.0 111.056 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 55' ' ' VAL . 17.5 m -105.72 125.06 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 0.0 110.679 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -77.23 82.14 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -69.47 128.12 35.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.93 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.614 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' PRO . 22.4 pttp . . . . . 0 C--O 1.227 -0.084 0 CA-C-O 121.524 0.678 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD2' ' C ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -103.29 176.5 5.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.012 177.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 40.6 t -60.1 124.35 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 54' ' ' ARG . 8.5 mm-40 -60.09 -22.1 62.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.117 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 40.3 t -98.75 -70.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.517 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -78.68 -19.02 53.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.841 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.79 2.37 81.16 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.337 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -80.19 164.63 23.13 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.788 0.328 . . . . 0.0 110.75 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.79 147.94 89.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.486 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.798 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 90.6 Cg_endo -79.04 122.32 5.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.765 2.31 . . . . 0.0 111.827 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 . . . . . 0 C--N 1.321 -0.647 0 CA-C-O 121.278 0.561 . . . . 0.0 110.575 -178.839 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo . . . . . 0 C--O 1.235 0.362 0 CA-C-O 121.066 0.361 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 17' ' ' PRO . 43.4 m-80 -136.37 166.1 24.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.487 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 18.8 mt 71.87 112.95 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.967 0.792 . . . . 0.0 111.032 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.509 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.1 OUTLIER -104.48 113.75 27.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.668 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 53' ' ' MET . 21.7 pttp -77.24 110.38 11.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.98 168.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.424 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -96.1 115.61 27.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.874 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.2 155.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.759 0.314 . . . . 0.0 110.178 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.5 126.85 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.256 0.551 . . . . 0.0 109.924 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.469 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.1 mt -79.69 144.89 61.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.929 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 31.3 Cg_exo -59.35 -21.3 60.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.54 2.16 . . . . 0.0 111.936 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.04 -17.23 62.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.522 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.59 3.93 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.108 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -123.03 153.34 39.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.684 0.278 . . . . 0.0 110.787 -176.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.51 119.8 52.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -136.27 137.26 40.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -90.69 124.33 35.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 88.1 mtp -134.62 160.78 37.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.001 0.429 . . . . 0.0 111.345 -175.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HB3' HD22 ' A' ' 38' ' ' LEU . 50.3 mtt85 -81.83 102.1 10.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.339 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.8 138.16 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 83.3 m -80.04 153.74 28.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.595 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 60' ' ' LEU . 3.4 m -61.15 -26.35 67.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.454 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -62.78 -42.77 99.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.325 0.583 . . . . 0.0 110.148 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 62.1 m -70.86 -33.78 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.121 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 57' ' ' THR . 96.4 mt -63.86 -36.03 82.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.2 -63.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.618 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -92.93 -24.62 18.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.869 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' CYS . . . 113.02 -101.79 1.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.826 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 17.8 3.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.587 . . . . 0.0 111.067 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 27.4 m -141.33 -179.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -79.39 -44.35 21.64 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 70.43 143.69 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 111.176 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 111.02 -177.288 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -86.33 -179.05 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.812 174.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' HB3' ' H ' ' A' ' 15' ' ' LYS . 44.8 t -60.96 114.58 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -62.74 -14.63 46.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 65' ' ' VAL . 45.8 t -80.39 -63.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.611 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 82.5 m -120.77 6.55 10.45 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -172.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.544 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 71.79 25.3 75.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.934 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG3' ' SG ' ' A' ' 59' ' ' CYS . 29.3 mmmt -74.9 160.91 30.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -91.74 144.04 28.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.4 Cg_endo -89.02 136.95 3.08 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.904 2.403 . . . . 0.0 113.19 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 18' ' ' ARG . 24.6 mtm180 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.563 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 CA-C-O 121.142 0.392 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.1 -5.9 32.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 54' ' ' ARG . 37.6 mt -116.3 135.91 53.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.671 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' CB ' HD11 ' A' ' 60' ' ' LEU . 7.9 mm-40 -86.64 109.79 19.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.528 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.66 109.12 15.79 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.59 165.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 42' ' ' ARG . 3.4 mpt_? -105.06 124.51 49.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.74 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 51' ' ' LYS . 25.0 m -108.0 152.64 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.893 0.378 . . . . 0.0 110.268 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.76 111.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HB ' ' A' ' 49' ' ' THR . 93.3 mt -71.3 145.11 90.34 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.786 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 32.7 Cg_exo -59.72 -15.2 30.44 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -85.08 1.78 46.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.116 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.17 34.42 29.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.345 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -120.6 148.98 43.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 42' ' ' ARG . 59.5 mt -98.55 118.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.3 tttm -124.12 124.91 43.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 0.0 110.004 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 3.1 ppt_? -97.63 136.0 38.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.112 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 70.6 mtm -142.61 169.19 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HB3' HD13 ' A' ' 38' ' ' LEU . 36.2 mtm180 -91.13 109.39 20.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.714 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.8 t -122.85 152.13 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.3 p -91.39 147.54 22.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.504 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 m -57.43 -28.13 63.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.827 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 p -61.74 -42.34 98.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.66 0.267 . . . . 0.0 111.095 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.606 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 57.3 m -70.56 -34.77 72.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.2 0.524 . . . . 0.0 110.543 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 57' ' ' THR . 53.9 mt -58.34 -51.85 68.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.977 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -79.61 -22.88 43.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.386 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 m -74.9 -28.21 60.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.17 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.43 29.56 63.77 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.248 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -79.17 -17.4 55.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 110.085 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 12' ' ' VAL . 32.6 m -97.54 162.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.844 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -81.45 73.65 8.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.406 0.622 . . . . 0.0 110.538 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -84.6 139.78 31.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.727 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.188 0.518 . . . . 0.0 110.077 177.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.56 0.695 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -112.44 176.7 4.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.841 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.4 t -78.98 125.87 29.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.84 -15.29 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 56.5 t -92.35 -64.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.773 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.3 m -93.0 -20.55 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.85 -1.45 85.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.1 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -68.18 162.19 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.62 0.248 . . . . 0.0 110.915 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -83.88 143.18 42.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.319 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.3 Cg_endo -90.72 96.48 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.825 2.35 . . . . 0.0 113.011 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.24 176.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 73.2 Cg_exo . . . . . 0 N--CA 1.464 -0.264 0 CA-C-O 120.602 0.168 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 17.6 m120 74.4 -0.69 3.28 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.345 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.3 mt -120.79 119.7 33.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.421 0.629 . . . . 0.0 112.022 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -92.68 118.87 31.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.807 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -86.14 118.25 25.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.065 0.459 . . . . 0.0 110.289 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.5 m -127.62 153.28 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.599 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 93.3 mtt180 -90.04 124.38 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.559 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.1 m -109.08 155.84 9.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.24 134.35 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.519 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.8 mt -98.38 147.37 33.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.999 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.11 -13.85 38.01 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.62 1.78 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.787 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.14 63.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.452 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.1 m -97.42 152.04 19.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.029 0.442 . . . . 0.0 110.834 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.51 130.11 70.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.178 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 43' ' ' VAL . 63.0 tttp -136.46 129.77 31.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' ARG . 3.1 ptt180 -91.41 130.41 37.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.1 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.4 mtp -129.41 157.57 41.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -82.43 107.52 15.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.571 0.7 . . . . 0.0 110.484 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.645 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 48.4 t -116.11 137.79 48.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.512 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.41 153.69 26.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -59.55 -30.63 68.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.551 -177.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -61.9 -42.35 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.7 -35.34 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 57' ' ' THR . 78.9 mt -63.43 -48.64 76.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.375 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -67.22 -37.08 82.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 m -78.83 -31.89 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.229 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 49.34 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.056 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -90.62 -22.72 21.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 35.4 m -69.21 148.01 11.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.972 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.69 -51.6 66.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.474 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 65' ' ' VAL . 75.9 tttt 66.88 152.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.913 0.758 . . . . 0.0 112.463 169.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.1 t80 . . . . . 0 C--N 1.322 -0.597 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.848 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 7.3 ppt_? -121.43 171.02 9.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.32 140.98 56.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 40.7 mt-10 -74.38 -8.18 55.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.046 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t -111.22 -72.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.385 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.8 t -67.23 -34.94 78.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.998 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 98.8 -15.8 60.36 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.277 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.77 152.3 25.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.682 0.277 . . . . 0.0 110.69 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.59 144.31 27.62 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.89 145.96 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.104 2.536 . . . . 0.0 112.418 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.221 179.051 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--O 1.234 0.292 0 N-CA-C 111.495 -0.233 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 -40.62 0.48 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.572 0.749 . . . . 0.0 111.583 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.6 mt -70.78 132.89 46.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.796 0.331 . . . . 0.0 110.618 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HB2' HD11 ' A' ' 60' ' ' LEU . 20.1 mt-30 -103.92 131.54 51.04 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' MET . 11.8 ptmt -92.05 109.95 21.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.6 m -116.46 156.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.536 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -88.43 128.16 35.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.587 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.8 m -124.56 153.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.563 177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 67' ' ' LYS . 88.2 t -83.2 126.45 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.746 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.505 HD11 ' HE3' ' A' ' 51' ' ' LYS . 87.0 mt -97.67 143.78 26.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.46 -8.86 20.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.932 2.422 . . . . 0.0 111.604 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -78.49 -3.75 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.499 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.48 37.45 27.36 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.341 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -140.19 155.73 46.81 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.51 121.82 62.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.1 ttmt -123.38 138.15 54.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.131 0.491 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -92.38 106.87 18.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.687 174.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 87.0 mtp -101.59 158.36 16.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.838 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB2' ' HG3' ' A' ' 11' ' ' GLU . 86.4 mtm180 -83.74 100.82 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.75 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.51 146.69 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.593 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.4 p -92.64 159.23 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 t -58.3 -26.7 63.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t -61.84 -51.14 69.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 110.403 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.64 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 75.4 m -65.21 -38.0 89.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.569 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 39' ' ' GLN . 91.5 mt -65.28 -43.33 91.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.624 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -64.48 -45.61 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.823 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 t -72.68 -32.01 65.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.822 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.31 29.44 66.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.883 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.64 ' HE2' ' HA ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -97.54 49.56 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.663 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 176.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.185 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -79.07 -57.7 3.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.652 0.263 . . . . 0.0 110.808 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.1 mttt 64.99 172.29 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.654 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.806 173.841 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.418 0.627 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -102.7 171.9 7.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.789 -175.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 50.2 t -69.83 131.2 44.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 169.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 45.1 mt-10 -68.37 -15.16 63.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.857 0.361 . . . . 0.0 111.065 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.23 -70.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.52 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.6 m -82.49 -32.91 28.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.911 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 95.71 10.7 56.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.101 -174.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -74.78 162.4 28.72 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.452 0.301 . . . . 0.0 110.973 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.66 151.07 49.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.92 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 86.5 Cg_endo -82.76 115.44 2.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.751 2.301 . . . . 0.0 113.119 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.881 175.81 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LEU . 60.2 Cg_endo . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.729 0.22 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.93 -7.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.481 0.712 . . . . 0.0 111.76 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.92 ' HG ' ' HB3' ' A' ' 17' ' ' PRO . 7.4 mt -95.52 107.02 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.094 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.448 ' HB3' HE21 ' A' ' 39' ' ' GLN . 5.8 mt-30 -84.44 106.7 16.23 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.769 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.0 ptmt -75.69 111.59 11.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 28.1 m -110.77 164.94 6.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.567 -173.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 42' ' ' ARG . 35.4 ttp-105 -89.29 106.56 18.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.662 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 28.0 m -118.66 170.81 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.72 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 68' ' ' TYR . 7.3 p -102.59 132.55 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.404 0.621 . . . . 0.0 110.879 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 49' ' ' THR . 83.3 mt -90.94 144.39 30.03 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.088 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.53 -22.13 73.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.716 2.277 . . . . 0.0 111.308 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.1 -15.79 63.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.931 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 40.23 5.3 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.487 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.5 m -138.28 158.2 44.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 126.49 55.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -134.81 144.42 47.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.903 0.382 . . . . 0.0 110.909 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.2 mtt180 -97.92 113.95 25.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.8 mtp -121.68 142.26 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.506 -174.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 42.2 mtm105 -65.96 113.2 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.108 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.713 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 46.3 t -124.61 130.92 73.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.615 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 p -78.1 150.52 33.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 27.4 m -57.89 -30.21 65.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.138 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -60.56 -38.68 85.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.597 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.1 m -79.32 -34.97 41.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.62 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 57' ' ' THR . 85.3 mt -62.8 -38.36 90.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.706 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -58.24 -58.75 7.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.709 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 m -68.9 -31.25 70.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.04 38.88 84.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.64 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 15.44 12.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.203 0.525 . . . . 0.0 111.078 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' LYS . 35.6 m -98.66 168.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.599 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mttt -78.72 81.79 5.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.324 0.583 . . . . 0.0 110.572 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG3' HG23 ' A' ' 65' ' ' VAL . 56.7 mtpt -81.69 143.85 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.429 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 60.7 t80 . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.98 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 38' ' ' LEU . 22.7 pttm . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.57 0.7 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 165.58 12.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.853 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 12' ' ' VAL . 50.6 t -82.02 114.53 20.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.87 28.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.487 0.661 . . . . 0.0 110.971 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 10' ' ' CYS . 63.9 t -128.22 -62.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.549 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.76 -29.42 7.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.181 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.06 5.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.368 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' CYS . 48.9 mtpt -102.15 174.62 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.18 89.55 39.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 38' ' ' LEU . 43.4 Cg_endo -67.03 119.66 6.7 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.166 2.577 . . . . 0.0 113.125 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.6 mtt-85 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.82 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 C--O 1.233 0.26 0 N-CA-C 109.927 -0.836 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 7.9 p30 -71.25 -165.85 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.95 173.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 54' ' ' ARG . 29.1 mt 66.47 114.7 0.03 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.584 0.707 . . . . 0.0 110.423 -174.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.502 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -75.14 94.5 2.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.867 177.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -92.48 107.72 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.553 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.68 169.07 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.859 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -83.13 131.11 35.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.523 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.74 166.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.078 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.752 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 34.6 t -101.77 135.87 36.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.941 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.769 HD11 ' HD3' ' A' ' 51' ' ' LYS . 71.8 mt -90.67 152.53 45.04 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.408 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.16 -25.51 64.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.316 2.011 . . . . 0.0 111.753 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.9 -28.98 69.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.83 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.41 -7.3 34.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.566 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.4 m -77.18 156.48 31.53 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.876 0.37 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.53 113.55 38.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.225 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HD3' HD11 ' A' ' 45' ' ' LEU . 18.0 tptp -102.47 152.86 20.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -113.61 114.14 26.04 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.0 mtm -131.52 163.6 27.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.373 0.606 . . . . 0.0 112.162 -173.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HB3' HD22 ' A' ' 38' ' ' LEU . 36.7 mtm180 -93.04 108.64 20.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.44 153.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.896 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.11 152.83 19.03 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.763 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -58.89 -28.67 66.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -60.34 -50.23 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.5 m -65.62 -34.31 77.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.082 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 60' ' ' LEU . 10.8 mt -68.08 -44.96 75.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.26 -40.5 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.792 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -75.7 -19.52 59.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.22 45.51 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.779 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -95.52 4.46 53.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.173 0.511 . . . . 0.0 110.445 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.96 150.85 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.095 0.474 . . . . 0.0 111.621 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.752 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 57.7 tptt -75.22 97.12 3.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -111.63 147.29 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.166 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.2 p90 . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.706 176.758 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' O ' HD11 ' A' ' 38' ' ' LEU . 25.1 mttt . . . . . 0 CA--C 1.519 -0.243 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -90.92 170.95 9.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.5 t -59.6 115.7 3.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.3 -1.83 16.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.562 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.8 t -90.96 -64.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 110.62 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -94.47 -54.42 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.152 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.27 6.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.346 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.11 169.73 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.711 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.74 143.68 27.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.777 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.54 77.09 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.768 2.312 . . . . 0.0 112.337 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.274 0.559 . . . . 0.0 110.143 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 0 C--O 1.236 0.41 0 N-CA-C 111.347 -0.29 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 54.1 m-80 71.33 -160.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.015 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 42.7 mt 71.86 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.676 0.751 . . . . 0.0 111.125 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.51 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.1 OUTLIER -98.52 96.94 8.32 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 20.8 pttp -74.47 110.06 8.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.81 164.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.294 0.569 . . . . 0.0 111.594 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 42' ' ' ARG . 37.3 ttp180 -99.59 109.83 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.488 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -109.08 161.77 7.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.58 129.38 60.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 0.0 110.63 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 49' ' ' THR . 74.8 mt -88.66 151.49 47.92 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.88 -32.66 86.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.508 2.805 . . . . 0.0 113.751 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.32 -2.85 54.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.119 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.5 42.35 3.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.281 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.578 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.5 149.88 35.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.3 mp -106.73 120.74 58.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 2.0 tpmt? -132.78 138.76 47.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 0.0 111.636 -174.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -91.87 122.7 34.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 79.3 mtp -128.68 150.51 50.22 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.843 0.354 . . . . 0.0 110.812 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 8' ' ' LYS . 67.0 mtt85 -91.14 101.63 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.415 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 65' ' ' VAL . 27.2 t -112.36 152.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.582 -173.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.3 p -92.06 154.6 18.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -61.52 -21.98 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.092 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -62.5 -51.7 66.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.407 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.8 m -64.81 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.571 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.99 -42.12 97.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.55 -48.73 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.12 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.4 m -64.89 -22.61 67.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.02 48.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.703 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -92.16 3.81 54.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.333 0.587 . . . . 0.0 110.556 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 55' ' ' VAL . 31.4 m -109.31 139.48 32.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.995 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.6 88.77 4.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.952 0.882 . . . . 0.0 109.156 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -76.22 148.38 37.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.191 -170.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.4 t80 . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 110.453 179.374 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.237 0.541 . . . . 0.0 111.35 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.617 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 9.6 ptm85 -154.14 162.0 41.49 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.742 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.85 123.51 19.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.22 -1.55 23.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.071 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 65' ' ' VAL . 51.7 t -98.4 -70.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.032 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.2 m -91.56 -15.81 28.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.75 27.99 52.33 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.131 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -100.57 144.65 29.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 144.54 86.79 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.617 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 84.1 Cg_endo -82.29 64.64 8.31 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.693 2.262 . . . . 0.0 111.798 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.121 177.356 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 120.747 0.228 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 m120 75.5 -12.04 1.03 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.872 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 11.9 mt -106.85 101.29 10.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.615 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -83.48 108.26 16.5 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 -177.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 53' ' ' MET . 51.7 mtmt -71.4 110.78 6.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.531 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.64 146.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.905 0.383 . . . . 0.0 110.35 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -83.53 120.16 25.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.241 0.543 . . . . 0.0 110.038 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.2 m -116.14 145.17 22.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.908 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 67' ' ' LYS . 14.2 p -89.02 113.37 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.678 0.751 . . . . 0.0 110.323 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.6 mt -74.83 147.81 84.39 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.269 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.6 -15.27 45.0 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.263 . . . . 0.0 111.668 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.85 -21.79 60.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.727 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.47 0.82 46.92 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.807 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.572 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.7 m -91.14 155.89 18.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.844 0.354 . . . . 0.0 110.438 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.91 127.14 62.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.258 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -132.35 136.62 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.878 0.371 . . . . 0.0 110.841 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -89.29 117.5 28.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.2 mtp -110.65 143.21 41.44 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.092 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HB3' HD13 ' A' ' 38' ' ' LEU . 54.4 mtt85 -79.52 100.18 7.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.767 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.16 138.6 40.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.001 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 23.1 p -88.94 163.85 15.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.922 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.561 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.1 p -59.0 -30.2 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.11 -177.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -59.84 -51.97 67.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.967 0.413 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.62 -33.8 69.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.8 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 57' ' ' THR . 79.7 mt -54.99 -43.42 73.56 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.46 -26.93 55.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.537 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.6 m -74.9 -31.56 61.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.897 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.22 77.3 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.593 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.16 -3.0 58.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.309 0.575 . . . . 0.0 110.484 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 67' ' ' LYS . 31.3 m -85.91 156.36 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.394 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.764 ' HE3' ' HA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -66.32 -37.85 86.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.514 -176.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' A' ' 65' ' ' VAL . 97.3 mttt 61.33 -172.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.702 0.627 . . . . 0.0 111.488 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.384 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 ptp180 -144.84 173.76 11.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.38 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 52.4 t -70.04 114.49 8.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 37.3 mt-10 -68.63 -5.73 21.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 0.0 111.617 -171.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' CG1' ' A' ' 65' ' ' VAL . 48.5 t -88.95 -58.28 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.166 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 m -102.18 -24.22 13.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.95 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 91.68 22.72 30.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.567 -177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.922 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.9 mmpt? -93.37 151.42 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.775 -0.25 . . . . 0.0 110.94 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 145.24 69.46 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.369 . . . . 0.0 111.475 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 37.7 Cg_endo -66.71 149.29 83.77 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.867 2.378 . . . . 0.0 111.871 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -175.395 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.46 -0.442 0 CA-C-O 121.063 0.359 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -133.89 -47.16 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.684 0.754 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' A' ' 54' ' ' ARG . 13.9 mt -85.0 153.4 22.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.043 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -119.75 110.02 16.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -84.43 109.39 17.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.42 165.45 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.68 114.56 24.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.96 148.78 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.421 . . . . 0.0 110.408 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -102.48 124.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.446 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.9 mt -84.66 146.34 46.48 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.03 -21.93 61.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.748 2.299 . . . . 0.0 111.83 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.69 -26.56 67.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.522 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.69 -0.72 23.24 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.125 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -87.01 149.77 24.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 111.398 -176.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -111.59 113.22 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 53' ' ' MET . 55.0 tptt -129.03 130.94 47.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.109 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -80.95 115.94 20.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 51' ' ' LYS . 64.0 mtm -123.88 157.51 34.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.319 0.581 . . . . 0.0 111.6 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 38' ' ' LEU . 87.0 mtm180 -77.72 109.4 11.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.757 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.82 141.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.514 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.52 159.28 16.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -59.25 -32.62 70.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.188 -177.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -60.91 -38.86 87.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.307 0.575 . . . . 0.0 110.765 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.66 -34.21 60.48 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.446 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 91.5 mt -61.09 -53.25 59.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.325 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -60.22 -50.61 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.13 0.491 . . . . 0.0 111.327 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -73.96 -17.46 61.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.138 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.41 40.75 96.53 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -73.16 -14.52 61.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.66 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 67' ' ' LYS . 35.0 m -108.46 158.81 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.132 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -54.59 -52.0 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.738 ' HB2' HG23 ' A' ' 65' ' ' VAL . 34.1 ttpt 62.06 12.91 5.29 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.739 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 t80 . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.345 -179.305 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttp . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.3 ppt_? -96.46 -164.75 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.918 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 47.9 t -55.11 135.32 49.3 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.053 0.454 . . . . 0.0 110.799 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.06 3.22 27.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.042 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.25 -73.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.544 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 83.5 m -108.85 8.33 26.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 84.28 -18.34 23.8 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.382 -0.913 . . . . 0.0 114.416 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -58.39 139.99 54.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.182 0.491 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 69.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.767 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.642 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 61.0 Cg_endo -71.97 94.62 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 111.653 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.688 -176.06 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.532 0.396 0 N-CA-C 113.746 0.633 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.71 -16.36 61.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.248 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 19.2 mt -89.1 108.33 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.489 HE21 ' HB3' ' A' ' 39' ' ' GLN . 3.3 mt-30 -68.67 97.38 0.8 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.638 0.732 . . . . 0.0 111.022 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 8.2 ptpp? -73.16 110.78 7.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.978 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.64 168.09 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.227 0.537 . . . . 0.0 111.173 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -88.68 114.81 25.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.702 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 m -120.97 159.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.282 0.563 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.0 t -104.57 124.26 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.231 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.595 HD12 ' HB ' ' A' ' 49' ' ' THR . 38.8 mt -60.64 148.69 81.13 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.989 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.54 -7.58 9.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.306 2.67 . . . . 0.0 113.774 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -98.78 -69.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.734 0.302 . . . . 0.0 110.249 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.46 57.89 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.021 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.595 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.1 m -144.5 156.65 44.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.52 129.26 67.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.794 0.331 . . . . 0.0 110.149 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HE2' HD21 ' A' ' 45' ' ' LEU . 39.3 ttpt -146.72 152.93 39.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.045 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -94.63 127.16 40.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.4 mtp -135.36 152.18 51.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 56.8 mtt85 -91.36 110.64 21.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.697 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.522 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 25.4 t -112.29 138.2 42.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.074 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.4 p -88.63 159.55 17.81 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.79 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 t -58.93 -25.82 63.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.572 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 m -63.74 -47.92 79.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 75.4 m -70.58 -34.5 72.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 56' ' ' CYS . 83.4 mt -61.3 -41.54 97.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.671 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -81.06 -24.81 37.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.157 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.2 t -68.28 -33.02 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.02 22.49 55.37 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.156 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 8.99 28.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.944 0.872 . . . . 0.0 111.182 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.21 161.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.724 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -76.29 147.72 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -152.2 160.56 43.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.0 111.971 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.861 172.829 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 121.239 0.542 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -128.35 161.3 29.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -62.48 135.62 57.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.602 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 49.6 mt-10 -81.98 3.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.229 0.538 . . . . 0.0 110.833 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.37 -60.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 t -96.8 -17.4 20.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.285 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.06 84.02 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.846 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -75.19 143.46 43.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.707 0.253 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.86 144.5 36.97 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.871 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -86.21 -0.22 8.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.159 2.572 . . . . 0.0 113.006 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.467 0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.391 -178.211 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.459 -0.544 0 CA-C-O 120.742 0.226 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -151.93 -47.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.888 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 54' ' ' ARG . 9.0 mt -71.12 113.07 7.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.847 0.356 . . . . 0.0 111.628 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.97 100.9 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.252 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.622 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 24.4 ttmt -75.86 110.62 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.73 159.15 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.686 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.629 ' HE ' HG21 ' A' ' 50' ' ' ILE . 65.9 ttt180 -87.02 117.65 25.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.389 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.74 157.33 30.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.857 0.36 . . . . 0.0 110.767 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.5 139.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.693 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' HB ' ' A' ' 49' ' ' THR . 73.6 mt -86.43 153.32 56.02 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.47 -26.17 52.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.933 2.422 . . . . 0.0 112.689 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.31 -21.88 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.276 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.72 -1.8 26.05 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.231 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.567 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.4 m -81.41 159.18 24.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.629 HG21 ' HE ' ' A' ' 42' ' ' ARG . 57.5 mt -121.8 133.19 68.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.674 0.273 . . . . 0.0 110.754 -177.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HD2' HD11 ' A' ' 45' ' ' LEU . 63.5 mttm -140.03 164.52 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -121.63 117.63 27.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.2 mtm -138.7 165.4 27.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.964 0.411 . . . . 0.0 111.823 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.634 ' HB3' HD22 ' A' ' 38' ' ' LEU . 27.8 mmt180 -76.87 119.56 20.8 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.734 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.619 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 39.4 t -126.64 139.71 50.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 p -77.39 145.81 37.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.438 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 t -55.08 -30.49 59.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -61.05 -47.39 86.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 55.5 m -72.19 -33.9 68.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.857 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.98 -53.19 60.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.6 -45.67 57.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.589 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 t -69.4 -26.74 64.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.646 0.26 . . . . 0.0 110.997 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.94 48.36 7.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.753 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.25 -28.63 22.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.203 0.525 . . . . 0.0 109.671 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.83 171.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 41.1 tptt -69.32 -44.91 70.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.616 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.8 tttt 71.07 135.19 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.771 0.669 . . . . 0.0 111.227 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 178.902 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.352 0.596 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.513 ' CD ' ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -80.43 155.29 27.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.738 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 48.8 t -60.61 144.68 51.24 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.05 -8.79 59.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.961 0.41 . . . . 0.0 110.933 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 55' ' ' VAL . 57.6 t -100.3 -62.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 42.8 t -91.06 -47.53 7.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.819 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 10' ' ' CYS . . . 112.02 -9.98 27.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 13' ' ' CYS . 28.7 mtpp -77.5 162.68 26.96 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.711 -0.288 . . . . 0.0 110.25 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.88 144.33 76.02 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.966 0.413 . . . . 0.0 111.416 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.644 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 98.2 Cg_endo -89.7 94.88 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.193 2.595 . . . . 0.0 112.178 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 . . . . . 0 C--O 1.236 0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.642 -179.413 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo . . . . . 0 N--CA 1.473 0.265 0 CA-C-O 121.057 0.357 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -109.81 -10.16 14.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.634 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 22.3 mt -120.02 99.75 6.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.706 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.479 ' NE2' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -89.68 123.19 33.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 15.4 ptmt -72.73 122.52 21.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.782 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 t -114.8 156.2 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.639 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -85.46 106.56 16.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.73 166.78 10.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.462 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.17 136.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.594 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 49' ' ' THR . 79.2 mt -97.42 152.2 38.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.55 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.37 -15.75 50.29 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.0 2.467 . . . . 0.0 112.704 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.16 -15.19 57.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.1 15.36 26.22 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.14 -0.553 . . . . 0.0 111.797 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.542 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -89.34 149.22 23.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.843 0.354 . . . . 0.0 110.247 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -128.05 111.69 25.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.72 149.42 34.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.788 0.328 . . . . 0.0 110.543 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.27 120.95 31.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.44 ' HE3' HG22 ' A' ' 12' ' ' VAL . 65.7 mtm -130.28 149.85 51.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.932 -177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 81.9 mtm180 -76.26 113.35 13.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.421 0.629 . . . . 0.0 110.923 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.9 t -105.23 148.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.089 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.82 148.55 25.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.326 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -58.71 -25.59 63.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.38 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -60.53 -40.72 92.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.365 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.79 -33.89 62.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.565 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.479 HD11 ' NE2' ' A' ' 39' ' ' GLN . 16.1 mt -56.67 -53.59 55.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 61' ' ' LYS . 21.5 ptmt -81.76 -2.49 50.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -86.8 -32.0 20.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.56 46.92 93.32 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.996 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.86 33.74 3.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.163 0.506 . . . . 0.0 111.213 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.22 149.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.779 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -86.37 102.79 14.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.536 0.684 . . . . 0.0 109.887 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -94.78 146.95 23.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.972 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.8 t80 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.864 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.12 0.486 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.3 ptm180 -143.77 155.6 44.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.513 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 55' ' ' VAL . 49.8 t -68.4 131.95 46.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.502 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.83 2.93 24.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.219 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 65' ' ' VAL . 49.1 t -102.54 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.809 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 64' ' ' LYS . 72.2 m -101.72 -21.23 14.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.581 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.607 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -79.29 145.83 33.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . . . -78.41 155.46 79.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.516 -176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.732 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 84.6 Cg_endo -78.05 109.33 2.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.992 2.462 . . . . 0.0 112.509 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 178.448 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.463 -0.295 0 N-CA-C 112.854 0.29 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -112.48 -27.42 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.497 0.665 . . . . 0.0 109.487 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 57.2 mt -86.26 159.77 19.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.609 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HB3' HE21 ' A' ' 39' ' ' GLN . 23.2 mt-30 -123.39 132.38 53.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 171.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -85.41 113.5 21.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.44 167.17 9.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.55 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 18.0 ptp180 -101.13 120.6 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.299 0.571 . . . . 0.0 110.935 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 34.1 m -110.46 167.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.112 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 68' ' ' TYR . 11.9 p -101.65 131.41 49.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.133 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.0 144.92 28.61 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.665 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 -20.1 57.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.616 2.211 . . . . 0.0 111.58 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.19 -27.15 68.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.524 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.74 44.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -99.77 158.31 15.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.757 0.313 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 42' ' ' ARG . 63.7 mt -105.3 116.38 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -106.14 144.75 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.087 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -110.6 125.84 53.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.116 0.484 . . . . 0.0 110.338 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.41 ' HE2' HG21 ' A' ' 43' ' ' VAL . 72.3 mtm -139.22 163.76 31.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.698 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -84.18 120.45 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 65' ' ' VAL . 58.5 t -122.87 147.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.706 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.732 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 24.7 p -88.57 155.13 19.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.488 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -57.49 -32.71 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.039 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -65.54 -43.08 91.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.977 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.5 m -72.65 -35.58 67.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.664 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.6 -47.01 87.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.614 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.117 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -70.41 -29.41 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.36 28.32 73.64 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.012 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' HD3' ' A' ' 64' ' ' LYS . 1.5 tmtp? -82.83 -21.08 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.379 0.609 . . . . 0.0 109.783 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 55' ' ' VAL . 35.4 m -61.79 163.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.331 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 31.5 mmtp -78.58 59.75 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.576 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -57.59 140.84 49.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.528 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p90 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.639 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.363 0.601 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -139.0 165.24 27.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.044 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.6 t -82.01 143.47 31.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.59 -2.22 25.03 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.68 -67.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.0 p -85.28 -39.41 17.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.777 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 9.97 51.11 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.125 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.59 158.46 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.37 149.53 47.06 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.022 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.8 Cg_endo -75.16 110.43 3.11 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.691 2.261 . . . . 0.0 112.299 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.47 -179.771 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--O 1.233 0.225 0 N-CA-C 113.46 0.523 . . . . 0.0 113.46 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -89.36 -5.45 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.6 mt -90.48 109.21 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -77.82 101.57 6.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.497 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' MET . 20.5 pttp -78.82 110.23 13.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 33.5 m -125.01 162.25 27.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.301 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.13 120.1 29.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 0.0 110.914 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.53 167.7 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.404 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' N ' ' HA ' ' A' ' 68' ' ' TYR . 9.5 p -89.31 138.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.614 0.721 . . . . 0.0 111.063 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.509 HD12 ' HB ' ' A' ' 49' ' ' THR . 88.6 mt -92.52 157.85 39.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.74 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.11 -24.29 39.98 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.724 2.282 . . . . 0.0 112.496 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.95 -19.01 60.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.486 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.71 54.61 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.509 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.9 m -86.73 158.38 19.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.163 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.14 122.81 66.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.0 ttmt -141.51 147.72 38.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.5 mtm180 -88.0 134.98 33.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 63.0 mtm -138.56 170.61 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.485 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -82.54 110.72 17.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.079 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 49.6 t -115.57 144.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.927 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 25.5 p -90.79 152.47 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.517 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -58.94 -25.42 63.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 m -61.08 -45.43 94.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.444 . . . . 0.0 110.351 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.71 -34.58 75.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.02 -45.55 77.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.796 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.59 -7.78 53.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.753 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 t -117.2 -4.12 11.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.866 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.92 62.05 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.118 -175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 64' ' ' LYS . 38.7 tptt -87.64 56.77 4.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.983 0.897 . . . . 0.0 111.08 -171.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 67' ' ' LYS . 5.6 m -143.43 156.84 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 3.14 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.57 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 65' ' ' VAL . 3.7 mppt? 57.77 -168.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.911 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.588 ' HA ' ' N ' ' A' ' 44' ' ' VAL . 13.1 p90 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 110.956 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.705 ' HG2' ' H ' ' A' ' 2' ' ' GLY . 25.8 tt0 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.705 ' H ' ' HG2' ' A' ' 1' ' ' GLN . . . 118.59 -14.8 11.68 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.922 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -97.24 -23.28 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.7 99.84 4.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.4 pt -103.39 9.58 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.7 ttm -86.06 88.47 7.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 110.108 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.08 157.71 38.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.732 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -91.11 122.04 33.42 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 23.5 ptt-85 -135.76 -174.08 3.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.44 119.69 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.732 0.301 . . . . 0.0 110.379 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.09 -5.52 46.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.145 0.498 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.22 -51.2 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.548 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.6 m -114.13 -12.6 12.51 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.42 -16.57 60.34 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.733 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -74.99 153.57 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.52 0.66 . . . . 0.0 111.267 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.19 153.78 69.25 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.181 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.847 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 94.3 Cg_endo -80.13 91.28 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.722 2.281 . . . . 0.0 111.464 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.036 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.9 m -149.94 101.68 3.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.795 0.331 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.45 25.63 4.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.014 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -88.28 76.43 8.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 110.549 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -155.27 112.47 3.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.21 118.68 30.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.329 0.585 . . . . 0.0 110.638 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -91.9 165.09 13.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.784 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -137.31 148.23 46.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.885 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.4 m 75.29 6.26 4.14 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.066 0.854 . . . . 0.0 112.297 174.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' C ' ' HD3' ' A' ' 28' ' ' LYS . 5.3 m-20 -78.03 -65.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.408 0.151 . . . . 0.0 111.408 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HD3' ' C ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 43.92 28.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.348 1.059 . . . . 0.0 111.951 -173.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -90.41 160.1 16.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.576 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 t -153.01 100.26 2.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.194 0.521 . . . . 0.0 111.064 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.83 71.57 1.3 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 32' ' ' ARG . 22.7 ttt180 58.52 48.71 11.59 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.605 -167.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 61.49 -169.73 0.17 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -100.83 153.58 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -96.36 156.19 37.16 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.07 98.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.48 2.12 . . . . 0.0 112.595 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 67.63 8.99 6.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.93 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.847 ' HG ' ' HG3' ' A' ' 17' ' ' PRO . 12.7 mt -116.95 122.76 45.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.255 0.55 . . . . 0.0 111.964 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.4 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -106.49 116.85 32.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.079 173.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 53' ' ' MET . 80.2 mttt -74.49 116.17 14.87 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 168.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -109.55 136.78 44.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.296 0.569 . . . . 0.0 109.526 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 42' ' ' ARG . 26.5 ttm180 -80.7 106.46 12.72 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.546 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.9 m -111.04 170.04 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.369 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.88 131.34 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 85.6 mt -90.52 144.18 30.3 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.058 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 25.3 Cg_exo -64.11 -14.58 44.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.947 2.431 . . . . 0.0 112.507 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -82.85 -4.0 57.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.636 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.77 55.05 2.22 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.82 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.4 m -149.14 159.02 44.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mm -114.94 127.12 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.87 141.85 44.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.0 0.428 . . . . 0.0 111.694 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -91.26 120.44 32.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 49.8 mtm -125.3 149.41 48.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.875 0.369 . . . . 0.0 111.015 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -80.11 107.95 13.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.17 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.36 134.98 56.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.6 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 17' ' ' PRO . 44.2 t -74.9 149.56 39.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.269 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.7 m -56.04 -30.99 62.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.344 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -59.11 -49.22 78.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.189 0.519 . . . . 0.0 110.151 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.4 m -69.11 -37.01 78.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.378 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.26 -41.29 99.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.143 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.55 -39.72 64.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -68.9 -32.94 72.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.7 62.05 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.727 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.29 19.14 7.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.052 0.453 . . . . 0.0 111.486 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -102.7 162.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.814 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.92 106.75 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -121.55 152.03 39.67 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.681 -167.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -114.33 15.5 18.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t 67.09 91.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.838 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.3 25.06 7.52 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.71 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.95 119.55 26.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m -122.03 22.54 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.023 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -57.37 142.42 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.2 -12.67 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.369 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -98.72 134.57 36.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.687 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.36 -63.15 3.36 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.584 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.804 175.421 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.13 133.09 1.55 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.349 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.89 -30.52 21.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.92 0.39 . . . . 0.0 111.215 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 94.92 8.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.823 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 tt -147.16 123.91 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.77 85.84 0.07 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.081 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.38 25.32 11.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.567 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 57.61 77.18 0.29 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.057 0.932 . . . . 0.0 109.912 -174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' A' ' 14' ' ' GLY . 21.3 ptt180 -97.74 -177.87 3.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.203 -171.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.3 t -67.37 120.79 14.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 167.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 53' ' ' MET . 41.6 mt-10 -71.71 -10.84 60.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.061 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG11 HG12 ' A' ' 65' ' ' VAL . 58.5 t -81.9 -71.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -97.41 -46.72 5.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 0.0 111.022 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 9' ' ' ARG . . . 120.27 21.3 3.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.059 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.73 177.57 8.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.877 0.339 . . . . 0.0 111.396 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . . . -110.62 91.35 12.06 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.692 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 36.2 Cg_endo -63.37 146.94 93.82 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.644 2.229 . . . . 0.0 112.093 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.53 13.94 0.85 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.78 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.8 p -90.57 115.83 28.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.591 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.52 -9.92 0.29 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.007 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -78.02 98.95 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.046 0.451 . . . . 0.0 110.554 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 23' ' ' VAL . 15.1 t -170.81 157.05 5.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.725 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.497 HG22 HG23 ' A' ' 22' ' ' THR . 25.5 m 43.69 85.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 O-C-N 124.373 1.045 . . . . 0.0 113.118 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -65.49 -46.5 79.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.052 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -160.2 28.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -71.41 107.42 4.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.338 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t0 69.05 134.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.87 0.731 . . . . 0.0 110.057 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -86.47 -9.15 56.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.17 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' NZ ' ' HB3' ' A' ' 29' ' ' LYS . 9.1 mtpm? -107.31 90.05 3.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.953 0.406 . . . . 0.0 111.287 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -80.68 74.9 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -44.72 -64.3 0.73 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.915 -169.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -134.06 30.52 3.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.76 0.79 . . . . 0.0 109.386 176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -102.72 78.07 1.66 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.74 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.531 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 76.0 t80 -160.11 98.36 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.521 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -146.89 144.48 20.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 83.3 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.803 2.335 . . . . 0.0 112.714 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 63.04 13.87 7.11 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.718 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 54' ' ' ARG . 14.1 mt -117.44 152.12 35.65 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.12 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.448 ' HB2' HD11 ' A' ' 60' ' ' LEU . 31.5 mm-40 -118.66 97.89 5.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 53' ' ' MET . 61.1 pttt -81.45 112.68 18.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.238 0.542 . . . . 0.0 110.228 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.88 168.37 21.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.836 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -78.66 135.51 37.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.958 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.88 143.91 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.92 136.19 45.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.396 0.617 . . . . 0.0 110.873 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.0 mt -98.53 143.01 25.54 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.486 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.61 -15.75 48.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.856 2.37 . . . . 0.0 112.321 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.63 -16.21 60.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.441 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.41 52.24 0.88 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.143 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.8 m -145.95 154.51 42.0 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.575 -0.368 . . . . 0.0 110.561 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.36 117.29 44.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -120.89 142.64 49.49 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -101.72 119.11 38.27 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.572 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 62.8 mtm -133.99 155.5 49.86 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.099 0.476 . . . . 0.0 111.834 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HB3' HD22 ' A' ' 38' ' ' LEU . 69.3 mtm180 -76.12 116.41 16.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.86 148.47 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.823 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 10.9 p -91.22 155.94 18.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.602 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -61.36 -26.71 68.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.095 -178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 p -64.51 -41.3 96.49 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.72 0.295 . . . . 0.0 110.836 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.22 -34.45 61.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.52 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 92.4 mt -59.34 -51.82 68.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.269 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -72.5 -33.98 67.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.8 p -74.37 -24.71 59.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.072 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.33 44.01 23.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.276 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -95.26 11.9 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.448 0.642 . . . . 0.0 109.932 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 HG11 ' A' ' 12' ' ' VAL . 28.5 m -120.94 138.46 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.898 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -86.08 98.89 11.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -94.4 30.8 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.952 -166.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 66.64 12.18 8.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.212 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.6 t 63.56 100.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.512 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 175.88 110.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.684 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -96.32 105.52 17.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.08 117.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.056 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 t -146.85 128.05 14.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -92.08 130.98 37.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.952 0.406 . . . . 0.0 110.455 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.8 -30.94 39.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.53 141.05 45.23 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.254 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.315 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.68 0.276 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.87 95.02 2.12 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -87.69 131.09 34.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.027 0.441 . . . . 0.0 110.13 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.9 ttm -76.22 -44.88 35.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.582 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.99 127.99 41.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.443 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.0 ttm -138.61 168.65 19.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.99 -60.4 2.64 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.418 0.449 . . . . 0.0 111.577 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.471 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 85.0 tttt -159.1 137.53 10.73 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -74.47 178.41 5.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.432 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 41.5 t -55.02 128.68 34.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.071 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 8' ' ' LYS . 38.7 mt-10 -76.57 5.14 7.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.639 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.28 -58.38 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.1 -23.09 5.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.93 4.4 36.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.474 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mttp -74.15 176.75 6.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.74 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.05 144.52 29.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.217 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 89.4 Cg_endo -82.28 150.87 15.53 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.4 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -101.38 -51.79 3.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.448 . . . . 0.0 109.986 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.1 t -88.03 -175.53 5.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.72 175.4 42.66 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 155.46 21.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.593 0.196 . . . . 0.0 110.78 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 m -61.34 106.76 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.139 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.41 135.25 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -73.99 106.78 5.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.97 125.14 25.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 110.76 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.1 m -116.23 130.68 56.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.585 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.68 5.91 31.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.905 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -126.17 148.56 49.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.747 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.694 ' HG2' ' H ' ' A' ' 30' ' ' SER . 72.1 tttt 69.31 -178.81 0.22 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.482 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.694 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 4.6 p -65.65 155.88 34.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.418 0.627 . . . . 0.0 112.596 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -89.27 80.4 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.676 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -79.84 146.81 32.03 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -44.86 127.46 6.4 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.834 0.709 . . . . 0.0 112.004 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -82.57 141.46 32.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -132.49 85.4 48.34 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 177.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.97 -35.31 5.52 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.684 2.256 . . . . 0.0 111.137 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 18.8 m120 -84.52 -171.13 3.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.276 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 28.6 mt 68.46 106.8 0.05 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.652 0.739 . . . . 0.0 110.162 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -77.66 93.43 4.24 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.783 -173.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' MET . 17.3 pttp -78.01 109.85 12.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.641 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -130.47 160.71 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.527 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -95.12 126.84 40.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.704 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 67' ' ' LYS . 34.3 m -123.42 156.04 29.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.014 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 68' ' ' TYR . 7.2 p -109.11 122.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.636 0.731 . . . . 0.0 110.44 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.9 mt -79.37 143.43 59.99 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.374 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.8 -21.48 69.41 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 122.98 2.453 . . . . 0.0 112.795 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.72 -23.89 56.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.111 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.27 67.09 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.695 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.489 ' HB ' HD12 ' A' ' 45' ' ' LEU . 3.4 m -153.38 154.6 34.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.578 -0.366 . . . . 0.0 110.13 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.58 113.28 22.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -134.84 148.23 50.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.765 0.317 . . . . 0.0 111.229 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -99.21 119.77 38.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.7 mtm -132.58 157.6 44.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.027 0.442 . . . . 0.0 110.851 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.683 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 49.9 mtm180 -87.68 103.92 16.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.464 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.505 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.7 t -98.98 154.34 4.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.825 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 15' ' ' LYS . 28.4 p -90.02 149.79 22.38 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.173 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -57.5 -29.45 64.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.111 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -62.68 -47.73 82.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.797 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.0 m -64.94 -34.29 78.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.293 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.18 -50.53 72.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.949 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -66.06 -30.31 70.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.13 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -31.75 54.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.946 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.73 31.18 56.68 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.571 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -79.02 -25.45 43.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.964 0.411 . . . . 0.0 110.91 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.489 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 28.0 m -77.04 143.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.61 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.06 -3.65 55.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.598 ' HA ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER 45.47 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.226 . . . . 0.0 114.206 174.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.8 t80 -142.06 14.59 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.734 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 69' ' ' VAL . 10.2 t 62.99 20.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.46 -175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.17 137.97 41.03 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.806 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -94.07 105.0 17.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.725 0.298 . . . . 0.0 110.443 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.91 154.69 37.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.132 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.0 m -126.57 132.24 51.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.673 0.273 . . . . 0.0 110.706 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 76' ' ' GLY . 2.1 tm-20 -81.67 151.13 27.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.72 -23.5 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -170.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' H ' ' CD ' ' A' ' 74' ' ' GLU . . . -85.82 -129.4 2.31 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.129 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.769 -177.035 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.3 150.73 24.96 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 58.84 32.65 22.43 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.4 tpt -54.13 -48.79 70.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.046 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 5' ' ' ILE . 14.9 mm -103.28 17.16 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.526 0.679 . . . . 0.0 110.158 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.5 ttt -100.43 6.07 44.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.248 0.547 . . . . 0.0 109.867 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 61.32 73.54 0.47 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.792 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -97.0 70.51 2.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.605 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 10.0 ptp180 -152.83 169.71 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.817 -172.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t -69.25 127.84 34.5 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 38.3 mt-10 -73.99 -15.02 61.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.758 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -80.02 -57.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.463 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -102.0 -36.14 8.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 103.39 8.34 41.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.572 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -87.36 150.23 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.83 144.49 85.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.678 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 71.5 Cg_endo -94.97 141.73 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.382 2.721 . . . . 0.0 113.312 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -121.4 -5.76 9.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.673 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 11.7 t 63.69 -155.67 0.32 Allowed 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.666 0.604 . . . . 0.0 109.943 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.81 -147.02 4.93 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -87.1 124.69 33.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.296 0.548 . . . . 0.0 109.699 175.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 m -81.21 92.76 6.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.965 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -79.61 118.99 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 64.63 -173.21 0.17 Allowed 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.686 0.616 . . . . 0.0 110.178 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -169.93 159.04 7.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -59.32 104.75 0.28 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.253 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -83.3 -31.6 26.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 109.594 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 55.5 mmtt -133.4 -171.98 2.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.726 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 74.69 96.65 0.07 Allowed 'General case' 0 N--CA 1.463 0.181 0 O-C-N 124.304 1.003 . . . . 0.0 110.028 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 33' ' ' TRP . 6.4 m -82.07 38.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.66 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -130.96 104.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 63.05 86.06 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.854 0.721 . . . . 0.0 110.984 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 30' ' ' SER . 81.8 m95 -78.51 -59.83 2.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.648 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -173.93 147.39 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.82 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -127.03 152.03 75.07 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.49 100.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.43 2.753 . . . . 0.0 113.704 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.673 ' HA ' ' HB2' ' A' ' 19' ' ' SER . 19.8 m120 71.48 -8.1 1.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.56 172.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.8 mt -117.55 123.62 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.296 0.569 . . . . 0.0 111.758 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -105.44 107.69 18.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.561 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 19.1 ttmm -76.57 108.51 9.61 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.67 168.91 7.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.945 -174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -81.02 117.33 21.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.785 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 67' ' ' LYS . 33.6 m -117.29 163.5 14.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.81 134.29 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.145 0.497 . . . . 0.0 110.245 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HB ' ' A' ' 49' ' ' THR . 90.0 mt -93.14 153.3 41.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.805 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.74 -27.58 43.41 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.34 2.694 . . . . 0.0 113.355 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.88 -1.44 52.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.592 0.234 . . . . 0.0 111.63 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.93 2.19 59.57 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.3 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.556 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -77.56 152.5 33.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.786 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.11 126.75 70.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -141.83 157.22 45.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.38 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 99.4 mtt180 -98.36 129.88 45.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.2 mtm -138.33 150.91 47.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.201 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 79.3 mtm180 -76.88 119.59 20.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 65' ' ' VAL . 37.6 t -120.77 148.18 24.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 17' ' ' PRO . 20.2 p -87.13 149.75 24.45 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 19' ' ' SER . 5.5 m -56.75 -30.26 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.499 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.76 -40.25 91.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.238 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.7 m -79.53 -35.53 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 57' ' ' THR . 95.2 mt -60.01 -49.99 75.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -78.92 -5.54 53.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.316 0.579 . . . . 0.0 110.644 -176.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -94.34 -27.4 16.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 109.74 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.79 56.12 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 9.4 mmmm -89.25 30.59 0.96 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.75 0.31 . . . . 0.0 110.983 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG11 HG11 ' A' ' 55' ' ' VAL . 20.1 m -122.12 129.43 75.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.674 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -80.49 98.28 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.0 pttt -110.77 177.54 4.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.727 -167.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' GLY . 19.0 t80 -99.81 63.54 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.87 172.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 70' ' ' GLY . 13.0 p 52.13 -60.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.229 1.812 . . . . 0.0 115.79 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' TYR . . . -68.94 86.56 0.22 Allowed Glycine 0 CA--C 1.518 0.263 0 CA-C-N 118.183 0.447 . . . . 0.0 113.879 -171.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.525 ' HG3' ' HD2' ' A' ' 67' ' ' LYS . 15.5 mm100 -109.08 3.65 22.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 0.0 110.165 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 73' ' ' SER . 16.3 m 44.79 -84.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.76 ' H ' HG23 ' A' ' 72' ' ' VAL . 18.4 t -98.0 26.49 5.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.863 0.363 . . . . 0.0 111.105 -171.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 71' ' ' GLN . 33.3 tt0 -69.37 117.27 10.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.62 93.59 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.42 -42.39 0.27 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.184 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.671 179.72 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.777 0.322 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.74 -78.78 0.36 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -72.33 160.71 31.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.707 0.289 . . . . 0.0 110.6 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.2 ttm -73.2 104.11 4.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.975 0.416 . . . . 0.0 111.387 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.776 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -98.06 160.62 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.817 ' HG3' ' HG3' ' A' ' 9' ' ' ARG . 24.7 ttt 66.88 95.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.655 0.597 . . . . 0.0 110.65 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.39 -79.65 0.27 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.08 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -127.96 103.19 7.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 109.903 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.817 ' HG3' ' HG3' ' A' ' 6' ' ' MET . 3.6 mmm180 -124.44 -176.2 3.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.246 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 53.1 t -64.89 123.68 20.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.13 -4.28 34.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 0.0 111.301 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.7 t -92.58 -65.88 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 111.12 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.02 -13.95 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.734 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.57 86.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.546 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -69.15 158.57 34.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.55 148.05 87.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.7 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.1 Cg_endo -74.12 113.77 3.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.482 2.121 . . . . 0.0 112.062 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 8.7 tpt180 -59.8 122.96 15.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.658 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -110.55 139.15 46.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.64 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.15 -178.06 17.8 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.62 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 72.2 -65.07 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.994 0.918 . . . . 0.0 112.231 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 m 66.46 102.06 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.33 0.586 . . . . 0.0 110.321 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.66 80.18 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.484 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 70.19 146.91 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.875 0.845 . . . . 0.0 112.566 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -124.32 149.24 46.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.025 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 p -160.27 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t70 67.27 91.08 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.537 0.685 . . . . 0.0 111.146 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -100.16 8.08 44.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.083 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt 59.63 59.0 2.69 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.928 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 t -93.72 -29.74 15.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 57.7 -85.57 0.02 OUTLIER 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.678 -1.147 . . . . 0.0 113.822 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.31 25.53 5.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.359 -166.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -74.91 -39.42 61.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.114 0.483 . . . . 0.0 109.974 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 92.1 m-85 -119.35 -178.04 3.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.892 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HB2' ' HB2' ' A' ' 38' ' ' LEU . 17.3 mmt180 -114.69 148.05 39.5 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.887 171.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.72 -36.44 81.9 Favored 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 122.876 2.384 . . . . 0.0 113.751 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -111.9 -9.19 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.55 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 35' ' ' ARG . 35.1 mt -121.14 118.67 30.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.083 0.468 . . . . 0.0 111.212 -174.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -88.37 107.65 18.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.249 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.584 ' HD3' ' HA ' ' A' ' 34' ' ' PHE . 47.0 mtpt -81.71 110.21 16.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.684 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.725 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 24.7 m -122.83 157.92 27.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.674 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 50' ' ' ILE . 68.5 mtp180 -92.73 123.28 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.104 0.478 . . . . 0.0 110.44 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.666 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 32.9 m -115.86 164.75 11.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.569 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.07 128.31 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.67 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -95.17 150.54 37.8 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.782 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.46 -11.28 27.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.772 2.315 . . . . 0.0 112.254 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.11 -13.67 56.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.713 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.37 3.66 58.6 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.576 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.83 154.45 17.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.523 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.531 HG22 ' HB3' ' A' ' 42' ' ' ARG . 55.4 mt -115.21 110.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.142 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.95 151.23 32.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.089 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 65.2 mtt180 -84.16 137.76 33.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 43' ' ' VAL . 86.7 mtp -133.04 154.64 50.35 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -85.73 103.88 14.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.86 146.15 18.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.961 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 28.0 p -96.24 157.52 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.76 0.314 . . . . 0.0 110.82 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 60' ' ' LEU . 1.2 p -61.13 -25.04 66.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.737 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.421 ' HB3' ' SG ' ' A' ' 56' ' ' CYS . 32.1 t -58.65 -52.38 65.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.3 m -64.3 -34.28 77.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.031 0.444 . . . . 0.0 111.006 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 57' ' ' THR . 81.4 mt -63.71 -50.51 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.22 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -81.13 -19.21 44.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 m -81.86 -12.16 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 0.0 109.992 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.566 ' HA3' ' HG3' ' A' ' 71' ' ' GLN . . . 64.77 54.91 25.56 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.372 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -135.89 76.02 1.58 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 0.0 109.449 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.77 172.86 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.51 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 12.1 ptmm? -122.37 45.75 2.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.613 0.721 . . . . 0.0 110.258 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.725 ' HE2' ' HB ' ' A' ' 41' ' ' VAL . 2.8 mmmp? -80.9 -177.91 6.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.162 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -89.38 -14.25 35.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.086 0.47 . . . . 0.0 111.084 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.9 m -144.89 155.04 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.369 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.53 -132.63 11.17 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.969 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.566 ' HG3' ' HA3' ' A' ' 63' ' ' GLY . 3.0 mm100 -76.61 94.91 3.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.7 109.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.865 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 m -83.55 82.02 8.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.31 123.59 20.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.029 -168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 75' ' ' VAL . 16.1 t 69.37 5.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.177 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.49 -84.47 1.46 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.628 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.252 1.2 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.867 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.762 0.315 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.64 165.34 39.44 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.794 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.513 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 38.7 p-80 -125.31 93.42 3.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.368 0.604 . . . . 0.0 110.455 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 49.0 ttm -90.12 136.74 32.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.791 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 16' ' ' ALA . 51.9 mt -84.54 112.81 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.075 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.5 ttt -112.55 -85.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.35 -57.34 2.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' H ' ' HD3' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -63.55 107.93 1.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 110.155 173.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.9 ptm180 -150.04 166.4 29.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.759 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.44 124.75 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.128 0.267 . . . . 0.0 110.354 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.22 -7.87 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.464 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -85.79 -67.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 0.0 111.114 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.2 m -94.16 -22.89 18.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.256 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.32 -2.7 61.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.329 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -77.66 166.12 23.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.74 0.305 . . . . 0.0 111.74 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HB2' HG12 ' A' ' 5' ' ' ILE . . . -76.63 144.12 72.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.906 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.608 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 95.9 Cg_endo -85.64 151.82 10.18 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.791 2.327 . . . . 0.0 113.644 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -121.92 103.66 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.966 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 21.0 p -70.63 137.44 49.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.769 -177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.13 -179.75 52.96 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.96 -40.31 80.27 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.264 0.225 . . . . 0.0 110.702 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m 71.48 102.6 0.07 Allowed 'General case' 0 CA--C 1.531 0.213 0 O-C-N 123.824 0.702 . . . . 0.0 111.418 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.62 -34.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.192 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 m -71.29 113.83 8.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.476 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -71.82 175.35 5.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.997 0.427 . . . . 0.0 110.691 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.2 m -107.05 170.33 8.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.532 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.65 118.85 24.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.087 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -74.06 86.18 1.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.452 0.644 . . . . 0.0 110.8 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.49 -56.06 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 m -101.91 106.44 17.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.811 171.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -87.73 17.16 4.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.703 -173.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 135.94 54.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.823 0.344 . . . . 0.0 110.366 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.607 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 16.3 m-90 -105.0 128.36 53.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.47 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -78.0 106.64 10.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.56 ' HB3' HD12 ' A' ' 38' ' ' LEU . 2.9 mpt_? 64.4 74.23 0.42 Allowed Pre-proline 0 N--CA 1.464 0.257 0 O-C-N 123.846 0.716 . . . . 0.0 110.256 -174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.607 ' HB3' ' HB2' ' A' ' 33' ' ' TRP . 96.5 Cg_endo -81.12 5.02 6.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.905 2.403 . . . . 0.0 112.944 -175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 13.3 m120 -111.91 3.48 17.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 109.826 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 54' ' ' ARG . 23.0 mt -126.3 129.73 49.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.239 -171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -82.82 89.19 6.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.327 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.53 114.22 4.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.103 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.55 153.86 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -93.32 124.84 37.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.941 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.3 m -115.86 155.46 17.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.6 t -90.02 117.56 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.274 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' HB ' ' A' ' 49' ' ' THR . 85.2 mt -82.07 152.87 69.0 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.938 175.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.75 -29.96 64.73 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.851 2.367 . . . . 0.0 112.917 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.15 -27.97 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.177 0.513 . . . . 0.0 110.65 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.86 7.05 25.91 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.3 m -83.1 151.03 25.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.051 0.453 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.5 mt -105.51 108.34 24.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -112.8 134.42 54.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.977 0.418 . . . . 0.0 111.199 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -91.0 120.5 32.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 43.3 mtm -127.62 157.01 41.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.566 0.698 . . . . 0.0 111.513 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.648 ' HB3' HD13 ' A' ' 38' ' ' LEU . 77.1 mtm180 -87.58 101.02 13.23 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.439 174.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 65' ' ' VAL . 21.2 t -115.12 145.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.56 -175.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.4 p -90.32 153.51 20.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.178 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.487 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -56.99 -26.38 60.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.595 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 t -64.09 -48.52 75.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.06 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 92.2 m -67.44 -33.26 74.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 57' ' ' THR . 76.1 mt -62.04 -53.38 56.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -77.75 -54.59 6.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.289 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -107.01 2.7 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.33 23.09 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.257 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 78.36 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.344 0.592 . . . . 0.0 111.056 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 55' ' ' VAL . 17.5 m -105.72 125.06 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 0.0 110.679 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -77.23 82.14 3.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -69.47 128.12 35.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.93 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.13 52.99 1.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t 61.96 91.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.575 0.702 . . . . 0.0 111.057 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.0 152.15 17.3 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -86.03 8.79 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.247 0.546 . . . . 0.0 110.893 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.92 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.45 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.5 p -104.77 133.46 49.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.22 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.42 179.7 6.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.06 0.457 . . . . 0.0 110.356 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.38 144.92 31.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.032 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.19 74.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.459 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.474 177.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.4 -137.96 8.18 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.457 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.0 m80 69.02 16.08 8.74 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.034 0.534 . . . . 0.0 110.379 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.439 ' SD ' ' HB2' ' A' ' 16' ' ' ALA . 50.8 ttp -107.44 2.02 23.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.529 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.3 mt -75.73 92.41 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.382 0.61 . . . . 0.0 110.88 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.6 tpt -152.05 145.84 25.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.3 71.37 2.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.958 0.408 . . . . 0.0 111.773 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 17' ' ' PRO . 22.4 pttp -168.2 36.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.524 0.678 . . . . 0.0 109.703 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD2' ' C ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -103.29 176.5 5.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.012 177.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 40.6 t -60.1 124.35 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 54' ' ' ARG . 8.5 mm-40 -60.09 -22.1 62.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.117 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 40.3 t -98.75 -70.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.517 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -78.68 -19.02 53.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.841 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.79 2.37 81.16 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.337 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -80.19 164.63 23.13 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.788 0.328 . . . . 0.0 110.75 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HB2' ' SD ' ' A' ' 4' ' ' MET . . . -72.79 147.94 89.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.486 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.798 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 90.6 Cg_endo -79.04 122.32 5.25 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.765 2.31 . . . . 0.0 111.827 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -140.75 96.9 3.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.278 0.561 . . . . 0.0 110.575 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p -83.26 -44.96 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.74 -48.85 2.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.644 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -132.25 144.46 50.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 110.586 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.6 t -99.73 127.01 45.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.18 -24.57 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.467 0.651 . . . . 0.0 109.935 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -81.15 107.21 13.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.208 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -68.69 -41.58 78.99 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.429 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 5.2 m -126.14 135.08 51.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.054 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -68.55 -44.29 74.83 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 26' ' ' SER . 9.0 mtmp? 64.91 160.87 0.12 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? 63.41 -167.86 0.21 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.062 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -141.7 156.06 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.042 173.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 58.19 84.44 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.455 0.645 . . . . 0.0 110.249 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.646 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -109.06 22.66 15.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.176 0.512 . . . . 0.0 110.728 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -137.98 155.31 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.391 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 90.9 mtt180 -121.9 160.62 46.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.106 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 35' ' ' ARG . 28.3 Cg_endo -63.69 -18.42 64.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.0 112.115 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 17' ' ' PRO . 43.4 m-80 -136.37 166.1 24.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.487 173.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 18.8 mt 71.87 112.95 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.967 0.792 . . . . 0.0 111.032 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.509 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.1 OUTLIER -104.48 113.75 27.53 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.668 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 53' ' ' MET . 21.7 pttp -77.24 110.38 11.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.98 168.03 20.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.424 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -96.1 115.61 27.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.874 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.8 m -115.2 155.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.759 0.314 . . . . 0.0 110.178 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.5 126.85 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.256 0.551 . . . . 0.0 109.924 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.469 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.1 mt -79.69 144.89 61.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.929 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 31.3 Cg_exo -59.35 -21.3 60.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.54 2.16 . . . . 0.0 111.936 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.04 -17.23 62.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.522 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.8 36.59 3.93 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.108 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -123.03 153.34 39.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.684 0.278 . . . . 0.0 110.787 -176.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.1 mm -103.51 119.8 52.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -136.27 137.26 40.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -90.69 124.33 35.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 88.1 mtp -134.62 160.78 37.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.001 0.429 . . . . 0.0 111.345 -175.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HB3' HD22 ' A' ' 38' ' ' LEU . 50.3 mtt85 -81.83 102.1 10.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.339 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.8 138.16 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.141 0.496 . . . . 0.0 111.174 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' CYS . 83.3 m -80.04 153.74 28.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.595 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 60' ' ' LEU . 3.4 m -61.15 -26.35 67.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.454 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -62.78 -42.77 99.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.325 0.583 . . . . 0.0 110.148 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 62.1 m -70.86 -33.78 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.121 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 57' ' ' THR . 96.4 mt -63.86 -36.03 82.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 176.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.2 -63.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.618 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.517 ' HA ' ' HA3' ' A' ' 76' ' ' GLY . 14.8 m -92.93 -24.62 18.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.869 -170.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' CYS . . . 113.02 -101.79 1.22 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.826 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.3 17.8 3.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.334 0.587 . . . . 0.0 111.067 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 27.4 m -141.33 -179.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -79.39 -44.35 21.64 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 70.43 143.69 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 111.176 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -81.85 42.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 111.02 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.1 m 43.93 32.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.275 1.03 . . . . 0.0 112.922 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.95 -178.73 35.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.501 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -63.18 139.27 58.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.131 0.491 . . . . 0.0 111.275 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.75 108.53 21.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -70.14 -17.16 63.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -158.08 154.74 28.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -85.02 -32.42 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 62' ' ' SER . . . 78.67 -62.12 3.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.816 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.253 1.237 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.002 -178.54 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.745 0.307 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.3 126.8 1.41 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.21 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -96.85 -6.75 35.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.1 ptt? -75.02 48.74 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.366 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 tt -143.45 -41.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.704 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.4 mmm 70.42 -47.96 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.726 0.81 . . . . 0.0 112.321 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.21 146.22 55.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.969 0.414 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -102.77 85.39 2.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.309 0.576 . . . . 0.0 111.531 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -86.33 -179.05 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.812 174.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' HB3' ' H ' ' A' ' 15' ' ' LYS . 44.8 t -60.96 114.58 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -62.74 -14.63 46.91 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 65' ' ' VAL . 45.8 t -80.39 -63.29 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.611 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 82.5 m -120.77 6.55 10.45 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -172.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.544 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 71.79 25.3 75.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.934 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG3' ' SG ' ' A' ' 59' ' ' CYS . 29.3 mmmt -74.9 160.91 30.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -91.74 144.04 28.82 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.4 Cg_endo -89.02 136.95 3.08 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.904 2.403 . . . . 0.0 113.19 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 18' ' ' ARG . 24.6 mtm180 -146.2 117.74 8.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.563 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.5 m 59.87 68.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.706 0.629 . . . . 0.0 111.054 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.56 17.42 57.65 Favored Glycine 0 N--CA 1.454 -0.151 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.839 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.448 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 49.3 t30 66.51 127.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.666 0.746 . . . . 0.0 112.207 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' HG22 ' A' ' 23' ' ' VAL . 6.0 m -64.54 -29.27 70.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.166 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 22' ' ' THR . 3.7 m 55.15 -179.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.796 1.238 . . . . 0.0 112.492 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 t -143.56 -170.11 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.795 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.8 t60 71.31 100.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.948 0.78 . . . . 0.0 111.233 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 m -107.07 119.68 40.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.1 m-20 -123.78 -158.76 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.46 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 90.2 mttt -51.4 132.58 29.54 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.921 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HD3' ' HZ ' ' A' ' 34' ' ' PHE . 88.9 mttt -87.21 111.75 21.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.258 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 m -145.08 78.77 1.57 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.239 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.92 32.12 21.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.369 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -136.55 167.12 21.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.171 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.6 m95 67.59 -165.22 0.21 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.694 0.621 . . . . 0.0 110.6 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.552 ' HZ ' ' HD3' ' A' ' 29' ' ' LYS . 73.1 m-85 66.75 -0.81 1.5 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.183 0.593 . . . . 0.0 112.201 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 2.1 mmp_? -129.16 86.8 55.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.501 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 22' ' ' THR . 6.3 Cg_exo -75.63 -6.53 17.73 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.003 2.468 . . . . 0.0 112.306 176.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -98.1 -5.9 32.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 54' ' ' ARG . 37.6 mt -116.3 135.91 53.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.671 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.448 ' NE2' ' HB3' ' A' ' 21' ' ' ASN . 7.9 mm-40 -86.64 109.79 19.41 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.528 173.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -81.66 109.12 15.79 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.59 165.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 42' ' ' ARG . 3.4 mpt_? -105.06 124.51 49.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.74 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 51' ' ' LYS . 25.0 m -108.0 152.64 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.893 0.378 . . . . 0.0 110.268 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.76 111.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' HB ' ' A' ' 49' ' ' THR . 93.3 mt -71.3 145.11 90.34 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.786 175.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 45' ' ' LEU . 32.7 Cg_exo -59.72 -15.2 30.44 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -85.08 1.78 46.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.116 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.17 34.42 29.8 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.345 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -120.6 148.98 43.17 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 42' ' ' ARG . 59.5 mt -98.55 118.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.901 0.382 . . . . 0.0 110.178 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.3 tttm -124.12 124.91 43.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 0.0 110.004 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 52' ' ' ARG . 3.1 ppt_? -97.63 136.0 38.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.112 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 70.6 mtm -142.61 169.19 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HB3' HD13 ' A' ' 38' ' ' LEU . 36.2 mtm180 -91.13 109.39 20.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.714 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.8 t -122.85 152.13 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.487 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.3 p -91.39 147.54 22.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.504 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 m -57.43 -28.13 63.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.827 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.1 p -61.74 -42.34 98.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.66 0.267 . . . . 0.0 111.095 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.606 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 57.3 m -70.56 -34.77 72.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.2 0.524 . . . . 0.0 110.543 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 57' ' ' THR . 53.9 mt -58.34 -51.85 68.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.977 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -79.61 -22.88 43.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.386 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 m -74.9 -28.21 60.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.17 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.43 29.56 63.77 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.248 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -79.17 -17.4 55.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 110.085 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 12' ' ' VAL . 32.6 m -97.54 162.91 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.844 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -81.45 73.65 8.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.406 0.622 . . . . 0.0 110.538 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -84.6 139.78 31.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.727 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.2 -6.69 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.188 0.518 . . . . 0.0 110.077 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.1 t 61.33 94.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.386 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.59 82.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.028 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 60.12 83.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.21 154.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.188 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.7 t -127.18 135.88 51.28 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.57 -31.7 28.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.717 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t 58.94 86.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 123.856 0.722 . . . . 0.0 111.274 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -176.34 39.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.598 179.273 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.61 37.76 92.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.594 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -88.03 -23.44 23.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.558 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 ttm -158.02 115.86 3.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.568 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 mp -103.06 113.26 39.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.931 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -118.09 143.62 46.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.387 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 64.89 177.35 0.19 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.805 0.691 . . . . 0.0 111.465 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -93.09 79.63 4.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.56 0.695 . . . . 0.0 110.154 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -112.44 176.7 4.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.841 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.4 t -78.98 125.87 29.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.84 -15.29 61.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.666 HG11 HG12 ' A' ' 65' ' ' VAL . 56.5 t -92.35 -64.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.773 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 62.3 m -93.0 -20.55 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.85 -1.45 85.21 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.1 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -68.18 162.19 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.62 0.248 . . . . 0.0 110.915 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . . . -83.88 143.18 42.85 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.319 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 16' ' ' ALA . 86.3 Cg_endo -90.72 96.48 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.825 2.35 . . . . 0.0 113.011 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -143.91 135.25 25.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.24 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.0 m -141.5 -66.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.4 -162.07 35.62 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -149.62 117.45 6.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.922 0.391 . . . . 0.0 110.834 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.9 m -152.33 126.34 9.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.971 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.52 -14.82 7.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.323 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.9 m -66.16 112.44 3.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.597 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m80 63.31 22.49 13.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.788 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -94.2 -25.38 17.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -139.85 151.67 45.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 112.034 -171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -111.44 -49.88 2.97 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.545 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 55.5 tttp -155.46 26.15 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.635 -171.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 t -96.1 160.74 14.29 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.814 -0.554 . . . . 0.0 109.733 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -128.82 -46.41 1.27 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -151.92 94.52 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.959 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.425 ' O ' ' HE2' ' A' ' 40' ' ' LYS . 51.2 t-105 -99.02 -18.09 17.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.959 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.91 178.2 9.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.312 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -88.06 157.28 51.36 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 123.332 0.395 . . . . 0.0 110.316 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 73.2 Cg_exo -50.34 109.12 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.667 2.245 . . . . 0.0 112.227 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 17.6 m120 74.4 -0.69 3.28 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.345 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.3 mt -120.79 119.7 33.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.421 0.629 . . . . 0.0 112.022 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -92.68 118.87 31.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.807 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 33' ' ' TRP . 55.4 pttt -86.14 118.25 25.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.065 0.459 . . . . 0.0 110.289 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.5 m -127.62 153.28 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.599 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 93.3 mtt180 -90.04 124.38 34.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.559 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 51' ' ' LYS . 29.1 m -109.08 155.84 9.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.24 134.35 46.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.519 HD12 ' HB ' ' A' ' 49' ' ' THR . 96.8 mt -98.38 147.37 33.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.999 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.11 -13.85 38.01 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.62 1.78 47.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.787 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.14 63.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.452 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.1 m -97.42 152.04 19.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.029 0.442 . . . . 0.0 110.834 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.51 130.11 70.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.178 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 43' ' ' VAL . 63.0 tttp -136.46 129.77 31.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.019 0.438 . . . . 0.0 110.687 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' ARG . 3.1 ptt180 -91.41 130.41 37.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.1 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.4 mtp -129.41 157.57 41.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -82.43 107.52 15.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.571 0.7 . . . . 0.0 110.484 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 48.4 t -116.11 137.79 48.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.512 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.9 p -81.41 153.69 26.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -59.55 -30.63 68.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.551 -177.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -61.9 -42.35 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.5 m -69.7 -35.34 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 57' ' ' THR . 78.9 mt -63.43 -48.64 76.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.375 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HE3' ' HB2' ' A' ' 77' ' ' SER . 31.3 mmmt -67.22 -37.08 82.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.9 m -78.83 -31.89 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.788 0.328 . . . . 0.0 111.229 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 49.34 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.056 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -90.62 -22.72 21.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 HG11 ' A' ' 12' ' ' VAL . 35.4 m -69.21 148.01 11.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.972 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.69 -51.6 66.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.474 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 65' ' ' VAL . 75.9 tttt 66.88 152.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.913 0.758 . . . . 0.0 112.463 169.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -96.39 87.88 4.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 170.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 70' ' ' GLY . 7.2 p 44.67 -75.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.601 ' H ' HG13 ' A' ' 69' ' ' VAL . . . -150.96 168.45 30.65 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.873 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.74 -44.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.748 0.274 . . . . 0.0 111.243 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.8 164.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 m -61.18 119.76 9.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 0.0 110.426 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 10.6 tm-20 -109.38 -76.83 0.6 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 74' ' ' GLU . 7.8 p 168.56 -31.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.82 172.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 178.71 29.07 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.477 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.545 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 8.8 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.081 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.587 0.232 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.22 60.2 9.28 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.088 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -79.59 81.01 5.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.197 0.522 . . . . 0.0 109.886 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.6 mtp -133.99 110.73 9.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.265 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.2 mm -110.17 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.768 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 168.08 20.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.68 -25.39 68.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.3 68.89 5.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.963 0.411 . . . . 0.0 110.872 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 7.3 ppt_? -121.43 171.02 9.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.32 140.98 56.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 40.7 mt-10 -74.38 -8.18 55.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.046 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.2 t -111.22 -72.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.385 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.8 t -67.23 -34.94 78.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.998 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 98.8 -15.8 60.36 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.277 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.77 152.3 25.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.682 0.277 . . . . 0.0 110.69 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.59 144.31 27.62 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.89 145.96 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.104 2.536 . . . . 0.0 112.418 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -106.86 -14.45 14.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.221 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.7 m -144.1 143.92 31.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.987 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.78 145.36 15.96 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.52 -154.34 0.34 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -146.06 -85.26 0.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -139.25 -26.28 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.782 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 m -86.89 143.41 27.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.145 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -87.45 171.13 10.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.291 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.6 m -67.0 116.04 7.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.314 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.62 136.75 51.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.211 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.7 tttm 70.18 17.56 7.16 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.784 0.802 . . . . 0.0 109.776 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HG2' ' H ' ' A' ' 30' ' ' SER . 20.2 ttmm -155.08 -178.81 7.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.193 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.634 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 24.1 m -138.86 48.54 1.9 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 61.29 -175.65 0.12 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.144 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -170.94 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.448 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -142.75 126.5 17.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.17 0.51 . . . . 0.0 111.366 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -135.69 -171.55 2.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.029 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.775 ' HG3' ' HG2' ' A' ' 54' ' ' ARG . 32.3 mmt180 -111.87 164.55 14.87 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.74 102.16 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.243 1.962 . . . . 0.0 111.495 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 -40.62 0.48 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.572 0.749 . . . . 0.0 111.583 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 27.6 mt -70.78 132.89 46.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.796 0.331 . . . . 0.0 110.618 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HB2' HD11 ' A' ' 60' ' ' LEU . 20.1 mt-30 -103.92 131.54 51.04 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' MET . 11.8 ptmt -92.05 109.95 21.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 35.6 m -116.46 156.32 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.536 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -88.43 128.16 35.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.587 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.8 m -124.56 153.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.563 177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 67' ' ' LYS . 88.2 t -83.2 126.45 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.746 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.505 HD11 ' HE3' ' A' ' 51' ' ' LYS . 87.0 mt -97.67 143.78 26.82 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.46 -8.86 20.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.932 2.422 . . . . 0.0 111.604 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -78.49 -3.75 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.499 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.48 37.45 27.36 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.341 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -140.19 155.73 46.81 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.51 121.82 62.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.1 ttmt -123.38 138.15 54.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.131 0.491 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -92.38 106.87 18.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.687 174.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 87.0 mtp -101.59 158.36 16.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.838 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.775 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 86.4 mtm180 -83.74 100.82 11.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.75 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.51 146.69 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.593 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.4 p -92.64 159.23 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.417 ' OG1' ' HA3' ' A' ' 76' ' ' GLY . 6.1 t -58.3 -26.7 63.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t -61.84 -51.14 69.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 110.403 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.64 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 75.4 m -65.21 -38.0 89.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.569 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 39' ' ' GLN . 91.5 mt -65.28 -43.33 91.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.624 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -64.48 -45.61 86.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.823 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 t -72.68 -32.01 65.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.822 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.31 29.44 66.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.883 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.64 ' HE2' ' HA ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -97.54 49.56 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.491 0.663 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.78 176.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.185 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -79.07 -57.7 3.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.652 0.263 . . . . 0.0 110.808 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.1 mttt 64.99 172.29 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.654 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -146.15 88.74 1.82 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.806 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.0 m 42.38 85.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.23 0.956 . . . . 0.0 113.186 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.06 130.81 1.89 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.885 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -144.57 130.08 18.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.17 18.68 2.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.556 0.694 . . . . 0.0 109.983 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.9 m 64.94 40.69 5.16 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.752 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -65.77 104.87 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.31 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.95 -49.11 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' OG1' ' A' ' 57' ' ' THR . . . 77.43 -130.5 10.38 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.757 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.248 0.995 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.034 176.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.724 0.297 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.05 93.67 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.258 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -104.26 127.19 51.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 110.62 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -92.48 -25.57 18.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 tt -163.68 145.46 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.209 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -117.36 81.76 1.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.574 0.702 . . . . 0.0 110.307 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.01 88.71 6.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.546 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt 62.27 84.37 0.14 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.503 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -102.7 171.9 7.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.789 -175.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.713 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 50.2 t -69.83 131.2 44.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 169.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 45.1 mt-10 -68.37 -15.16 63.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.857 0.361 . . . . 0.0 111.065 -175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.23 -70.76 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.52 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.6 m -82.49 -32.91 28.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.911 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 95.71 10.7 56.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.101 -174.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -74.78 162.4 28.72 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.452 0.301 . . . . 0.0 110.973 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.66 151.07 49.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.92 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 86.5 Cg_endo -82.76 115.44 2.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.751 2.301 . . . . 0.0 113.119 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.66 111.2 9.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.881 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.459 ' HB3' ' OG1' ' A' ' 22' ' ' THR . 7.4 m -143.84 -24.05 0.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.202 0.525 . . . . 0.0 111.169 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.23 -73.72 2.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' HB3' HG22 ' A' ' 23' ' ' VAL . 59.2 m-80 -138.49 -72.82 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 19' ' ' SER . 6.1 m 62.22 5.09 1.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.623 0.725 . . . . 0.0 111.626 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 21' ' ' ASN . 27.3 m -86.38 14.96 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -59.33 -46.99 87.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.718 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -155.19 96.53 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.434 0.635 . . . . 0.0 110.764 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 m -96.65 -71.31 0.68 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -149.83 142.09 24.16 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HA ' HH21 ' A' ' 32' ' ' ARG . 0.0 OUTLIER -119.93 18.38 12.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.839 0.352 . . . . 0.0 111.484 -174.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 -38.2 2.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 p -89.51 171.51 9.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.89 0.376 . . . . 0.0 111.517 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -81.63 131.95 35.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.745 HH21 ' HA ' ' A' ' 28' ' ' LYS . 41.6 mtt180 -103.01 103.22 13.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -80.44 -71.86 0.44 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.738 0.304 . . . . 0.0 110.318 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -163.88 137.84 5.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.9 88.11 4.92 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.52 0.676 . . . . 0.0 111.043 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LEU . 60.2 Cg_endo -72.78 75.88 2.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.718 2.278 . . . . 0.0 112.239 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 m120 69.93 -7.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.481 0.712 . . . . 0.0 111.76 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.92 ' HG ' ' HB3' ' A' ' 17' ' ' PRO . 7.4 mt -95.52 107.02 19.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.094 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 39' ' ' GLN . 5.8 mt-30 -84.44 106.7 16.23 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.769 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.0 ptmt -75.69 111.59 11.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 173.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 28.1 m -110.77 164.94 6.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.567 -173.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 42' ' ' ARG . 35.4 ttp-105 -89.29 106.56 18.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.662 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 28.0 m -118.66 170.81 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.72 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 68' ' ' TYR . 7.3 p -102.59 132.55 48.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.404 0.621 . . . . 0.0 110.879 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 49' ' ' THR . 83.3 mt -90.94 144.39 30.03 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.088 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.53 -22.13 73.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.716 2.277 . . . . 0.0 111.308 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.1 -15.79 63.39 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.931 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.88 40.23 5.3 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.487 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.5 m -138.28 158.2 44.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.98 126.49 55.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -134.81 144.42 47.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.903 0.382 . . . . 0.0 110.909 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.2 mtt180 -97.92 113.95 25.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.8 mtp -121.68 142.26 50.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.506 -174.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 42.2 mtm105 -65.96 113.2 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.108 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.713 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 46.3 t -124.61 130.92 73.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.615 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 p -78.1 150.52 33.68 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 27.4 m -57.89 -30.21 65.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.138 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -60.56 -38.68 85.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.597 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.1 m -79.32 -34.97 41.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.62 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 57' ' ' THR . 85.3 mt -62.8 -38.36 90.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.706 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -58.24 -58.75 7.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.709 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 m -68.9 -31.25 70.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.04 38.88 84.65 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.64 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 15.44 12.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.203 0.525 . . . . 0.0 111.078 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' LYS . 35.6 m -98.66 168.0 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.599 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mttt -78.72 81.79 5.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.324 0.583 . . . . 0.0 110.572 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG3' HG23 ' A' ' 65' ' ' VAL . 56.7 mtpt -81.69 143.85 31.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.429 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 60.7 t80 -91.26 107.91 19.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.98 175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.4 t -92.56 108.9 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.208 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.99 81.1 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.32 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 57.42 45.79 19.24 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.358 0.599 . . . . 0.0 111.003 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -93.94 21.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.732 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.2 m 66.59 41.35 3.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.276 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.532 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -76.3 -14.26 60.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.661 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.25 138.07 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.248 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -48.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.815 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.612 175.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.835 0.35 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.96 -159.32 9.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -83.25 3.52 30.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.674 0.737 . . . . 0.0 110.087 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 mtm -71.03 -29.4 65.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.248 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.878 HG22 ' H ' ' A' ' 6' ' ' MET . 6.8 mt 60.02 -164.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.43 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.878 ' H ' HG22 ' A' ' 5' ' ' ILE . 66.1 mtt -87.52 108.48 19.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.64 -24.23 63.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.915 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 38' ' ' LEU . 22.7 pttm -81.54 64.92 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.57 0.7 . . . . 0.0 111.191 -177.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.89 165.58 12.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.853 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 12' ' ' VAL . 50.6 t -82.02 114.53 20.65 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.87 28.5 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.487 0.661 . . . . 0.0 110.971 -174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 10' ' ' CYS . 63.9 t -128.22 -62.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.549 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.76 -29.42 7.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.181 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.06 5.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.368 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 10' ' ' CYS . 48.9 mtpt -102.15 174.62 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.18 89.55 39.82 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 38' ' ' LEU . 43.4 Cg_endo -67.03 119.66 6.7 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.166 2.577 . . . . 0.0 113.125 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.6 mtt-85 -96.05 102.12 13.87 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.1 m 69.56 164.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.416 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.33 -66.32 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -163.09 105.31 1.01 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.129 0.49 . . . . 0.0 109.683 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -84.67 91.4 7.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.294 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.408 HG23 ' HE2' ' A' ' 28' ' ' LYS . 21.5 m -73.58 152.23 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.84 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 t -77.87 -164.64 0.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.7 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -113.13 93.62 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 112.201 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -77.32 -56.93 4.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 167.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -143.34 93.93 2.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.529 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HE2' HG23 ' A' ' 23' ' ' VAL . 65.8 mttp -137.97 97.85 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.827 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 16.5 pttm -78.66 84.15 4.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.546 0.689 . . . . 0.0 111.312 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 p -173.36 117.68 0.28 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.348 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.66 -50.05 75.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -105.42 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -67.48 99.96 0.81 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.227 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.547 ' HB3' HH11 ' A' ' 35' ' ' ARG . 91.2 t80 -63.45 -25.64 68.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.417 0.627 . . . . 0.0 110.953 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.547 HH11 ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -140.35 84.5 14.3 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.04 178.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.67 -39.27 4.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.738 2.292 . . . . 0.0 109.927 172.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 7.9 p30 -71.25 -165.85 0.15 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.95 173.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 54' ' ' ARG . 29.1 mt 66.47 114.7 0.03 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.584 0.707 . . . . 0.0 110.423 -174.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.502 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -75.14 94.5 2.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.867 177.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -92.48 107.72 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.553 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.68 169.07 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.859 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -83.13 131.11 35.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.523 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.74 166.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.078 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.752 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 34.6 t -101.77 135.87 36.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.941 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.769 HD11 ' HD3' ' A' ' 51' ' ' LYS . 71.8 mt -90.67 152.53 45.04 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.408 173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.16 -25.51 64.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.316 2.011 . . . . 0.0 111.753 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.9 -28.98 69.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.83 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.41 -7.3 34.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.566 ' HB ' HD12 ' A' ' 45' ' ' LEU . 2.4 m -77.18 156.48 31.53 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.876 0.37 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.3 mt -101.53 113.55 38.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.225 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HD3' HD11 ' A' ' 45' ' ' LEU . 18.0 tptp -102.47 152.86 20.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -113.61 114.14 26.04 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.0 mtm -131.52 163.6 27.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.373 0.606 . . . . 0.0 112.162 -173.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.658 ' HB3' HD22 ' A' ' 38' ' ' LEU . 36.7 mtm180 -93.04 108.64 20.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.44 153.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.896 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.3 p -93.11 152.83 19.03 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.763 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -58.89 -28.67 66.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -60.34 -50.23 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.5 m -65.62 -34.31 77.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.082 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 60' ' ' LEU . 10.8 mt -68.08 -44.96 75.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -67.26 -40.5 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.792 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -75.7 -19.52 59.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.22 45.51 61.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.779 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -95.52 4.46 53.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.173 0.511 . . . . 0.0 110.445 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.96 150.85 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.095 0.474 . . . . 0.0 111.621 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.752 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 57.7 tptt -75.22 97.12 3.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 172.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -111.63 147.29 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.166 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -94.08 24.84 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.706 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.0 t 68.87 102.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.565 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.25 -178.53 42.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.258 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.28 -41.64 19.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.062 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 m -78.48 61.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.457 0.646 . . . . 0.0 111.896 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 t -81.82 -15.87 52.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.656 0.741 . . . . 0.0 109.024 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.98 141.57 48.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.616 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 m -80.21 118.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 111.146 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.96 70.47 2.29 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.056 -176.883 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.18 -132.99 7.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.237 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 m170 49.43 66.18 1.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.172 0.51 . . . . 0.0 111.247 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.2 ttp -84.5 106.02 15.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.253 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.73 100.68 5.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.595 ' HA ' ' CE ' ' A' ' 6' ' ' MET . 0.9 OUTLIER -81.36 76.82 8.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -175.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.52 -172.98 1.56 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' O ' HD11 ' A' ' 38' ' ' LEU . 25.1 mttt -87.84 165.47 15.27 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -90.92 170.95 9.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.5 t -59.6 115.7 3.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -72.3 -1.83 16.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.562 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.8 t -90.96 -64.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.102 0.477 . . . . 0.0 110.62 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -94.47 -54.42 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.152 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.27 6.83 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.346 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.11 169.73 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.0 110.711 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.74 143.68 27.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.777 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.54 77.09 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.768 2.312 . . . . 0.0 112.337 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -80.0 -34.62 38.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.274 0.559 . . . . 0.0 110.143 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 m -94.69 153.31 17.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.435 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.12 135.72 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.58 115.01 9.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 110.205 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m -107.34 2.6 24.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.454 0.645 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 t -82.89 83.04 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.159 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -152.98 168.57 25.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.72 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -115.31 107.86 15.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 p -67.61 109.69 3.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.4 t70 -144.53 143.71 30.97 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 40.2 ttmt 74.73 -24.06 0.22 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.219 0.608 . . . . 0.0 111.449 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 27' ' ' ASP . 18.3 ttmm -89.64 30.64 1.0 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.0 110.881 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.0 m 74.15 -54.17 0.68 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.7 25.59 11.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.712 0.405 . . . . 0.0 110.624 -174.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -93.84 -53.43 4.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.04 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -118.87 95.58 4.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.542 0.686 . . . . 0.0 111.43 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -146.13 127.35 14.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.102 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -97.89 165.37 15.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.151 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.89 100.07 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.275 1.984 . . . . 0.0 111.347 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 54.1 m-80 71.33 -160.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.015 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 42.7 mt 71.86 122.01 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.676 0.751 . . . . 0.0 111.125 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.51 ' HA ' HE21 ' A' ' 39' ' ' GLN . 0.1 OUTLIER -98.52 96.94 8.32 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 20.8 pttp -74.47 110.06 8.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.81 164.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.294 0.569 . . . . 0.0 111.594 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 42' ' ' ARG . 37.3 ttp180 -99.59 109.83 22.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.488 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -109.08 161.77 7.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.58 129.38 60.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 0.0 110.63 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 49' ' ' THR . 74.8 mt -88.66 151.49 47.92 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.88 -32.66 86.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.508 2.805 . . . . 0.0 113.751 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.32 -2.85 54.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.119 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.5 42.35 3.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.281 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.578 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -114.5 149.88 35.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.3 mp -106.73 120.74 58.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 2.0 tpmt? -132.78 138.76 47.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 0.0 111.636 -174.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -91.87 122.7 34.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 79.3 mtp -128.68 150.51 50.22 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.843 0.354 . . . . 0.0 110.812 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 8' ' ' LYS . 67.0 mtt85 -91.14 101.63 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.415 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 65' ' ' VAL . 27.2 t -112.36 152.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.582 -173.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.3 p -92.06 154.6 18.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -61.52 -21.98 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.092 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -62.5 -51.7 66.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.407 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.8 m -64.81 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.571 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.99 -42.12 97.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.871 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.55 -48.73 59.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.12 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.4 m -64.89 -22.61 67.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.972 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.02 48.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.703 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -92.16 3.81 54.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.333 0.587 . . . . 0.0 110.556 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 55' ' ' VAL . 31.4 m -109.31 139.48 32.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.995 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.6 88.77 4.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.952 0.882 . . . . 0.0 109.156 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.782 ' HE2' ' HB3' ' A' ' 71' ' ' GLN . 71.9 tttt -76.22 148.38 37.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.191 -170.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -81.59 11.62 4.52 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 110.453 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t 75.24 -34.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.514 0.726 . . . . 0.0 112.794 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.24 66.28 0.72 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.782 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 5.9 tp-100 -176.04 99.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.361 0.664 . . . . 0.0 109.428 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.59 -35.84 6.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.119 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.4 p 53.57 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.001 0.92 . . . . 0.0 112.422 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -99.53 127.32 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.02 -0.425 . . . . 0.0 110.538 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -91.59 100.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.871 0.367 . . . . 0.0 110.25 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.09 74.67 2.37 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.315 -177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.322 179.222 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.665 0.269 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.17 144.75 14.32 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.567 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -85.51 74.31 10.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.11 -0.82 29.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.079 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt 72.62 119.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.259 0.552 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.2 ttt -66.69 113.25 4.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.155 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.5 80.97 3.97 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -54.53 140.83 33.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.35 -176.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.617 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 9.6 ptm85 -154.14 162.0 41.49 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.742 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.85 123.51 19.98 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.22 -1.55 23.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.071 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.653 HG21 HG12 ' A' ' 65' ' ' VAL . 51.7 t -98.4 -70.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.032 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.2 m -91.56 -15.81 28.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.75 27.99 52.33 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.131 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -100.57 144.65 29.29 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.41 144.54 86.79 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.617 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 84.1 Cg_endo -82.29 64.64 8.31 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.693 2.262 . . . . 0.0 111.798 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -98.8 106.27 18.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.121 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 m -99.13 -38.68 8.83 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.728 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.09 -115.23 7.51 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.678 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -167.76 123.27 1.04 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.991 0.424 . . . . 0.0 110.056 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 p -71.76 -58.6 3.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 109.937 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.04 -70.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -178.18 126.99 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.845 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -103.49 151.04 23.3 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -80.89 18.74 0.95 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 46.1 t0 64.55 167.36 0.17 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.719 0.407 . . . . 0.0 110.98 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt 50.08 54.06 11.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.523 0.678 . . . . 0.0 109.844 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.879 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -80.06 44.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.568 -173.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.9 m 61.04 26.49 16.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.299 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 24.5 tt0 -64.85 -56.4 13.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.745 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 62.51 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 167.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -108.89 2.91 21.82 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.427 0.632 . . . . 0.0 110.762 -173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.566 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 44.0 m-85 -84.1 176.56 8.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.646 ' HD2' ' HD2' ' A' ' 36' ' ' PRO . 21.0 tpt180 -95.7 143.07 25.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.646 ' HD2' ' HD2' ' A' ' 35' ' ' ARG . 4.5 Cg_endo -48.07 108.21 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.958 2.438 . . . . 0.0 112.656 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 m120 75.5 -12.04 1.03 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.872 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 8' ' ' LYS . 11.9 mt -106.85 101.29 10.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.615 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -83.48 108.26 16.5 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 -177.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 34' ' ' PHE . 51.7 mtmt -71.4 110.78 6.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.531 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.64 146.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.905 0.383 . . . . 0.0 110.35 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -83.53 120.16 25.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.241 0.543 . . . . 0.0 110.038 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 67' ' ' LYS . 34.2 m -116.14 145.17 22.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.908 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 67' ' ' LYS . 14.2 p -89.02 113.37 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.678 0.751 . . . . 0.0 110.323 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HB ' ' A' ' 49' ' ' THR . 94.6 mt -74.83 147.81 84.39 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.269 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.6 -15.27 45.0 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.695 2.263 . . . . 0.0 111.668 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.85 -21.79 60.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.727 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.47 0.82 46.92 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.807 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.572 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.7 m -91.14 155.89 18.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.844 0.354 . . . . 0.0 110.438 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -106.91 127.14 62.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.258 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -132.35 136.62 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.878 0.371 . . . . 0.0 110.841 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -89.29 117.5 28.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 80.2 mtp -110.65 143.21 41.44 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.092 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HB3' HD13 ' A' ' 38' ' ' LEU . 54.4 mtt85 -79.52 100.18 7.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.767 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.16 138.6 40.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.001 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 23.1 p -88.94 163.85 15.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.922 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.561 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.1 p -59.0 -30.2 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.11 -177.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 m -59.84 -51.97 67.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.967 0.413 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.62 -33.8 69.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.8 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 57' ' ' THR . 79.7 mt -54.99 -43.42 73.56 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.46 -26.93 55.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.537 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.6 m -74.9 -31.56 61.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.897 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.22 77.3 Favored Glycine 0 C--O 1.228 -0.25 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.593 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.16 -3.0 58.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.309 0.575 . . . . 0.0 110.484 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 67' ' ' LYS . 31.3 m -85.91 156.36 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.394 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.764 ' HE3' ' HA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -66.32 -37.85 86.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.514 -176.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' A' ' 65' ' ' VAL . 97.3 mttt 61.33 -172.26 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.702 0.627 . . . . 0.0 111.488 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -115.58 70.5 0.75 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.48 -45.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.614 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.96 -76.81 1.87 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.809 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -78.78 122.47 26.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.711 0.291 . . . . 0.0 111.098 -176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.84 105.49 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.2 m -117.95 152.78 34.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.767 -174.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -84.52 87.93 7.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.036 0.446 . . . . 0.0 110.14 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -171.16 148.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.118 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.16 39.02 0.61 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.832 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.275 179.039 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.747 0.308 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.35 -59.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.588 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -86.61 85.76 7.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -82.64 -20.88 35.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.67 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 5' ' ' ILE . 1.4 pp -87.76 140.48 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 170.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 67.3 mtt 59.43 -164.87 0.2 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -166.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 9' ' ' ARG . . . 55.09 30.34 14.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.25 100.33 2.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.578 0.704 . . . . 0.0 110.296 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.95 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 ptp180 -144.84 173.76 11.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.38 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 52.4 t -70.04 114.49 8.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 37.3 mt-10 -68.63 -5.73 21.77 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.207 0.527 . . . . 0.0 111.617 -171.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' CG1' ' A' ' 65' ' ' VAL . 48.5 t -88.95 -58.28 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.166 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 m -102.18 -24.22 13.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.95 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 91.68 22.72 30.3 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.567 -177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.922 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.9 mmpt? -93.37 151.42 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.775 -0.25 . . . . 0.0 110.94 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 145.24 69.46 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.369 . . . . 0.0 111.475 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HB3' ' HG ' ' A' ' 38' ' ' LEU . 37.7 Cg_endo -66.71 149.29 83.77 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.867 2.378 . . . . 0.0 111.871 176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -153.64 112.16 3.65 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 m 69.95 -56.06 0.59 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.161 171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.92 -127.99 9.78 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.49 110.19 4.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -116.79 148.66 40.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.054 0.454 . . . . 0.0 111.424 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -161.85 140.21 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.152 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 p -87.11 100.69 12.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.107 0.48 . . . . 0.0 110.673 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -155.94 73.98 0.84 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.5 m -80.68 95.43 6.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.331 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -148.98 107.59 3.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.075 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 59.2 92.8 0.04 OUTLIER 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.986 0.804 . . . . 0.0 111.357 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -115.88 -175.05 2.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.781 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.4 t -139.12 -178.44 5.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.668 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.02 -5.6 52.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.607 -175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.3 mpt_? -87.44 86.53 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.494 0.664 . . . . 0.0 111.446 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -116.77 98.84 6.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.403 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -144.44 22.03 1.68 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.278 0.561 . . . . 0.0 110.254 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 15.9 ptt180 -140.58 64.22 22.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.464 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.27 -16.18 2.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.459 2.106 . . . . 0.0 112.629 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -133.89 -47.16 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.684 0.754 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' A' ' 54' ' ' ARG . 13.9 mt -85.0 153.4 22.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.043 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -119.75 110.02 16.3 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -84.43 109.39 17.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.42 165.45 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -87.68 114.56 24.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.96 148.78 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.421 . . . . 0.0 110.408 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -102.48 124.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.446 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.444 HD12 ' HB ' ' A' ' 49' ' ' THR . 89.9 mt -84.66 146.34 46.48 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.682 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.03 -21.93 61.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.748 2.299 . . . . 0.0 111.83 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.69 -26.56 67.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.522 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.69 -0.72 23.24 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.125 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.444 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -87.01 149.77 24.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 111.398 -176.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -111.59 113.22 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HG3' ' HG3' ' A' ' 53' ' ' MET . 55.0 tptt -129.03 130.94 47.24 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.109 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -80.95 115.94 20.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.521 ' HG3' ' HG3' ' A' ' 51' ' ' LYS . 64.0 mtm -123.88 157.51 34.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.319 0.581 . . . . 0.0 111.6 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HB3' HD13 ' A' ' 38' ' ' LEU . 87.0 mtm180 -77.72 109.4 11.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.757 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.82 141.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.514 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.52 159.28 16.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -59.25 -32.62 70.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.188 -177.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -60.91 -38.86 87.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.307 0.575 . . . . 0.0 110.765 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.66 -34.21 60.48 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.446 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 57' ' ' THR . 91.5 mt -61.09 -53.25 59.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.325 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -60.22 -50.61 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.13 0.491 . . . . 0.0 111.327 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.3 m -73.96 -17.46 61.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.138 -172.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.41 40.75 96.53 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -73.16 -14.52 61.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.66 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 67' ' ' LYS . 35.0 m -108.46 158.81 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.132 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -54.59 -52.0 63.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.738 ' HB2' HG23 ' A' ' 65' ' ' VAL . 34.1 ttpt 62.06 12.91 5.29 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.739 172.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 t80 65.74 18.67 11.24 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.345 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 69' ' ' VAL . 6.4 t 61.87 30.64 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.631 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . -70.72 162.65 53.7 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.859 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 96.5 mt-30 68.39 161.94 0.2 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.81 0.444 . . . . 0.0 111.351 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p 43.5 45.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 122.102 0.953 . . . . 0.0 111.201 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.86 -82.85 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.272 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -167.29 100.56 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.263 0.554 . . . . 0.0 110.921 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.8 103.22 13.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.069 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.64 76.23 0.55 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.633 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 C--O 1.251 1.163 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.828 0.347 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.33 105.32 0.51 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.292 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -96.59 -39.56 9.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.807 0.337 . . . . 0.0 111.272 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.1 ttm -149.84 135.62 18.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.865 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.7 mp -89.12 -38.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.2 ttp 71.29 -69.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.036 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.95 -58.62 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.89 0.376 . . . . 0.0 110.978 -175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -156.17 110.69 2.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.098 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 3.3 ppt_? -96.46 -164.75 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.918 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 47.9 t -55.11 135.32 49.3 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.053 0.454 . . . . 0.0 110.799 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -82.06 3.22 27.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.042 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.25 -73.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.544 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 83.5 m -108.85 8.33 26.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 9' ' ' ARG . . . 84.28 -18.34 23.8 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.382 -0.913 . . . . 0.0 114.416 173.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -58.39 139.99 54.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.182 0.491 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 69.15 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.767 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.642 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 61.0 Cg_endo -71.97 94.62 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 111.653 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -62.96 -56.82 13.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.688 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -143.27 -67.63 0.35 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.354 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.38 -63.59 0.31 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.152 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.578 ' O ' ' HB ' ' A' ' 22' ' ' THR . 64.0 t30 74.42 164.7 0.28 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.347 0.659 . . . . 0.0 110.147 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 21' ' ' ASN . 1.1 m 75.36 142.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 110.903 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.02 123.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.646 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -71.17 98.71 1.74 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.897 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -148.47 133.45 18.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.294 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -142.49 -75.86 0.27 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -162.38 135.53 6.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -87.32 76.45 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.6 . . . . 0.0 110.641 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -126.16 101.37 6.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.479 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.3 m 65.84 17.87 10.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.816 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 57.58 77.4 0.28 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.312 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -95.32 76.65 3.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 109.052 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.9 t-105 -119.93 19.46 12.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.132 -171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -63.61 112.64 2.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 57.29 82.21 0.24 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.904 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.53 -38.87 2.25 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.903 2.402 . . . . 0.0 113.746 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -73.71 -16.36 61.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.088 0.47 . . . . 0.0 111.248 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 19.2 mt -89.1 108.33 19.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.489 HE21 ' HB3' ' A' ' 39' ' ' GLN . 3.3 mt-30 -68.67 97.38 0.8 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.638 0.732 . . . . 0.0 111.022 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 8.2 ptpp? -73.16 110.78 7.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.978 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.64 168.09 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.227 0.537 . . . . 0.0 111.173 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -88.68 114.81 25.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.702 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.1 m -120.97 159.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.282 0.563 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.0 t -104.57 124.26 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.231 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.595 HD12 ' HB ' ' A' ' 49' ' ' THR . 38.8 mt -60.64 148.69 81.13 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.989 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.54 -7.58 9.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.306 2.67 . . . . 0.0 113.774 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -98.78 -69.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.734 0.302 . . . . 0.0 110.249 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.46 57.89 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.021 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.595 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.1 m -144.5 156.65 44.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.52 129.26 67.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.794 0.331 . . . . 0.0 110.149 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HE2' HD21 ' A' ' 45' ' ' LEU . 39.3 ttpt -146.72 152.93 39.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.045 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -94.63 127.16 40.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.4 mtp -135.36 152.18 51.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 56.8 mtt85 -91.36 110.64 21.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.697 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 25.4 t -112.29 138.2 42.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.074 -177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.4 p -88.63 159.55 17.81 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.79 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 t -58.93 -25.82 63.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.572 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 m -63.74 -47.92 79.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.709 0.29 . . . . 0.0 110.584 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 75.4 m -70.58 -34.5 72.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 56' ' ' CYS . 83.4 mt -61.3 -41.54 97.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.671 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -81.06 -24.81 37.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.157 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.2 t -68.28 -33.02 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.02 22.49 55.37 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.156 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.95 8.99 28.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.944 0.872 . . . . 0.0 111.182 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -88.21 161.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.724 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -76.29 147.72 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -152.2 160.56 43.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.178 0.513 . . . . 0.0 111.971 -172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -102.92 3.8 36.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.861 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t 63.49 86.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.08 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.43 -147.45 16.99 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.427 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -136.88 140.94 42.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 0.0 110.899 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -116.48 27.64 3.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.207 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m 74.9 146.33 0.09 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.739 -170.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.82 115.55 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.459 . . . . 0.0 110.845 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.05 -48.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.94 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.87 -144.24 49.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.007 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.19 -0.91 . . . . 0.0 109.494 176.015 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.27 53.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.933 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -80.83 87.63 5.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.147 0.499 . . . . 0.0 110.437 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.419 ' N ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -148.25 79.55 1.45 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 173.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 4' ' ' MET . 4.5 mp -125.81 89.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.46 -176.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -87.55 -60.25 2.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.94 -41.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.29 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 mttp 66.22 89.75 0.1 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.922 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -128.35 161.3 29.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 49.8 t -62.48 135.62 57.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.602 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 54' ' ' ARG . 49.6 mt-10 -81.98 3.6 25.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.229 0.538 . . . . 0.0 110.833 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.37 -60.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 t -96.8 -17.4 20.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.285 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.06 84.02 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.846 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -75.19 143.46 43.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.707 0.253 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.86 144.5 36.97 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.871 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -86.21 -0.22 8.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.159 2.572 . . . . 0.0 113.006 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 60.01 -164.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.391 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -116.83 113.36 22.4 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.788 0.327 . . . . 0.0 110.379 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.74 -175.19 28.39 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.775 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -149.67 157.47 43.27 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 23' ' ' VAL . 12.5 t -76.67 -10.94 59.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.474 0.176 . . . . 0.0 111.474 -177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 22' ' ' THR . 0.9 OUTLIER 66.31 -40.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.433 1.493 . . . . 0.0 113.9 174.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 100.24 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.955 0.407 . . . . 0.0 110.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -178.79 130.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -90.1 -65.3 1.03 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.944 0.402 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -154.33 104.09 2.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.194 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 86.7 mttt -144.09 -49.32 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.568 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 39.0 ttmt 69.81 -53.75 0.61 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.324 0.649 . . . . 0.0 110.412 -170.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.6 m 68.2 82.07 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.589 0.756 . . . . 0.0 111.975 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.8 80.15 2.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -141.54 61.69 1.47 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.486 -1.234 . . . . 0.0 107.862 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 60.2 79.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.196 -167.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -68.24 121.95 17.29 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.024 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.599 ' H ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -130.8 143.61 50.07 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.937 -177.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' ARG . 5.7 Cg_exo -78.78 -37.38 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.525 2.15 . . . . 0.0 112.345 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -151.93 -47.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.888 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 54' ' ' ARG . 9.0 mt -71.12 113.07 7.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.847 0.356 . . . . 0.0 111.628 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.97 100.9 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.252 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.622 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 24.4 ttmt -75.86 110.62 10.45 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.73 159.15 24.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.686 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.629 ' HE ' HG21 ' A' ' 50' ' ' ILE . 65.9 ttt180 -87.02 117.65 25.88 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.389 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -123.74 157.33 30.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.857 0.36 . . . . 0.0 110.767 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.5 139.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.693 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.567 HD12 ' HB ' ' A' ' 49' ' ' THR . 73.6 mt -86.43 153.32 56.02 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.47 -26.17 52.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.933 2.422 . . . . 0.0 112.689 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.31 -21.88 48.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.276 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.72 -1.8 26.05 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.231 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.567 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.4 m -81.41 159.18 24.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.629 HG21 ' HE ' ' A' ' 42' ' ' ARG . 57.5 mt -121.8 133.19 68.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.674 0.273 . . . . 0.0 110.754 -177.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HD2' HD11 ' A' ' 45' ' ' LEU . 63.5 mttm -140.03 164.52 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -121.63 117.63 27.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 71.2 mtm -138.7 165.4 27.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.964 0.411 . . . . 0.0 111.823 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.634 ' HB3' HD22 ' A' ' 38' ' ' LEU . 27.8 mmt180 -76.87 119.56 20.8 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.734 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.619 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 39.4 t -126.64 139.71 50.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 p -77.39 145.81 37.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.438 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 t -55.08 -30.49 59.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.37 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -61.05 -47.39 86.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 55.5 m -72.19 -33.9 68.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.857 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.98 -53.19 60.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.6 -45.67 57.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.589 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 t -69.4 -26.74 64.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.646 0.26 . . . . 0.0 110.997 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.94 48.36 7.8 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.753 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.25 -28.63 22.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.203 0.525 . . . . 0.0 109.671 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.83 171.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 41.1 tptt -69.32 -44.91 70.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.616 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.703 ' HG2' ' H ' ' A' ' 69' ' ' VAL . 85.8 tttt 71.07 135.19 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.771 0.669 . . . . 0.0 111.227 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.63 -15.22 61.72 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 109.968 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.703 ' H ' ' HG2' ' A' ' 67' ' ' LYS . 35.4 t 57.47 78.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.184 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.75 -56.24 1.66 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 167.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -99.99 141.49 32.75 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.736 HG23 ' H ' ' A' ' 73' ' ' SER . 2.5 m -84.38 -75.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.736 ' H ' HG23 ' A' ' 72' ' ' VAL . 10.6 p -99.99 156.23 17.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.608 0.242 . . . . 0.0 110.874 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.46 128.68 36.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.2 126.61 24.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.953 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.52 -27.0 3.01 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.248 0.982 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.12 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.908 0.385 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.63 -44.41 3.03 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.929 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -98.99 93.8 6.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.733 0.301 . . . . 0.0 110.544 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.7 ttt -95.87 70.71 2.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.487 0.66 . . . . 0.0 110.108 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.9 mm -99.02 99.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.531 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 145.89 28.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.765 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.14 71.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.71 50.49 0.8 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.352 0.596 . . . . 0.0 110.554 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.513 ' CD ' ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -80.43 155.29 27.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.738 178.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 48.8 t -60.61 144.68 51.24 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.597 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.05 -8.79 59.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.961 0.41 . . . . 0.0 110.933 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 55' ' ' VAL . 57.6 t -100.3 -62.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 15' ' ' LYS . 42.8 t -91.06 -47.53 7.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.819 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 10' ' ' CYS . . . 112.02 -9.98 27.21 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 13' ' ' CYS . 28.7 mtpp -77.5 162.68 26.96 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.711 -0.288 . . . . 0.0 110.25 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.88 144.33 76.02 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.966 0.413 . . . . 0.0 111.416 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.644 ' HG3' ' HG ' ' A' ' 38' ' ' LEU . 98.2 Cg_endo -89.7 94.88 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.193 2.595 . . . . 0.0 112.178 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -77.6 -28.47 51.55 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.642 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m 57.82 -155.42 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.921 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.64 23.05 30.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.699 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 m120 59.97 61.96 1.76 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m 75.09 145.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.14 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -105.59 170.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t 65.04 -158.49 0.29 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -95.57 -12.55 25.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 110.654 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 p -142.16 -68.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.001 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.73 -58.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.548 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 25.2 ttmm 66.57 -70.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.447 0.699 . . . . 0.0 111.304 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 28' ' ' LYS . 27.1 mmtp -133.76 -52.13 0.86 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.465 0.174 . . . . 0.0 111.149 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t 72.63 -1.82 2.85 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.065 0.853 . . . . 0.0 110.888 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 61.55 102.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.611 0.764 . . . . 0.0 112.083 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 73.27 138.17 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.454 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -90.31 -28.19 18.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.718 0.771 . . . . 0.0 108.957 173.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -85.11 104.83 15.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.493 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 35' ' ' ARG . 29.6 mmt180 61.16 69.98 0.98 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.67 0.607 . . . . 0.0 110.579 -175.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.64 5.43 2.88 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.264 2.643 . . . . 0.0 112.797 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -109.81 -10.16 14.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.634 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 54' ' ' ARG . 22.3 mt -120.02 99.75 6.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.706 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.479 ' NE2' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -89.68 123.19 33.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 15.4 ptmt -72.73 122.52 21.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.782 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 t -114.8 156.2 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.639 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -85.46 106.56 16.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.73 166.78 10.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.462 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.17 136.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.594 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD12 ' HB ' ' A' ' 49' ' ' THR . 79.2 mt -97.42 152.2 38.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.55 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.37 -15.75 50.29 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.0 2.467 . . . . 0.0 112.704 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.16 -15.19 57.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.1 15.36 26.22 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.14 -0.553 . . . . 0.0 111.797 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.542 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -89.34 149.22 23.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.843 0.354 . . . . 0.0 110.247 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -128.05 111.69 25.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.72 149.42 34.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.788 0.328 . . . . 0.0 110.543 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.27 120.95 31.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.44 ' HE3' HG22 ' A' ' 12' ' ' VAL . 65.7 mtm -130.28 149.85 51.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.932 -177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 81.9 mtm180 -76.26 113.35 13.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.421 0.629 . . . . 0.0 110.923 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 17.9 t -105.23 148.62 9.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.089 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.82 148.55 25.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.326 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 m -58.71 -25.59 63.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.38 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -60.53 -40.72 92.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.365 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -74.79 -33.89 62.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.565 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.479 HD11 ' NE2' ' A' ' 39' ' ' GLN . 16.1 mt -56.67 -53.59 55.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 61' ' ' LYS . 21.5 ptmt -81.76 -2.49 50.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -86.8 -32.0 20.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.56 46.92 93.32 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.996 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.86 33.74 3.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.163 0.506 . . . . 0.0 111.213 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.22 149.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.779 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -86.37 102.79 14.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.536 0.684 . . . . 0.0 109.887 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -94.78 146.95 23.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.972 -173.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -107.25 43.85 1.13 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.4 t 67.72 102.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.824 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -161.72 121.37 1.02 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.709 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 68.88 89.26 0.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.406 0.622 . . . . 0.0 111.175 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.17 145.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.662 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.0 m 64.05 75.25 0.39 Allowed 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.406 0.622 . . . . 0.0 110.282 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -83.47 146.49 28.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.86 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.76 100.5 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.0 82.71 1.67 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.958 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.687 179.238 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.31 0.576 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.12 -25.49 55.17 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.471 -175.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -87.64 158.01 18.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -77.2 93.33 3.93 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.839 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -66.0 105.55 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.646 0.736 . . . . 0.0 111.156 -178.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -114.0 147.32 38.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.024 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.72 174.75 7.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -67.53 109.66 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.968 178.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.3 ptm180 -143.77 155.6 44.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.513 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 55' ' ' VAL . 49.8 t -68.4 131.95 46.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.502 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.83 2.93 24.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.219 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 65' ' ' VAL . 49.1 t -102.54 -59.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.809 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 64' ' ' LYS . 72.2 m -101.72 -21.23 14.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.581 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.607 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -79.29 145.83 33.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . . . -78.41 155.46 79.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.516 -176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.732 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 84.6 Cg_endo -78.05 109.33 2.68 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.992 2.462 . . . . 0.0 112.509 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.01 85.9 3.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -100.66 101.75 12.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.351 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.9 -9.27 32.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.698 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -92.03 -28.24 17.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 109.96 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 m 56.94 76.44 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.139 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.86 119.78 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.608 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.6 m -144.98 106.3 4.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 111.232 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -120.73 112.11 18.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.549 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.3 m -136.16 12.79 3.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.47 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 11.7 t70 -173.45 -86.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.014 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 25.0 mmmt -173.78 -52.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 29' ' ' LYS . 28.3 ttpt -78.62 -55.04 5.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.358 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m 54.73 69.19 0.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.408 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -82.98 160.54 21.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 1.014 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 60.1 mtt-85 -118.43 104.97 11.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 111.666 -170.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -125.37 -66.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.83 -13.58 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.734 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.647 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -151.45 86.25 4.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.265 177.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.014 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 2.9 Cg_exo -76.72 -55.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.843 2.362 . . . . 0.0 112.854 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -112.48 -27.42 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.497 0.665 . . . . 0.0 109.487 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.647 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 57.2 mt -86.26 159.77 19.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.609 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HB3' HE21 ' A' ' 39' ' ' GLN . 23.2 mt-30 -123.39 132.38 53.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 171.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -85.41 113.5 21.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.44 167.17 9.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.55 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . 18.0 ptp180 -101.13 120.6 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.299 0.571 . . . . 0.0 110.935 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' LYS . 34.1 m -110.46 167.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.112 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 68' ' ' TYR . 11.9 p -101.65 131.41 49.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.133 -178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -95.0 144.92 28.61 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.665 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 -20.1 57.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.616 2.211 . . . . 0.0 111.58 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.19 -27.15 68.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.524 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.74 44.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -99.77 158.31 15.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.757 0.313 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 42' ' ' ARG . 63.7 mt -105.3 116.38 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -106.14 144.75 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.087 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -110.6 125.84 53.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.116 0.484 . . . . 0.0 110.338 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.41 ' HE2' HG21 ' A' ' 43' ' ' VAL . 72.3 mtm -139.22 163.76 31.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.698 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -84.18 120.45 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.907 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 65' ' ' VAL . 58.5 t -122.87 147.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.706 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.732 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 24.7 p -88.57 155.13 19.81 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.488 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -57.49 -32.71 67.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.039 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 m -65.54 -43.08 91.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.977 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 99.5 m -72.65 -35.58 67.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.664 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.6 -47.01 87.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.614 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.117 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -70.41 -29.41 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.166 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.36 28.32 73.64 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.012 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HD3' ' O ' ' A' ' 64' ' ' LYS . 1.5 tmtp? -82.83 -21.08 34.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.379 0.609 . . . . 0.0 109.783 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 55' ' ' VAL . 35.4 m -61.79 163.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.331 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 31.5 mmtp -78.58 59.75 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.576 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -57.59 140.84 49.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.528 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.519 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p90 -78.11 14.49 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.639 -175.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.0 p 44.36 82.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 112.026 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.7 52.55 0.19 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.692 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 59.33 88.92 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.278 0.561 . . . . 0.0 111.72 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.74 6.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.409 0.623 . . . . 0.0 110.658 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -96.08 108.66 21.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.526 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 66.89 95.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.56 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -134.88 93.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.665 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.82 -92.92 2.17 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.245 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.046 178.739 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.07 -143.72 5.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.373 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -94.1 91.19 6.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.052 0.453 . . . . 0.0 110.721 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 mmt -127.35 -24.41 3.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.175 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.5 mt 69.55 -58.74 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.585 0.553 . . . . 0.0 111.334 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 167.33 11.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.22 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.62 -37.9 0.45 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 58.18 85.16 0.09 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.879 0.737 . . . . 0.0 111.446 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -139.0 165.24 27.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.044 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 55' ' ' VAL . 42.6 t -82.01 143.47 31.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.59 -2.22 25.03 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.68 -67.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 110.855 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.0 p -85.28 -39.41 17.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.777 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 9.97 51.11 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.125 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.59 158.46 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.37 149.53 47.06 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.022 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 65.8 Cg_endo -75.16 110.43 3.11 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.691 2.261 . . . . 0.0 112.299 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -91.67 88.36 6.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.47 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.0 m 65.5 104.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.004 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.02 174.6 39.08 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.834 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -117.05 163.88 15.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.776 0.322 . . . . 0.0 110.263 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -82.93 142.31 31.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 0.0 110.798 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.03 -38.12 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.648 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 p -162.85 -36.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.67 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 72.61 103.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.879 0.737 . . . . 0.0 110.688 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 m -67.93 -62.94 1.17 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.486 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 t70 56.0 26.62 10.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.597 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.961 ' HB3' ' HG2' ' A' ' 31' ' ' GLU . 82.1 tttt -82.84 133.89 35.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.961 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -67.79 -5.33 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.037 0.446 . . . . 0.0 111.511 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.459 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 5.1 m -104.01 3.15 33.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.961 ' HG2' ' HB3' ' A' ' 28' ' ' LYS . 43.0 mm-40 -76.71 126.1 30.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.292 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -76.75 167.24 22.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -54.04 109.84 0.52 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.274 0.559 . . . . 0.0 111.901 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.498 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 36.8 p90 -106.54 -166.38 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.261 -175.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.743 ' HB3' ' HB2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -112.43 86.96 8.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.158 -176.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 34' ' ' PHE . 16.7 Cg_exo -67.55 -55.68 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.796 2.331 . . . . 0.0 113.46 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -89.36 -5.45 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.743 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . 20.6 mt -90.48 109.21 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -77.82 101.57 6.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.497 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 53' ' ' MET . 20.5 pttp -78.82 110.23 13.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 33.5 m -125.01 162.25 27.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.301 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -88.13 120.1 29.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 0.0 110.914 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.53 167.7 16.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.404 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' N ' ' HA ' ' A' ' 68' ' ' TYR . 9.5 p -89.31 138.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.614 0.721 . . . . 0.0 111.063 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.509 HD12 ' HB ' ' A' ' 49' ' ' THR . 88.6 mt -92.52 157.85 39.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.74 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.11 -24.29 39.98 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.724 2.282 . . . . 0.0 112.496 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.95 -19.01 60.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.486 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.71 54.61 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.509 ' HB ' HD12 ' A' ' 45' ' ' LEU . 1.9 m -86.73 158.38 19.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.163 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.14 122.81 66.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HE3' HD11 ' A' ' 45' ' ' LEU . 41.0 ttmt -141.51 147.72 38.24 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' VAL . 60.5 mtm180 -88.0 134.98 33.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.932 0.396 . . . . 0.0 110.982 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 63.0 mtm -138.56 170.61 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.485 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -82.54 110.72 17.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.079 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 49.6 t -115.57 144.72 22.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.927 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 25.5 p -90.79 152.47 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.517 -178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -58.94 -25.42 63.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 m -61.08 -45.43 94.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.031 0.444 . . . . 0.0 110.351 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.4 m -68.71 -34.58 75.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.636 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.02 -45.55 77.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.796 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.59 -7.78 53.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.753 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 t -117.2 -4.12 11.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.866 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.92 62.05 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.118 -175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 64' ' ' LYS . 38.7 tptt -87.64 56.77 4.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.983 0.897 . . . . 0.0 111.08 -171.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 67' ' ' LYS . 5.6 m -143.43 156.84 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 3.14 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.57 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HD3' HG23 ' A' ' 65' ' ' VAL . 3.7 mppt? 57.77 -168.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.911 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.588 ' HA ' ' N ' ' A' ' 44' ' ' VAL . 13.1 p90 -94.83 -12.05 27.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.0 110.956 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.31 -52.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.91 144.36 4.43 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -144.28 148.9 35.44 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.69 -177.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.181 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.0 m 67.52 23.87 8.84 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.507 0.504 . . . . 0.0 111.327 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.37 -33.46 75.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.446 0.641 . . . . 0.0 109.634 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.08 40.4 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.023 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.11 -25.57 69.67 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.063 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.958 177.414 . . . . . . . . 0 0 . 1 stop_ save_